,Assay_Type,AssemblyName,AvgSpotLen,BioProject,BioSample,Center_Name,Consent,DATASTORE_filetype,Experiment,InsertSize,Instrument,LibraryLayout,LibrarySelection,LibrarySource,Library_Name,LoadDate,MBases,MBytes,Platform,RUN,ReleaseDate,Run,SEQUENCING_DATE,SRA_Sample,SRA_Study,Sample_Name,analyte_type,biospecimen_repository_sample_id,body_site,gap_accession,gap_parent_phs,histological_type,is_tumor,sex,study_name,submitted_subject_id,DATASTORE_provider,Organism,biospecimen_repository,study_design,disease,sname,disease_new,age,revised annotation,disease_new2,disease_type,disease_subtype
SRR1286836,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02260581,BCCAGSC,PCR,sra,SRX542522,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31942,2014-05-14,12156,6144,ILLUMINA,137292.0,2014-05-14,SRR1286836,2013-10-23T18:58:14Z,SRS605650,SRP012000,TARGET-20-PASPTM-09A-03R,RNA,TARGET-20-PASPTM-09A-03R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASPTM,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1286836,"Acute Myeloid Leukemia,n=476",14.0328767123287,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1286837,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02260482,BCCAGSC,PCR,sra,SRX542461,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31955,2014-05-14,17843,8538,ILLUMINA,136947.0,2014-05-14,SRR1286837,2013-10-09T21:19:32Z,SRS605621,SRP012000,TARGET-20-PATELT-03A-05R,RNA,TARGET-20-PATELT-03A-05R,Primary Blood Derived Cancer - Peripheral Blood,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PATELT,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute leukemia of Ambiguous Lineage (ALAL),SRR1286837,"Acute Myeloid Leukemia,n=476",12.0575342465753,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1286838,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02260546,BCCAGSC,PCR,sra,SRX542505,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31923,2014-05-14,15818,8207,ILLUMINA,137230.0,2014-05-14,SRR1286838,2013-10-22T18:40:55Z,SRS605620,SRP012000,TARGET-20-PARYFN-03A-01R,RNA,TARGET-20-PARYFN-03A-01R,Primary Blood Derived Cancer - Peripheral Blood,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARYFN,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute leukemia of Ambiguous Lineage (ALAL),SRR1286838,"Acute Myeloid Leukemia,n=476",4.37534246575342,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1286839,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02260457,BCCAGSC,PCR,sra,SRX542499,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31928,2014-05-14,18789,9807,ILLUMINA,137230.0,2014-05-14,SRR1286839,2013-10-22T18:40:55Z,SRS605583,SRP012000,TARGET-20-PAKSMZ-03A-02R,RNA,TARGET-20-PAKSMZ-03A-02R,Primary Blood Derived Cancer - Peripheral Blood,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PAKSMZ,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1286839,"Acute Myeloid Leukemia,n=476",17.2684931506849,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1286840,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02260520,BCCAGSC,PCR,sra,SRX542468,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31998,2014-05-14,16226,7796,ILLUMINA,136945.0,2014-05-14,SRR1286840,2013-10-09T21:14:51Z,SRS605588,SRP012000,TARGET-20-PASPLU-04A-01R,RNA,TARGET-20-PASPLU-04A-01R,Recurrent Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASPLU,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1286840,"Acute Myeloid Leukemia,n=476",9.31232876712328,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1286841,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02260542,BCCAGSC,PCR,sra,SRX542475,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31990,2014-05-14,12380,5971,ILLUMINA,136951.0,2014-05-14,SRR1286841,2013-10-09T21:19:44Z,SRS605846,SRP012000,TARGET-20-PAEFGR-09A-02R,RNA,TARGET-20-PAEFGR-09A-02R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PAEFGR,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute leukemia of Ambiguous Lineage (ALAL),SRR1286841,"Acute Myeloid Leukemia,n=476",1.50410958904109,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1286842,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02260592,BCCAGSC,PCR,sra,SRX542480,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31959,2014-05-14,15083,7733,ILLUMINA,137281.0,2014-05-14,SRR1286842,2013-10-23T18:56:03Z,SRS605622,SRP012000,TARGET-20-PANLIR-09A-02R,RNA,TARGET-20-PANLIR-09A-02R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PANLIR,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute leukemia of Ambiguous Lineage (ALAL),SRR1286842,"Acute Myeloid Leukemia,n=476",16.1232876712328,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1286843,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02260483,BCCAGSC,PCR,sra,SRX542511,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31980,2014-05-14,15779,7479,ILLUMINA,137357.0,2014-05-14,SRR1286843,2013-10-25T18:34:49Z,SRS605844,SRP012000,TARGET-20-PASBPK-09A-02R,RNA,TARGET-20-PASBPK-09A-02R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASBPK,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute leukemia of Ambiguous Lineage (ALAL),SRR1286843,"INFANT_Acute Myeloid Leukemia,n=21",0.441095890410958,AML_INFANT,"INFANT_Acute Myeloid Leukemia,n=21",Acute Myeloid Leukemia,"INFANT,n=21/TARGET"
SRR1286844,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02260627,BCCAGSC,PCR,sra,SRX542483,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31927,2014-05-14,14562,7291,ILLUMINA,137288.0,2014-05-14,SRR1286844,2013-10-23T18:58:05Z,SRS605591,SRP012000,TARGET-20-PAKTCX-09A-02R,RNA,TARGET-20-PAKTCX-09A-02R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PAKTCX,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1286844,"Acute Myeloid Leukemia,n=476",8.93698630136986,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1286845,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02260641,BCCAGSC,PCR,sra,SRX542476,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31951,2014-05-14,18863,9414,ILLUMINA,137288.0,2014-05-14,SRR1286845,2013-10-23T18:58:05Z,SRS605603,SRP012000,TARGET-20-PARXMP-09A-02R,RNA,TARGET-20-PARXMP-09A-02R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARXMP,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1286845,"Acute Myeloid Leukemia,n=476",1.46301369863013,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1286846,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02260458,BCCAGSC,PCR,sra,SRX542506,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31920,2014-05-14,11431,5199,ILLUMINA,136950.0,2014-05-14,SRR1286846,2013-10-09T21:19:41Z,SRS605560,SRP012000,TARGET-20-PASVVS-09A-03R,RNA,TARGET-20-PASVVS-09A-03R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASVVS,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1286846,"INFANT_Acute Myeloid Leukemia, KMT2A rearrangement,n=17",0.775342465753424,AML-KMT2A_INFANT,"INFANT_Acute Myeloid Leukemia, KMT2A rearrangement,n=17",Acute Myeloid Leukemia,"INFANT,KMT2A rearrangement,n=17/TARGET"
SRR1286847,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02260601,BCCAGSC,PCR,sra,SRX542531,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31954,2014-05-14,16023,7950,ILLUMINA,137284.0,2014-05-14,SRR1286847,2013-10-23T18:56:09Z,SRS605635,SRP012000,TARGET-20-PARUDL-03A-01R,RNA,TARGET-20-PARUDL-03A-01R,Primary Blood Derived Cancer - Peripheral Blood,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARUDL,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1286847,"Acute Myeloid Leukemia,n=476",17.6602739726027,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1286848,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02260480,BCCAGSC,PCR,sra,SRX542487,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31926,2014-05-14,19123,9475,ILLUMINA,137352.0,2014-05-14,SRR1286848,2013-10-25T18:30:02Z,SRS605564,SRP012000,TARGET-20-PASGWH-09A-04R,RNA,TARGET-20-PASGWH-09A-04R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASGWH,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1286848,"Acute Myeloid Leukemia,n=476",14.386301369863,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1286849,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02260624,BCCAGSC,PCR,sra,SRX542518,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31935,2014-05-14,16722,8254,ILLUMINA,137348.0,2014-05-14,SRR1286849,2013-10-25T18:29:52Z,SRS605651,SRP012000,TARGET-20-PARYVW-09A-01R,RNA,TARGET-20-PARYVW-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARYVW,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1286849,"Acute Myeloid Leukemia,n=476",1.81917808219178,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1286850,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02260591,BCCAGSC,PCR,sra,SRX542469,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31983,2014-05-14,21096,10141,ILLUMINA,136946.0,2014-05-14,SRR1286850,2013-10-09T21:14:53Z,SRS605637,SRP012000,TARGET-20-PANLLX-09A-01R,RNA,TARGET-20-PANLLX-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PANLLX,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1286850,"Acute Myeloid Leukemia,n=476",12.4904109589041,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1286851,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02260579,BCCAGSC,PCR,sra,SRX542482,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31982,2014-05-14,19662,9809,ILLUMINA,137348.0,2014-05-14,SRR1286851,2013-10-25T18:29:52Z,SRS605659,SRP012000,TARGET-20-PAMYGX-09A-03R,RNA,TARGET-20-PAMYGX-09A-03R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PAMYGX,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute leukemia of Ambiguous Lineage (ALAL),SRR1286851,"Acute Myeloid Leukemia,n=476",3.44931506849315,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1286852,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02260662,BCCAGSC,PCR,sra,SRX542504,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31962,2014-05-14,15604,7823,ILLUMINA,137235.0,2014-05-14,SRR1286852,2013-10-22T18:41:08Z,SRS605599,SRP012000,TARGET-20-PANUTB-09A-05R,RNA,TARGET-20-PANUTB-09A-05R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PANUTB,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1286852,"Acute Myeloid Leukemia,n=476",15.3068493150684,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1286853,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02260559,BCCAGSC,PCR,sra,SRX542520,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31958,2014-05-14,16495,8481,ILLUMINA,137233.0,2014-05-14,SRR1286853,2013-10-22T18:41:03Z,SRS605611,SRP012000,TARGET-20-PANGTF-09A-04R,RNA,TARGET-20-PANGTF-09A-04R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PANGTF,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1286853,"Acute Myeloid Leukemia,n=476",15.9287671232876,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1286854,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02260586,BCCAGSC,PCR,sra,SRX542462,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31963,2014-05-14,17063,8120,ILLUMINA,137350.0,2014-05-14,SRR1286854,2013-10-25T18:29:57Z,SRS605573,SRP012000,TARGET-20-PANYNR-03A-03R,RNA,TARGET-20-PANYNR-03A-03R,Primary Blood Derived Cancer - Peripheral Blood,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PANYNR,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1286854,"Acute Myeloid Leukemia,n=476",9.06849315068493,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1286855,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02047528,BCCAGSC,PCR,sra,SRX542510,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31985,2014-05-14,14471,6686,ILLUMINA,137701.0,2014-05-14,SRR1286855,2013-11-13T22:42:33Z,SRS605609,SRP012000,TARGET-20-PASPLU-09A-02R,RNA,TARGET-20-PASPLU-09A-02R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASPLU,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1286855,"Acute Myeloid Leukemia,n=476",9.31232876712328,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1286856,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02260518,BCCAGSC,PCR,sra,SRX542513,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31977,2014-05-14,14791,7406,ILLUMINA,137229.0,2014-05-14,SRR1286856,2013-10-22T18:40:51Z,SRS605607,SRP012000,TARGET-20-PARWDZ-09A-01R,RNA,TARGET-20-PARWDZ-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARWDZ,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1286856,"Acute Myeloid Leukemia, KMT2A rearrangement,n=60",13.3013698630136,AML-KMT2A,"Acute Myeloid Leukemia, KMT2A rearrangement,n=60",Acute Myeloid Leukemia,"KMT2A rearrangement,n=60/TARGET"
SRR1286857,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02260658,BCCAGSC,PCR,sra,SRX542526,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31973,2014-05-14,13733,7200,ILLUMINA,137232.0,2014-05-14,SRR1286857,2013-10-22T18:41:01Z,SRS605578,SRP012000,TARGET-20-PANNHB-09A-03R,RNA,TARGET-20-PANNHB-09A-03R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PANNHB,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1286857,"Acute Myeloid Leukemia,n=476",4.06027397260274,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1286858,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02260479,BCCAGSC,PCR,sra,SRX542512,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31917,2014-05-14,23042,11698,ILLUMINA,137291.0,2014-05-14,SRR1286858,2013-10-23T18:58:12Z,SRS605634,SRP012000,TARGET-20-PADZCG-09A-02R,RNA,TARGET-20-PADZCG-09A-02R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PADZCG,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1286858,"Acute Myeloid Leukemia,n=476",14.5890410958904,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1286859,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02260455,BCCAGSC,PCR,sra,SRX542500,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31931,2014-05-14,18220,9040,ILLUMINA,137284.0,2014-05-14,SRR1286859,2013-10-23T18:56:09Z,SRS605604,SRP012000,TARGET-20-PARCZL-09A-02R,RNA,TARGET-20-PARCZL-09A-02R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARCZL,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1286859,"Acute Myeloid Leukemia,n=476",10.4273972602739,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1286860,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02260512,BCCAGSC,PCR,sra,SRX542525,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31947,2014-05-14,15989,7799,ILLUMINA,137352.0,2014-05-14,SRR1286860,2013-10-25T18:30:02Z,SRS605858,SRP012000,TARGET-20-PASPGA-09A-02R,RNA,TARGET-20-PASPGA-09A-02R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASPGA,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1286860,"Acute Myeloid Leukemia,n=476",3.25753424657534,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1286861,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02260473,BCCAGSC,PCR,sra,SRX542509,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31938,2014-05-14,16365,8470,ILLUMINA,137231.0,2014-05-14,SRR1286861,2013-10-22T18:40:58Z,SRS605630,SRP012000,TARGET-20-PAEIKD-09A-01R,RNA,TARGET-20-PAEIKD-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PAEIKD,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1286861,"INFANT_Acute Myeloid Leukemia,n=21",0.772602739726027,AML_INFANT,"INFANT_Acute Myeloid Leukemia,n=21",Acute Myeloid Leukemia,"INFANT,n=21/TARGET"
SRR1286862,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02260653,BCCAGSC,PCR,sra,SRX542516,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31966,2014-05-14,18500,8916,ILLUMINA,136951.0,2014-05-14,SRR1286862,2013-10-09T21:19:44Z,SRS605567,SRP012000,TARGET-20-PASFJB-03A-01R,RNA,TARGET-20-PASFJB-03A-01R,Primary Blood Derived Cancer - Peripheral Blood,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASFJB,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1286862,"Acute Myeloid Leukemia,n=476",11.372602739726,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1286864,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02260571,BCCAGSC,PCR,sra,SRX542514,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31993,2014-05-14,18381,8617,ILLUMINA,136949.0,2014-05-14,SRR1286864,2013-10-09T21:19:38Z,SRS605555,SRP012000,TARGET-20-PASTTW-09A-01R,RNA,TARGET-20-PASTTW-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASTTW,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1286864,"Acute Myeloid Leukemia,n=476",2.07397260273972,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1286865,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02047530,BCCAGSC,PCR,sra,SRX542460,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31974,2014-05-14,12005,5922,ILLUMINA,137279.0,2014-05-14,SRR1286865,2013-10-23T18:55:59Z,SRS605647,SRP012000,TARGET-20-PARXBT-09A-02R,RNA,TARGET-20-PARXBT-09A-02R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARXBT,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1286865,"Acute Myeloid Leukemia,n=476",9.26301369863013,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1286866,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02260587,BCCAGSC,PCR,sra,SRX542456,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31911,2014-05-14,12919,6734,ILLUMINA,137283.0,2014-05-14,SRR1286866,2013-10-23T18:56:07Z,SRS605857,SRP012000,TARGET-20-PAKVGI-09A-01R,RNA,TARGET-20-PAKVGI-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PAKVGI,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1286866,"Acute Myeloid Leukemia,n=476",1.76712328767123,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1286867,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02260517,BCCAGSC,PCR,sra,SRX542532,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31999,2014-05-14,19924,10161,ILLUMINA,137281.0,2014-05-14,SRR1286867,2013-10-23T18:56:03Z,SRS605554,SRP012000,TARGET-20-PASINN-04A-02R,RNA,TARGET-20-PASINN-04A-02R,Recurrent Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASINN,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1286867,"Acute Myeloid Leukemia,n=476",3.64383561643835,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1286868,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02260509,BCCAGSC,PCR,sra,SRX542473,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31929,2014-05-14,17006,8654,ILLUMINA,137289.0,2014-05-14,SRR1286868,2013-10-23T18:58:07Z,SRS605571,SRP012000,TARGET-20-PARSHM-03A-02R,RNA,TARGET-20-PARSHM-03A-02R,Primary Blood Derived Cancer - Peripheral Blood,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARSHM,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1286868,"INFANT_Acute Myeloid Leukemia,n=21",0.980821917808219,AML_INFANT,"INFANT_Acute Myeloid Leukemia,n=21",Acute Myeloid Leukemia,"INFANT,n=21/TARGET"
SRR1286869,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02260456,BCCAGSC,PCR,sra,SRX542478,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31979,2014-05-14,12849,6449,ILLUMINA,137280.0,2014-05-14,SRR1286869,2013-10-23T18:56:01Z,SRS605563,SRP012000,TARGET-20-PARVAI-03A-02R,RNA,TARGET-20-PARVAI-03A-02R,Primary Blood Derived Cancer - Peripheral Blood,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARVAI,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1286869,"Acute Myeloid Leukemia,n=476",16.717808219178,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1286870,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02260490,BCCAGSC,PCR,sra,SRX542521,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31957,2014-05-14,21112,10437,ILLUMINA,137292.0,2014-05-14,SRR1286870,2013-10-23T18:58:14Z,SRS605600,SRP012000,TARGET-20-PANDIX-09A-03R,RNA,TARGET-20-PANDIX-09A-03R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PANDIX,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1286870,"Acute Myeloid Leukemia,n=476",18.0082191780821,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1286871,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02260645,BCCAGSC,PCR,sra,SRX542471,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31965,2014-05-14,19639,9632,ILLUMINA,137349.0,2014-05-14,SRR1286871,2013-10-25T18:29:54Z,SRS605656,SRP012000,TARGET-20-PASXYG-09A-05R,RNA,TARGET-20-PASXYG-09A-05R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASXYG,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1286871,"Acute Myeloid Leukemia,n=476",11.2410958904109,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1286872,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02260489,BCCAGSC,PCR,sra,SRX542533,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31924,2014-05-14,19657,10072,ILLUMINA,137278.0,2014-05-14,SRR1286872,2013-10-23T18:55:56Z,SRS605587,SRP012000,TARGET-20-PASCGR-03A-02R,RNA,TARGET-20-PASCGR-03A-02R,Primary Blood Derived Cancer - Peripheral Blood,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASCGR,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1286872,"Acute Myeloid Leukemia, KMT2A rearrangement,n=60",18.2465753424657,AML-KMT2A,"Acute Myeloid Leukemia, KMT2A rearrangement,n=60",Acute Myeloid Leukemia,"KMT2A rearrangement,n=60/TARGET"
SRR1286873,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02260459,BCCAGSC,PCR,sra,SRX542467,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31992,2014-05-14,20297,10099,ILLUMINA,137279.0,2014-05-14,SRR1286873,2013-10-23T18:55:59Z,SRS605645,SRP012000,TARGET-20-PARPDS-09A-01R,RNA,TARGET-20-PARPDS-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARPDS,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1286873,"Acute Myeloid Leukemia,n=476",10.3397260273972,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1286874,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02260663,BCCAGSC,PCR,sra,SRX542474,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31918,2014-05-14,10690,5621,ILLUMINA,137290.0,2014-05-14,SRR1286874,2013-10-23T18:58:09Z,SRS605614,SRP012000,TARGET-20-PAEFGT-03A-01R,RNA,TARGET-20-PAEFGT-03A-01R,Primary Blood Derived Cancer - Peripheral Blood,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PAEFGT,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute leukemia of Ambiguous Lineage (ALAL),SRR1286874,"Acute Myeloid Leukemia,n=476",14.9369863013698,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1286875,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02260599,BCCAGSC,PCR,sra,SRX542529,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31989,2014-05-14,14292,7492,ILLUMINA,137282.0,2014-05-14,SRR1286875,2013-10-23T18:56:05Z,SRS605596,SRP012000,TARGET-20-PASCFW-09A-01R,RNA,TARGET-20-PASCFW-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASCFW,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1286875,"Acute Myeloid Leukemia,n=476",2.00821917808219,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1286876,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02260574,BCCAGSC,PCR,sra,SRX542488,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31933,2014-05-14,18313,8401,ILLUMINA,137356.0,2014-05-14,SRR1286876,2013-10-25T18:34:47Z,SRS605598,SRP012000,TARGET-20-PARIHK-03A-03R,RNA,TARGET-20-PARIHK-03A-03R,Primary Blood Derived Cancer - Peripheral Blood,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARIHK,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1286876,"Acute Myeloid Leukemia,n=476",10.4931506849315,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1286879,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02260636,BCCAGSC,PCR,sra,SRX542477,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31994,2014-05-14,14796,7294,ILLUMINA,137349.0,2014-05-14,SRR1286879,2013-10-25T18:29:54Z,SRS605577,SRP012000,TARGET-20-PARYGA-09A-03R,RNA,TARGET-20-PARYGA-09A-03R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARYGA,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1286879,"Acute Myeloid Leukemia,n=476",16.2082191780821,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1286880,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02260565,BCCAGSC,PCR,sra,SRX542495,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31976,2014-05-14,12593,6410,ILLUMINA,137291.0,2014-05-14,SRR1286880,2013-10-23T18:58:12Z,SRS605556,SRP012000,TARGET-20-PASWPD-09A-02R,RNA,TARGET-20-PASWPD-09A-02R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASWPD,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1286880,"Acute Myeloid Leukemia,n=476",3.98356164383561,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1286881,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02260618,BCCAGSC,PCR,sra,SRX542536,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31934,2014-05-14,14482,7006,ILLUMINA,136946.0,2014-05-14,SRR1286881,2013-10-09T21:14:53Z,SRS605662,SRP012000,TARGET-20-PAEERJ-09A-01R,RNA,TARGET-20-PAEERJ-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PAEERJ,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute leukemia of Ambiguous Lineage (ALAL),SRR1286881,"Acute Myeloid Leukemia,n=476",13.9232876712328,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1286882,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02260655,BCCAGSC,PCR,sra,SRX542484,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31937,2014-05-14,17506,7905,ILLUMINA,136948.0,2014-05-14,SRR1286882,2013-10-09T21:19:35Z,SRS605605,SRP012000,TARGET-20-PAKERZ-09A-01R,RNA,TARGET-20-PAKERZ-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PAKERZ,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1286882,"Acute Myeloid Leukemia,n=476",2.8,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1286883,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02260532,BCCAGSC,PCR,sra,SRX542492,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31971,2014-05-14,17521,8829,ILLUMINA,137286.0,2014-05-14,SRR1286883,2013-10-23T18:58:01Z,SRS605851,SRP012000,TARGET-20-PANPLS-03A-04R,RNA,TARGET-20-PANPLS-03A-04R,Primary Blood Derived Cancer - Peripheral Blood,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PANPLS,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1286883,"Acute Myeloid Leukemia,n=476",1.92602739726027,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1286884,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02260630,BCCAGSC,PCR,sra,SRX542486,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31910,2014-05-14,24921,13094,ILLUMINA,137290.0,2014-05-14,SRR1286884,2013-10-23T18:58:09Z,SRS605847,SRP012000,TARGET-20-PANCSC-09A-03R,RNA,TARGET-20-PANCSC-09A-03R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PANCSC,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute leukemia of Ambiguous Lineage (ALAL),SRR1286884,"Acute Myeloid Leukemia,n=476",10.6575342465753,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1286885,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02260647,BCCAGSC,PCR,sra,SRX542534,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31978,2014-05-14,13018,6001,ILLUMINA,137356.0,2014-05-14,SRR1286885,2013-10-25T18:34:47Z,SRS605856,SRP012000,TARGET-20-PASBHI-09A-01R,RNA,TARGET-20-PASBHI-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASBHI,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1286885,"Acute Myeloid Leukemia,n=476",6.03013698630137,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1286886,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02260661,BCCAGSC,PCR,sra,SRX542530,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31936,2014-05-14,18595,9255,ILLUMINA,137229.0,2014-05-14,SRR1286886,2013-10-22T18:40:51Z,SRS605617,SRP012000,TARGET-20-PASTUH-03A-01R,RNA,TARGET-20-PASTUH-03A-01R,Primary Blood Derived Cancer - Peripheral Blood,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASTUH,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute leukemia of Ambiguous Lineage (ALAL),SRR1286886,"Acute Myeloid Leukemia, KMT2A rearrangement,n=60",14.5342465753424,AML-KMT2A,"Acute Myeloid Leukemia, KMT2A rearrangement,n=60",Acute Myeloid Leukemia,"KMT2A rearrangement,n=60/TARGET"
SRR1286887,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02260463,BCCAGSC,PCR,sra,SRX542457,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31946,2014-05-14,16785,7442,ILLUMINA,136950.0,2014-05-14,SRR1286887,2013-10-09T21:19:41Z,SRS605569,SRP012000,TARGET-20-PASJTM-09A-01R,RNA,TARGET-20-PASJTM-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASJTM,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1286887,"Acute Myeloid Leukemia,n=476",2.46849315068493,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1286888,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02260554,BCCAGSC,PCR,sra,SRX542490,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31991,2014-05-14,12688,5827,ILLUMINA,136948.0,2014-05-14,SRR1286888,2013-10-09T21:19:35Z,SRS605561,SRP012000,TARGET-20-PARSAN-03A-01R,RNA,TARGET-20-PARSAN-03A-01R,Primary Blood Derived Cancer - Peripheral Blood,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARSAN,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1286888,"Acute Myeloid Leukemia,n=476",14.8493150684931,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1286889,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02260513,BCCAGSC,PCR,sra,SRX542481,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31972,2014-05-14,16709,8206,ILLUMINA,137234.0,2014-05-14,SRR1286889,2013-10-22T18:41:06Z,SRS605654,SRP012000,TARGET-20-PANLXM-09A-03R,RNA,TARGET-20-PANLXM-09A-03R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PANLXM,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1286889,"Acute Myeloid Leukemia,n=476",10.2684931506849,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1286890,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02260508,BCCAGSC,PCR,sra,SRX542501,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31941,2014-05-14,13255,6598,ILLUMINA,137351.0,2014-05-14,SRR1286890,2013-10-25T18:29:59Z,SRS605612,SRP012000,TARGET-20-PARUBT-09A-02R,RNA,TARGET-20-PARUBT-09A-02R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARUBT,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1286890,"Acute Myeloid Leukemia,n=476",7.37534246575342,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1286891,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02260523,BCCAGSC,PCR,sra,SRX542535,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31921,2014-05-14,14890,7639,ILLUMINA,137278.0,2014-05-14,SRR1286891,2013-10-23T18:55:56Z,SRS605565,SRP012000,TARGET-20-PARDMG-09A-03R,RNA,TARGET-20-PARDMG-09A-03R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARDMG,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1286891,"Acute Myeloid Leukemia,n=476",17.904109589041,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1286892,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02260570,BCCAGSC,PCR,sra,SRX542459,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31987,2016-06-25,21402,10204,ILLUMINA,137351.0,2014-05-14,SRR1286892,2013-10-25T18:29:59Z,SRS605646,SRP012000,TARGET-20-PARCCH-03A-03R,RNA,TARGET-20-PARCCH-03A-03R,Primary Blood Derived Cancer - Peripheral Blood,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARCCH,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1286892,"INFANT_Acute Myeloid Leukemia,n=21",0.928767123287671,AML_INFANT,"INFANT_Acute Myeloid Leukemia,n=21",Acute Myeloid Leukemia,"INFANT,n=21/TARGET"
SRR1286893,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02260496,BCCAGSC,PCR,sra,SRX542493,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31995,2014-05-14,17832,8920,ILLUMINA,137235.0,2014-05-14,SRR1286893,2013-10-22T18:41:08Z,SRS605610,SRP012000,TARGET-20-PARCVS-04A-01R,RNA,TARGET-20-PARCVS-04A-01R,Recurrent Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARCVS,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1286893,"Acute Myeloid Leukemia,n=476",15.3424657534246,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1286894,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02260557,BCCAGSC,PCR,sra,SRX542470,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31930,2014-05-14,19721,10051,ILLUMINA,137237.0,2014-05-14,SRR1286894,2013-10-22T18:41:24Z,SRS605863,SRP012000,TARGET-20-PANLIZ-09A-03R,RNA,TARGET-20-PANLIZ-09A-03R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PANLIZ,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1286894,"Acute Myeloid Leukemia,n=476",8.4986301369863,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1286895,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02260643,BCCAGSC,PCR,sra,SRX542528,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31948,2014-05-14,14659,6926,ILLUMINA,136949.0,2014-05-14,SRR1286895,2013-10-09T21:19:38Z,SRS605862,SRP012000,TARGET-20-PANHYK-09A-01R,RNA,TARGET-20-PANHYK-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PANHYK,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1286895,"Acute Myeloid Leukemia,n=476",6.00273972602739,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1286896,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02260503,BCCAGSC,PCR,sra,SRX542524,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31996,2014-05-14,16949,8085,ILLUMINA,136947.0,2014-05-14,SRR1286896,2013-10-09T21:19:32Z,SRS605661,SRP012000,TARGET-20-PASGZS-04A-01R,RNA,TARGET-20-PASGZS-04A-01R,Recurrent Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASGZS,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute leukemia of Ambiguous Lineage (ALAL),SRR1286896,"Acute Myeloid Leukemia, KMT2A rearrangement,n=60",1.22191780821917,AML-KMT2A,"Acute Myeloid Leukemia, KMT2A rearrangement,n=60",Acute Myeloid Leukemia,"KMT2A rearrangement,n=60/TARGET"
SRR1286897,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02260611,BCCAGSC,PCR,sra,SRX542515,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31964,2014-05-14,20237,10626,ILLUMINA,137282.0,2014-05-14,SRR1286897,2013-10-23T18:56:05Z,SRS605566,SRP012000,TARGET-20-PAPBEJ-09A-03R,RNA,TARGET-20-PAPBEJ-09A-03R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PAPBEJ,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1286897,"Acute Myeloid Leukemia,n=476",1.00547945205479,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1286898,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN01778083,BCCAGSC,PCR,sra,SRX542527,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31988,2014-05-14,17785,9176,ILLUMINA,137233.0,2014-05-14,SRR1286898,2013-10-22T18:41:03Z,SRS605613,SRP012000,TARGET-20-PARXNG-09A-01R,RNA,TARGET-20-PARXNG-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARXNG,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1286898,"Acute Myeloid Leukemia,n=476",10.1013698630136,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1286899,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02260590,BCCAGSC,PCR,sra,SRX542455,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31956,2014-05-14,19470,9404,ILLUMINA,136945.0,2014-05-14,SRR1286899,2013-10-09T21:14:51Z,SRS605585,SRP012000,TARGET-20-PARZUU-09A-04R,RNA,TARGET-20-PARZUU-09A-04R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARZUU,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1286899,"Acute Myeloid Leukemia,n=476",8.96712328767123,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1286901,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02260634,BCCAGSC,PCR,sra,SRX542502,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31981,2014-05-14,15638,7203,ILLUMINA,137701.0,2014-05-14,SRR1286901,2013-11-13T22:42:33Z,SRS605616,SRP012000,TARGET-20-PARKCX-09A-03R,RNA,TARGET-20-PARKCX-09A-03R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARKCX,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute leukemia of Ambiguous Lineage (ALAL),SRR1286901,"INFANT_Acute Myeloid Leukemia, KMT2A rearrangement,n=17",0.8,AML-KMT2A_INFANT,"INFANT_Acute Myeloid Leukemia, KMT2A rearrangement,n=17",Acute Myeloid Leukemia,"INFANT,KMT2A rearrangement,n=17/TARGET"
SRR1286902,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02260504,BCCAGSC,PCR,sra,SRX542472,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31932,2014-05-14,17135,8208,ILLUMINA,137357.0,2014-05-14,SRR1286902,2013-10-25T18:34:49Z,SRS605589,SRP012000,TARGET-20-PARUNX-09A-04R,RNA,TARGET-20-PARUNX-09A-04R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARUNX,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1286902,"Acute Myeloid Leukemia,n=476",6.35890410958904,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1286903,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02260468,BCCAGSC,PCR,sra,SRX542479,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31915,2014-05-14,18554,9600,ILLUMINA,137231.0,2014-05-14,SRR1286903,2013-10-22T18:40:58Z,SRS605845,SRP012000,TARGET-20-PAKIWK-09A-01R,RNA,TARGET-20-PAKIWK-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PAKIWK,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute leukemia of Ambiguous Lineage (ALAL),SRR1286903,"Acute Myeloid Leukemia,n=476",3.41917808219178,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1286904,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02260481,BCCAGSC,PCR,sra,SRX542464,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31986,2014-05-14,19096,9703,ILLUMINA,137287.0,2014-05-14,SRR1286904,2013-10-23T18:58:03Z,SRS605852,SRP012000,TARGET-20-PASIBG-09A-01R,RNA,TARGET-20-PASIBG-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASIBG,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1286904,"Acute Myeloid Leukemia,n=476",2.04931506849315,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1286905,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02260622,BCCAGSC,PCR,sra,SRX542491,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31912,2014-05-14,18175,8927,ILLUMINA,137277.0,2014-05-14,SRR1286905,2013-10-23T18:55:54Z,SRS605644,SRP012000,TARGET-20-PAPXRJ-09A-01R,RNA,TARGET-20-PAPXRJ-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PAPXRJ,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1286905,"Acute Myeloid Leukemia,n=476",7.82191780821917,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1286906,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02443325,BCCAGSC,PCR,sra,SRX542519,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A34410,2014-05-14,14707,7603,ILLUMINA,138618.0,2014-05-14,SRR1286906,2013-12-31T21:26:52Z,SRS606818,SRP012000,TARGET-20-PABLDZ-09A-04R,RNA,TARGET-20-PABLDZ-09A-04R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PABLDZ,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute leukemia of Ambiguous Lineage (ALAL),SRR1286906,"Acute Myeloid Leukemia,n=476",6.72602739726027,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1286907,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02260484,BCCAGSC,PCR,sra,SRX542497,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31984,2014-05-14,20696,10671,ILLUMINA,137283.0,2014-05-14,SRR1286907,2013-10-23T18:56:07Z,SRS605572,SRP012000,TARGET-20-PANYSN-03A-04R,RNA,TARGET-20-PANYSN-03A-04R,Primary Blood Derived Cancer - Peripheral Blood,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PANYSN,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1286907,"Acute Myeloid Leukemia,n=476",17.7260273972602,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1286908,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02260529,BCCAGSC,PCR,sra,SRX542463,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31940,2014-05-14,21844,11352,ILLUMINA,137232.0,2014-05-14,SRR1286908,2013-10-22T18:41:01Z,SRS605653,SRP012000,TARGET-20-PADYIR-09A-01R,RNA,TARGET-20-PADYIR-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PADYIR,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1286908,"Acute Myeloid Leukemia,n=476",3.17534246575342,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1286909,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02260654,BCCAGSC,PCR,sra,SRX542523,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31953,2014-05-14,15022,7436,ILLUMINA,137285.0,2014-05-14,SRR1286909,2013-10-23T18:57:58Z,SRS605586,SRP012000,TARGET-20-PARIZR-03A-02R,RNA,TARGET-20-PARIZR-03A-02R,Primary Blood Derived Cancer - Peripheral Blood,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARIZR,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1286909,"Acute Myeloid Leukemia,n=476",7.38356164383561,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1286910,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02260644,BCCAGSC,PCR,sra,SRX542498,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31968,2014-05-14,15209,7841,ILLUMINA,137237.0,2014-05-14,SRR1286910,2013-10-22T18:41:24Z,SRS605568,SRP012000,TARGET-20-PAKIYW-09A-01R,RNA,TARGET-20-PAKIYW-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PAKIYW,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1286910,"INFANT_Acute Myeloid Leukemia, KMT2A rearrangement,n=17",0.446575342465753,AML-KMT2A_INFANT,"INFANT_Acute Myeloid Leukemia, KMT2A rearrangement,n=17",Acute Myeloid Leukemia,"INFANT,KMT2A rearrangement,n=17/TARGET"
SRR1286911,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02260469,BCCAGSC,PCR,sra,SRX542503,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31922,2014-05-14,17251,8553,ILLUMINA,137285.0,2014-05-14,SRR1286911,2013-10-23T18:57:58Z,SRS605649,SRP012000,TARGET-20-PARTAL-09A-02R,RNA,TARGET-20-PARTAL-09A-02R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARTAL,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1286911,"Acute Myeloid Leukemia,n=476",16.4383561643835,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1286912,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02260637,BCCAGSC,PCR,sra,SRX542466,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31975,2014-05-14,15504,7678,ILLUMINA,137234.0,2014-05-14,SRR1286912,2013-10-22T18:41:06Z,SRS605576,SRP012000,TARGET-20-PASFEW-09A-05R,RNA,TARGET-20-PASFEW-09A-05R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASFEW,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1286912,"Acute Myeloid Leukemia,n=476",1.17260273972602,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1286913,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02260465,BCCAGSC,PCR,sra,SRX542508,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32000,2014-05-14,14588,7196,ILLUMINA,137277.0,2014-05-14,SRR1286913,2013-10-23T18:55:54Z,SRS605601,SRP012000,TARGET-20-PASXNR-04A-01R,RNA,TARGET-20-PASXNR-04A-01R,Recurrent Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASXNR,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1286913,"Acute Myeloid Leukemia,n=476",2.43835616438356,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1286914,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02260522,BCCAGSC,PCR,sra,SRX542489,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31939,2014-05-14,22096,11020,ILLUMINA,137280.0,2014-05-14,SRR1286914,2013-10-23T18:56:01Z,SRS605597,SRP012000,TARGET-20-PAECCE-09A-01R,RNA,TARGET-20-PAECCE-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PAECCE,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1286914,"Acute Myeloid Leukemia,n=476",2.46575342465753,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1286915,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02260553,BCCAGSC,PCR,sra,SRX542458,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31952,2014-05-14,15493,7830,ILLUMINA,137287.0,2014-05-14,SRR1286915,2013-10-23T18:58:03Z,SRS605606,SRP012000,TARGET-20-PARIMT-03A-01R,RNA,TARGET-20-PARIMT-03A-01R,Primary Blood Derived Cancer - Peripheral Blood,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARIMT,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1286915,"Acute Myeloid Leukemia,n=476",7.52876712328767,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1286916,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02260609,BCCAGSC,PCR,sra,SRX542485,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31967,2014-05-14,16105,7714,ILLUMINA,137350.0,2014-05-14,SRR1286916,2013-10-25T18:29:57Z,SRS605861,SRP012000,TARGET-20-PANPKN-09A-03R,RNA,TARGET-20-PANPKN-09A-03R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PANPKN,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1286916,"INFANT_Acute Myeloid Leukemia, KMT2A rearrangement,n=17",0.983561643835616,AML-KMT2A_INFANT,"INFANT_Acute Myeloid Leukemia, KMT2A rearrangement,n=17",Acute Myeloid Leukemia,"INFANT,KMT2A rearrangement,n=17/TARGET"
SRR1286917,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02260506,BCCAGSC,PCR,sra,SRX542517,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31997,2014-05-14,18189,9265,ILLUMINA,137289.0,2014-05-14,SRR1286917,2013-10-23T18:58:07Z,SRS605558,SRP012000,TARGET-20-PAPXRJ-04A-02R,RNA,TARGET-20-PAPXRJ-04A-02R,Recurrent Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PAPXRJ,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1286917,"Acute Myeloid Leukemia,n=476",7.82191780821917,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1286918,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02260664,BCCAGSC,PCR,sra,SRX542454,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31919,2014-05-14,16554,8324,ILLUMINA,137286.0,2014-05-14,SRR1286918,2013-10-23T18:58:01Z,SRS605625,SRP012000,TARGET-20-PASMHY-03A-03R,RNA,TARGET-20-PASMHY-03A-03R,Primary Blood Derived Cancer - Peripheral Blood,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASMHY,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute leukemia of Ambiguous Lineage (ALAL),SRR1286918,"Acute Myeloid Leukemia,n=476",19.1205479452054,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1288006,RNA-Seq,GCA_000001405.13,150,PRJNA89529,SAMN02385794,BCCAGSC,PCR,sra,SRX543413,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32692,2014-05-15,17858,8750,ILLUMINA,137855.0,2014-05-15,SRR1288006,2013-11-19T21:01:54Z,SRS602112,SRP011999,TARGET-10-PANKDT-03A-01R,RNA,TARGET-10-PANKDT-03A-01R,Primary Blood Derived Cancer - Peripheral Blood,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PANKDT,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1288006,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",10.0794520547945,BALL-NOS,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",B-cell Acute Lymphoblastic Leukemia,"NOS,n=71/TARGET"
SRR1288009,RNA-Seq,GCA_000001405.13,150,PRJNA89529,SAMN02385914,BCCAGSC,PCR,sra,SRX543395,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32651,2014-05-15,8440,3710,ILLUMINA,137867.0,2014-05-15,SRR1288009,2013-11-19T22:48:50Z,SRS602034,SRP011999,TARGET-10-PANCVR-03A-01R,RNA,TARGET-10-PANCVR-03A-01R,Primary Blood Derived Cancer - Peripheral Blood,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PANCVR,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Induction Failure AML (AML-IF),SRR1288009,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",6.38082191780821,BALL-NOS,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",B-cell Acute Lymphoblastic Leukemia,"NOS,n=71/TARGET"
SRR1288012,RNA-Seq,GCA_000001405.13,150,PRJNA89529,SAMN02385826,BCCAGSC,PCR,sra,SRX543464,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32624,2014-05-15,11972,5263,ILLUMINA,137951.0,2014-05-15,SRR1288012,2013-11-26T22:01:56Z,SRS602086,SRP011999,TARGET-10-PARIAD-03A-01R,RNA,TARGET-10-PARIAD-03A-01R,Primary Blood Derived Cancer - Peripheral Blood,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PARIAD,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1288012,"B-cell Acute Lymphoblastic Leukemia, TCF3-PBX1,n=11",1.63287671232876,BALL-TCF3PBX1,"B-cell Acute Lymphoblastic Leukemia, TCF3-PBX1,n=11",B-cell Acute Lymphoblastic Leukemia,"TCF3-PBX1,n=11/TARGET"
SRR1288014,RNA-Seq,GCA_000001405.13,150,PRJNA89529,SAMN02386017,BCCAGSC,PCR,sra,SRX543468,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32695,2014-05-15,14578,6591,ILLUMINA,137852.0,2014-05-15,SRR1288014,2013-11-19T21:01:44Z,SRS602107,SRP011999,TARGET-10-PANPJI-09A-01R,RNA,TARGET-10-PANPJI-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PANPJI,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1288014,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",17.1780821917808,BALL-NOS,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",B-cell Acute Lymphoblastic Leukemia,"NOS,n=71/TARGET"
SRR1288022,RNA-Seq,GCA_000001405.13,150,PRJNA89529,SAMN02385838,BCCAGSC,PCR,sra,SRX543425,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32667,2014-05-15,10939,4981,ILLUMINA,137974.0,2014-05-15,SRR1288022,2013-11-26T22:08:59Z,SRS602063,SRP011999,TARGET-10-PAPIRZ-09A-01R,RNA,TARGET-10-PAPIRZ-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PAPIRZ,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1288022,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",13.4027397260273,BALL-NOS,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",B-cell Acute Lymphoblastic Leukemia,"NOS,n=71/TARGET"
SRR1288043,RNA-Seq,GCA_000001405.13,150,PRJNA89529,SAMN02385944,BCCAGSC,PCR,sra,SRX543397,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32669,2014-05-15,16224,7410,ILLUMINA,137928.0,2014-05-15,SRR1288043,2013-11-22T21:46:10Z,SRS602098,SRP011999,TARGET-10-PAPJHR-09A-01R,RNA,TARGET-10-PAPJHR-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PAPJHR,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1288043,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",11.0027397260273,BALL-NOS,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",B-cell Acute Lymphoblastic Leukemia,"NOS,n=71/TARGET"
SRR1288046,RNA-Seq,GCA_000001405.13,150,PRJNA89529,SAMN02386039,BCCAGSC,PCR,sra,SRX543417,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32687,2014-05-15,16534,7907,ILLUMINA,137999.0,2014-05-15,SRR1288046,2013-11-27T21:55:00Z,SRS602094,SRP011999,TARGET-10-PARSZH-09A-01R,RNA,TARGET-10-PARSZH-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PARSZH,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1288046,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",12.9287671232876,BALL-NOS,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",B-cell Acute Lymphoblastic Leukemia,"NOS,n=71/TARGET"
SRR1288050,RNA-Seq,GCA_000001405.13,150,PRJNA89529,SAMN02385788,BCCAGSC,PCR,sra,SRX543404,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32691,2014-05-15,11959,5419,ILLUMINA,137852.0,2014-05-15,SRR1288050,2013-11-19T21:01:44Z,SRS602130,SRP011999,TARGET-10-PANJPG-09A-01R,RNA,TARGET-10-PANJPG-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PANJPG,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1288050,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",13.1780821917808,BALL-NOS,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",B-cell Acute Lymphoblastic Leukemia,"NOS,n=71/TARGET"
SRR1288053,RNA-Seq,GCA_000001405.13,150,PRJNA89529,SAMN02385902,BCCAGSC,PCR,sra,SRX543402,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32690,2014-05-15,12906,5687,ILLUMINA,137972.0,2014-05-15,SRR1288053,2013-11-26T22:08:54Z,SRS602167,SRP011999,TARGET-10-PAMXSP-09A-01R,RNA,TARGET-10-PAMXSP-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PAMXSP,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1288053,"B-cell Acute Lymphoblastic Leukemia, Hyperdiploidy,n=20",3.35068493150684,BALL-hyperdiploid,"B-cell Acute Lymphoblastic Leukemia, Hyperdiploidy,n=20",B-cell Acute Lymphoblastic Leukemia,"Hyperdiploidy,n=20/TARGET"
SRR1288057,RNA-Seq,GCA_000001405.13,150,PRJNA89529,SAMN02386119,BCCAGSC,PCR,sra,SRX543460,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32672,2014-05-15,15364,6623,ILLUMINA,137967.0,2014-05-15,SRR1288057,2013-11-26T22:08:41Z,SRS602081,SRP011999,TARGET-10-PAPLDL-03A-01R,RNA,TARGET-10-PAPLDL-03A-01R,Primary Blood Derived Cancer - Peripheral Blood,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PAPLDL,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1288057,"B-cell Acute Lymphoblastic Leukemia, iAMP21,n=1",7.33424657534246,BALL-iAMP21,"B-cell Acute Lymphoblastic Leukemia, iAMP21,n=1",B-cell Acute Lymphoblastic Leukemia,"iAMP21,n=1/TARGET"
SRR1288059,RNA-Seq,GCA_000001405.13,150,PRJNA89529,SAMN02385922,BCCAGSC,PCR,sra,SRX543447,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32693,2014-05-15,7014,3282,ILLUMINA,137931.0,2014-05-15,SRR1288059,2013-11-22T21:46:17Z,SRS602147,SRP011999,TARGET-10-PANKGK-09A-01R,RNA,TARGET-10-PANKGK-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PANKGK,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1288059,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",12.7534246575342,BALL-NOS,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",B-cell Acute Lymphoblastic Leukemia,"NOS,n=71/TARGET"
SRR1288060,RNA-Seq,GCA_000001405.13,150,PRJNA89529,SAMN02386026,BCCAGSC,PCR,sra,SRX543393,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32684,2014-05-15,9595,4728,ILLUMINA,137853.0,2014-05-15,SRR1288060,2013-11-19T21:01:48Z,SRS602043,SRP011999,TARGET-10-PARPNM-09A-01R,RNA,TARGET-10-PARPNM-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PARPNM,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Induction Failure AML (AML-IF),SRR1288060,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",13.5369863013698,BALL-NOS,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",B-cell Acute Lymphoblastic Leukemia,"NOS,n=71/TARGET"
SRR1288062,RNA-Seq,GCA_000001405.13,150,PRJNA89529,SAMN02385848,BCCAGSC,PCR,sra,SRX543465,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32656,2014-05-15,13767,6137,ILLUMINA,137969.0,2014-05-15,SRR1288062,2013-11-26T22:08:46Z,SRS602101,SRP011999,TARGET-10-PANUSN-03A-01R,RNA,TARGET-10-PANUSN-03A-01R,Primary Blood Derived Cancer - Peripheral Blood,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PANUSN,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1288062,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",2.85753424657534,BALL-NOS,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",B-cell Acute Lymphoblastic Leukemia,"NOS,n=71/TARGET"
SRR1288063,RNA-Seq,GCA_000001405.13,150,PRJNA89529,SAMN02386143,BCCAGSC,PCR,sra,SRX543394,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32694,2016-05-26,22193,10522,ILLUMINA,137865.0,2014-05-15,SRR1288063,2013-11-19T22:48:41Z,SRS602164,SRP011999,TARGET-10-PANLIC-09A-01R,RNA,TARGET-10-PANLIC-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PANLIC,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1288063,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",14.8520547945205,BALL-NOS,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",B-cell Acute Lymphoblastic Leukemia,"NOS,n=71/TARGET"
SRR1288067,RNA-Seq,GCA_000001405.13,150,PRJNA89529,SAMN02386001,BCCAGSC,PCR,sra,SRX543454,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32631,2014-05-15,17362,8033,ILLUMINA,137929.0,2014-05-15,SRR1288067,2013-11-22T21:46:12Z,SRS602088,SRP011999,TARGET-10-PARMXF-03A-01R,RNA,TARGET-10-PARMXF-03A-01R,Primary Blood Derived Cancer - Peripheral Blood,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PARMXF,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1288067,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",4.01095890410958,BALL-NOS,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",B-cell Acute Lymphoblastic Leukemia,"NOS,n=71/TARGET"
SRR1288070,RNA-Seq,GCA_000001405.13,150,PRJNA89529,SAMN02385805,BCCAGSC,PCR,sra,SRX543408,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32621,2014-05-15,17755,8669,ILLUMINA,137933.0,2014-05-15,SRR1288070,2013-11-22T21:46:21Z,SRS602027,SRP011999,TARGET-10-PARDWE-03A-01R,RNA,TARGET-10-PARDWE-03A-01R,Primary Blood Derived Cancer - Peripheral Blood,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PARDWE,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Induction Failure AML (AML-IF),SRR1288070,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",18.3150684931506,BALL-NOS,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",B-cell Acute Lymphoblastic Leukemia,"NOS,n=71/TARGET"
SRR1288072,RNA-Seq,GCA_000001405.13,150,PRJNA89529,SAMN02386020,BCCAGSC,PCR,sra,SRX543410,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32683,2014-05-15,11934,5136,ILLUMINA,137949.0,2014-05-15,SRR1288072,2013-11-26T21:56:14Z,SRS602077,SRP011999,TARGET-10-PARNSH-03A-01R,RNA,TARGET-10-PARNSH-03A-01R,Primary Blood Derived Cancer - Peripheral Blood,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PARNSH,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1288072,"B-cell Acute Lymphoblastic Leukemia, TCF3-PBX1,n=11",17.586301369863,BALL-TCF3PBX1,"B-cell Acute Lymphoblastic Leukemia, TCF3-PBX1,n=11",B-cell Acute Lymphoblastic Leukemia,"TCF3-PBX1,n=11/TARGET"
SRR1288077,RNA-Seq,GCA_000001405.13,150,PRJNA89529,SAMN02385912,BCCAGSC,PCR,sra,SRX543467,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32610,2014-05-15,8862,4479,ILLUMINA,139795.0,2014-05-15,SRR1288077,2014-02-21T20:52:23Z,SRS602026,SRP011999,TARGET-10-PASFXA-03A-01R,RNA,TARGET-10-PASFXA-03A-01R,Primary Blood Derived Cancer - Peripheral Blood,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PASFXA,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Induction Failure AML (AML-IF),SRR1288077,"B-cell Acute Lymphoblastic Leukemia, TCF3-PBX1,n=11",6.50410958904109,BALL-TCF3PBX1,"B-cell Acute Lymphoblastic Leukemia, TCF3-PBX1,n=11",B-cell Acute Lymphoblastic Leukemia,"TCF3-PBX1,n=11/TARGET"
SRR1288081,RNA-Seq,GCA_000001405.13,150,PRJNA89529,SAMN02386141,BCCAGSC,PCR,sra,SRX543442,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32609,2014-05-15,24348,10826,ILLUMINA,137943.0,2014-05-15,SRR1288081,2013-11-26T21:55:46Z,SRS602028,SRP011999,TARGET-10-PASCIU-03A-01R,RNA,TARGET-10-PASCIU-03A-01R,Primary Blood Derived Cancer - Peripheral Blood,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PASCIU,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Induction Failure AML (AML-IF),SRR1288081,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",2.17808219178082,BALL-NOS,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",B-cell Acute Lymphoblastic Leukemia,"NOS,n=71/TARGET"
SRR1288084,RNA-Seq,GCA_000001405.13,150,PRJNA89529,SAMN02386075,BCCAGSC,PCR,sra,SRX543457,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32663,2014-05-15,13747,6155,ILLUMINA,137958.0,2014-05-15,SRR1288084,2013-11-26T22:02:16Z,SRS602041,SRP011999,TARGET-10-PAPHEK-03A-01R,RNA,TARGET-10-PAPHEK-03A-01R,Primary Blood Derived Cancer - Peripheral Blood,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PAPHEK,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Induction Failure AML (AML-IF),SRR1288084,"B-cell Acute Lymphoblastic Leukemia, BCR-ABL1,n=5",8.73150684931507,BALL-BCRABL1,"B-cell Acute Lymphoblastic Leukemia, BCR-ABL1,n=5",B-cell Acute Lymphoblastic Leukemia,"BCR-ABL1,n=5/TARGET"
SRR1288085,RNA-Seq,GCA_000001405.13,150,PRJNA89529,SAMN02386123,BCCAGSC,PCR,sra,SRX543416,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32659,2014-05-15,13741,6440,ILLUMINA,137970.0,2014-05-15,SRR1288085,2013-11-26T22:08:49Z,SRS602050,SRP011999,TARGET-10-PANWHJ-09A-01R,RNA,TARGET-10-PANWHJ-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PANWHJ,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1288085,"B-cell Acute Lymphoblastic Leukemia, Hyperdiploidy,n=20",3.0986301369863,BALL-hyperdiploid,"B-cell Acute Lymphoblastic Leukemia, Hyperdiploidy,n=20",B-cell Acute Lymphoblastic Leukemia,"Hyperdiploidy,n=20/TARGET"
SRR1288087,RNA-Seq,GCA_000001405.13,150,PRJNA89529,SAMN02385890,BCCAGSC,PCR,sra,SRX543462,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32689,2014-05-15,16937,8279,ILLUMINA,137933.0,2014-05-15,SRR1288087,2013-11-22T21:46:21Z,SRS602182,SRP011999,TARGET-10-PAMXHJ-09A-01R,RNA,TARGET-10-PAMXHJ-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PAMXHJ,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1288087,"B-cell Acute Lymphoblastic Leukemia, Hyperdiploidy,n=20",6.07945205479452,BALL-hyperdiploid,"B-cell Acute Lymphoblastic Leukemia, Hyperdiploidy,n=20",B-cell Acute Lymphoblastic Leukemia,"Hyperdiploidy,n=20/TARGET"
SRR1288090,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02260585,BCCAGSC,PCR,sra,SRX543505,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32029,2014-05-15,28638,14614,ILLUMINA,136940.0,2014-05-15,SRR1288090,2013-10-09T21:14:40Z,SRS605628,SRP012000,TARGET-20-PATIAK-04A-01R,RNA,TARGET-20-PATIAK-04A-01R,Recurrent Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PATIAK,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute leukemia of Ambiguous Lineage (ALAL),SRR1288090,"INFANT_Acute Myeloid Leukemia,n=21",0.621917808219178,AML_INFANT,"INFANT_Acute Myeloid Leukemia,n=21",Acute Myeloid Leukemia,"INFANT,n=21/TARGET"
SRR1288091,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02386334,BCCAGSC,PCR,sra,SRX543479,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32041,2014-05-15,15105,7114,ILLUMINA,136540.0,2014-05-15,SRR1288091,2013-09-19T20:28:33Z,SRS605641,SRP012000,TARGET-20-PASMYS-04A-02R,RNA,TARGET-20-PASMYS-04A-02R,Recurrent Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASMYS,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1288091,"Acute Myeloid Leukemia,n=476",2.10410958904109,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1288092,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02260492,BCCAGSC,PCR,sra,SRX543476,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32006,2014-05-15,12105,5559,ILLUMINA,137346.0,2014-05-15,SRR1288092,2013-10-25T18:29:47Z,SRS605581,SRP012000,TARGET-20-PARYFN-04A-01R,RNA,TARGET-20-PARYFN-04A-01R,Recurrent Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARYFN,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1288092,"Acute Myeloid Leukemia,n=476",4.37534246575342,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1288093,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02260578,BCCAGSC,PCR,sra,SRX543513,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32010,2014-05-15,16544,7819,ILLUMINA,136540.0,2014-05-15,SRR1288093,2013-09-19T20:28:33Z,SRS605580,SRP012000,TARGET-20-PANLIZ-04A-02R,RNA,TARGET-20-PANLIZ-04A-02R,Recurrent Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PANLIZ,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1288093,"Acute Myeloid Leukemia,n=476",8.4986301369863,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1288094,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02260539,BCCAGSC,PCR,sra,SRX543512,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32020,2014-05-15,7892,3475,ILLUMINA,136543.0,2014-05-15,SRR1288094,2013-09-19T20:28:40Z,SRS605648,SRP012000,TARGET-20-PAMYAS-04A-03R,RNA,TARGET-20-PAMYAS-04A-03R,Recurrent Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PAMYAS,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1288094,"Acute Myeloid Leukemia,n=476",10.8821917808219,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1288095,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02260500,BCCAGSC,PCR,sra,SRX543507,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32031,2014-05-15,14401,6702,ILLUMINA,136784.0,2014-05-15,SRR1288095,2013-10-02T18:29:46Z,SRS605608,SRP012000,TARGET-20-PASJGZ-04A-01R,RNA,TARGET-20-PASJGZ-04A-01R,Recurrent Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASJGZ,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1288095,"Acute Myeloid Leukemia,n=476",1.80273972602739,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1288096,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02386258,BCCAGSC,PCR,sra,SRX543503,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32033,2014-05-15,24820,12423,ILLUMINA,136782.0,2014-05-15,SRR1288096,2013-10-02T18:29:42Z,SRS605557,SRP012000,TARGET-20-PAEDKB-04A-01R,RNA,TARGET-20-PAEDKB-04A-01R,Recurrent Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PAEDKB,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1288096,"Acute Myeloid Leukemia,n=476",2.23287671232876,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1288097,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02260515,BCCAGSC,PCR,sra,SRX543497,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32036,2014-05-15,15655,7892,ILLUMINA,136778.0,2014-05-15,SRR1288097,2013-10-02T18:28:00Z,SRS605849,SRP012000,TARGET-20-PASCGR-04A-01R,RNA,TARGET-20-PASCGR-04A-01R,Recurrent Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASCGR,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1288097,"Acute Myeloid Leukemia, KMT2A rearrangement,n=60",18.2465753424657,AML-KMT2A,"Acute Myeloid Leukemia, KMT2A rearrangement,n=60",Acute Myeloid Leukemia,"KMT2A rearrangement,n=60/TARGET"
SRR1288098,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02260646,BCCAGSC,PCR,sra,SRX543486,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32030,2014-05-15,9680,5086,ILLUMINA,136542.0,2014-05-15,SRR1288098,2013-09-19T20:28:38Z,SRS605624,SRP012000,TARGET-20-PATJHJ-40A-01R,RNA,TARGET-20-PATJHJ-40A-01R,Recurrent Blood Derived Cancer - Peripheral Blood,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PATJHJ,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute leukemia of Ambiguous Lineage (ALAL),SRR1288098,"INFANT_Acute Myeloid Leukemia, KMT2A rearrangement,n=17",0.375342465753424,AML-KMT2A_INFANT,"INFANT_Acute Myeloid Leukemia, KMT2A rearrangement,n=17",Acute Myeloid Leukemia,"INFANT,KMT2A rearrangement,n=17/TARGET"
SRR1288099,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02260501,BCCAGSC,PCR,sra,SRX543492,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32008,2014-05-15,19415,8446,ILLUMINA,136780.0,2014-05-15,SRR1288099,2013-10-02T18:29:37Z,SRS605643,SRP012000,TARGET-20-PASGWH-04A-02R,RNA,TARGET-20-PASGWH-04A-02R,Recurrent Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASGWH,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1288099,"Acute Myeloid Leukemia,n=476",14.386301369863,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1288100,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02260530,BCCAGSC,PCR,sra,SRX543483,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32015,2014-05-15,17027,8753,ILLUMINA,136538.0,2014-05-15,SRR1288100,2013-09-19T20:28:29Z,SRS605639,SRP012000,TARGET-20-PAEIKD-04A-01R,RNA,TARGET-20-PAEIKD-04A-01R,Recurrent Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PAEIKD,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1288100,"INFANT_Acute Myeloid Leukemia,n=21",0.772602739726027,AML_INFANT,"INFANT_Acute Myeloid Leukemia,n=21",Acute Myeloid Leukemia,"INFANT,n=21/TARGET"
SRR1288101,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02260556,BCCAGSC,PCR,sra,SRX543504,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32025,2014-05-15,2333,1059,ILLUMINA,136780.0,2014-05-15,SRR1288101,2013-10-02T18:29:37Z,SRS605660,SRP012000,TARGET-20-PARDDY-04A-01R,RNA,TARGET-20-PARDDY-04A-01R,Recurrent Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARDDY,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute leukemia of Ambiguous Lineage (ALAL),SRR1288101,"Acute Myeloid Leukemia,n=476",1.85479452054794,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1288102,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02260535,BCCAGSC,PCR,sra,SRX543477,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32014,2014-05-15,20721,10252,ILLUMINA,136781.0,2014-05-15,SRR1288102,2013-10-02T18:29:40Z,SRS605632,SRP012000,TARGET-20-PAKERZ-04A-01R,RNA,TARGET-20-PAKERZ-04A-01R,Recurrent Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PAKERZ,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1288102,"Acute Myeloid Leukemia,n=476",2.8,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1288103,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02260466,BCCAGSC,PCR,sra,SRX543498,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32018,2014-05-15,12768,6358,ILLUMINA,136781.0,2014-05-15,SRR1288103,2013-10-02T18:29:40Z,SRS605590,SRP012000,TARGET-20-PALGKX-04A-01R,RNA,TARGET-20-PALGKX-04A-01R,Recurrent Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PALGKX,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1288103,"Acute Myeloid Leukemia,n=476",12.9397260273972,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1288104,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02260549,BCCAGSC,PCR,sra,SRX543475,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32023,2014-05-15,16908,7374,ILLUMINA,136543.0,2014-05-15,SRR1288104,2013-09-19T20:28:40Z,SRS605629,SRP012000,TARGET-20-PASWAJ-04A-02R,RNA,TARGET-20-PASWAJ-04A-02R,Recurrent Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASWAJ,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1288104,"Acute Myeloid Leukemia, KMT2A rearrangement,n=60",9.03561643835616,AML-KMT2A,"Acute Myeloid Leukemia, KMT2A rearrangement,n=60",Acute Myeloid Leukemia,"KMT2A rearrangement,n=60/TARGET"
SRR1288105,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02260507,BCCAGSC,PCR,sra,SRX543474,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32013,2014-05-15,9062,3913,ILLUMINA,136779.0,2014-05-15,SRR1288105,2013-10-02T18:29:35Z,SRS605640,SRP012000,TARGET-20-PASTUH-04A-01R,RNA,TARGET-20-PASTUH-04A-01R,Recurrent Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASTUH,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1288105,"Acute Myeloid Leukemia, KMT2A rearrangement,n=60",14.5342465753424,AML-KMT2A,"Acute Myeloid Leukemia, KMT2A rearrangement,n=60",Acute Myeloid Leukemia,"KMT2A rearrangement,n=60/TARGET"
SRR1288106,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02386214,BCCAGSC,PCR,sra,SRX543482,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32038,2014-05-15,17642,9029,ILLUMINA,136541.0,2014-05-15,SRR1288106,2013-09-19T20:28:36Z,SRS605658,SRP012000,TARGET-20-PASBBE-04A-02R,RNA,TARGET-20-PASBBE-04A-02R,Recurrent Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASBBE,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute leukemia of Ambiguous Lineage (ALAL),SRR1288106,"Acute Myeloid Leukemia,n=476",10.6547945205479,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1288107,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02260536,BCCAGSC,PCR,sra,SRX543506,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32028,2014-05-15,13164,5690,ILLUMINA,136779.0,2014-05-15,SRR1288107,2013-10-02T18:29:35Z,SRS605842,SRP012000,TARGET-20-PASVYA-04A-01R,RNA,TARGET-20-PASVYA-04A-01R,Recurrent Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASVYA,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute leukemia of Ambiguous Lineage (ALAL),SRR1288107,"Acute Myeloid Leukemia,n=476",1.61643835616438,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1288108,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02260538,BCCAGSC,PCR,sra,SRX543489,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32022,2014-05-15,24336,12332,ILLUMINA,136539.0,2014-05-15,SRR1288108,2013-09-19T20:28:31Z,SRS605627,SRP012000,TARGET-20-PARFAL-04A-01R,RNA,TARGET-20-PARFAL-04A-01R,Recurrent Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARFAL,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute leukemia of Ambiguous Lineage (ALAL),SRR1288108,"Acute Myeloid Leukemia, KMT2A rearrangement,n=60",18.9643835616438,AML-KMT2A,"Acute Myeloid Leukemia, KMT2A rearrangement,n=60",Acute Myeloid Leukemia,"KMT2A rearrangement,n=60/TARGET"
SRR1288109,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02260476,BCCAGSC,PCR,sra,SRX543488,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32001,2014-05-15,19300,9659,ILLUMINA,136778.0,2014-05-15,SRR1288109,2013-10-02T18:28:00Z,SRS605642,SRP012000,TARGET-20-PAKIWK-04A-01R,RNA,TARGET-20-PAKIWK-04A-01R,Recurrent Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PAKIWK,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1288109,"Acute Myeloid Leukemia,n=476",3.41917808219178,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1288110,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02260657,BCCAGSC,PCR,sra,SRX543491,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32035,2014-05-15,17778,8173,ILLUMINA,137346.0,2014-05-15,SRR1288110,2013-10-25T18:29:47Z,SRS605594,SRP012000,TARGET-20-PASVVS-04A-01R,RNA,TARGET-20-PASVVS-04A-01R,Recurrent Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASVVS,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1288110,"INFANT_Acute Myeloid Leukemia, KMT2A rearrangement,n=17",0.775342465753424,AML-KMT2A_INFANT,"INFANT_Acute Myeloid Leukemia, KMT2A rearrangement,n=17",Acute Myeloid Leukemia,"INFANT,KMT2A rearrangement,n=17/TARGET"
SRR1288111,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02260548,BCCAGSC,PCR,sra,SRX543484,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32021,2014-05-15,14315,7329,ILLUMINA,136539.0,2014-05-15,SRR1288111,2013-09-19T20:28:31Z,SRS605631,SRP012000,TARGET-20-PARBIU-04A-02R,RNA,TARGET-20-PARBIU-04A-02R,Recurrent Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARBIU,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1288111,"Acute Myeloid Leukemia,n=476",15.972602739726,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1288112,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02260639,BCCAGSC,PCR,sra,SRX543490,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32026,2014-05-15,24225,12107,ILLUMINA,137768.0,2014-05-15,SRR1288112,2013-11-15T21:17:03Z,SRS605619,SRP012000,TARGET-20-PATDNN-04A-02R,RNA,TARGET-20-PATDNN-04A-02R,Recurrent Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PATDNN,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute leukemia of Ambiguous Lineage (ALAL),SRR1288112,"Acute Myeloid Leukemia, KMT2A rearrangement,n=60",3.45753424657534,AML-KMT2A,"Acute Myeloid Leukemia, KMT2A rearrangement,n=60",Acute Myeloid Leukemia,"KMT2A rearrangement,n=60/TARGET"
SRR1288113,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02260652,BCCAGSC,PCR,sra,SRX543500,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32016,2014-05-15,18565,9768,ILLUMINA,136542.0,2014-05-15,SRR1288113,2013-09-19T20:28:38Z,SRS605853,SRP012000,TARGET-20-PAECCE-04A-01R,RNA,TARGET-20-PAECCE-04A-01R,Recurrent Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PAECCE,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1288113,"Acute Myeloid Leukemia,n=476",2.46575342465753,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1288114,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02260614,BCCAGSC,PCR,sra,SRX543494,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32027,2014-05-15,3937,1892,ILLUMINA,136785.0,2014-05-15,SRR1288114,2013-10-02T18:29:49Z,SRS605860,SRP012000,TARGET-20-PASHYZ-04A-01R,RNA,TARGET-20-PASHYZ-04A-01R,Recurrent Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASHYZ,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1288114,"Acute Myeloid Leukemia,n=476",4.64383561643835,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1288115,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02260567,BCCAGSC,PCR,sra,SRX543501,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32002,2014-05-15,15960,7604,ILLUMINA,136942.0,2014-05-15,SRR1288115,2013-10-09T21:14:44Z,SRS605602,SRP012000,TARGET-20-PABLDZ-04A-01R,RNA,TARGET-20-PABLDZ-04A-01R,Recurrent Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PABLDZ,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1288115,"Acute Myeloid Leukemia,n=476",6.72602739726027,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1288118,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02260454,BCCAGSC,PCR,sra,SRX543511,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32039,2014-05-15,20846,10190,ILLUMINA,136783.0,2014-05-15,SRR1288118,2013-10-02T18:29:44Z,SRS605593,SRP012000,TARGET-20-PARUNX-04A-01R,RNA,TARGET-20-PARUNX-04A-01R,Recurrent Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARUNX,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1288118,"Acute Myeloid Leukemia,n=476",6.35890410958904,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1288119,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02260626,BCCAGSC,PCR,sra,SRX543495,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32012,2014-05-15,20592,10500,ILLUMINA,136538.0,2014-05-15,SRR1288119,2013-09-19T20:28:29Z,SRS605582,SRP012000,TARGET-20-PAEERJ-04A-01R,RNA,TARGET-20-PAEERJ-04A-01R,Recurrent Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PAEERJ,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1288119,"Acute Myeloid Leukemia,n=476",13.9232876712328,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1288120,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02260615,BCCAGSC,PCR,sra,SRX543493,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32040,2014-05-15,18610,8934,ILLUMINA,136537.0,2014-05-15,SRR1288120,2013-09-19T20:28:27Z,SRS605615,SRP012000,TARGET-20-PARYVW-04A-02R,RNA,TARGET-20-PARYVW-04A-02R,Recurrent Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARYVW,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute leukemia of Ambiguous Lineage (ALAL),SRR1288120,"Acute Myeloid Leukemia,n=476",1.81917808219178,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1288121,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02260505,BCCAGSC,PCR,sra,SRX543478,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32017,2014-05-15,15864,8198,ILLUMINA,136541.0,2014-05-15,SRR1288121,2013-09-19T20:28:36Z,SRS605864,SRP012000,TARGET-20-PADYIR-04A-01R,RNA,TARGET-20-PADYIR-04A-01R,Recurrent Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PADYIR,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1288121,"Acute Myeloid Leukemia,n=476",3.17534246575342,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1288122,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02260621,BCCAGSC,PCR,sra,SRX543502,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32004,2014-05-15,15140,7315,ILLUMINA,136537.0,2014-05-15,SRR1288122,2013-09-19T20:28:27Z,SRS605592,SRP012000,TARGET-20-PAEFGT-04A-01R,RNA,TARGET-20-PAEFGT-04A-01R,Recurrent Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PAEFGT,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1288122,"Acute Myeloid Leukemia,n=476",14.9369863013698,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1288123,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02260462,BCCAGSC,PCR,sra,SRX543510,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32009,2014-05-15,15137,7148,ILLUMINA,136942.0,2014-05-15,SRR1288123,2013-10-09T21:14:44Z,SRS605574,SRP012000,TARGET-20-PAKTCX-04A-01R,RNA,TARGET-20-PAKTCX-04A-01R,Recurrent Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PAKTCX,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1288123,"Acute Myeloid Leukemia, KMT2A rearrangement,n=60",8.93698630136986,AML-KMT2A,"Acute Myeloid Leukemia, KMT2A rearrangement,n=60",Acute Myeloid Leukemia,"KMT2A rearrangement,n=60/TARGET"
SRR1288124,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02260640,BCCAGSC,PCR,sra,SRX543485,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32005,2014-05-15,13117,6497,ILLUMINA,136783.0,2014-05-15,SRR1288124,2013-10-02T18:29:44Z,SRS605855,SRP012000,TARGET-20-PARTAL-04A-01R,RNA,TARGET-20-PARTAL-04A-01R,Recurrent Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARTAL,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1288124,"Acute Myeloid Leukemia,n=476",16.4383561643835,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1288125,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02260467,BCCAGSC,PCR,sra,SRX543499,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32007,2014-05-15,10534,5356,ILLUMINA,136782.0,2014-05-15,SRR1288125,2013-10-02T18:29:42Z,SRS605575,SRP012000,TARGET-20-PASCRZ-04A-01R,RNA,TARGET-20-PASCRZ-04A-01R,Recurrent Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASCRZ,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1288125,"Acute Myeloid Leukemia,n=476",14.6739726027397,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1288126,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02260583,BCCAGSC,PCR,sra,SRX543481,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32024,2014-05-15,24565,11507,ILLUMINA,136785.0,2014-05-15,SRR1288126,2013-10-02T18:29:49Z,SRS605850,SRP012000,TARGET-20-PASYJI-04A-02R,RNA,TARGET-20-PASYJI-04A-02R,Recurrent Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASYJI,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1288126,"Acute Myeloid Leukemia,n=476",12.4520547945205,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1288127,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02260545,BCCAGSC,PCR,sra,SRX543509,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32003,2014-05-15,11612,5518,ILLUMINA,136784.0,2014-05-15,SRR1288127,2013-10-02T18:29:46Z,SRS605854,SRP012000,TARGET-20-PADZCG-04A-01R,RNA,TARGET-20-PADZCG-04A-01R,Recurrent Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PADZCG,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1288127,"Acute Myeloid Leukemia,n=476",14.5890410958904,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1288128,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02386279,BCCAGSC,PCR,sra,SRX543487,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32037,2014-05-15,7301,3749,ILLUMINA,136940.0,2014-05-15,SRR1288128,2013-10-09T21:14:40Z,SRS605657,SRP012000,TARGET-20-PARLVL-04A-02R,RNA,TARGET-20-PARLVL-04A-02R,Recurrent Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARLVL,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1288128,"Acute Myeloid Leukemia,n=476",2.63835616438356,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1292945,RNA-Seq,GCA_000001405.13,150,PRJNA89529,SAMN02385871,BCCAGSC,PCR,sra,SRX547591,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32773,2014-05-20,21165,10557,ILLUMINA,138058.0,2014-05-20,SRR1292945,2013-11-29T20:52:20Z,SRS602126,SRP011999,TARGET-10-PAPDUF-09A-01R,RNA,TARGET-10-PAPDUF-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PAPDUF,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1292945,"B-cell Acute Lymphoblastic Leukemia, Hyperdiploidy,n=20",3.33424657534246,BALL-hyperdiploid,"B-cell Acute Lymphoblastic Leukemia, Hyperdiploidy,n=20",B-cell Acute Lymphoblastic Leukemia,"Hyperdiploidy,n=20/TARGET"
SRR1292948,RNA-Seq,GCA_000001405.13,150,PRJNA89529,SAMN02385993,BCCAGSC,PCR,sra,SRX547589,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32744,2014-05-20,21422,9761,ILLUMINA,137960.0,2014-05-20,SRR1292948,2013-11-26T22:06:35Z,SRS602183,SRP011999,TARGET-10-PAPIJM-09A-01R,RNA,TARGET-10-PAPIJM-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PAPIJM,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1292948,"B-cell Acute Lymphoblastic Leukemia, Hyperdiploidy,n=20",10.9013698630136,BALL-hyperdiploid,"B-cell Acute Lymphoblastic Leukemia, Hyperdiploidy,n=20",B-cell Acute Lymphoblastic Leukemia,"Hyperdiploidy,n=20/TARGET"
SRR1292950,RNA-Seq,GCA_000001405.13,150,PRJNA89529,SAMN02386145,BCCAGSC,PCR,sra,SRX547581,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32780,2014-05-20,8283,3807,ILLUMINA,137960.0,2014-05-20,SRR1292950,2013-11-26T22:06:35Z,SRS602176,SRP011999,TARGET-10-PARACA-09A-01R,RNA,TARGET-10-PARACA-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PARACA,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1292950,"B-cell Acute Lymphoblastic Leukemia, TCF3-PBX1,n=11",2.66301369863013,BALL-TCF3PBX1,"B-cell Acute Lymphoblastic Leukemia, TCF3-PBX1,n=11",B-cell Acute Lymphoblastic Leukemia,"TCF3-PBX1,n=11/TARGET"
SRR1292953,RNA-Seq,GCA_000001405.13,150,PRJNA89529,SAMN02385977,BCCAGSC,PCR,sra,SRX547620,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32709,2014-05-20,20354,9953,ILLUMINA,138067.0,2014-05-20,SRR1292953,2013-11-29T22:14:26Z,SRS602129,SRP011999,TARGET-10-PANIEU-03A-01R,RNA,TARGET-10-PANIEU-03A-01R,Primary Blood Derived Cancer - Peripheral Blood,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PANIEU,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1292953,"B-cell Acute Lymphoblastic Leukemia, BCR-ABL1,n=5",7.73424657534246,BALL-BCRABL1,"B-cell Acute Lymphoblastic Leukemia, BCR-ABL1,n=5",B-cell Acute Lymphoblastic Leukemia,"BCR-ABL1,n=5/TARGET"
SRR1292954,RNA-Seq,GCA_000001405.13,150,PRJNA89529,SAMN02385943,BCCAGSC,PCR,sra,SRX547616,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32715,2014-05-20,22000,10916,ILLUMINA,138070.0,2014-05-20,SRR1292954,2013-11-29T22:14:34Z,SRS602108,SRP011999,TARGET-10-PAPBFN-09A-01R,RNA,TARGET-10-PAPBFN-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PAPBFN,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1292954,"B-cell Acute Lymphoblastic Leukemia, Hyperdiploidy,n=20",10.8931506849315,BALL-hyperdiploid,"B-cell Acute Lymphoblastic Leukemia, Hyperdiploidy,n=20",B-cell Acute Lymphoblastic Leukemia,"Hyperdiploidy,n=20/TARGET"
SRR1292958,RNA-Seq,GCA_000001405.13,150,PRJNA89529,SAMN02386082,BCCAGSC,PCR,sra,SRX547631,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32747,2014-05-20,18055,8830,ILLUMINA,138003.0,2014-05-20,SRR1292958,2013-11-27T21:55:09Z,SRS602143,SRP011999,TARGET-10-PAPTLM-09A-01R,RNA,TARGET-10-PAPTLM-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PAPTLM,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1292958,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",1.86027397260273,BALL-NOS,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",B-cell Acute Lymphoblastic Leukemia,"NOS,n=71/TARGET"
SRR1292959,RNA-Seq,GCA_000001405.13,150,PRJNA89529,SAMN02385968,BCCAGSC,PCR,sra,SRX547584,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32724,2014-05-20,13708,6051,ILLUMINA,138014.0,2014-05-20,SRR1292959,2013-11-27T21:55:28Z,SRS602166,SRP011999,TARGET-10-PANXDB-03A-01R,RNA,TARGET-10-PANXDB-03A-01R,Primary Blood Derived Cancer - Peripheral Blood,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PANXDB,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1292959,"B-cell Acute Lymphoblastic Leukemia, KMT2A rearrangement,n=4",7.98904109589041,BALL-KMT2A,"B-cell Acute Lymphoblastic Leukemia, KMT2A rearrangement,n=4",B-cell Acute Lymphoblastic Leukemia,"KMT2A rearrangement,n=4/TARGET"
SRR1292960,RNA-Seq,GCA_000001405.13,150,PRJNA89529,SAMN02386111,BCCAGSC,PCR,sra,SRX547576,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32703,2014-05-20,23347,11714,ILLUMINA,138065.0,2014-05-20,SRR1292960,2013-11-29T22:14:21Z,SRS602190,SRP011999,TARGET-10-PANRDC-03A-01R,RNA,TARGET-10-PANRDC-03A-01R,Primary Blood Derived Cancer - Peripheral Blood,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PANRDC,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1292960,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",1.47671232876712,BALL-NOS,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",B-cell Acute Lymphoblastic Leukemia,"NOS,n=71/TARGET"
SRR1292961,RNA-Seq,GCA_000001405.13,150,PRJNA89529,SAMN02385931,BCCAGSC,PCR,sra,SRX547599,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32781,2014-05-20,18113,8636,ILLUMINA,138061.0,2014-05-20,SRR1292961,2013-11-29T20:52:27Z,SRS602119,SRP011999,TARGET-10-PASUBW-09A-01R,RNA,TARGET-10-PASUBW-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PASUBW,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1292961,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",13.9671232876712,BALL-NOS,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",B-cell Acute Lymphoblastic Leukemia,"NOS,n=71/TARGET"
SRR1292962,RNA-Seq,GCA_000001405.13,150,PRJNA89529,SAMN02386146,BCCAGSC,PCR,sra,SRX547567,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32722,2014-05-20,22130,9603,ILLUMINA,137966.0,2014-05-20,SRR1292962,2013-11-26T22:06:51Z,SRS602155,SRP011999,TARGET-10-PANWHW-09A-01R,RNA,TARGET-10-PANWHW-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PANWHW,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1292962,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",4.02191780821917,BALL-NOS,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",B-cell Acute Lymphoblastic Leukemia,"NOS,n=71/TARGET"
SRR1292963,RNA-Seq,GCA_000001405.13,150,PRJNA89529,SAMN02385866,BCCAGSC,PCR,sra,SRX547574,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32723,2014-05-20,13427,6841,ILLUMINA,138065.0,2014-05-20,SRR1292963,2013-11-29T22:14:21Z,SRS602141,SRP011999,TARGET-10-PAPAIZ-09A-01R,RNA,TARGET-10-PAPAIZ-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PAPAIZ,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1292963,"B-cell Acute Lymphoblastic Leukemia, Hyperdiploidy,n=20",6.45479452054794,BALL-hyperdiploid,"B-cell Acute Lymphoblastic Leukemia, Hyperdiploidy,n=20",B-cell Acute Lymphoblastic Leukemia,"Hyperdiploidy,n=20/TARGET"
SRR1292965,RNA-Seq,GCA_000001405.13,150,PRJNA89529,SAMN02385948,BCCAGSC,PCR,sra,SRX547585,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32743,2014-05-20,22265,10717,ILLUMINA,138010.0,2014-05-20,SRR1292965,2013-11-27T21:55:20Z,SRS602178,SRP011999,TARGET-10-PAPHZT-09A-01R,RNA,TARGET-10-PAPHZT-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PAPHZT,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1292965,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",1.50958904109589,BALL-NOS,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",B-cell Acute Lymphoblastic Leukemia,"NOS,n=71/TARGET"
SRR1292968,RNA-Seq,GCA_000001405.13,150,PRJNA89529,SAMN02386072,BCCAGSC,PCR,sra,SRX547582,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32711,2014-05-20,15604,7833,ILLUMINA,138066.0,2014-05-20,SRR1292968,2013-11-29T22:14:24Z,SRS602173,SRP011999,TARGET-10-PANFNZ-03A-01R,RNA,TARGET-10-PANFNZ-03A-01R,Primary Blood Derived Cancer - Peripheral Blood,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PANFNZ,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1292968,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",4.02739726027397,BALL-NOS,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",B-cell Acute Lymphoblastic Leukemia,"NOS,n=71/TARGET"
SRR1292969,RNA-Seq,GCA_000001405.13,150,PRJNA89529,SAMN02386074,BCCAGSC,PCR,sra,SRX547593,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32708,2014-05-20,15221,7363,ILLUMINA,138004.0,2014-05-20,SRR1292969,2013-11-27T21:55:12Z,SRS602189,SRP011999,TARGET-10-PANEUH-09A-01R,RNA,TARGET-10-PANEUH-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PANEUH,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1292969,"B-cell Acute Lymphoblastic Leukemia, Hyperdiploidy,n=20",1.77534246575342,BALL-hyperdiploid,"B-cell Acute Lymphoblastic Leukemia, Hyperdiploidy,n=20",B-cell Acute Lymphoblastic Leukemia,"Hyperdiploidy,n=20/TARGET"
SRR1292970,RNA-Seq,GCA_000001405.13,150,PRJNA89529,SAMN02386065,BCCAGSC,PCR,sra,SRX547606,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32730,2014-05-20,17743,8066,ILLUMINA,137961.0,2014-05-20,SRR1292970,2013-11-26T22:06:38Z,SRS602180,SRP011999,TARGET-10-PANUHA-09A-01R,RNA,TARGET-10-PANUHA-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PANUHA,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1292970,"B-cell Acute Lymphoblastic Leukemia, ETV6-RUNX1,n=5",3.56712328767123,BALL-ETV6RUNX1,"B-cell Acute Lymphoblastic Leukemia, ETV6-RUNX1,n=5",B-cell Acute Lymphoblastic Leukemia,"ETV6-RUNX1,n=5/TARGET"
SRR1292972,RNA-Seq,GCA_000001405.13,150,PRJNA89529,SAMN02385802,BCCAGSC,PCR,sra,SRX547639,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32774,2014-05-20,14362,7162,ILLUMINA,138070.0,2014-05-20,SRR1292972,2013-11-29T22:14:34Z,SRS602124,SRP011999,TARGET-10-PARWVN-03A-01R,RNA,TARGET-10-PARWVN-03A-01R,Primary Blood Derived Cancer - Peripheral Blood,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PARWVN,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1292972,"B-cell Acute Lymphoblastic Leukemia, TCF3-PBX1,n=11",2.31506849315068,BALL-TCF3PBX1,"B-cell Acute Lymphoblastic Leukemia, TCF3-PBX1,n=11",B-cell Acute Lymphoblastic Leukemia,"TCF3-PBX1,n=11/TARGET"
SRR1292973,RNA-Seq,GCA_000001405.13,150,PRJNA89529,SAMN02385763,BCCAGSC,PCR,sra,SRX547609,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32770,2014-05-20,14861,6203,ILLUMINA,138062.0,2014-05-20,SRR1292973,2013-11-29T20:52:29Z,SRS602134,SRP011999,TARGET-10-PASSXJ-03A-01R,RNA,TARGET-10-PASSXJ-03A-01R,Primary Blood Derived Cancer - Peripheral Blood,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PASSXJ,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1292973,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",3.64109589041095,BALL-NOS,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",B-cell Acute Lymphoblastic Leukemia,"NOS,n=71/TARGET"
SRR1292974,RNA-Seq,GCA_000001405.13,150,PRJNA89529,SAMN02385892,BCCAGSC,PCR,sra,SRX547634,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32733,2014-05-20,14424,6661,ILLUMINA,138012.0,2014-05-20,SRR1292974,2013-11-27T21:55:23Z,SRS602186,SRP011999,TARGET-10-PANWVW-09A-01R,RNA,TARGET-10-PANWVW-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PANWVW,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1292974,"B-cell Acute Lymphoblastic Leukemia, BCR-ABL1,n=5",2.95068493150684,BALL-BCRABL1,"B-cell Acute Lymphoblastic Leukemia, BCR-ABL1,n=5",B-cell Acute Lymphoblastic Leukemia,"BCR-ABL1,n=5/TARGET"
SRR1292976,RNA-Seq,GCA_000001405.13,150,PRJNA89529,SAMN02385975,BCCAGSC,PCR,sra,SRX547577,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32750,2014-05-20,11997,5630,ILLUMINA,138007.0,2014-05-20,SRR1292976,2013-11-27T21:55:16Z,SRS602122,SRP011999,TARGET-10-PARLEK-03A-01R,RNA,TARGET-10-PARLEK-03A-01R,Primary Blood Derived Cancer - Peripheral Blood,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PARLEK,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1292976,"B-cell Acute Lymphoblastic Leukemia, KMT2A rearrangement,n=4",8.80821917808219,BALL-KMT2A,"B-cell Acute Lymphoblastic Leukemia, KMT2A rearrangement,n=4",B-cell Acute Lymphoblastic Leukemia,"KMT2A rearrangement,n=4/TARGET"
SRR1292977,RNA-Seq,GCA_000001405.13,150,PRJNA89529,SAMN02385936,BCCAGSC,PCR,sra,SRX547571,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32752,2014-05-20,11711,5753,ILLUMINA,138056.0,2014-05-20,SRR1292977,2013-11-29T20:52:17Z,SRS602159,SRP011999,TARGET-10-PARUGP-09A-01R,RNA,TARGET-10-PARUGP-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PARUGP,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1292977,"B-cell Acute Lymphoblastic Leukemia, TCF3-PBX1,n=11",2.07945205479452,BALL-TCF3PBX1,"B-cell Acute Lymphoblastic Leukemia, TCF3-PBX1,n=11",B-cell Acute Lymphoblastic Leukemia,"TCF3-PBX1,n=11/TARGET"
SRR1292981,RNA-Seq,GCA_000001405.13,150,PRJNA89529,SAMN02385979,BCCAGSC,PCR,sra,SRX547625,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32712,2014-05-20,16270,7894,ILLUMINA,138006.0,2014-05-20,SRR1292981,2013-11-27T21:55:14Z,SRS602136,SRP011999,TARGET-10-PANGIF-03A-01R,RNA,TARGET-10-PANGIF-03A-01R,Primary Blood Derived Cancer - Peripheral Blood,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PANGIF,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1292981,"B-cell Acute Lymphoblastic Leukemia, TCF3-PBX1,n=11",11.1972602739726,BALL-TCF3PBX1,"B-cell Acute Lymphoblastic Leukemia, TCF3-PBX1,n=11",B-cell Acute Lymphoblastic Leukemia,"TCF3-PBX1,n=11/TARGET"
SRR1292982,RNA-Seq,GCA_000001405.13,150,PRJNA89529,SAMN02386033,BCCAGSC,PCR,sra,SRX547619,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32754,2014-05-20,17777,8489,ILLUMINA,138068.0,2014-05-20,SRR1292982,2013-11-29T22:14:29Z,SRS602184,SRP011999,TARGET-10-PAPRFE-09A-01R,RNA,TARGET-10-PAPRFE-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PAPRFE,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1292982,"B-cell Acute Lymphoblastic Leukemia, TCF3-PBX1,n=11",2.57534246575342,BALL-TCF3PBX1,"B-cell Acute Lymphoblastic Leukemia, TCF3-PBX1,n=11",B-cell Acute Lymphoblastic Leukemia,"TCF3-PBX1,n=11/TARGET"
SRR1292983,RNA-Seq,GCA_000001405.13,150,PRJNA89529,SAMN02385849,BCCAGSC,PCR,sra,SRX547587,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32713,2014-05-20,13449,6072,ILLUMINA,138005.0,2014-05-20,SRR1292983,2013-11-27T21:55:13Z,SRS602113,SRP011999,TARGET-10-PANSPW-09A-01R,RNA,TARGET-10-PANSPW-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PANSPW,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1292983,"B-cell Acute Lymphoblastic Leukemia, BCR-ABL1,n=5",13.145205479452,BALL-BCRABL1,"B-cell Acute Lymphoblastic Leukemia, BCR-ABL1,n=5",B-cell Acute Lymphoblastic Leukemia,"BCR-ABL1,n=5/TARGET"
SRR1292985,RNA-Seq,GCA_000001405.13,150,PRJNA89529,SAMN02385978,BCCAGSC,PCR,sra,SRX547570,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32728,2016-05-26,19809,10058,ILLUMINA,138000.0,2014-05-20,SRR1292985,2013-11-27T21:55:04Z,SRS602115,SRP011999,TARGET-10-PAPGGT-03A-01R,RNA,TARGET-10-PAPGGT-03A-01R,Primary Blood Derived Cancer - Peripheral Blood,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PAPGGT,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1292985,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",14.4465753424657,BALL-NOS,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",B-cell Acute Lymphoblastic Leukemia,"NOS,n=71/TARGET"
SRR1292986,RNA-Seq,GCA_000001405.13,150,PRJNA89529,SAMN02386142,BCCAGSC,PCR,sra,SRX547621,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32741,2014-05-20,11710,5956,ILLUMINA,138000.0,2014-05-20,SRR1292986,2013-11-27T21:55:04Z,SRS602150,SRP011999,TARGET-10-PAPGYC-09A-01R,RNA,TARGET-10-PAPGYC-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PAPGYC,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1292986,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",3.65753424657534,BALL-NOS,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",B-cell Acute Lymphoblastic Leukemia,"NOS,n=71/TARGET"
SRR1292988,RNA-Seq,GCA_000001405.13,150,PRJNA89529,SAMN02386027,BCCAGSC,PCR,sra,SRX547578,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32746,2014-05-20,8424,4032,ILLUMINA,138010.0,2014-05-20,SRR1292988,2013-11-27T21:55:20Z,SRS602135,SRP011999,TARGET-10-PAPMYD-03A-01R,RNA,TARGET-10-PAPMYD-03A-01R,Primary Blood Derived Cancer - Peripheral Blood,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PAPMYD,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1292988,"B-cell Acute Lymphoblastic Leukemia, Hyperdiploidy,n=20",13.9808219178082,BALL-hyperdiploid,"B-cell Acute Lymphoblastic Leukemia, Hyperdiploidy,n=20",B-cell Acute Lymphoblastic Leukemia,"Hyperdiploidy,n=20/TARGET"
SRR1292989,RNA-Seq,GCA_000001405.13,150,PRJNA89529,SAMN02386070,BCCAGSC,PCR,sra,SRX547579,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32731,2014-05-20,13960,6964,ILLUMINA,138003.0,2014-05-20,SRR1292989,2013-11-27T21:55:09Z,SRS602128,SRP011999,TARGET-10-PAPBCI-09A-01R,RNA,TARGET-10-PAPBCI-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PAPBCI,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1292989,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",9.93150684931506,BALL-NOS,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",B-cell Acute Lymphoblastic Leukemia,"NOS,n=71/TARGET"
SRR1292991,RNA-Seq,GCA_000001405.13,150,PRJNA89529,SAMN02385859,BCCAGSC,PCR,sra,SRX547617,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32742,2014-05-20,17557,8140,ILLUMINA,137965.0,2014-05-20,SRR1292991,2013-11-26T22:06:48Z,SRS602132,SRP011999,TARGET-10-PAPHGD-09A-01R,RNA,TARGET-10-PAPHGD-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PAPHGD,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1292991,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",1.7835616438356099,BALL-NOS,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",B-cell Acute Lymphoblastic Leukemia,"NOS,n=71/TARGET"
SRR1292993,RNA-Seq,GCA_000001405.13,150,PRJNA89529,SAMN02385781,BCCAGSC,PCR,sra,SRX547608,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32707,2014-05-20,17271,8133,ILLUMINA,138013.0,2014-05-20,SRR1292993,2013-11-27T21:55:26Z,SRS602162,SRP011999,TARGET-10-PANSUL-09A-01R,RNA,TARGET-10-PANSUL-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PANSUL,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1292993,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",2.42739726027397,BALL-NOS,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",B-cell Acute Lymphoblastic Leukemia,"NOS,n=71/TARGET"
SRR1292994,RNA-Seq,GCA_000001405.13,150,PRJNA89529,SAMN02385919,BCCAGSC,PCR,sra,SRX547572,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32751,2014-05-20,19627,9480,ILLUMINA,138008.0,2014-05-20,SRR1292994,2013-11-27T21:55:17Z,SRS602145,SRP011999,TARGET-10-PARUBK-03A-01R,RNA,TARGET-10-PARUBK-03A-01R,Primary Blood Derived Cancer - Peripheral Blood,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PARUBK,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1292994,"B-cell Acute Lymphoblastic Leukemia, KMT2A rearrangement,n=4",12.6054794520547,BALL-KMT2A,"B-cell Acute Lymphoblastic Leukemia, KMT2A rearrangement,n=4",B-cell Acute Lymphoblastic Leukemia,"KMT2A rearrangement,n=4/TARGET"
SRR1292995,RNA-Seq,GCA_000001405.13,150,PRJNA89529,SAMN02385829,BCCAGSC,PCR,sra,SRX547605,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32719,2014-05-20,23109,11477,ILLUMINA,139795.0,2014-05-20,SRR1292995,2014-02-21T20:52:23Z,SRS602172,SRP011999,TARGET-10-PAPFWH-09A-01R,RNA,TARGET-10-PAPFWH-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PAPFWH,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1292995,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",16.7205479452054,BALL-NOS,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",B-cell Acute Lymphoblastic Leukemia,"NOS,n=71/TARGET"
SRR1292996,RNA-Seq,GCA_000001405.13,150,PRJNA89529,SAMN02385984,BCCAGSC,PCR,sra,SRX547590,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32710,2014-05-20,14608,6856,ILLUMINA,138012.0,2014-05-20,SRR1292996,2013-11-27T21:55:23Z,SRS602170,SRP011999,TARGET-10-PANJWJ-09A-01R,RNA,TARGET-10-PANJWJ-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PANJWJ,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1292996,"B-cell Acute Lymphoblastic Leukemia, BCR-ABL1,n=5",11.0082191780821,BALL-BCRABL1,"B-cell Acute Lymphoblastic Leukemia, BCR-ABL1,n=5",B-cell Acute Lymphoblastic Leukemia,"BCR-ABL1,n=5/TARGET"
SRR1292999,RNA-Seq,GCA_000001405.13,150,PRJNA89529,SAMN02385776,BCCAGSC,PCR,sra,SRX547637,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32706,2014-05-20,20718,10386,ILLUMINA,138066.0,2014-05-20,SRR1292999,2013-11-29T22:14:24Z,SRS602171,SRP011999,TARGET-10-PANSBR-09A-01R,RNA,TARGET-10-PANSBR-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PANSBR,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1292999,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",20.6,BALL-NOS,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",B-cell Acute Lymphoblastic Leukemia,"NOS,n=71/TARGET"
SRR1293000,RNA-Seq,GCA_000001405.13,150,PRJNA89529,SAMN02386112,BCCAGSC,PCR,sra,SRX547612,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32714,2014-05-20,16931,7740,ILLUMINA,138007.0,2014-05-20,SRR1293000,2013-11-27T21:55:16Z,SRS602177,SRP011999,TARGET-10-PANYZE-09A-01R,RNA,TARGET-10-PANYZE-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PANYZE,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1293000,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",4.05205479452054,BALL-NOS,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",B-cell Acute Lymphoblastic Leukemia,"NOS,n=71/TARGET"
SRR1293001,RNA-Seq,GCA_000001405.13,150,PRJNA89529,SAMN02386063,BCCAGSC,PCR,sra,SRX547580,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32749,2014-05-20,27259,12836,ILLUMINA,138001.0,2014-05-20,SRR1293001,2013-11-27T21:55:07Z,SRS602125,SRP011999,TARGET-10-PARARJ-09A-01R,RNA,TARGET-10-PARARJ-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PARARJ,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1293001,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",3.0931506849315,BALL-NOS,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",B-cell Acute Lymphoblastic Leukemia,"NOS,n=71/TARGET"
SRR1293002,RNA-Seq,GCA_000001405.13,150,PRJNA89529,SAMN02385806,BCCAGSC,PCR,sra,SRX547636,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32771,2014-05-20,14633,6959,ILLUMINA,137964.0,2014-05-20,SRR1293002,2013-11-26T22:06:45Z,SRS602152,SRP011999,TARGET-10-PAPLUG-09A-01R,RNA,TARGET-10-PAPLUG-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PAPLUG,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1293002,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",1.38630136986301,BALL-NOS,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",B-cell Acute Lymphoblastic Leukemia,"NOS,n=71/TARGET"
SRR1293003,RNA-Seq,GCA_000001405.13,150,PRJNA89529,SAMN02386035,BCCAGSC,PCR,sra,SRX547611,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32753,2014-05-20,11651,5378,ILLUMINA,138002.0,2014-05-20,SRR1293003,2013-11-27T21:55:09Z,SRS602110,SRP011999,TARGET-10-PARVWD-09A-01R,RNA,TARGET-10-PARVWD-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PARVWD,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1293003,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",17.4657534246575,BALL-NOS,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",B-cell Acute Lymphoblastic Leukemia,"NOS,n=71/TARGET"
SRR1293005,RNA-Seq,GCA_000001405.13,150,PRJNA89529,SAMN02386000,BCCAGSC,PCR,sra,SRX547635,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32729,2014-05-20,13967,6332,ILLUMINA,138005.0,2014-05-20,SRR1293005,2013-11-27T21:55:13Z,SRS602161,SRP011999,TARGET-10-PANXDR-09A-01R,RNA,TARGET-10-PANXDR-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PANXDR,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1293005,"B-cell Acute Lymphoblastic Leukemia, Hyperdiploidy,n=20",3.25753424657534,BALL-hyperdiploid,"B-cell Acute Lymphoblastic Leukemia, Hyperdiploidy,n=20",B-cell Acute Lymphoblastic Leukemia,"Hyperdiploidy,n=20/TARGET"
SRR1293006,RNA-Seq,GCA_000001405.13,150,PRJNA89529,SAMN02385960,BCCAGSC,PCR,sra,SRX547569,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32732,2014-05-20,15513,7609,ILLUMINA,138068.0,2014-05-20,SRR1293006,2013-11-29T22:14:29Z,SRS602105,SRP011999,TARGET-10-PAPBES-03A-01R,RNA,TARGET-10-PAPBES-03A-01R,Primary Blood Derived Cancer - Peripheral Blood,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PAPBES,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1293006,"B-cell Acute Lymphoblastic Leukemia, Hyperdiploidy,n=20",2.22465753424657,BALL-hyperdiploid,"B-cell Acute Lymphoblastic Leukemia, Hyperdiploidy,n=20",B-cell Acute Lymphoblastic Leukemia,"Hyperdiploidy,n=20/TARGET"
SRR1293007,RNA-Seq,GCA_000001405.13,150,PRJNA89529,SAMN02385887,BCCAGSC,PCR,sra,SRX547595,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32734,2014-05-20,13679,6275,ILLUMINA,137965.0,2014-05-20,SRR1293007,2013-11-26T22:06:48Z,SRS602149,SRP011999,TARGET-10-PANYEJ-09A-01R,RNA,TARGET-10-PANYEJ-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PANYEJ,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1293007,"B-cell Acute Lymphoblastic Leukemia, Hyperdiploidy,n=20",1.86027397260273,BALL-hyperdiploid,"B-cell Acute Lymphoblastic Leukemia, Hyperdiploidy,n=20",B-cell Acute Lymphoblastic Leukemia,"Hyperdiploidy,n=20/TARGET"
SRR1293008,RNA-Seq,GCA_000001405.13,150,PRJNA89529,SAMN02386061,BCCAGSC,PCR,sra,SRX547633,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32775,2014-05-20,18993,9191,ILLUMINA,138069.0,2014-05-20,SRR1293008,2013-11-29T22:14:31Z,SRS602151,SRP011999,TARGET-10-PAPDKJ-09A-01R,RNA,TARGET-10-PAPDKJ-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PAPDKJ,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1293008,"B-cell Acute Lymphoblastic Leukemia, ETV6-RUNX1,n=5",3.96986301369863,BALL-ETV6RUNX1,"B-cell Acute Lymphoblastic Leukemia, ETV6-RUNX1,n=5",B-cell Acute Lymphoblastic Leukemia,"ETV6-RUNX1,n=5/TARGET"
SRR1293009,RNA-Seq,GCA_000001405.13,150,PRJNA89529,SAMN02385872,BCCAGSC,PCR,sra,SRX547630,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32720,2014-05-20,20604,9869,ILLUMINA,138071.0,2014-05-20,SRR1293009,2013-11-29T22:14:36Z,SRS602138,SRP011999,TARGET-10-PAPFXN-09A-01R,RNA,TARGET-10-PAPFXN-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PAPFXN,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1293009,"B-cell Acute Lymphoblastic Leukemia, Hyperdiploidy,n=20",1.84383561643835,BALL-hyperdiploid,"B-cell Acute Lymphoblastic Leukemia, Hyperdiploidy,n=20",B-cell Acute Lymphoblastic Leukemia,"Hyperdiploidy,n=20/TARGET"
SRR1293010,RNA-Seq,GCA_000001405.13,150,PRJNA89529,SAMN02385973,BCCAGSC,PCR,sra,SRX547603,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32716,2014-05-20,13417,6363,ILLUMINA,138013.0,2014-05-20,SRR1293010,2013-11-27T21:55:26Z,SRS602158,SRP011999,TARGET-10-PAPBSY-09A-01R,RNA,TARGET-10-PAPBSY-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PAPBSY,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1293010,"B-cell Acute Lymphoblastic Leukemia, TCF3-PBX1,n=11",2.41917808219178,BALL-TCF3PBX1,"B-cell Acute Lymphoblastic Leukemia, TCF3-PBX1,n=11",B-cell Acute Lymphoblastic Leukemia,"TCF3-PBX1,n=11/TARGET"
SRR1293011,RNA-Seq,GCA_000001405.13,150,PRJNA89529,SAMN02386096,BCCAGSC,PCR,sra,SRX547575,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32704,2014-05-20,10751,4755,ILLUMINA,138014.0,2014-05-20,SRR1293011,2013-11-27T21:55:28Z,SRS602137,SRP011999,TARGET-10-PANRWG-09A-01R,RNA,TARGET-10-PANRWG-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PANRWG,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1293011,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",2.67945205479452,BALL-NOS,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",B-cell Acute Lymphoblastic Leukemia,"NOS,n=71/TARGET"
SRR1293014,RNA-Seq,GCA_000001405.13,150,PRJNA89529,SAMN02385842,BCCAGSC,PCR,sra,SRX547601,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32745,2014-05-20,14027,6316,ILLUMINA,138011.0,2014-05-20,SRR1293014,2013-11-27T21:55:21Z,SRS602133,SRP011999,TARGET-10-PAPKNC-09A-01R,RNA,TARGET-10-PAPKNC-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PAPKNC,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1293014,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",18.0794520547945,BALL-NOS,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",B-cell Acute Lymphoblastic Leukemia,"NOS,n=71/TARGET"
SRR1293015,RNA-Seq,GCA_000001405.13,150,PRJNA89529,SAMN02385966,BCCAGSC,PCR,sra,SRX547624,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32726,2014-05-20,19610,9525,ILLUMINA,138054.0,2014-05-20,SRR1293015,2013-11-29T20:52:14Z,SRS602140,SRP011999,TARGET-10-PANWFB-09A-01R,RNA,TARGET-10-PANWFB-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PANWFB,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1293015,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",17.2520547945205,BALL-NOS,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",B-cell Acute Lymphoblastic Leukemia,"NOS,n=71/TARGET"
SRR1293016,RNA-Seq,GCA_000001405.13,150,PRJNA89529,SAMN02386151,BCCAGSC,PCR,sra,SRX547640,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32705,2014-05-20,12929,6156,ILLUMINA,138009.0,2014-05-20,SRR1293016,2013-11-27T21:55:18Z,SRS602153,SRP011999,TARGET-10-PANRYM-09A-01R,RNA,TARGET-10-PANRYM-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PANRYM,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1293016,"B-cell Acute Lymphoblastic Leukemia, Hyperdiploidy,n=20",2.33424657534246,BALL-hyperdiploid,"B-cell Acute Lymphoblastic Leukemia, Hyperdiploidy,n=20",B-cell Acute Lymphoblastic Leukemia,"Hyperdiploidy,n=20/TARGET"
SRR1293018,RNA-Seq,GCA_000001405.13,150,PRJNA89529,SAMN02386018,BCCAGSC,PCR,sra,SRX547573,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32717,2014-05-20,11606,5460,ILLUMINA,138061.0,2014-05-20,SRR1293018,2013-11-29T20:52:27Z,SRS602169,SRP011999,TARGET-10-PAPBZK-09A-01R,RNA,TARGET-10-PAPBZK-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PAPBZK,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1293018,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",18.3917808219178,BALL-NOS,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",B-cell Acute Lymphoblastic Leukemia,"NOS,n=71/TARGET"
SRR1293019,RNA-Seq,GCA_000001405.13,150,PRJNA89529,SAMN02723798,BCCAGSC,PCR,sra,SRX547654,200,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A33604,2014-05-20,14674,6436,ILLUMINA,137829.0,2014-06-12,SRR1293019,2013-11-19T19:16:47Z,SRS602217,SRP011999,TARGET-10-PARNMF-03A-02R,RNA,TARGET-10-PARNMF-03A-02R,Primary Blood Derived Cancer - Peripheral Blood,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PARNMF,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1293019,"B-cell Acute Lymphoblastic Leukemia, ETV6-RUNX1,n=5",2.80547945205479,BALL-ETV6RUNX1,"B-cell Acute Lymphoblastic Leukemia, ETV6-RUNX1,n=5",B-cell Acute Lymphoblastic Leukemia,"ETV6-RUNX1,n=5/TARGET"
SRR1293020,RNA-Seq,GCA_000001405.13,150,PRJNA89529,SAMN02722971,BCCAGSC,PCR,sra,SRX547648,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A33616,2014-05-20,10756,4764,ILLUMINA,137926.0,2014-06-12,SRR1293020,2013-11-22T21:44:17Z,SRS602234,SRP011999,TARGET-10-PARPZJ-03A-02R,RNA,TARGET-10-PARPZJ-03A-02R,Primary Blood Derived Cancer - Peripheral Blood,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PARPZJ,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1293020,"B-cell Acute Lymphoblastic Leukemia, ETV6-RUNX1,n=5",1.77534246575342,BALL-ETV6RUNX1,"B-cell Acute Lymphoblastic Leukemia, ETV6-RUNX1,n=5",B-cell Acute Lymphoblastic Leukemia,"ETV6-RUNX1,n=5/TARGET"
SRR1293021,RNA-Seq,GCA_000001405.13,150,PRJNA89529,SAMN02724029,BCCAGSC,PCR,sra,SRX547641,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A33595,2014-05-20,10226,4678,ILLUMINA,137849.0,2014-06-12,SRR1293021,2013-11-19T20:59:58Z,SRS602201,SRP011999,TARGET-10-PASYGM-03A-02R,RNA,TARGET-10-PASYGM-03A-02R,Primary Blood Derived Cancer - Peripheral Blood,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PASYGM,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1293021,"B-cell Acute Lymphoblastic Leukemia, TCF3-PBX1,n=11",7.53424657534246,BALL-TCF3PBX1,"B-cell Acute Lymphoblastic Leukemia, TCF3-PBX1,n=11",B-cell Acute Lymphoblastic Leukemia,"TCF3-PBX1,n=11/TARGET"
SRR1293023,RNA-Seq,GCA_000001405.13,150,PRJNA89529,SAMN02722912,BCCAGSC,PCR,sra,SRX547680,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A33587,2014-05-20,17046,7623,ILLUMINA,137872.0,2014-06-12,SRR1293023,2013-11-19T22:49:32Z,SRS602200,SRP011999,TARGET-10-PAKSWW-03A-02R,RNA,TARGET-10-PAKSWW-03A-02R,Primary Blood Derived Cancer - Peripheral Blood,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PAKSWW,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1293023,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",15.1123287671232,BALL-NOS,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",B-cell Acute Lymphoblastic Leukemia,"NOS,n=71/TARGET"
SRR1293025,RNA-Seq,GCA_000001405.13,150,PRJNA89529,SAMN02723280,BCCAGSC,PCR,sra,SRX547676,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A33596,2014-05-20,8991,4123,ILLUMINA,137851.0,2014-06-12,SRR1293025,2013-11-19T21:00:04Z,SRS602213,SRP011999,TARGET-10-PATTEE-03A-02R,RNA,TARGET-10-PATTEE-03A-02R,Primary Blood Derived Cancer - Peripheral Blood,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PATTEE,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1293025,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",13.7561643835616,BALL-NOS,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",B-cell Acute Lymphoblastic Leukemia,"NOS,n=71/TARGET"
SRR1293027,RNA-Seq,GCA_000001405.13,150,PRJNA89529,SAMN02724109,BCCAGSC,PCR,sra,SRX547653,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A33626,2014-05-20,11527,5082,ILLUMINA,137919.0,2014-06-12,SRR1293027,2013-11-22T21:43:59Z,SRS602194,SRP011999,TARGET-10-PASKHT-03A-02R,RNA,TARGET-10-PASKHT-03A-02R,Primary Blood Derived Cancer - Peripheral Blood,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PASKHT,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1293027,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",12.4986301369863,BALL-NOS,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",B-cell Acute Lymphoblastic Leukemia,"NOS,n=71/TARGET"
SRR1293028,RNA-Seq,GCA_000001405.13,150,PRJNA89529,SAMN02722943,BCCAGSC,PCR,sra,SRX547670,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A33618,2014-05-20,11248,4599,ILLUMINA,137925.0,2014-06-12,SRR1293028,2013-11-22T21:44:14Z,SRS602204,SRP011999,TARGET-10-PARSGC-03A-02R,RNA,TARGET-10-PARSGC-03A-02R,Primary Blood Derived Cancer - Peripheral Blood,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PARSGC,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1293028,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",3.10410958904109,BALL-NOS,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",B-cell Acute Lymphoblastic Leukemia,"NOS,n=71/TARGET"
SRR1293030,RNA-Seq,GCA_000001405.13,150,PRJNA89529,SAMN02723277,BCCAGSC,PCR,sra,SRX547686,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A33582,2014-05-20,16426,7289,ILLUMINA,137920.0,2014-06-12,SRR1293030,2013-11-22T21:44:02Z,SRS602226,SRP011999,TARGET-10-PANDWE-03A-02R,RNA,TARGET-10-PANDWE-03A-02R,Primary Blood Derived Cancer - Peripheral Blood,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PANDWE,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1293030,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",14.2821917808219,BALL-NOS,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",B-cell Acute Lymphoblastic Leukemia,"NOS,n=71/TARGET"
SRR1293031,RNA-Seq,GCA_000001405.13,150,PRJNA89529,SAMN02724355,BCCAGSC,PCR,sra,SRX547658,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A33628,2014-05-20,15722,7039,ILLUMINA,137926.0,2014-06-12,SRR1293031,2013-11-22T21:44:17Z,SRS602192,SRP011999,TARGET-10-PASDYK-03A-02R,RNA,TARGET-10-PASDYK-03A-02R,Primary Blood Derived Cancer - Peripheral Blood,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PASDYK,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1293031,"B-cell Acute Lymphoblastic Leukemia, Hyperdiploidy,n=20",3.58904109589041,BALL-hyperdiploid,"B-cell Acute Lymphoblastic Leukemia, Hyperdiploidy,n=20",B-cell Acute Lymphoblastic Leukemia,"Hyperdiploidy,n=20/TARGET"
SRR1293033,RNA-Seq,GCA_000001405.13,150,PRJNA89529,SAMN02723947,BCCAGSC,PCR,sra,SRX547669,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A33630,2014-05-20,12764,5391,ILLUMINA,137927.0,2014-06-12,SRR1293033,2013-11-22T21:46:07Z,SRS602216,SRP011999,TARGET-10-PARTKL-09A-02R,RNA,TARGET-10-PARTKL-09A-02R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PARTKL,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1293033,"B-cell Acute Lymphoblastic Leukemia, Hyperdiploidy,n=20",2.98356164383561,BALL-hyperdiploid,"B-cell Acute Lymphoblastic Leukemia, Hyperdiploidy,n=20",B-cell Acute Lymphoblastic Leukemia,"Hyperdiploidy,n=20/TARGET"
SRR1293035,RNA-Seq,GCA_000001405.13,150,PRJNA89529,SAMN02723009,BCCAGSC,PCR,sra,SRX547682,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A33588,2014-05-20,14767,6515,ILLUMINA,137868.0,2014-06-12,SRR1293035,2013-11-19T22:49:17Z,SRS602202,SRP011999,TARGET-10-PAPGNC-03A-02R,RNA,TARGET-10-PAPGNC-03A-02R,Primary Blood Derived Cancer - Peripheral Blood,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PAPGNC,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1293035,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",15.4849315068493,BALL-NOS,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",B-cell Acute Lymphoblastic Leukemia,"NOS,n=71/TARGET"
SRR1293037,RNA-Seq,GCA_000001405.13,150,PRJNA89529,SAMN02723859,BCCAGSC,PCR,sra,SRX547675,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A33599,2014-05-20,13945,6417,ILLUMINA,137874.0,2014-06-12,SRR1293037,2013-11-19T22:49:40Z,SRS602231,SRP011999,TARGET-10-PAPHMH-09A-02R,RNA,TARGET-10-PAPHMH-09A-02R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PAPHMH,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1293037,"B-cell Acute Lymphoblastic Leukemia, KMT2A rearrangement,n=4",29.9890410958904,BALL-KMT2A,"B-cell Acute Lymphoblastic Leukemia, KMT2A rearrangement,n=4",B-cell Acute Lymphoblastic Leukemia,"KMT2A rearrangement,n=4/TARGET"
SRR1293038,RNA-Seq,GCA_000001405.13,150,PRJNA89529,SAMN02722872,BCCAGSC,PCR,sra,SRX547645,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A33605,2014-05-20,11957,5349,ILLUMINA,137837.0,2014-06-12,SRR1293038,2013-11-19T19:19:18Z,SRS602193,SRP011999,TARGET-10-PARCHB-03A-02R,RNA,TARGET-10-PARCHB-03A-02R,Primary Blood Derived Cancer - Peripheral Blood,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PARCHB,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1293038,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",2.15616438356164,BALL-NOS,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",B-cell Acute Lymphoblastic Leukemia,"NOS,n=71/TARGET"
SRR1293042,RNA-Seq,GCA_000001405.13,150,PRJNA89529,SAMN02723415,BCCAGSC,PCR,sra,SRX547678,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A33581,2014-05-20,15814,7443,ILLUMINA,137835.0,2014-06-12,SRR1293042,2013-11-19T19:19:11Z,SRS602212,SRP011999,TARGET-10-PANKMB-09A-02R,RNA,TARGET-10-PANKMB-09A-02R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PANKMB,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1293042,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",8.21917808219178,BALL-NOS,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",B-cell Acute Lymphoblastic Leukemia,"NOS,n=71/TARGET"
SRR1293044,RNA-Seq,GCA_000001405.13,150,PRJNA89529,SAMN02723955,BCCAGSC,PCR,sra,SRX547662,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A33622,2014-05-20,9952,4369,ILLUMINA,137845.0,2014-06-12,SRR1293044,2013-11-19T20:59:48Z,SRS602241,SRP011999,TARGET-10-PANSIA-09A-02R,RNA,TARGET-10-PANSIA-09A-02R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PANSIA,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1293044,"B-cell Acute Lymphoblastic Leukemia, Hyperdiploidy,n=20",5.5917808219178,BALL-hyperdiploid,"B-cell Acute Lymphoblastic Leukemia, Hyperdiploidy,n=20",B-cell Acute Lymphoblastic Leukemia,"Hyperdiploidy,n=20/TARGET"
SRR1293045,RNA-Seq,GCA_000001405.13,150,PRJNA89529,SAMN02724414,BCCAGSC,PCR,sra,SRX547672,202,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A33614,2014-05-20,13232,4963,ILLUMINA,137828138416.0,2014-06-12,SRR1293045,"2013-11-19T19:16:43Z,2013-12-17T21:46:44Z",SRS602205,SRP011999,TARGET-10-PANWYH-09A-02R,RNA,TARGET-10-PANWYH-09A-02R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PANWYH,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1293045,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",4.8931506849315,BALL-NOS,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",B-cell Acute Lymphoblastic Leukemia,"NOS,n=71/TARGET"
SRR1293048,RNA-Seq,GCA_000001405.13,150,PRJNA89529,SAMN02722920,BCCAGSC,PCR,sra,SRX547657,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A33615,2014-05-20,16113,7623,ILLUMINA,137835.0,2014-06-12,SRR1293048,2013-11-19T19:19:11Z,SRS602228,SRP011999,TARGET-10-PANUUF-09A-02R,RNA,TARGET-10-PANUUF-09A-02R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PANUUF,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1293048,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",11.0383561643835,BALL-NOS,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",B-cell Acute Lymphoblastic Leukemia,"NOS,n=71/TARGET"
SRR1293049,RNA-Seq,GCA_000001405.13,150,PRJNA89529,SAMN02723328,BCCAGSC,PCR,sra,SRX547656,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A33610,2014-05-20,10509,4725,ILLUMINA,137920.0,2014-06-12,SRR1293049,2013-11-22T21:44:02Z,SRS602229,SRP011999,TARGET-10-PARGML-03A-02R,RNA,TARGET-10-PARGML-03A-02R,Primary Blood Derived Cancer - Peripheral Blood,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PARGML,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1293049,"B-cell Acute Lymphoblastic Leukemia, TCF3-PBX1,n=11",2.16164383561643,BALL-TCF3PBX1,"B-cell Acute Lymphoblastic Leukemia, TCF3-PBX1,n=11",B-cell Acute Lymphoblastic Leukemia,"TCF3-PBX1,n=11/TARGET"
SRR1293054,RNA-Seq,GCA_000001405.13,150,PRJNA89529,SAMN02723986,BCCAGSC,PCR,sra,SRX547664,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A33621,2014-05-20,2660,1070,ILLUMINA,137922.0,2014-06-12,SRR1293054,2013-11-22T21:44:07Z,SRS602214,SRP011999,TARGET-10-PARTJL-09A-02R,RNA,TARGET-10-PARTJL-09A-02R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PARTJL,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1293054,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",2.90410958904109,BALL-NOS,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",B-cell Acute Lymphoblastic Leukemia,"NOS,n=71/TARGET"
SRR1293061,RNA-Seq,GCA_000001405.13,150,PRJNA89529,SAMN02724028,BCCAGSC,PCR,sra,SRX547674,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A33624,2014-05-20,13231,6936,ILLUMINA,137833.0,2014-06-12,SRR1293061,2013-11-19T19:19:03Z,SRS602208,SRP011999,TARGET-10-PANSXG-09A-02R,RNA,TARGET-10-PANSXG-09A-02R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PANSXG,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1293061,"B-cell Acute Lymphoblastic Leukemia, Hyperdiploidy,n=20",7.60273972602739,BALL-hyperdiploid,"B-cell Acute Lymphoblastic Leukemia, Hyperdiploidy,n=20",B-cell Acute Lymphoblastic Leukemia,"Hyperdiploidy,n=20/TARGET"
SRR1293063,RNA-Seq,GCA_000001405.13,150,PRJNA89529,SAMN02723121,BCCAGSC,PCR,sra,SRX547673,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A33594,2014-05-20,10033,4171,ILLUMINA,137923.0,2014-06-12,SRR1293063,2013-11-22T21:44:09Z,SRS602240,SRP011999,TARGET-10-PAPIGX-09A-02R,RNA,TARGET-10-PAPIGX-09A-02R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PAPIGX,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1293063,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",14.331506849315,BALL-NOS,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",B-cell Acute Lymphoblastic Leukemia,"NOS,n=71/TARGET"
SRR1293064,RNA-Seq,GCA_000001405.13,150,PRJNA89529,SAMN02723059,BCCAGSC,PCR,sra,SRX547647,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A33585,2014-05-20,13420,5912,ILLUMINA,137823.0,2014-06-12,SRR1293064,2013-11-19T19:16:24Z,SRS602198,SRP011999,TARGET-10-PANKRG-03A-02R,RNA,TARGET-10-PANKRG-03A-02R,Primary Blood Derived Cancer - Peripheral Blood,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PANKRG,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1293064,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",1.18082191780821,BALL-NOS,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",B-cell Acute Lymphoblastic Leukemia,"NOS,n=71/TARGET"
SRR1293065,RNA-Seq,GCA_000001405.13,150,PRJNA89529,SAMN02723674,BCCAGSC,PCR,sra,SRX547679,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A33608,2014-05-20,16302,7579,ILLUMINA,137830.0,2014-06-12,SRR1293065,2013-11-19T19:18:52Z,SRS602232,SRP011999,TARGET-10-PAPNFY-03A-02R,RNA,TARGET-10-PAPNFY-03A-02R,Primary Blood Derived Cancer - Peripheral Blood,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PAPNFY,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1293065,"B-cell Acute Lymphoblastic Leukemia, Hyperdiploidy,n=20",11.372602739726,BALL-hyperdiploid,"B-cell Acute Lymphoblastic Leukemia, Hyperdiploidy,n=20",B-cell Acute Lymphoblastic Leukemia,"Hyperdiploidy,n=20/TARGET"
SRR1293066,RNA-Seq,GCA_000001405.13,150,PRJNA89529,SAMN02723157,BCCAGSC,PCR,sra,SRX547677,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A33598,2014-05-20,14335,6527,ILLUMINA,137850.0,2014-06-12,SRR1293066,2013-11-19T21:00:01Z,SRS602237,SRP011999,TARGET-10-PAPESW-09A-02R,RNA,TARGET-10-PAPESW-09A-02R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PAPESW,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1293066,"B-cell Acute Lymphoblastic Leukemia, Hyperdiploidy,n=20",2.88767123287671,BALL-hyperdiploid,"B-cell Acute Lymphoblastic Leukemia, Hyperdiploidy,n=20",B-cell Acute Lymphoblastic Leukemia,"Hyperdiploidy,n=20/TARGET"
SRR1293067,RNA-Seq,GCA_000001405.13,150,PRJNA89529,SAMN02724373,BCCAGSC,PCR,sra,SRX547667,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A33593,2014-05-20,14868,6544,ILLUMINA,137826.0,2014-06-12,SRR1293067,2013-11-19T19:16:35Z,SRS602211,SRP011999,TARGET-10-PANZXZ-03A-02R,RNA,TARGET-10-PANZXZ-03A-02R,Primary Blood Derived Cancer - Peripheral Blood,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PANZXZ,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1293067,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",13.2739726027397,BALL-NOS,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",B-cell Acute Lymphoblastic Leukemia,"NOS,n=71/TARGET"
SRR1294215,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN01778235,BCCAGSC,PCR,sra,SRX548861,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12554,2014-05-21,19476,9664,ILLUMINA,136387.0,2014-05-21,SRR1294215,2013-09-17T19:33:22Z,SRS380285,SRP012000,TARGET-20-PARBFJ-09A-02R,RNA,TARGET-20-PARBFJ-09A-02R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARBFJ,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1294215,"Acute Myeloid Leukemia,n=476",12.8794520547945,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1294216,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN01778030,BCCAGSC,PCR,sra,SRX548883,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12610,2014-05-21,18069,9587,ILLUMINA,136477.0,2014-05-21,SRR1294216,2013-09-18T20:31:08Z,SRS380329,SRP012000,TARGET-20-PASPKE-09A-04R,RNA,TARGET-20-PASPKE-09A-04R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASPKE,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1294216,"Acute Myeloid Leukemia,n=476",8.76712328767123,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1294217,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN01778175,BCCAGSC,PCR,sra,SRX548912,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12541,2014-05-21,13860,7047,ILLUMINA,136474.0,2014-05-21,SRR1294217,2013-09-18T20:31:01Z,SRS380411,SRP012000,TARGET-20-PAPVCN-09A-03R,RNA,TARGET-20-PAPVCN-09A-03R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PAPVCN,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1294217,"Acute Myeloid Leukemia,n=476",11.5917808219178,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1294218,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN01778248,BCCAGSC,PCR,sra,SRX548847,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12640,2014-05-21,18216,8863,ILLUMINA,136396.0,2014-05-21,SRR1294218,2013-09-17T19:38:47Z,SRS380409,SRP012000,TARGET-20-PASZLJ-09A-01R,RNA,TARGET-20-PASZLJ-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASZLJ,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1294218,"Acute Myeloid Leukemia, KMT2A rearrangement,n=60",9.70684931506849,AML-KMT2A,"Acute Myeloid Leukemia, KMT2A rearrangement,n=60",Acute Myeloid Leukemia,"KMT2A rearrangement,n=60/TARGET"
SRR1294219,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN01778303,BCCAGSC,PCR,sra,SRX548875,214,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12580,2014-05-21,19390,9831,ILLUMINA,136401.0,2014-05-21,SRR1294219,2013-09-17T19:38:59Z,SRS380446,SRP012000,TARGET-20-PARUTH-09A-04R,RNA,TARGET-20-PARUTH-09A-04R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARUTH,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1294219,"Acute Myeloid Leukemia,n=476",9.46301369863013,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1294222,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN01778260,BCCAGSC,PCR,sra,SRX548867,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12643,2014-05-21,17451,9052,ILLUMINA,136473.0,2014-05-21,SRR1294222,2013-09-18T20:30:31Z,SRS380303,SRP012000,TARGET-20-PATDHA-09A-01R,RNA,TARGET-20-PATDHA-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PATDHA,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1294222,"Acute Myeloid Leukemia,n=476",15.1890410958904,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1294223,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN01778321,BCCAGSC,PCR,sra,SRX548848,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12552,2014-05-21,15739,8174,ILLUMINA,136472.0,2014-05-21,SRR1294223,2013-09-18T20:30:29Z,SRS380376,SRP012000,TARGET-20-PARANT-09A-02R,RNA,TARGET-20-PARANT-09A-02R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARANT,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1294223,"Acute Myeloid Leukemia,n=476",17.5260273972602,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1294224,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN01778109,BCCAGSC,PCR,sra,SRX548920,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12514,2014-05-21,15610,8163,ILLUMINA,136476.0,2014-05-21,SRR1294224,2013-09-18T20:31:06Z,SRS380386,SRP012000,TARGET-20-PANDER-09A-02R,RNA,TARGET-20-PANDER-09A-02R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PANDER,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1294224,"Acute Myeloid Leukemia,n=476",11.8136986301369,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1294225,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN01778064,BCCAGSC,PCR,sra,SRX548918,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12532,2014-05-21,17364,9072,ILLUMINA,136476.0,2014-05-21,SRR1294225,2013-09-18T20:31:06Z,SRS380423,SRP012000,TARGET-20-PANTPW-09A-02R,RNA,TARGET-20-PANTPW-09A-02R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PANTPW,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1294225,"Acute Myeloid Leukemia,n=476",2.24931506849315,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1294226,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN01778152,BCCAGSC,PCR,sra,SRX548885,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12599,2014-05-21,16531,8162,ILLUMINA,136398.0,2014-05-21,SRR1294226,2013-09-17T19:38:52Z,SRS380433,SRP012000,TARGET-20-PARPWL-09A-03R,RNA,TARGET-20-PARPWL-09A-03R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARPWL,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1294226,"Acute Myeloid Leukemia,n=476",2.0986301369863,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1294227,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN01778173,BCCAGSC,PCR,sra,SRX548880,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12538,2014-05-21,17352,9462,ILLUMINA,136479.0,2014-05-21,SRR1294227,2013-09-18T20:31:12Z,SRS380302,SRP012000,TARGET-20-PANZKA-09A-02R,RNA,TARGET-20-PANZKA-09A-02R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PANZKA,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1294227,"Acute Myeloid Leukemia, KMT2A rearrangement,n=60",1.74520547945205,AML-KMT2A,"Acute Myeloid Leukemia, KMT2A rearrangement,n=60",Acute Myeloid Leukemia,"KMT2A rearrangement,n=60/TARGET"
SRR1294228,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN01778162,BCCAGSC,PCR,sra,SRX548881,215,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12583,2014-05-21,16542,8413,ILLUMINA,136393.0,2014-05-21,SRR1294228,2013-09-17T19:33:38Z,SRS380345,SRP012000,TARGET-20-PARZWH-09A-03R,RNA,TARGET-20-PARZWH-09A-03R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARZWH,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1294228,"Acute Myeloid Leukemia,n=476",11.6246575342465,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1294229,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN01778252,BCCAGSC,PCR,sra,SRX548902,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12649,2014-05-21,15908,8439,ILLUMINA,136391.0,2014-05-21,SRR1294229,2013-09-17T19:33:32Z,SRS380288,SRP012000,TARGET-20-PASVYA-09A-01R,RNA,TARGET-20-PASVYA-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASVYA,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1294229,"Acute Myeloid Leukemia,n=476",1.61643835616438,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1294230,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN01778308,BCCAGSC,PCR,sra,SRX548858,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12598,2014-05-21,16297,8761,ILLUMINA,136468.0,2014-05-21,SRR1294230,2013-09-18T20:30:20Z,SRS380356,SRP012000,TARGET-20-PASYJI-09A-03R,RNA,TARGET-20-PASYJI-09A-03R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASYJI,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1294230,"Acute Myeloid Leukemia,n=476",12.4520547945205,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1294232,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN01778230,BCCAGSC,PCR,sra,SRX548898,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12571,2014-05-21,17190,8794,ILLUMINA,136481.0,2014-05-21,SRR1294232,2013-09-18T20:31:17Z,SRS380418,SRP012000,TARGET-20-PARJYP-03A-01R,RNA,TARGET-20-PARJYP-03A-01R,Primary Blood Derived Cancer - Peripheral Blood,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARJYP,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1294232,"Acute Myeloid Leukemia,n=476",14.8849315068493,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1294233,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN01778031,BCCAGSC,PCR,sra,SRX548870,214,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12636,2014-05-21,19184,9175,ILLUMINA,136939.0,2014-05-21,SRR1294233,2013-10-09T21:14:37Z,SRS380328,SRP012000,TARGET-20-PASVYL-09A-01R,RNA,TARGET-20-PASVYL-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASVYL,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1294233,"Acute Myeloid Leukemia, KMT2A rearrangement,n=60",16.6849315068493,AML-KMT2A,"Acute Myeloid Leukemia, KMT2A rearrangement,n=60",Acute Myeloid Leukemia,"KMT2A rearrangement,n=60/TARGET"
SRR1294234,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN01778086,BCCAGSC,PCR,sra,SRX548852,214,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12535,2014-05-21,10161,4435,ILLUMINA,136777.0,2014-05-21,SRR1294234,2013-10-02T18:27:57Z,SRS380340,SRP012000,TARGET-20-PANVGE-09A-02R,RNA,TARGET-20-PANVGE-09A-02R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PANVGE,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1294234,"Acute Myeloid Leukemia,n=476",14.6465753424657,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1294235,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN01778237,BCCAGSC,PCR,sra,SRX548897,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12546,2014-05-21,16090,8272,ILLUMINA,136400.0,2014-05-21,SRR1294235,2013-09-17T19:38:56Z,SRS380309,SRP012000,TARGET-20-PAPWYK-09A-03R,RNA,TARGET-20-PAPWYK-09A-03R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PAPWYK,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1294235,"Acute Myeloid Leukemia,n=476",22.5506849315068,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1294236,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN01778229,BCCAGSC,PCR,sra,SRX548849,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12520,2014-05-21,18603,9552,ILLUMINA,136466.0,2014-05-21,SRR1294236,2013-09-18T20:30:15Z,SRS380396,SRP012000,TARGET-20-PANJGR-09A-03R,RNA,TARGET-20-PANJGR-09A-03R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PANJGR,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1294236,"Acute Myeloid Leukemia,n=476",12.1232876712328,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1294238,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN01778206,BCCAGSC,PCR,sra,SRX548909,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12501,2014-05-21,16798,8405,ILLUMINA,136388.0,2014-05-21,SRR1294238,2013-09-17T19:33:25Z,SRS380277,SRP012000,TARGET-20-PAKLPD-09A-02R,RNA,TARGET-20-PAKLPD-09A-02R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PAKLPD,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1294238,"INFANT_Acute Myeloid Leukemia, KMT2A rearrangement,n=17",0.402739726027397,AML-KMT2A_INFANT,"INFANT_Acute Myeloid Leukemia, KMT2A rearrangement,n=17",Acute Myeloid Leukemia,"INFANT,KMT2A rearrangement,n=17/TARGET"
SRR1294239,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN01778316,BCCAGSC,PCR,sra,SRX548906,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12510,2014-05-21,13545,7015,ILLUMINA,136466.0,2014-05-21,SRR1294239,2013-09-18T20:30:15Z,SRS380383,SRP012000,TARGET-20-PANAEV-09A-03R,RNA,TARGET-20-PANAEV-09A-03R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PANAEV,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1294239,"Acute Myeloid Leukemia,n=476",9.6958904109589,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1294241,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN01778299,BCCAGSC,PCR,sra,SRX548905,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12507,2014-05-21,16604,8797,ILLUMINA,136392.0,2014-05-21,SRR1294241,2013-09-17T19:33:35Z,SRS380360,SRP012000,TARGET-20-PAMVKZ-09A-03R,RNA,TARGET-20-PAMVKZ-09A-03R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PAMVKZ,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1294241,"Acute Myeloid Leukemia,n=476",16.2575342465753,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1294242,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN01778094,BCCAGSC,PCR,sra,SRX548871,214,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12525,2014-05-21,11689,5014,ILLUMINA,136777.0,2014-05-21,SRR1294242,2013-10-02T18:27:57Z,SRS380395,SRP012000,TARGET-20-PANLJN-09A-03R,RNA,TARGET-20-PANLJN-09A-03R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PANLJN,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1294242,"Acute Myeloid Leukemia,n=476",17.8739726027397,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1294243,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN01778221,BCCAGSC,PCR,sra,SRX548891,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12530,2014-05-21,22332,11698,ILLUMINA,136478.0,2014-05-21,SRR1294243,2013-09-18T20:31:10Z,SRS380424,SRP012000,TARGET-20-PANSJB-09A-03R,RNA,TARGET-20-PANSJB-09A-03R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PANSJB,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1294243,"Acute Myeloid Leukemia,n=476",11.1616438356164,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1294244,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN01778220,BCCAGSC,PCR,sra,SRX548886,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12539,2014-05-21,12091,6354,ILLUMINA,136478.0,2014-05-21,SRR1294244,2013-09-18T20:31:10Z,SRS380372,SRP012000,TARGET-20-PANZWB-09A-02R,RNA,TARGET-20-PANZWB-09A-02R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PANZWB,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1294244,"Acute Myeloid Leukemia,n=476",13.5123287671232,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1294245,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN01778121,BCCAGSC,PCR,sra,SRX548851,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12622,2014-05-21,16041,8084,ILLUMINA,136386.0,2014-05-21,SRR1294245,2013-09-17T19:33:19Z,SRS380417,SRP012000,TARGET-20-PATIAK-09A-01R,RNA,TARGET-20-PATIAK-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PATIAK,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1294245,"INFANT_Acute Myeloid Leukemia,n=21",0.621917808219178,AML_INFANT,"INFANT_Acute Myeloid Leukemia,n=21",Acute Myeloid Leukemia,"INFANT,n=21/TARGET"
SRR1294246,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN01778310,BCCAGSC,PCR,sra,SRX548896,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12644,2014-05-21,16991,8562,ILLUMINA,136386.0,2014-05-21,SRR1294246,2013-09-17T19:33:19Z,SRS380284,SRP012000,TARGET-20-PASWPT-09A-01R,RNA,TARGET-20-PASWPT-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASWPT,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1294246,"Acute Myeloid Leukemia,n=476",9.41917808219178,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1294247,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN01778259,BCCAGSC,PCR,sra,SRX548877,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12548,2014-05-21,17950,9688,ILLUMINA,136477.0,2014-05-21,SRR1294247,2013-09-18T20:31:08Z,SRS380394,SRP012000,TARGET-20-PAPXWI-09A-03R,RNA,TARGET-20-PAPXWI-09A-03R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PAPXWI,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1294247,"Acute Myeloid Leukemia,n=476",3.91780821917808,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1294248,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN01778211,BCCAGSC,PCR,sra,SRX548856,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12600,2014-05-21,16623,8219,ILLUMINA,136398.0,2014-05-21,SRR1294248,2013-09-17T19:38:52Z,SRS380448,SRP012000,TARGET-20-PATDNN-09A-03R,RNA,TARGET-20-PATDNN-09A-03R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PATDNN,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1294248,"Acute Myeloid Leukemia, KMT2A rearrangement,n=60",3.45753424657534,AML-KMT2A,"Acute Myeloid Leukemia, KMT2A rearrangement,n=60",Acute Myeloid Leukemia,"KMT2A rearrangement,n=60/TARGET"
SRR1294249,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN01778112,BCCAGSC,PCR,sra,SRX548866,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12551,2014-05-21,13504,7084,ILLUMINA,136467.0,2014-05-21,SRR1294249,2013-09-18T20:30:18Z,SRS380311,SRP012000,TARGET-20-PARAJX-09A-02R,RNA,TARGET-20-PARAJX-09A-02R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARAJX,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1294249,"Acute Myeloid Leukemia,n=476",1.6931506849315,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1294250,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN01778036,BCCAGSC,PCR,sra,SRX548882,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12561,2014-05-21,11844,5408,ILLUMINA,136534.0,2014-05-21,SRR1294250,2013-09-19T20:28:03Z,SRS380378,SRP012000,TARGET-20-PARCUK-09A-03R,RNA,TARGET-20-PARCUK-09A-03R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARCUK,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1294250,"Acute Myeloid Leukemia,n=476",16.4027397260274,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1294251,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN01778037,BCCAGSC,PCR,sra,SRX548911,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12602,2014-05-21,18687,10019,ILLUMINA,136468.0,2014-05-21,SRR1294251,2013-09-18T20:30:20Z,SRS380443,SRP012000,TARGET-20-PASWAJ-09A-04R,RNA,TARGET-20-PASWAJ-09A-04R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASWAJ,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1294251,"Acute Myeloid Leukemia, KMT2A rearrangement,n=60",9.03561643835616,AML-KMT2A,"Acute Myeloid Leukemia, KMT2A rearrangement,n=60",Acute Myeloid Leukemia,"KMT2A rearrangement,n=60/TARGET"
SRR1294253,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN01778014,BCCAGSC,PCR,sra,SRX548892,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12597,2014-05-21,15699,7978,ILLUMINA,136394.0,2014-05-21,SRR1294253,2013-09-17T19:38:42Z,SRS380283,SRP012000,TARGET-20-PASSSI-09A-02R,RNA,TARGET-20-PASSSI-09A-02R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASSSI,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1294253,"Acute Myeloid Leukemia, KMT2A rearrangement,n=60",1.45205479452054,AML-KMT2A,"Acute Myeloid Leukemia, KMT2A rearrangement,n=60",Acute Myeloid Leukemia,"KMT2A rearrangement,n=60/TARGET"
SRR1294254,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN01778233,BCCAGSC,PCR,sra,SRX548846,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12528,2014-05-21,17904,9558,ILLUMINA,136471.0,2014-05-21,SRR1294254,2013-09-18T20:30:27Z,SRS380289,SRP012000,TARGET-20-PANNJI-09A-03R,RNA,TARGET-20-PANNJI-09A-03R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PANNJI,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1294254,"Acute Myeloid Leukemia,n=476",14.1835616438356,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1294255,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN01778224,BCCAGSC,PCR,sra,SRX548884,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12553,2014-05-21,19228,10189,ILLUMINA,136392.0,2014-05-21,SRR1294255,2013-09-17T19:33:35Z,SRS380308,SRP012000,TARGET-20-PARASV-03A-03R,RNA,TARGET-20-PARASV-03A-03R,Primary Blood Derived Cancer - Peripheral Blood,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARASV,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1294255,"Acute Myeloid Leukemia, KMT2A rearrangement,n=60",12.0575342465753,AML-KMT2A,"Acute Myeloid Leukemia, KMT2A rearrangement,n=60",Acute Myeloid Leukemia,"KMT2A rearrangement,n=60/TARGET"
SRR1294257,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN01778024,BCCAGSC,PCR,sra,SRX548862,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12526,2014-05-21,15897,7808,ILLUMINA,136535.0,2014-05-21,SRR1294257,2013-09-19T20:28:05Z,SRS380315,SRP012000,TARGET-20-PANLKB-09A-03R,RNA,TARGET-20-PANLKB-09A-03R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PANLKB,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1294257,"Acute Myeloid Leukemia,n=476",4.5972602739726,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1294258,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN01778108,BCCAGSC,PCR,sra,SRX548864,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12614,2014-05-21,19385,9817,ILLUMINA,136400.0,2014-05-21,SRR1294258,2013-09-17T19:38:56Z,SRS380358,SRP012000,TARGET-20-PASHBI-09A-01R,RNA,TARGET-20-PASHBI-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASHBI,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1294258,"Acute Myeloid Leukemia,n=476",15.6904109589041,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1294259,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN01778197,BCCAGSC,PCR,sra,SRX548850,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12489,2014-05-21,21526,11101,ILLUMINA,136397.0,2014-05-21,SRR1294259,2013-09-17T19:38:49Z,SRS380429,SRP012000,TARGET-20-PAEAKL-09A-03R,RNA,TARGET-20-PAEAKL-09A-03R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PAEAKL,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1294259,"Acute Myeloid Leukemia, KMT2A rearrangement,n=60",14.2958904109589,AML-KMT2A,"Acute Myeloid Leukemia, KMT2A rearrangement,n=60",Acute Myeloid Leukemia,"KMT2A rearrangement,n=60/TARGET"
SRR1294260,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN01778293,BCCAGSC,PCR,sra,SRX548919,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12587,2014-05-21,17344,8678,ILLUMINA,136474.0,2014-05-21,SRR1294260,2013-09-18T20:31:01Z,SRS380403,SRP012000,TARGET-20-PASHYZ-09A-03R,RNA,TARGET-20-PASHYZ-09A-03R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASHYZ,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1294260,"Acute Myeloid Leukemia,n=476",4.64383561643835,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1294261,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN01778124,BCCAGSC,PCR,sra,SRX548857,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12524,2014-05-21,12944,6512,ILLUMINA,136387.0,2014-05-21,SRR1294261,2013-09-17T19:33:22Z,SRS380272,SRP012000,TARGET-20-PANKNB-09A-03R,RNA,TARGET-20-PANKNB-09A-03R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PANKNB,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1294261,"Acute Myeloid Leukemia,n=476",17.6986301369863,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1294262,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN01778294,BCCAGSC,PCR,sra,SRX548894,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12531,2014-05-21,13973,6901,ILLUMINA,136396.0,2014-05-21,SRR1294262,2013-09-17T19:38:47Z,SRS380333,SRP012000,TARGET-20-PANTNA-09A-02R,RNA,TARGET-20-PANTNA-09A-02R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PANTNA,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1294262,"Acute Myeloid Leukemia,n=476",17.5780821917808,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1294263,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN01778200,BCCAGSC,PCR,sra,SRX548888,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12612,2014-05-21,15909,7177,ILLUMINA,136534.0,2014-05-21,SRR1294263,2013-09-19T20:28:03Z,SRS380361,SRP012000,TARGET-20-PARGVC-03A-03R,RNA,TARGET-20-PARGVC-03A-03R,Primary Blood Derived Cancer - Peripheral Blood,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARGVC,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1294263,"Acute Myeloid Leukemia,n=476",4.93698630136986,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1294264,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN01778242,BCCAGSC,PCR,sra,SRX548854,215,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12557,2014-05-21,17872,9209,ILLUMINA,136393.0,2014-05-21,SRR1294264,2013-09-17T19:33:38Z,SRS380404,SRP012000,TARGET-20-PARBRA-09A-03R,RNA,TARGET-20-PARBRA-09A-03R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARBRA,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1294264,"Acute Myeloid Leukemia, KMT2A rearrangement,n=60",7.64931506849315,AML-KMT2A,"Acute Myeloid Leukemia, KMT2A rearrangement,n=60",Acute Myeloid Leukemia,"KMT2A rearrangement,n=60/TARGET"
SRR1294265,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN01778285,BCCAGSC,PCR,sra,SRX548900,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12536,2014-05-21,18129,9634,ILLUMINA,136480.0,2014-05-21,SRR1294265,2013-09-18T20:31:15Z,SRS380357,SRP012000,TARGET-20-PANWHP-09A-02R,RNA,TARGET-20-PANWHP-09A-02R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PANWHP,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1294265,"Acute Myeloid Leukemia,n=476",5.07397260273972,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1294266,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN01778136,BCCAGSC,PCR,sra,SRX548869,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12537,2014-05-21,14632,7175,ILLUMINA,136395.0,2014-05-21,SRR1294266,2013-09-17T19:38:45Z,SRS380365,SRP012000,TARGET-20-PANYGP-09A-01R,RNA,TARGET-20-PANYGP-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PANYGP,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1294266,"Acute Myeloid Leukemia,n=476",5.64109589041095,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1294267,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN01778057,BCCAGSC,PCR,sra,SRX548910,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12522,2014-05-21,15391,8070,ILLUMINA,136469.0,2014-05-21,SRR1294267,2013-09-18T20:30:22Z,SRS380369,SRP012000,TARGET-20-PANKFZ-09A-04R,RNA,TARGET-20-PANKFZ-09A-04R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PANKFZ,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1294267,"Acute Myeloid Leukemia,n=476",1.8904109589041,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1294268,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN01778002,BCCAGSC,PCR,sra,SRX548908,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12516,2014-05-21,16083,8496,ILLUMINA,136480.0,2014-05-21,SRR1294268,2013-09-18T20:31:15Z,SRS380442,SRP012000,TARGET-20-PANGCM-03A-03R,RNA,TARGET-20-PANGCM-03A-03R,Primary Blood Derived Cancer - Peripheral Blood,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PANGCM,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1294268,"Acute Myeloid Leukemia,n=476",8.86301369863013,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1294269,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN01778062,BCCAGSC,PCR,sra,SRX548903,217,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12625,2014-05-21,16065,8113,ILLUMINA,136470.0,2014-05-21,SRR1294269,2013-09-18T20:30:25Z,SRS380273,SRP012000,TARGET-20-PASCCS-09A-01R,RNA,TARGET-20-PASCCS-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASCCS,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1294269,"Acute Myeloid Leukemia,n=476",11.9369863013698,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1294270,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN01778077,BCCAGSC,PCR,sra,SRX548913,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12626,2014-05-21,16029,7949,ILLUMINA,136388.0,2014-05-21,SRR1294270,2013-09-17T19:33:25Z,SRS380413,SRP012000,TARGET-20-PATAST-09A-01R,RNA,TARGET-20-PATAST-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PATAST,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1294270,"Acute Myeloid Leukemia,n=476",16.2356164383561,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1294271,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN01778250,BCCAGSC,PCR,sra,SRX548860,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12509,2014-05-21,14998,7790,ILLUMINA,136473.0,2014-05-21,SRR1294271,2013-09-18T20:30:31Z,SRS380291,SRP012000,TARGET-20-PAMYAS-09A-03R,RNA,TARGET-20-PAMYAS-09A-03R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PAMYAS,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1294271,"Acute Myeloid Leukemia,n=476",10.8821917808219,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1294272,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN01778081,BCCAGSC,PCR,sra,SRX548845,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12533,2014-05-21,18165,9722,ILLUMINA,136479.0,2014-05-21,SRR1294272,2013-09-18T20:31:12Z,SRS380334,SRP012000,TARGET-20-PANUUA-09A-02R,RNA,TARGET-20-PANUUA-09A-02R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PANUUA,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1294272,"Acute Myeloid Leukemia,n=476",14.8082191780821,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1294273,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN01778012,BCCAGSC,PCR,sra,SRX548872,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12544,2014-05-21,16813,9037,ILLUMINA,136471.0,2014-05-21,SRR1294273,2013-09-18T20:30:27Z,SRS380268,SRP012000,TARGET-20-PAPWHS-09A-03R,RNA,TARGET-20-PAPWHS-09A-03R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PAPWHS,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1294273,"Acute Myeloid Leukemia,n=476",13.2931506849315,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1294274,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN01778282,BCCAGSC,PCR,sra,SRX548925,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12519,2014-05-21,17744,9360,ILLUMINA,136469.0,2014-05-21,SRR1294274,2013-09-18T20:30:22Z,SRS380296,SRP012000,TARGET-20-PANINI-09A-03R,RNA,TARGET-20-PANINI-09A-03R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PANINI,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1294274,"Acute Myeloid Leukemia,n=476",16.7616438356164,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1294275,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN01778249,BCCAGSC,PCR,sra,SRX548916,214,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12581,2014-05-21,15896,7576,ILLUMINA,136939.0,2014-05-21,SRR1294275,2013-10-09T21:14:37Z,SRS380390,SRP012000,TARGET-20-PARUWX-09A-02R,RNA,TARGET-20-PARUWX-09A-02R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARUWX,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1294275,"Acute Myeloid Leukemia,n=476",2.87397260273972,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1294276,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN01778115,BCCAGSC,PCR,sra,SRX548923,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12619,2014-05-21,17215,8553,ILLUMINA,136389.0,2014-05-21,SRR1294276,2013-09-17T19:33:27Z,SRS380344,SRP012000,TARGET-20-PASLSD-03A-01R,RNA,TARGET-20-PASLSD-03A-01R,Primary Blood Derived Cancer - Peripheral Blood,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASLSD,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1294276,"Acute Myeloid Leukemia, KMT2A rearrangement,n=60",2.65479452054794,AML-KMT2A,"Acute Myeloid Leukemia, KMT2A rearrangement,n=60",Acute Myeloid Leukemia,"KMT2A rearrangement,n=60/TARGET"
SRR1294278,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN01778184,BCCAGSC,PCR,sra,SRX548876,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12632,2014-05-21,19631,10301,ILLUMINA,136467.0,2014-05-21,SRR1294278,2013-09-18T20:30:18Z,SRS380299,SRP012000,TARGET-20-PASFLM-09A-01R,RNA,TARGET-20-PASFLM-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASFLM,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1294278,"Acute Myeloid Leukemia,n=476",14.0821917808219,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1294279,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN01778283,BCCAGSC,PCR,sra,SRX548895,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12523,2014-05-21,17140,8744,ILLUMINA,136475.0,2014-05-21,SRR1294279,2013-09-18T20:31:04Z,SRS380279,SRP012000,TARGET-20-PANKKE-09A-03R,RNA,TARGET-20-PANKKE-09A-03R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PANKKE,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1294279,"INFANT_Acute Myeloid Leukemia,n=21",0.715068493150684,AML_INFANT,"INFANT_Acute Myeloid Leukemia,n=21",Acute Myeloid Leukemia,"INFANT,n=21/TARGET"
SRR1294280,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN01778269,BCCAGSC,PCR,sra,SRX548904,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12641,2014-05-21,20526,10829,ILLUMINA,136391.0,2014-05-21,SRR1294280,2013-09-17T19:33:32Z,SRS380318,SRP012000,TARGET-20-PATJHJ-09A-01R,RNA,TARGET-20-PATJHJ-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PATJHJ,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1294280,"INFANT_Acute Myeloid Leukemia, KMT2A rearrangement,n=17",0.375342465753424,AML-KMT2A_INFANT,"INFANT_Acute Myeloid Leukemia, KMT2A rearrangement,n=17",Acute Myeloid Leukemia,"INFANT,KMT2A rearrangement,n=17/TARGET"
SRR1294281,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN01778155,BCCAGSC,PCR,sra,SRX548924,217,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12570,2014-05-21,15390,7765,ILLUMINA,136470.0,2014-05-21,SRR1294281,2013-09-18T20:30:25Z,SRS380336,SRP012000,TARGET-20-PARJCR-09A-01R,RNA,TARGET-20-PARJCR-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARJCR,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1294281,"Acute Myeloid Leukemia, KMT2A rearrangement,n=60",14.6520547945205,AML-KMT2A,"Acute Myeloid Leukemia, KMT2A rearrangement,n=60",Acute Myeloid Leukemia,"KMT2A rearrangement,n=60/TARGET"
SRR1294282,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN01778128,BCCAGSC,PCR,sra,SRX548868,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12615,2014-05-21,14446,7312,ILLUMINA,136397.0,2014-05-21,SRR1294282,2013-09-17T19:38:49Z,SRS380304,SRP012000,TARGET-20-PASGMZ-09A-01R,RNA,TARGET-20-PASGMZ-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASGMZ,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1294282,"Acute Myeloid Leukemia,n=476",14.0520547945205,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1294283,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN01778247,BCCAGSC,PCR,sra,SRX548889,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12627,2014-05-21,19162,9620,ILLUMINA,136394.0,2014-05-21,SRR1294283,2013-09-17T19:38:42Z,SRS380397,SRP012000,TARGET-20-PASMGW-09A-01R,RNA,TARGET-20-PASMGW-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASMGW,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1294283,"Acute Myeloid Leukemia, KMT2A rearrangement,n=60",8.46301369863013,AML-KMT2A,"Acute Myeloid Leukemia, KMT2A rearrangement,n=60",Acute Myeloid Leukemia,"KMT2A rearrangement,n=60/TARGET"
SRR1294284,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN01778183,BCCAGSC,PCR,sra,SRX548926,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12529,2014-05-21,12366,5565,ILLUMINA,136533.0,2014-05-21,SRR1294284,2013-09-19T20:28:01Z,SRS380382,SRP012000,TARGET-20-PANPTM-09A-02R,RNA,TARGET-20-PANPTM-09A-02R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PANPTM,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1294284,"Acute Myeloid Leukemia,n=476",16.0356164383561,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1294285,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN01778272,BCCAGSC,PCR,sra,SRX548893,214,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12543,2014-05-21,15988,8123,ILLUMINA,136401.0,2014-05-21,SRR1294285,2013-09-17T19:38:59Z,SRS380368,SRP012000,TARGET-20-PAPVZK-09A-03R,RNA,TARGET-20-PAPVZK-09A-03R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PAPVZK,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1294285,"Acute Myeloid Leukemia,n=476",15.9506849315068,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1294286,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN01778174,BCCAGSC,PCR,sra,SRX548855,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12639,2014-05-21,17836,8489,ILLUMINA,136535.0,2014-05-21,SRR1294286,2013-09-19T20:28:05Z,SRS380359,SRP012000,TARGET-20-PASIEJ-09A-01R,RNA,TARGET-20-PASIEJ-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASIEJ,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1294286,"Acute Myeloid Leukemia,n=476",7.35890410958904,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1294287,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02443026,BCCAGSC,PCR,sra,SRX548922,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A34422,2014-05-21,13266,6725,ILLUMINA,138619.0,2014-05-21,SRR1294287,2013-12-31T21:26:54Z,SRS616790,SRP012000,TARGET-20-PARENB-09A-03R,RNA,TARGET-20-PARENB-09A-03R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARENB,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute leukemia of Ambiguous Lineage (ALAL),SRR1294287,"Acute Myeloid Leukemia,n=476",7.55616438356164,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1294288,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN01778215,BCCAGSC,PCR,sra,SRX548859,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12604,2014-05-21,15358,6977,ILLUMINA,136533.0,2014-05-21,SRR1294288,2013-09-19T20:28:01Z,SRS380354,SRP012000,TARGET-20-PAPAWN-09A-02R,RNA,TARGET-20-PAPAWN-09A-02R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PAPAWN,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1294288,"Acute Myeloid Leukemia,n=476",5.90136986301369,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1294289,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN01778034,BCCAGSC,PCR,sra,SRX548901,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12576,2014-05-21,16292,8239,ILLUMINA,136389.0,2014-05-21,SRR1294289,2013-09-17T19:33:27Z,SRS380267,SRP012000,TARGET-20-PARMZF-09A-02R,RNA,TARGET-20-PARMZF-09A-02R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARMZF,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1294289,"Acute Myeloid Leukemia,n=476",8.66575342465753,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1294290,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN01778177,BCCAGSC,PCR,sra,SRX548915,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12513,2014-05-21,19778,10398,ILLUMINA,136399.0,2014-05-21,SRR1294290,2013-09-17T19:38:54Z,SRS380434,SRP012000,TARGET-20-PANBZH-09A-03R,RNA,TARGET-20-PANBZH-09A-03R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PANBZH,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1294290,"Acute Myeloid Leukemia,n=476",10.7424657534246,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1294291,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN01778167,BCCAGSC,PCR,sra,SRX548914,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12518,2014-05-21,17475,9156,ILLUMINA,136472.0,2014-05-21,SRR1294291,2013-09-18T20:30:29Z,SRS380426,SRP012000,TARGET-20-PANGJY-09A-03R,RNA,TARGET-20-PANGJY-09A-03R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PANGJY,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1294291,"Acute Myeloid Leukemia,n=476",1.62739726027397,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1294292,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN01778146,BCCAGSC,PCR,sra,SRX548917,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12569,2014-05-21,17165,8349,ILLUMINA,136395.0,2014-05-21,SRR1294292,2013-09-17T19:38:45Z,SRS380271,SRP012000,TARGET-20-PARHVK-09A-04R,RNA,TARGET-20-PARHVK-09A-04R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARHVK,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1294292,"Acute Myeloid Leukemia, KMT2A rearrangement,n=60",13.6520547945205,AML-KMT2A,"Acute Myeloid Leukemia, KMT2A rearrangement,n=60",Acute Myeloid Leukemia,"KMT2A rearrangement,n=60/TARGET"
SRR1294293,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN01778039,BCCAGSC,PCR,sra,SRX548921,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12658,2014-05-21,16128,8211,ILLUMINA,136481.0,2014-05-21,SRR1294293,2013-09-18T20:31:17Z,SRS380432,SRP012000,TARGET-20-PASWLN-09A-01R,RNA,TARGET-20-PASWLN-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASWLN,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1294293,"Acute Myeloid Leukemia, KMT2A rearrangement,n=60",18.1671232876712,AML-KMT2A,"Acute Myeloid Leukemia, KMT2A rearrangement,n=60",Acute Myeloid Leukemia,"KMT2A rearrangement,n=60/TARGET"
SRR1294294,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN01778056,BCCAGSC,PCR,sra,SRX548879,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12545,2014-05-21,14414,7392,ILLUMINA,136475.0,2014-05-21,SRR1294294,2013-09-18T20:31:04Z,SRS380373,SRP012000,TARGET-20-PAPWIU-09A-03R,RNA,TARGET-20-PAPWIU-09A-03R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PAPWIU,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1294294,"Acute Myeloid Leukemia,n=476",12.1123287671232,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1294296,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN01778091,BCCAGSC,PCR,sra,SRX548899,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12655,2014-05-21,16570,8655,ILLUMINA,136399.0,2014-05-21,SRR1294296,2013-09-17T19:38:54Z,SRS380388,SRP012000,TARGET-20-PASWAT-09A-01R,RNA,TARGET-20-PASWAT-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASWAT,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1294296,"Acute Myeloid Leukemia,n=476",14.1287671232876,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1379910,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02260660,BCCAGSC,PCR,sra,SRX590870,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32032,2014-06-12,8861,4089,ILLUMINA,139993.0,2014-06-12,SRR1379910,2014-02-27T20:45:34Z,SRS605618,SRP012000,TARGET-20-PARUBT-40A-01R,RNA,TARGET-20-PARUBT-40A-01R,Recurrent Blood Derived Cancer - Peripheral Blood,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARUBT,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute leukemia of Ambiguous Lineage (ALAL),SRR1379910,"Acute Myeloid Leukemia,n=476",7.37534246575342,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1610443,RNA-Seq,GCA_000001405.13,150,PRJNA89529,SAMN03178163,BCCAGSC,PCR,sra,SRX730960,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A35283,2014-10-10,19266,9371,ILLUMINA,140240.0,2014-10-10,SRR1610443,2014-03-07T21:34:04Z,SRS748341,SRP011999,TARGET-10-PASEVJ-09B-01R,RNA,TARGET-10-PASEVJ-09B-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PASEVJ,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1610443,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",11.1945205479452,BALL-NOS,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",B-cell Acute Lymphoblastic Leukemia,"NOS,n=71/TARGET"
SRR1610444,RNA-Seq,GCA_000001405.13,150,PRJNA89529,SAMN02385791,BCCAGSC,PCR,sra,SRX730958,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32637,2014-10-10,15096,6615,ILLUMINA,137957.0,2014-10-10,SRR1610444,2013-11-26T22:02:14Z,SRS602045,SRP011999,TARGET-10-PAPCUR-09A-01R,RNA,TARGET-10-PAPCUR-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PAPCUR,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Induction Failure AML (AML-IF),SRR1610444,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",3.00821917808219,BALL-NOS,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",B-cell Acute Lymphoblastic Leukemia,"NOS,n=71/TARGET"
SRR1610446,RNA-Seq,GCA_000001405.13,150,PRJNA89529,SAMN02385787,BCCAGSC,PCR,sra,SRX730959,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32718,2014-10-10,13302,6076,ILLUMINA,138011.0,2014-10-10,SRR1610446,2013-11-27T21:55:21Z,SRS602165,SRP011999,TARGET-10-PAPEWB-09A-01R,RNA,TARGET-10-PAPEWB-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PAPEWB,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1610446,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",7.13972602739726,BALL-NOS,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",B-cell Acute Lymphoblastic Leukemia,"NOS,n=71/TARGET"
SRR1664631,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02443001,BCCAGSC,PCR,sra,SRX548887,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A34423,2014-11-27,21519,10857,ILLUMINA,138619.0,2014-11-27,SRR1664631,2013-12-31T21:26:54Z,SRS616787,SRP012000,TARGET-20-PARFAL-09A-05R,RNA,TARGET-20-PARFAL-09A-05R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARFAL,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute leukemia of Ambiguous Lineage (ALAL),SRR1664631,"Acute Myeloid Leukemia, KMT2A rearrangement,n=60",18.9643835616438,AML-KMT2A,"Acute Myeloid Leukemia, KMT2A rearrangement,n=60",Acute Myeloid Leukemia,"KMT2A rearrangement,n=60/TARGET"
SRR1664632,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02442949,BCCAGSC,PCR,sra,SRX542494,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A34412,2014-11-27,32899,16646,ILLUMINA,138620.0,2014-11-28,SRR1664632,2013-12-31T21:28:19Z,SRS606815,SRP012000,TARGET-20-PAMYJX-09A-04R,RNA,TARGET-20-PAMYJX-09A-04R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PAMYJX,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute leukemia of Ambiguous Lineage (ALAL),SRR1664632,"Acute Myeloid Leukemia,n=476",12.6219178082191,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1664633,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN01778032,BCCAGSC,PCR,sra,SRX548907,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A34424,2014-11-27,17440,4536,ILLUMINA,147088.0,2014-11-27,SRR1664633,2014-11-07T18:35:35Z,SRS380408,SRP012000,TARGET-20-PARUUB-09A-02R,RNA,TARGET-20-PARUUB-09A-02R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARUUB,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1664633,"Acute Myeloid Leukemia,n=476",17.3013698630136,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1664634,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02443402,BCCAGSC,PCR,sra,SRX548874,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A34419,2014-11-27,20446,10389,ILLUMINA,138615.0,2014-11-27,SRR1664634,2013-12-31T21:26:45Z,SRS616785,SRP012000,TARGET-20-PARBIU-09A-03R,RNA,TARGET-20-PARBIU-09A-03R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARBIU,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute leukemia of Ambiguous Lineage (ALAL),SRR1664634,"Acute Myeloid Leukemia,n=476",15.972602739726,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1664635,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02443372,BCCAGSC,PCR,sra,SRX542496,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A34415,2014-11-27,18010,8944,ILLUMINA,138617.0,2014-11-27,SRR1664635,2013-12-31T21:26:50Z,SRS606816,SRP012000,TARGET-20-PANKFG-09A-02R,RNA,TARGET-20-PANKFG-09A-02R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PANKFG,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute leukemia of Ambiguous Lineage (ALAL),SRR1664635,"Acute Myeloid Leukemia,n=476",1.11780821917808,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1664636,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02443106,BCCAGSC,PCR,sra,SRX548853,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A34411,2014-11-27,18457,9269,ILLUMINA,138635.0,2014-11-28,SRR1664636,2013-12-31T21:30:01Z,SRS616781,SRP012000,TARGET-20-PALGKX-09A-03R,RNA,TARGET-20-PALGKX-09A-03R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PALGKX,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute leukemia of Ambiguous Lineage (ALAL),SRR1664636,"Acute Myeloid Leukemia,n=476",12.9397260273972,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1664637,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02443124,BCCAGSC,PCR,sra,SRX548878,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A34413,2014-11-27,16387,8118,ILLUMINA,138616.0,2014-11-27,SRR1664637,2013-12-31T21:26:48Z,SRS616786,SRP012000,TARGET-20-PANFMG-09A-04R,RNA,TARGET-20-PANFMG-09A-04R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PANFMG,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute leukemia of Ambiguous Lineage (ALAL),SRR1664637,"Acute Myeloid Leukemia, KMT2A rearrangement,n=60",3.91780821917808,AML-KMT2A,"Acute Myeloid Leukemia, KMT2A rearrangement,n=60",Acute Myeloid Leukemia,"KMT2A rearrangement,n=60/TARGET"
SRR1664638,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02443214,BCCAGSC,PCR,sra,SRX548927,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A34420,2014-11-27,18646,9405,ILLUMINA,138618.0,2014-11-27,SRR1664638,2013-12-31T21:26:52Z,SRS616789,SRP012000,TARGET-20-PARBXE-09A-04R,RNA,TARGET-20-PARBXE-09A-04R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARBXE,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute leukemia of Ambiguous Lineage (ALAL),SRR1664638,"Acute Myeloid Leukemia,n=476",1.22465753424657,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1664639,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02443062,BCCAGSC,PCR,sra,SRX548863,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A34414,2014-11-27,18064,9101,ILLUMINA,138621.0,2014-11-27,SRR1664639,2013-12-31T21:28:22Z,SRS616782,SRP012000,TARGET-20-PANGDN-09A-05R,RNA,TARGET-20-PANGDN-09A-05R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PANGDN,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute leukemia of Ambiguous Lineage (ALAL),SRR1664639,"Acute Myeloid Leukemia,n=476",18.0547945205479,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1664640,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02443376,BCCAGSC,PCR,sra,SRX548890,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A34425,2014-11-27,14948,7421,ILLUMINA,138621.0,2014-11-27,SRR1664640,2013-12-31T21:28:22Z,SRS616788,SRP012000,TARGET-20-PASGGK-03A-01R,RNA,TARGET-20-PASGGK-03A-01R,Primary Blood Derived Cancer - Peripheral Blood,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASGGK,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute leukemia of Ambiguous Lineage (ALAL),SRR1664640,"Acute Myeloid Leukemia, KMT2A rearrangement,n=60",12.2136986301369,AML-KMT2A,"Acute Myeloid Leukemia, KMT2A rearrangement,n=60",Acute Myeloid Leukemia,"KMT2A rearrangement,n=60/TARGET"
SRR1664641,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02443233,BCCAGSC,PCR,sra,SRX543496,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A34428,2014-11-27,17589,8784,ILLUMINA,138635.0,2014-11-28,SRR1664641,2013-12-31T21:30:01Z,SRS607426,SRP012000,TARGET-20-PARCZL-04A-02R,RNA,TARGET-20-PARCZL-04A-02R,Recurrent Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARCZL,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute leukemia of Ambiguous Lineage (ALAL),SRR1664641,"Acute Myeloid Leukemia,n=476",10.4273972602739,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1664642,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02443319,BCCAGSC,PCR,sra,SRX548865,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A34421,2014-11-27,16438,8139,ILLUMINA,138616.0,2014-11-27,SRR1664642,2013-12-31T21:26:48Z,SRS616783,SRP012000,TARGET-20-PARDDY-09A-05R,RNA,TARGET-20-PARDDY-09A-05R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARDDY,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute leukemia of Ambiguous Lineage (ALAL),SRR1664642,"Acute Myeloid Leukemia,n=476",1.85479452054794,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1664643,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02443240,BCCAGSC,PCR,sra,SRX542507,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A34417,2014-11-27,17120,4185,ILLUMINA,147088.0,2014-11-27,SRR1664643,2014-11-07T18:35:35Z,SRS606817,SRP012000,TARGET-20-PANVGP-03A-04R,RNA,TARGET-20-PANVGP-03A-04R,Primary Blood Derived Cancer - Peripheral Blood,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PANVGP,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute leukemia of Ambiguous Lineage (ALAL),SRR1664643,"Acute Myeloid Leukemia,n=476",13.5616438356164,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1664644,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02443197,BCCAGSC,PCR,sra,SRX542465,205,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A34416,2014-11-27,10657,5428,ILLUMINA,138615.0,2014-11-27,SRR1664644,2013-12-31T21:26:45Z,SRS606814,SRP012000,TARGET-20-PANSBH-09A-05R,RNA,TARGET-20-PANSBH-09A-05R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PANSBH,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1664644,"Acute Myeloid Leukemia,n=476",1.34520547945205,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1664645,RNA-Seq,GCA_000001405.13,150,PRJNA89525,SAMN02443093,BCCAGSC,PCR,sra,SRX548873,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A34418,2014-11-27,15514,7724,ILLUMINA,138617.0,2014-11-27,SRR1664645,2013-12-31T21:26:50Z,SRS616784,SRP012000,TARGET-20-PAPVDV-03A-01R,RNA,TARGET-20-PAPVDV-03A-01R,Primary Blood Derived Cancer - Peripheral Blood,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PAPVDV,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute leukemia of Ambiguous Lineage (ALAL),SRR1664645,"Acute Myeloid Leukemia,n=476",6.35068493150685,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1791120,RNA-Seq,,150,PRJNA89525,SAMN02386258,BCCAGSC,PCR,sra,SRX543503,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32033,2015-02-05,24820,16795,ILLUMINA,136782.0,2015-02-05,SRR1791120,2013-10-02T18:29:42Z,SRS605557,SRP012000,TARGET-20-PAEDKB-04A-01R,RNA,TARGET-20-PAEDKB-04A-01R,Recurrent Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PAEDKB,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1791120,"Acute Myeloid Leukemia,n=476",2.23287671232876,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1791121,RNA-Seq,,150,PRJNA89525,SAMN02260523,BCCAGSC,PCR,sra,SRX542535,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31921,2015-02-05,14890,10167,ILLUMINA,137278.0,2015-02-05,SRR1791121,2013-10-23T18:55:56Z,SRS605565,SRP012000,TARGET-20-PARDMG-09A-03R,RNA,TARGET-20-PARDMG-09A-03R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARDMG,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1791121,"Acute Myeloid Leukemia,n=476",17.904109589041,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1791122,RNA-Seq,,150,PRJNA89525,SAMN02260643,BCCAGSC,PCR,sra,SRX542528,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31948,2015-02-05,14659,9601,ILLUMINA,136949.0,2015-02-05,SRR1791122,2013-10-09T21:19:38Z,SRS605862,SRP012000,TARGET-20-PANHYK-09A-01R,RNA,TARGET-20-PANHYK-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PANHYK,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1791122,"Acute Myeloid Leukemia,n=476",6.00273972602739,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1791123,RNA-Seq,,150,PRJNA89525,SAMN02260542,BCCAGSC,PCR,sra,SRX542475,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31990,2015-02-05,12380,8186,ILLUMINA,136951.0,2015-02-05,SRR1791123,2013-10-09T21:19:44Z,SRS605846,SRP012000,TARGET-20-PAEFGR-09A-02R,RNA,TARGET-20-PAEFGR-09A-02R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PAEFGR,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute leukemia of Ambiguous Lineage (ALAL),SRR1791123,"Acute Myeloid Leukemia,n=476",1.50410958904109,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1791124,RNA-Seq,,150,PRJNA89525,SAMN02260644,BCCAGSC,PCR,sra,SRX542498,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31968,2015-02-05,15209,10357,ILLUMINA,137237.0,2015-02-05,SRR1791124,2013-10-22T18:41:24Z,SRS605568,SRP012000,TARGET-20-PAKIYW-09A-01R,RNA,TARGET-20-PAKIYW-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PAKIYW,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1791124,"INFANT_Acute Myeloid Leukemia,n=21",0.446575342465753,AML_INFANT,"INFANT_Acute Myeloid Leukemia,n=21",Acute Myeloid Leukemia,"INFANT,n=21/TARGET"
SRR1791125,RNA-Seq,,150,PRJNA89525,SAMN02260621,BCCAGSC,PCR,sra,SRX543502,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32004,2015-02-05,15140,10048,ILLUMINA,136537.0,2015-02-05,SRR1791125,2013-09-19T20:28:27Z,SRS605592,SRP012000,TARGET-20-PAEFGT-04A-01R,RNA,TARGET-20-PAEFGT-04A-01R,Recurrent Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PAEFGT,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1791125,"Acute Myeloid Leukemia,n=476",14.9369863013698,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1791126,RNA-Seq,,150,PRJNA89525,SAMN02260466,BCCAGSC,PCR,sra,SRX543498,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32018,2015-02-05,12768,8580,ILLUMINA,136781.0,2015-02-05,SRR1791126,2013-10-02T18:29:40Z,SRS605590,SRP012000,TARGET-20-PALGKX-04A-01R,RNA,TARGET-20-PALGKX-04A-01R,Recurrent Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PALGKX,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1791126,"Acute Myeloid Leukemia,n=476",12.9397260273972,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1791127,RNA-Seq,,150,PRJNA89525,SAMN02260549,BCCAGSC,PCR,sra,SRX543475,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32023,2015-02-05,16908,10539,ILLUMINA,136543.0,2015-02-05,SRR1791127,2013-09-19T20:28:40Z,SRS605629,SRP012000,TARGET-20-PASWAJ-04A-02R,RNA,TARGET-20-PASWAJ-04A-02R,Recurrent Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASWAJ,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1791127,"Acute Myeloid Leukemia, KMT2A rearrangement,n=60",9.03561643835616,AML-KMT2A,"Acute Myeloid Leukemia, KMT2A rearrangement,n=60",Acute Myeloid Leukemia,"KMT2A rearrangement,n=60/TARGET"
SRR1791128,RNA-Seq,,150,PRJNA89525,SAMN02260468,BCCAGSC,PCR,sra,SRX542479,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31915,2015-02-05,18554,12664,ILLUMINA,137231.0,2015-02-05,SRR1791128,2013-10-22T18:40:58Z,SRS605845,SRP012000,TARGET-20-PAKIWK-09A-01R,RNA,TARGET-20-PAKIWK-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PAKIWK,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute leukemia of Ambiguous Lineage (ALAL),SRR1791128,"Acute Myeloid Leukemia,n=476",3.41917808219178,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1791129,RNA-Seq,,150,PRJNA89525,SAMN02260517,BCCAGSC,PCR,sra,SRX542532,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31999,2015-02-05,19924,13516,ILLUMINA,137281.0,2015-02-05,SRR1791129,2013-10-23T18:56:03Z,SRS605554,SRP012000,TARGET-20-PASINN-04A-02R,RNA,TARGET-20-PASINN-04A-02R,Recurrent Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASINN,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1791129,"Acute Myeloid Leukemia,n=476",3.64383561643835,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1791130,RNA-Seq,,150,PRJNA89525,SAMN02260578,BCCAGSC,PCR,sra,SRX543513,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32010,2015-02-05,16544,10801,ILLUMINA,136540.0,2015-02-05,SRR1791130,2013-09-19T20:28:33Z,SRS605580,SRP012000,TARGET-20-PANLIZ-04A-02R,RNA,TARGET-20-PANLIZ-04A-02R,Recurrent Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PANLIZ,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1791130,"Acute Myeloid Leukemia,n=476",8.4986301369863,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1791131,RNA-Seq,,150,PRJNA89525,SAMN02260529,BCCAGSC,PCR,sra,SRX542463,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31940,2015-02-05,21844,14927,ILLUMINA,137232.0,2015-02-05,SRR1791131,2013-10-22T18:41:01Z,SRS605653,SRP012000,TARGET-20-PADYIR-09A-01R,RNA,TARGET-20-PADYIR-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PADYIR,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1791131,"Acute Myeloid Leukemia,n=476",3.17534246575342,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1791132,RNA-Seq,,150,PRJNA89525,SAMN02260653,BCCAGSC,PCR,sra,SRX542516,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31966,2015-02-05,18500,12102,ILLUMINA,136951.0,2015-02-05,SRR1791132,2013-10-09T21:19:44Z,SRS605567,SRP012000,TARGET-20-PASFJB-03A-01R,RNA,TARGET-20-PASFJB-03A-01R,Primary Blood Derived Cancer - Peripheral Blood,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASFJB,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1791132,"Acute Myeloid Leukemia,n=476",11.372602739726,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1791133,RNA-Seq,,150,PRJNA89525,SAMN02260548,BCCAGSC,PCR,sra,SRX543484,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32021,2015-02-05,14315,9750,ILLUMINA,136539.0,2015-02-05,SRR1791133,2013-09-19T20:28:31Z,SRS605631,SRP012000,TARGET-20-PARBIU-04A-02R,RNA,TARGET-20-PARBIU-04A-02R,Recurrent Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARBIU,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1791133,"Acute Myeloid Leukemia,n=476",15.972602739726,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1791134,RNA-Seq,,150,PRJNA89525,SAMN02260618,BCCAGSC,PCR,sra,SRX542536,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31934,2015-02-05,14482,9649,ILLUMINA,136946.0,2015-02-05,SRR1791134,2013-10-09T21:14:53Z,SRS605662,SRP012000,TARGET-20-PAEERJ-09A-01R,RNA,TARGET-20-PAEERJ-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PAEERJ,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute leukemia of Ambiguous Lineage (ALAL),SRR1791134,"Acute Myeloid Leukemia,n=476",13.9232876712328,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1791135,RNA-Seq,,150,PRJNA89525,SAMN02260500,BCCAGSC,PCR,sra,SRX543507,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32031,2015-02-05,14401,9349,ILLUMINA,136784.0,2015-02-05,SRR1791135,2013-10-02T18:29:46Z,SRS605608,SRP012000,TARGET-20-PASJGZ-04A-01R,RNA,TARGET-20-PASJGZ-04A-01R,Recurrent Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASJGZ,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1791135,"Acute Myeloid Leukemia,n=476",1.80273972602739,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1791136,RNA-Seq,,150,PRJNA89525,SAMN02260539,BCCAGSC,PCR,sra,SRX543512,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32020,2015-02-05,7892,4941,ILLUMINA,136543.0,2015-02-05,SRR1791136,2013-09-19T20:28:40Z,SRS605648,SRP012000,TARGET-20-PAMYAS-04A-03R,RNA,TARGET-20-PAMYAS-04A-03R,Recurrent Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PAMYAS,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1791136,"Acute Myeloid Leukemia,n=476",10.8821917808219,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1791137,RNA-Seq,,150,PRJNA89525,SAMN01778083,BCCAGSC,PCR,sra,SRX542527,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31988,2015-02-05,17785,12079,ILLUMINA,137233.0,2015-02-05,SRR1791137,2013-10-22T18:41:03Z,SRS605613,SRP012000,TARGET-20-PARXNG-09A-01R,RNA,TARGET-20-PARXNG-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARXNG,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1791137,"Acute Myeloid Leukemia,n=476",10.1013698630136,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1791138,RNA-Seq,,150,PRJNA89525,SAMN02260545,BCCAGSC,PCR,sra,SRX543509,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32003,2015-02-05,11612,7599,ILLUMINA,136784.0,2015-02-05,SRR1791138,2013-10-02T18:29:46Z,SRS605854,SRP012000,TARGET-20-PADZCG-04A-01R,RNA,TARGET-20-PADZCG-04A-01R,Recurrent Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PADZCG,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1791138,"Acute Myeloid Leukemia,n=476",14.5890410958904,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1791139,RNA-Seq,,150,PRJNA89525,SAMN02260476,BCCAGSC,PCR,sra,SRX543488,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32001,2015-02-05,19300,13071,ILLUMINA,136778.0,2015-02-05,SRR1791139,2013-10-02T18:28:00Z,SRS605642,SRP012000,TARGET-20-PAKIWK-04A-01R,RNA,TARGET-20-PAKIWK-04A-01R,Recurrent Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PAKIWK,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1791139,"Acute Myeloid Leukemia,n=476",3.41917808219178,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1791140,RNA-Seq,,150,PRJNA89525,SAMN02260530,BCCAGSC,PCR,sra,SRX543483,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32015,2015-02-05,17027,11550,ILLUMINA,136538.0,2015-02-05,SRR1791140,2013-09-19T20:28:29Z,SRS605639,SRP012000,TARGET-20-PAEIKD-04A-01R,RNA,TARGET-20-PAEIKD-04A-01R,Recurrent Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PAEIKD,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1791140,"INFANT_Acute Myeloid Leukemia, KMT2A rearrangement,n=17",0.772602739726027,AML-KMT2A_INFANT,"INFANT_Acute Myeloid Leukemia, KMT2A rearrangement,n=17",Acute Myeloid Leukemia,"INFANT,KMT2A rearrangement,n=17/TARGET"
SRR1791141,RNA-Seq,,150,PRJNA89525,SAMN02260556,BCCAGSC,PCR,sra,SRX543504,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32025,2015-02-05,2333,1488,ILLUMINA,136780.0,2015-02-05,SRR1791141,2013-10-02T18:29:37Z,SRS605660,SRP012000,TARGET-20-PARDDY-04A-01R,RNA,TARGET-20-PARDDY-04A-01R,Recurrent Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARDDY,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute leukemia of Ambiguous Lineage (ALAL),SRR1791141,"Acute Myeloid Leukemia,n=476",1.85479452054794,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1791142,RNA-Seq,,150,PRJNA89525,SAMN02260462,BCCAGSC,PCR,sra,SRX543510,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32009,2015-02-05,15137,9816,ILLUMINA,136942.0,2015-02-05,SRR1791142,2013-10-09T21:14:44Z,SRS605574,SRP012000,TARGET-20-PAKTCX-04A-01R,RNA,TARGET-20-PAKTCX-04A-01R,Recurrent Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PAKTCX,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1791142,"Acute Myeloid Leukemia,n=476",8.93698630136986,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1791143,RNA-Seq,,150,PRJNA89525,SAMN02260591,BCCAGSC,PCR,sra,SRX542469,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31983,2015-02-05,21096,13938,ILLUMINA,136946.0,2015-02-05,SRR1791143,2013-10-09T21:14:53Z,SRS605637,SRP012000,TARGET-20-PANLLX-09A-01R,RNA,TARGET-20-PANLLX-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PANLLX,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1791143,"Acute Myeloid Leukemia,n=476",12.4904109589041,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1791144,RNA-Seq,,150,PRJNA89525,SAMN02260546,BCCAGSC,PCR,sra,SRX542505,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31923,2015-02-05,15818,10681,ILLUMINA,137230.0,2015-02-05,SRR1791144,2013-10-22T18:40:55Z,SRS605620,SRP012000,TARGET-20-PARYFN-03A-01R,RNA,TARGET-20-PARYFN-03A-01R,Primary Blood Derived Cancer - Peripheral Blood,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARYFN,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute leukemia of Ambiguous Lineage (ALAL),SRR1791144,"Acute Myeloid Leukemia,n=476",4.37534246575342,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1791145,RNA-Seq,,150,PRJNA89525,SAMN02260592,BCCAGSC,PCR,sra,SRX542480,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31959,2015-02-05,15083,10232,ILLUMINA,137281.0,2015-02-05,SRR1791145,2013-10-23T18:56:03Z,SRS605622,SRP012000,TARGET-20-PANLIR-09A-02R,RNA,TARGET-20-PANLIR-09A-02R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PANLIR,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute leukemia of Ambiguous Lineage (ALAL),SRR1791145,"Acute Myeloid Leukemia,n=476",16.1232876712328,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1791146,RNA-Seq,,150,PRJNA89525,SAMN02260554,BCCAGSC,PCR,sra,SRX542490,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31991,2015-02-05,12688,8182,ILLUMINA,136948.0,2015-02-05,SRR1791146,2013-10-09T21:19:35Z,SRS605561,SRP012000,TARGET-20-PARSAN-03A-01R,RNA,TARGET-20-PARSAN-03A-01R,Primary Blood Derived Cancer - Peripheral Blood,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARSAN,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1791146,"Acute Myeloid Leukemia,n=476",14.8493150684931,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1791147,RNA-Seq,,150,PRJNA89525,SAMN02260652,BCCAGSC,PCR,sra,SRX543500,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32016,2015-02-05,18565,12764,ILLUMINA,136542.0,2015-02-05,SRR1791147,2013-09-19T20:28:38Z,SRS605853,SRP012000,TARGET-20-PAECCE-04A-01R,RNA,TARGET-20-PAECCE-04A-01R,Recurrent Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PAECCE,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1791147,"Acute Myeloid Leukemia,n=476",2.46575342465753,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1791148,RNA-Seq,,150,PRJNA89525,SAMN02260662,BCCAGSC,PCR,sra,SRX542504,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31962,2015-02-05,15604,10616,ILLUMINA,137235.0,2015-02-05,SRR1791148,2013-10-22T18:41:08Z,SRS605599,SRP012000,TARGET-20-PANUTB-09A-05R,RNA,TARGET-20-PANUTB-09A-05R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PANUTB,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1791148,"Acute Myeloid Leukemia,n=476",15.3068493150684,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1791149,RNA-Seq,,150,PRJNA89525,SAMN02260615,BCCAGSC,PCR,sra,SRX543493,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32040,2015-02-05,18610,12315,ILLUMINA,136537.0,2015-02-05,SRR1791149,2013-09-19T20:28:27Z,SRS605615,SRP012000,TARGET-20-PARYVW-04A-02R,RNA,TARGET-20-PARYVW-04A-02R,Recurrent Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARYVW,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute leukemia of Ambiguous Lineage (ALAL),SRR1791149,"Acute Myeloid Leukemia,n=476",1.81917808219178,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1791150,RNA-Seq,,150,PRJNA89525,SAMN02260535,BCCAGSC,PCR,sra,SRX543477,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32014,2015-02-05,20721,13904,ILLUMINA,136781.0,2015-02-05,SRR1791150,2013-10-02T18:29:40Z,SRS605632,SRP012000,TARGET-20-PAKERZ-04A-01R,RNA,TARGET-20-PAKERZ-04A-01R,Recurrent Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PAKERZ,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1791150,"Acute Myeloid Leukemia,n=476",2.8,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1791151,RNA-Seq,,150,PRJNA89525,SAMN02386334,BCCAGSC,PCR,sra,SRX543479,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32041,2015-02-05,15105,9858,ILLUMINA,136540.0,2015-02-05,SRR1791151,2013-09-19T20:28:33Z,SRS605641,SRP012000,TARGET-20-PASMYS-04A-02R,RNA,TARGET-20-PASMYS-04A-02R,Recurrent Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASMYS,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1791151,"Acute Myeloid Leukemia,n=476",2.10410958904109,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1791152,RNA-Seq,,150,PRJNA89525,SAMN02260465,BCCAGSC,PCR,sra,SRX542508,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32000,2015-02-05,14588,9771,ILLUMINA,137277.0,2015-02-05,SRR1791152,2013-10-23T18:55:54Z,SRS605601,SRP012000,TARGET-20-PASXNR-04A-01R,RNA,TARGET-20-PASXNR-04A-01R,Recurrent Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASXNR,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1791152,"Acute Myeloid Leukemia,n=476",2.43835616438356,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1791153,RNA-Seq,,150,PRJNA89525,SAMN02260457,BCCAGSC,PCR,sra,SRX542499,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31928,2015-02-05,18789,12763,ILLUMINA,137230.0,2015-02-05,SRR1791153,2013-10-22T18:40:55Z,SRS605583,SRP012000,TARGET-20-PAKSMZ-03A-02R,RNA,TARGET-20-PAKSMZ-03A-02R,Primary Blood Derived Cancer - Peripheral Blood,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PAKSMZ,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1791153,"Acute Myeloid Leukemia,n=476",17.2684931506849,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1791154,RNA-Seq,,150,PRJNA89525,SAMN02260489,BCCAGSC,PCR,sra,SRX542533,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31924,2015-02-05,19657,13376,ILLUMINA,137278.0,2015-02-05,SRR1791154,2013-10-23T18:55:56Z,SRS605587,SRP012000,TARGET-20-PASCGR-03A-02R,RNA,TARGET-20-PASCGR-03A-02R,Primary Blood Derived Cancer - Peripheral Blood,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASCGR,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1791154,"Acute Myeloid Leukemia, KMT2A rearrangement,n=60",18.2465753424657,AML-KMT2A,"Acute Myeloid Leukemia, KMT2A rearrangement,n=60",Acute Myeloid Leukemia,"KMT2A rearrangement,n=60/TARGET"
SRR1791155,RNA-Seq,,150,PRJNA89525,SAMN02260637,BCCAGSC,PCR,sra,SRX542466,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31975,2015-02-05,15504,10462,ILLUMINA,137234.0,2015-02-05,SRR1791155,2013-10-22T18:41:06Z,SRS605576,SRP012000,TARGET-20-PASFEW-09A-05R,RNA,TARGET-20-PASFEW-09A-05R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASFEW,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1791155,"Acute Myeloid Leukemia,n=476",1.17260273972602,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1791156,RNA-Seq,,150,PRJNA89525,SAMN02386214,BCCAGSC,PCR,sra,SRX543482,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32038,2015-02-05,17642,12003,ILLUMINA,136541.0,2015-02-05,SRR1791156,2013-09-19T20:28:36Z,SRS605658,SRP012000,TARGET-20-PASBBE-04A-02R,RNA,TARGET-20-PASBBE-04A-02R,Recurrent Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASBBE,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute leukemia of Ambiguous Lineage (ALAL),SRR1791156,"Acute Myeloid Leukemia,n=476",10.6547945205479,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1791157,RNA-Seq,,150,PRJNA89525,SAMN02260567,BCCAGSC,PCR,sra,SRX543501,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32002,2015-02-05,15960,10280,ILLUMINA,136942.0,2015-02-05,SRR1791157,2013-10-09T21:14:44Z,SRS605602,SRP012000,TARGET-20-PABLDZ-04A-01R,RNA,TARGET-20-PABLDZ-04A-01R,Recurrent Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PABLDZ,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1791157,"Acute Myeloid Leukemia,n=476",6.72602739726027,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1791158,RNA-Seq,,150,PRJNA89525,SAMN02260496,BCCAGSC,PCR,sra,SRX542493,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31995,2015-02-05,17832,12116,ILLUMINA,137235.0,2015-02-05,SRR1791158,2013-10-22T18:41:08Z,SRS605610,SRP012000,TARGET-20-PARCVS-04A-01R,RNA,TARGET-20-PARCVS-04A-01R,Recurrent Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARCVS,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1791158,"Acute Myeloid Leukemia,n=476",15.3424657534246,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1791159,RNA-Seq,,150,PRJNA89525,SAMN02260622,BCCAGSC,PCR,sra,SRX542491,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31912,2015-02-05,18175,12123,ILLUMINA,137277.0,2015-02-05,SRR1791159,2013-10-23T18:55:54Z,SRS605644,SRP012000,TARGET-20-PAPXRJ-09A-01R,RNA,TARGET-20-PAPXRJ-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PAPXRJ,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1791159,"Acute Myeloid Leukemia,n=476",7.82191780821917,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1791160,RNA-Seq,,150,PRJNA89525,SAMN02260501,BCCAGSC,PCR,sra,SRX543492,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32008,2015-02-05,19415,12130,ILLUMINA,136780.0,2015-02-05,SRR1791160,2013-10-02T18:29:37Z,SRS605643,SRP012000,TARGET-20-PASGWH-04A-02R,RNA,TARGET-20-PASGWH-04A-02R,Recurrent Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASGWH,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1791160,"Acute Myeloid Leukemia,n=476",14.386301369863,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1791161,RNA-Seq,,150,PRJNA89525,SAMN02260559,BCCAGSC,PCR,sra,SRX542520,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31958,2015-02-05,16495,11251,ILLUMINA,137233.0,2015-02-05,SRR1791161,2013-10-22T18:41:03Z,SRS605611,SRP012000,TARGET-20-PANGTF-09A-04R,RNA,TARGET-20-PANGTF-09A-04R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PANGTF,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1791161,"Acute Myeloid Leukemia,n=476",15.9287671232876,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1791162,RNA-Seq,,150,PRJNA89525,SAMN02260538,BCCAGSC,PCR,sra,SRX543489,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32022,2015-02-05,24336,16487,ILLUMINA,136539.0,2015-02-05,SRR1791162,2013-09-19T20:28:31Z,SRS605627,SRP012000,TARGET-20-PARFAL-04A-01R,RNA,TARGET-20-PARFAL-04A-01R,Recurrent Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARFAL,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute leukemia of Ambiguous Lineage (ALAL),SRR1791162,"Acute Myeloid Leukemia, KMT2A rearrangement,n=60",18.9643835616438,AML-KMT2A,"Acute Myeloid Leukemia, KMT2A rearrangement,n=60",Acute Myeloid Leukemia,"KMT2A rearrangement,n=60/TARGET"
SRR1791163,RNA-Seq,,150,PRJNA89525,SAMN02260505,BCCAGSC,PCR,sra,SRX543478,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32017,2015-02-05,15864,10861,ILLUMINA,136541.0,2015-02-05,SRR1791163,2013-09-19T20:28:36Z,SRS605864,SRP012000,TARGET-20-PADYIR-04A-01R,RNA,TARGET-20-PADYIR-04A-01R,Recurrent Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PADYIR,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1791163,"Acute Myeloid Leukemia,n=476",3.17534246575342,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1791164,RNA-Seq,,150,PRJNA89525,SAMN02260646,BCCAGSC,PCR,sra,SRX543486,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32030,2015-02-05,9680,6638,ILLUMINA,136542.0,2015-02-05,SRR1791164,2013-09-19T20:28:38Z,SRS605624,SRP012000,TARGET-20-PATJHJ-40A-01R,RNA,TARGET-20-PATJHJ-40A-01R,Recurrent Blood Derived Cancer - Peripheral Blood,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PATJHJ,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute leukemia of Ambiguous Lineage (ALAL),SRR1791164,"INFANT_Acute Myeloid Leukemia, KMT2A rearrangement,n=17",0.375342465753424,AML-KMT2A_INFANT,"INFANT_Acute Myeloid Leukemia, KMT2A rearrangement,n=17",Acute Myeloid Leukemia,"INFANT,KMT2A rearrangement,n=17/TARGET"
SRR1791165,RNA-Seq,,150,PRJNA89525,SAMN02260467,BCCAGSC,PCR,sra,SRX543499,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32007,2015-02-05,10534,7184,ILLUMINA,136782.0,2015-02-05,SRR1791165,2013-10-02T18:29:42Z,SRS605575,SRP012000,TARGET-20-PASCRZ-04A-01R,RNA,TARGET-20-PASCRZ-04A-01R,Recurrent Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASCRZ,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1791165,"Acute Myeloid Leukemia,n=476",14.6739726027397,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1791166,RNA-Seq,,150,PRJNA89525,SAMN02260557,BCCAGSC,PCR,sra,SRX542470,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31930,2015-02-05,19721,13334,ILLUMINA,137237.0,2015-02-05,SRR1791166,2013-10-22T18:41:24Z,SRS605863,SRP012000,TARGET-20-PANLIZ-09A-03R,RNA,TARGET-20-PANLIZ-09A-03R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PANLIZ,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1791166,"Acute Myeloid Leukemia,n=476",8.4986301369863,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1791167,RNA-Seq,,150,PRJNA89525,SAMN02260515,BCCAGSC,PCR,sra,SRX543497,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32036,2015-02-05,15655,10587,ILLUMINA,136778.0,2015-02-05,SRR1791167,2013-10-02T18:28:00Z,SRS605849,SRP012000,TARGET-20-PASCGR-04A-01R,RNA,TARGET-20-PASCGR-04A-01R,Recurrent Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASCGR,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1791167,"Acute Myeloid Leukemia, KMT2A rearrangement,n=60",18.2465753424657,AML-KMT2A,"Acute Myeloid Leukemia, KMT2A rearrangement,n=60",Acute Myeloid Leukemia,"KMT2A rearrangement,n=60/TARGET"
SRR1791168,RNA-Seq,,150,PRJNA89525,SAMN02260473,BCCAGSC,PCR,sra,SRX542509,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31938,2015-02-05,16365,11153,ILLUMINA,137231.0,2015-02-05,SRR1791168,2013-10-22T18:40:58Z,SRS605630,SRP012000,TARGET-20-PAEIKD-09A-01R,RNA,TARGET-20-PAEIKD-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PAEIKD,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1791168,"INFANT_Acute Myeloid Leukemia,n=21",0.772602739726027,AML_INFANT,"INFANT_Acute Myeloid Leukemia,n=21",Acute Myeloid Leukemia,"INFANT,n=21/TARGET"
SRR1791169,RNA-Seq,,150,PRJNA89525,SAMN02260513,BCCAGSC,PCR,sra,SRX542481,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31972,2015-02-05,16709,11245,ILLUMINA,137234.0,2015-02-05,SRR1791169,2013-10-22T18:41:06Z,SRS605654,SRP012000,TARGET-20-PANLXM-09A-03R,RNA,TARGET-20-PANLXM-09A-03R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PANLXM,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1791169,"Acute Myeloid Leukemia,n=476",10.2684931506849,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1791170,RNA-Seq,,150,PRJNA89525,SAMN02260626,BCCAGSC,PCR,sra,SRX543495,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32012,2015-02-05,20592,13938,ILLUMINA,136538.0,2015-02-05,SRR1791170,2013-09-19T20:28:29Z,SRS605582,SRP012000,TARGET-20-PAEERJ-04A-01R,RNA,TARGET-20-PAEERJ-04A-01R,Recurrent Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PAEERJ,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1791170,"Acute Myeloid Leukemia,n=476",13.9232876712328,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1791171,RNA-Seq,,150,PRJNA89525,SAMN02260655,BCCAGSC,PCR,sra,SRX542484,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31937,2015-02-05,17506,11194,ILLUMINA,136948.0,2015-02-05,SRR1791171,2013-10-09T21:19:35Z,SRS605605,SRP012000,TARGET-20-PAKERZ-09A-01R,RNA,TARGET-20-PAKERZ-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PAKERZ,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1791171,"Acute Myeloid Leukemia,n=476",2.8,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1791172,RNA-Seq,,150,PRJNA89525,SAMN02260571,BCCAGSC,PCR,sra,SRX542514,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31993,2015-02-05,18381,12020,ILLUMINA,136949.0,2015-02-05,SRR1791172,2013-10-09T21:19:38Z,SRS605555,SRP012000,TARGET-20-PASTTW-09A-01R,RNA,TARGET-20-PASTTW-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASTTW,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1791172,"Acute Myeloid Leukemia,n=476",2.07397260273972,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1791173,RNA-Seq,,150,PRJNA89525,SAMN02260658,BCCAGSC,PCR,sra,SRX542526,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31973,2015-02-05,13733,9462,ILLUMINA,137232.0,2015-02-05,SRR1791173,2013-10-22T18:41:01Z,SRS605578,SRP012000,TARGET-20-PANNHB-09A-03R,RNA,TARGET-20-PANNHB-09A-03R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PANNHB,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1791173,"Acute Myeloid Leukemia,n=476",4.06027397260274,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1796857,RNA-Seq,,150,PRJNA89525,SAMN02260507,BCCAGSC,PCR,sra,SRX543474,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32013,2015-02-11,9062,5641,ILLUMINA,136779.0,2015-02-11,SRR1796857,2013-10-02T18:29:35Z,SRS605640,SRP012000,TARGET-20-PASTUH-04A-01R,RNA,TARGET-20-PASTUH-04A-01R,Recurrent Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASTUH,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1796857,"Acute Myeloid Leukemia, KMT2A rearrangement,n=60",14.5342465753424,AML-KMT2A,"Acute Myeloid Leukemia, KMT2A rearrangement,n=60",Acute Myeloid Leukemia,"KMT2A rearrangement,n=60/TARGET"
SRR1796858,RNA-Seq,,150,PRJNA89525,SAMN02260536,BCCAGSC,PCR,sra,SRX543506,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32028,2015-02-11,13164,8150,ILLUMINA,136779.0,2015-02-11,SRR1796858,2013-10-02T18:29:35Z,SRS605842,SRP012000,TARGET-20-PASVYA-04A-01R,RNA,TARGET-20-PASVYA-04A-01R,Recurrent Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASVYA,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute leukemia of Ambiguous Lineage (ALAL),SRR1796858,"Acute Myeloid Leukemia,n=476",1.61643835616438,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1796859,RNA-Seq,,150,PRJNA89525,SAMN02443240,BCCAGSC,PCR,sra,SRX542507,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A34417,2015-02-11,17120,7462,ILLUMINA,147088.0,2015-02-11,SRR1796859,2014-11-07T18:35:35Z,SRS606817,SRP012000,TARGET-20-PANVGP-03A-04R,RNA,TARGET-20-PANVGP-03A-04R,Primary Blood Derived Cancer - Peripheral Blood,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PANVGP,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute leukemia of Ambiguous Lineage (ALAL),SRR1796859,"Acute Myeloid Leukemia,n=476",13.5616438356164,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1796860,RNA-Seq,,150,PRJNA89525,SAMN02260532,BCCAGSC,PCR,sra,SRX542492,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31971,2015-02-11,17521,11852,ILLUMINA,137286.0,2015-02-11,SRR1796860,2013-10-23T18:58:01Z,SRS605851,SRP012000,TARGET-20-PANPLS-03A-04R,RNA,TARGET-20-PANPLS-03A-04R,Primary Blood Derived Cancer - Peripheral Blood,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PANPLS,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1796860,"Acute Myeloid Leukemia,n=476",1.92602739726027,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1796861,RNA-Seq,,150,PRJNA89525,SAMN02260581,BCCAGSC,PCR,sra,SRX542522,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31942,2015-02-10,12156,8185,ILLUMINA,137292.0,2015-02-10,SRR1796861,2013-10-23T18:58:14Z,SRS605650,SRP012000,TARGET-20-PASPTM-09A-03R,RNA,TARGET-20-PASPTM-09A-03R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASPTM,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1796861,"Acute Myeloid Leukemia,n=476",14.0328767123287,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1796862,RNA-Seq,,150,PRJNA89525,SAMN02443319,BCCAGSC,PCR,sra,SRX548865,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A34421,2015-02-10,16438,11010,ILLUMINA,138616.0,2015-02-11,SRR1796862,2013-12-31T21:26:48Z,SRS616783,SRP012000,TARGET-20-PARDDY-09A-05R,RNA,TARGET-20-PARDDY-09A-05R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARDDY,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute leukemia of Ambiguous Lineage (ALAL),SRR1796862,"Acute Myeloid Leukemia,n=476",1.85479452054794,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1796863,RNA-Seq,,150,PRJNA89525,SAMN02260509,BCCAGSC,PCR,sra,SRX542473,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31929,2015-02-11,17006,11529,ILLUMINA,137289.0,2015-02-11,SRR1796863,2013-10-23T18:58:07Z,SRS605571,SRP012000,TARGET-20-PARSHM-03A-02R,RNA,TARGET-20-PARSHM-03A-02R,Primary Blood Derived Cancer - Peripheral Blood,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARSHM,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1796863,"INFANT_Acute Myeloid Leukemia,n=21",0.980821917808219,AML_INFANT,"INFANT_Acute Myeloid Leukemia,n=21",Acute Myeloid Leukemia,"INFANT,n=21/TARGET"
SRR1796864,RNA-Seq,,150,PRJNA89525,SAMN02260614,BCCAGSC,PCR,sra,SRX543494,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32027,2015-02-10,3937,2594,ILLUMINA,136785.0,2015-02-10,SRR1796864,2013-10-02T18:29:49Z,SRS605860,SRP012000,TARGET-20-PASHYZ-04A-01R,RNA,TARGET-20-PASHYZ-04A-01R,Recurrent Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASHYZ,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1796864,"Acute Myeloid Leukemia,n=476",4.64383561643835,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1796865,RNA-Seq,,150,PRJNA89525,SAMN02260627,BCCAGSC,PCR,sra,SRX542483,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31927,2015-02-10,14562,9763,ILLUMINA,137288.0,2015-02-10,SRR1796865,2013-10-23T18:58:05Z,SRS605591,SRP012000,TARGET-20-PAKTCX-09A-02R,RNA,TARGET-20-PAKTCX-09A-02R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PAKTCX,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1796865,"Acute Myeloid Leukemia,n=476",8.93698630136986,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1796866,RNA-Seq,,150,PRJNA89525,SAMN02260482,BCCAGSC,PCR,sra,SRX542461,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31955,2015-02-11,17843,11799,ILLUMINA,136947.0,2015-02-11,SRR1796866,2013-10-09T21:19:32Z,SRS605621,SRP012000,TARGET-20-PATELT-03A-05R,RNA,TARGET-20-PATELT-03A-05R,Primary Blood Derived Cancer - Peripheral Blood,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PATELT,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute leukemia of Ambiguous Lineage (ALAL),SRR1796866,"Acute Myeloid Leukemia,n=476",12.0575342465753,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1796867,RNA-Seq,,150,PRJNA89525,SAMN02260522,BCCAGSC,PCR,sra,SRX542489,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31939,2015-02-11,22096,14877,ILLUMINA,137280.0,2015-02-11,SRR1796867,2013-10-23T18:56:01Z,SRS605597,SRP012000,TARGET-20-PAECCE-09A-01R,RNA,TARGET-20-PAECCE-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PAECCE,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1796867,"Acute Myeloid Leukemia,n=476",2.46575342465753,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1796868,RNA-Seq,,150,PRJNA89525,SAMN02260587,BCCAGSC,PCR,sra,SRX542456,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31911,2015-02-10,12919,8771,ILLUMINA,137283.0,2015-02-10,SRR1796868,2013-10-23T18:56:07Z,SRS605857,SRP012000,TARGET-20-PAKVGI-09A-01R,RNA,TARGET-20-PAKVGI-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PAKVGI,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1796868,"Acute Myeloid Leukemia,n=476",1.76712328767123,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1796869,RNA-Seq,,150,PRJNA89525,SAMN01778032,BCCAGSC,PCR,sra,SRX548907,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A34424,2015-02-10,17440,7743,ILLUMINA,147088.0,2015-02-11,SRR1796869,2014-11-07T18:35:35Z,SRS380408,SRP012000,TARGET-20-PARUUB-09A-02R,RNA,TARGET-20-PARUUB-09A-02R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARUUB,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1796869,"Acute Myeloid Leukemia,n=476",17.3013698630136,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1796870,RNA-Seq,,150,PRJNA89525,SAMN02260574,BCCAGSC,PCR,sra,SRX542488,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31933,2015-02-11,18313,11857,ILLUMINA,137356.0,2015-02-11,SRR1796870,2013-10-25T18:34:47Z,SRS605598,SRP012000,TARGET-20-PARIHK-03A-03R,RNA,TARGET-20-PARIHK-03A-03R,Primary Blood Derived Cancer - Peripheral Blood,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARIHK,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1796870,"Acute Myeloid Leukemia,n=476",10.4931506849315,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1796871,RNA-Seq,,150,PRJNA89525,SAMN02443106,BCCAGSC,PCR,sra,SRX548853,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A34411,2015-02-10,18457,12257,ILLUMINA,138635.0,2015-02-10,SRR1796871,2013-12-31T21:30:01Z,SRS616781,SRP012000,TARGET-20-PALGKX-09A-03R,RNA,TARGET-20-PALGKX-09A-03R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PALGKX,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute leukemia of Ambiguous Lineage (ALAL),SRR1796871,"Acute Myeloid Leukemia,n=476",12.9397260273972,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1796872,RNA-Seq,,150,PRJNA89525,SAMN02386279,BCCAGSC,PCR,sra,SRX543487,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32037,2015-02-10,7301,4709,ILLUMINA,136940.0,2015-02-10,SRR1796872,2013-10-09T21:14:40Z,SRS605657,SRP012000,TARGET-20-PARLVL-04A-02R,RNA,TARGET-20-PARLVL-04A-02R,Recurrent Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARLVL,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1796872,"Acute Myeloid Leukemia,n=476",2.63835616438356,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1796873,RNA-Seq,,150,PRJNA89525,SAMN02260508,BCCAGSC,PCR,sra,SRX542501,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31941,2015-02-10,13255,8808,ILLUMINA,137351.0,2015-02-10,SRR1796873,2013-10-25T18:29:59Z,SRS605612,SRP012000,TARGET-20-PARUBT-09A-02R,RNA,TARGET-20-PARUBT-09A-02R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARUBT,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1796873,"Acute Myeloid Leukemia,n=476",7.37534246575342,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1796874,RNA-Seq,,150,PRJNA89525,SAMN02260565,BCCAGSC,PCR,sra,SRX542495,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31976,2015-02-10,12593,8592,ILLUMINA,137291.0,2015-02-10,SRR1796874,2013-10-23T18:58:12Z,SRS605556,SRP012000,TARGET-20-PASWPD-09A-02R,RNA,TARGET-20-PASWPD-09A-02R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASWPD,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1796874,"Acute Myeloid Leukemia,n=476",3.98356164383561,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1796875,RNA-Seq,,150,PRJNA89525,SAMN02443124,BCCAGSC,PCR,sra,SRX548878,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A34413,2015-02-11,16387,10951,ILLUMINA,138616.0,2015-02-11,SRR1796875,2013-12-31T21:26:48Z,SRS616786,SRP012000,TARGET-20-PANFMG-09A-04R,RNA,TARGET-20-PANFMG-09A-04R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PANFMG,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute leukemia of Ambiguous Lineage (ALAL),SRR1796875,"Acute Myeloid Leukemia,n=476",3.91780821917808,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1796876,RNA-Seq,,150,PRJNA89525,SAMN02260601,BCCAGSC,PCR,sra,SRX542531,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31954,2015-02-11,16023,10746,ILLUMINA,137284.0,2015-02-11,SRR1796876,2013-10-23T18:56:09Z,SRS605635,SRP012000,TARGET-20-PARUDL-03A-01R,RNA,TARGET-20-PARUDL-03A-01R,Primary Blood Derived Cancer - Peripheral Blood,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARUDL,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1796876,"Acute Myeloid Leukemia,n=476",17.6602739726027,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1796877,RNA-Seq,,150,PRJNA89525,SAMN02260456,BCCAGSC,PCR,sra,SRX542478,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31979,2015-02-11,12849,8711,ILLUMINA,137280.0,2015-02-11,SRR1796877,2013-10-23T18:56:01Z,SRS605563,SRP012000,TARGET-20-PARVAI-03A-02R,RNA,TARGET-20-PARVAI-03A-02R,Primary Blood Derived Cancer - Peripheral Blood,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARVAI,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1796877,"Acute Myeloid Leukemia,n=476",16.717808219178,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1796878,RNA-Seq,,150,PRJNA89525,SAMN02443376,BCCAGSC,PCR,sra,SRX548890,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A34425,2015-02-10,14948,9965,ILLUMINA,138621.0,2015-02-11,SRR1796878,2013-12-31T21:28:22Z,SRS616788,SRP012000,TARGET-20-PASGGK-03A-01R,RNA,TARGET-20-PASGGK-03A-01R,Primary Blood Derived Cancer - Peripheral Blood,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASGGK,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute leukemia of Ambiguous Lineage (ALAL),SRR1796878,"Acute Myeloid Leukemia, KMT2A rearrangement,n=60",12.2136986301369,AML-KMT2A,"Acute Myeloid Leukemia, KMT2A rearrangement,n=60",Acute Myeloid Leukemia,"KMT2A rearrangement,n=60/TARGET"
SRR1796879,RNA-Seq,,150,PRJNA89525,SAMN02047528,BCCAGSC,PCR,sra,SRX542510,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31985,2015-02-10,14471,9367,ILLUMINA,137701.0,2015-02-10,SRR1796879,2013-11-13T22:42:33Z,SRS605609,SRP012000,TARGET-20-PASPLU-09A-02R,RNA,TARGET-20-PASPLU-09A-02R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASPLU,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1796879,"Acute Myeloid Leukemia,n=476",9.31232876712328,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1796880,RNA-Seq,,150,PRJNA89525,SAMN02443197,BCCAGSC,PCR,sra,SRX542465,205,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A34416,2015-02-11,10657,7264,ILLUMINA,138615.0,2015-02-11,SRR1796880,2013-12-31T21:26:45Z,SRS606814,SRP012000,TARGET-20-PANSBH-09A-05R,RNA,TARGET-20-PANSBH-09A-05R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PANSBH,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute leukemia of Ambiguous Lineage (ALAL),SRR1796880,"Acute Myeloid Leukemia,n=476",1.34520547945205,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1796881,RNA-Seq,,150,PRJNA89525,SAMN02260518,BCCAGSC,PCR,sra,SRX542513,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31977,2015-02-10,14791,10052,ILLUMINA,137229.0,2015-02-10,SRR1796881,2013-10-22T18:40:51Z,SRS605607,SRP012000,TARGET-20-PARWDZ-09A-01R,RNA,TARGET-20-PARWDZ-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARWDZ,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1796881,"Acute Myeloid Leukemia, KMT2A rearrangement,n=60",13.3013698630136,AML-KMT2A,"Acute Myeloid Leukemia, KMT2A rearrangement,n=60",Acute Myeloid Leukemia,"KMT2A rearrangement,n=60/TARGET"
SRR1796882,RNA-Seq,,150,PRJNA89525,SAMN02260506,BCCAGSC,PCR,sra,SRX542517,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31997,2015-02-11,18189,12342,ILLUMINA,137289.0,2015-02-11,SRR1796882,2013-10-23T18:58:07Z,SRS605558,SRP012000,TARGET-20-PAPXRJ-04A-02R,RNA,TARGET-20-PAPXRJ-04A-02R,Recurrent Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PAPXRJ,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1796882,"Acute Myeloid Leukemia,n=476",7.82191780821917,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1796883,RNA-Seq,,150,PRJNA89525,SAMN02260609,BCCAGSC,PCR,sra,SRX542485,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31967,2015-02-10,16105,10571,ILLUMINA,137350.0,2015-02-11,SRR1796883,2013-10-25T18:29:57Z,SRS605861,SRP012000,TARGET-20-PANPKN-09A-03R,RNA,TARGET-20-PANPKN-09A-03R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PANPKN,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1796883,"INFANT_Acute Myeloid Leukemia, KMT2A rearrangement,n=17",0.983561643835616,AML-KMT2A_INFANT,"INFANT_Acute Myeloid Leukemia, KMT2A rearrangement,n=17",Acute Myeloid Leukemia,"INFANT,KMT2A rearrangement,n=17/TARGET"
SRR1796884,RNA-Seq,,150,PRJNA89525,SAMN02260483,BCCAGSC,PCR,sra,SRX542511,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31980,2015-02-10,15779,10388,ILLUMINA,137357.0,2015-02-10,SRR1796884,2013-10-25T18:34:49Z,SRS605844,SRP012000,TARGET-20-PASBPK-09A-02R,RNA,TARGET-20-PASBPK-09A-02R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASBPK,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute leukemia of Ambiguous Lineage (ALAL),SRR1796884,"INFANT_Acute Myeloid Leukemia,n=21",0.441095890410958,AML_INFANT,"INFANT_Acute Myeloid Leukemia,n=21",Acute Myeloid Leukemia,"INFANT,n=21/TARGET"
SRR1796885,RNA-Seq,,150,PRJNA89525,SAMN02260645,BCCAGSC,PCR,sra,SRX542471,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31965,2015-02-10,19639,13084,ILLUMINA,137349.0,2015-02-10,SRR1796885,2013-10-25T18:29:54Z,SRS605656,SRP012000,TARGET-20-PASXYG-09A-05R,RNA,TARGET-20-PASXYG-09A-05R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASXYG,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1796885,"Acute Myeloid Leukemia,n=476",11.2410958904109,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1796886,RNA-Seq,,150,PRJNA89525,SAMN02443214,BCCAGSC,PCR,sra,SRX548927,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A34420,2015-02-10,18646,12599,ILLUMINA,138618.0,2015-02-10,SRR1796886,2013-12-31T21:26:52Z,SRS616789,SRP012000,TARGET-20-PARBXE-09A-04R,RNA,TARGET-20-PARBXE-09A-04R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARBXE,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute leukemia of Ambiguous Lineage (ALAL),SRR1796886,"Acute Myeloid Leukemia,n=476",1.22465753424657,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1796887,RNA-Seq,,150,PRJNA89525,SAMN02260455,BCCAGSC,PCR,sra,SRX542500,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31931,2015-02-10,18220,12142,ILLUMINA,137284.0,2015-02-10,SRR1796887,2013-10-23T18:56:09Z,SRS605604,SRP012000,TARGET-20-PARCZL-09A-02R,RNA,TARGET-20-PARCZL-09A-02R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARCZL,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1796887,"Acute Myeloid Leukemia,n=476",10.4273972602739,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1796888,RNA-Seq,,150,PRJNA89525,SAMN02260553,BCCAGSC,PCR,sra,SRX542458,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31952,2015-02-10,15493,10517,ILLUMINA,137287.0,2015-02-10,SRR1796888,2013-10-23T18:58:03Z,SRS605606,SRP012000,TARGET-20-PARIMT-03A-01R,RNA,TARGET-20-PARIMT-03A-01R,Primary Blood Derived Cancer - Peripheral Blood,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARIMT,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1796888,"Acute Myeloid Leukemia,n=476",7.52876712328767,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1796889,RNA-Seq,,150,PRJNA89525,SAMN02260630,BCCAGSC,PCR,sra,SRX542486,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31910,2015-02-10,24921,16890,ILLUMINA,137290.0,2015-02-10,SRR1796889,2013-10-23T18:58:09Z,SRS605847,SRP012000,TARGET-20-PANCSC-09A-03R,RNA,TARGET-20-PANCSC-09A-03R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PANCSC,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1796889,"Acute Myeloid Leukemia,n=476",10.6575342465753,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1796890,RNA-Seq,,150,PRJNA89525,SAMN02260454,BCCAGSC,PCR,sra,SRX543511,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32039,2015-02-10,20846,13926,ILLUMINA,136783.0,2015-02-10,SRR1796890,2013-10-02T18:29:44Z,SRS605593,SRP012000,TARGET-20-PARUNX-04A-01R,RNA,TARGET-20-PARUNX-04A-01R,Recurrent Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARUNX,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1796890,"Acute Myeloid Leukemia,n=476",6.35890410958904,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1796891,RNA-Seq,,150,PRJNA89525,SAMN02443093,BCCAGSC,PCR,sra,SRX548873,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A34418,2015-02-10,15514,10459,ILLUMINA,138617.0,2015-02-10,SRR1796891,2013-12-31T21:26:50Z,SRS616784,SRP012000,TARGET-20-PAPVDV-03A-01R,RNA,TARGET-20-PAPVDV-03A-01R,Primary Blood Derived Cancer - Peripheral Blood,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PAPVDV,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute leukemia of Ambiguous Lineage (ALAL),SRR1796891,"Acute Myeloid Leukemia,n=476",6.35068493150685,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1796892,RNA-Seq,,150,PRJNA89525,SAMN02260583,BCCAGSC,PCR,sra,SRX543481,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32024,2015-02-10,24565,16025,ILLUMINA,136785.0,2015-02-10,SRR1796892,2013-10-02T18:29:49Z,SRS605850,SRP012000,TARGET-20-PASYJI-04A-02R,RNA,TARGET-20-PASYJI-04A-02R,Recurrent Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASYJI,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1796892,"Acute Myeloid Leukemia,n=476",12.4520547945205,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1796893,RNA-Seq,,150,PRJNA89525,SAMN02443325,BCCAGSC,PCR,sra,SRX542519,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A34410,2015-02-10,14707,10020,ILLUMINA,138618.0,2015-02-10,SRR1796893,2013-12-31T21:26:52Z,SRS606818,SRP012000,TARGET-20-PABLDZ-09A-04R,RNA,TARGET-20-PABLDZ-09A-04R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PABLDZ,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute leukemia of Ambiguous Lineage (ALAL),SRR1796893,"Acute Myeloid Leukemia,n=476",6.72602739726027,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1796894,RNA-Seq,,150,PRJNA89525,SAMN02443001,BCCAGSC,PCR,sra,SRX548887,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A34423,2015-02-10,21519,14374,ILLUMINA,138619.0,2015-02-10,SRR1796894,2013-12-31T21:26:54Z,SRS616787,SRP012000,TARGET-20-PARFAL-09A-05R,RNA,TARGET-20-PARFAL-09A-05R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARFAL,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute leukemia of Ambiguous Lineage (ALAL),SRR1796894,"Acute Myeloid Leukemia, KMT2A rearrangement,n=60",18.9643835616438,AML-KMT2A,"Acute Myeloid Leukemia, KMT2A rearrangement,n=60",Acute Myeloid Leukemia,"KMT2A rearrangement,n=60/TARGET"
SRR1796895,RNA-Seq,,150,PRJNA89525,SAMN02260599,BCCAGSC,PCR,sra,SRX542529,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31989,2015-02-10,14292,9635,ILLUMINA,137282.0,2015-02-10,SRR1796895,2013-10-23T18:56:05Z,SRS605596,SRP012000,TARGET-20-PASCFW-09A-01R,RNA,TARGET-20-PASCFW-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASCFW,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1796895,"Acute Myeloid Leukemia,n=476",2.00821917808219,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1796896,RNA-Seq,,150,PRJNA89525,SAMN02260611,BCCAGSC,PCR,sra,SRX542515,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31964,2015-02-10,20237,13728,ILLUMINA,137282.0,2015-02-10,SRR1796896,2013-10-23T18:56:05Z,SRS605566,SRP012000,TARGET-20-PAPBEJ-09A-03R,RNA,TARGET-20-PAPBEJ-09A-03R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PAPBEJ,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1796896,"Acute Myeloid Leukemia,n=476",1.00547945205479,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1796897,RNA-Seq,,150,PRJNA89525,SAMN02260586,BCCAGSC,PCR,sra,SRX542462,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31963,2015-02-10,17063,11146,ILLUMINA,137350.0,2015-02-10,SRR1796897,2013-10-25T18:29:57Z,SRS605573,SRP012000,TARGET-20-PANYNR-03A-03R,RNA,TARGET-20-PANYNR-03A-03R,Primary Blood Derived Cancer - Peripheral Blood,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PANYNR,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1796897,"Acute Myeloid Leukemia,n=476",9.06849315068493,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1796898,RNA-Seq,,150,PRJNA89525,SAMN02260463,BCCAGSC,PCR,sra,SRX542457,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31946,2015-02-10,16785,10586,ILLUMINA,136950.0,2015-02-10,SRR1796898,2013-10-09T21:19:41Z,SRS605569,SRP012000,TARGET-20-PASJTM-09A-01R,RNA,TARGET-20-PASJTM-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASJTM,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1796898,"Acute Myeloid Leukemia,n=476",2.46849315068493,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1796899,RNA-Seq,,150,PRJNA89525,SAMN02260459,BCCAGSC,PCR,sra,SRX542467,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31992,2015-02-10,20297,13645,ILLUMINA,137279.0,2015-02-10,SRR1796899,2013-10-23T18:55:59Z,SRS605645,SRP012000,TARGET-20-PARPDS-09A-01R,RNA,TARGET-20-PARPDS-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARPDS,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1796899,"Acute Myeloid Leukemia,n=476",10.3397260273972,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1796900,RNA-Seq,,150,PRJNA89525,SAMN02260647,BCCAGSC,PCR,sra,SRX542534,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31978,2015-02-10,13018,8418,ILLUMINA,137356.0,2015-02-10,SRR1796900,2013-10-25T18:34:47Z,SRS605856,SRP012000,TARGET-20-PASBHI-09A-01R,RNA,TARGET-20-PASBHI-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASBHI,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1796900,"Acute Myeloid Leukemia,n=476",6.03013698630137,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1796901,RNA-Seq,,150,PRJNA89525,SAMN02443402,BCCAGSC,PCR,sra,SRX548874,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A34419,2015-02-10,20446,13826,ILLUMINA,138615.0,2015-02-10,SRR1796901,2013-12-31T21:26:45Z,SRS616785,SRP012000,TARGET-20-PARBIU-09A-03R,RNA,TARGET-20-PARBIU-09A-03R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARBIU,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute leukemia of Ambiguous Lineage (ALAL),SRR1796901,"Acute Myeloid Leukemia,n=476",15.972602739726,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1796902,RNA-Seq,,150,PRJNA89525,SAMN02260636,BCCAGSC,PCR,sra,SRX542477,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31994,2015-02-10,14796,9909,ILLUMINA,137349.0,2015-02-10,SRR1796902,2013-10-25T18:29:54Z,SRS605577,SRP012000,TARGET-20-PARYGA-09A-03R,RNA,TARGET-20-PARYGA-09A-03R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARYGA,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1796902,"Acute Myeloid Leukemia,n=476",16.2082191780821,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1796903,RNA-Seq,,150,PRJNA89525,SAMN02260480,BCCAGSC,PCR,sra,SRX542487,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31926,2015-02-10,19123,12755,ILLUMINA,137352.0,2015-02-10,SRR1796903,2013-10-25T18:30:02Z,SRS605564,SRP012000,TARGET-20-PASGWH-09A-04R,RNA,TARGET-20-PASGWH-09A-04R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASGWH,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1796903,"Acute Myeloid Leukemia,n=476",14.386301369863,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1796904,RNA-Seq,,150,PRJNA89525,SAMN02260585,BCCAGSC,PCR,sra,SRX543505,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32029,2015-02-10,28638,18399,ILLUMINA,136940.0,2015-02-10,SRR1796904,2013-10-09T21:14:40Z,SRS605628,SRP012000,TARGET-20-PATIAK-04A-01R,RNA,TARGET-20-PATIAK-04A-01R,Recurrent Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PATIAK,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute leukemia of Ambiguous Lineage (ALAL),SRR1796904,"INFANT_Acute Myeloid Leukemia,n=21",0.621917808219178,AML_INFANT,"INFANT_Acute Myeloid Leukemia,n=21",Acute Myeloid Leukemia,"INFANT,n=21/TARGET"
SRR1796905,RNA-Seq,,150,PRJNA89525,SAMN02260657,BCCAGSC,PCR,sra,SRX543491,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32035,2015-02-10,17778,11426,ILLUMINA,137346.0,2015-02-10,SRR1796905,2013-10-25T18:29:47Z,SRS605594,SRP012000,TARGET-20-PASVVS-04A-01R,RNA,TARGET-20-PASVVS-04A-01R,Recurrent Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASVVS,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1796905,"INFANT_Acute Myeloid Leukemia, KMT2A rearrangement,n=17",0.775342465753424,AML-KMT2A_INFANT,"INFANT_Acute Myeloid Leukemia, KMT2A rearrangement,n=17",Acute Myeloid Leukemia,"INFANT,KMT2A rearrangement,n=17/TARGET"
SRR1796906,RNA-Seq,,150,PRJNA89525,SAMN02260458,BCCAGSC,PCR,sra,SRX542506,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31920,2015-02-10,11431,7323,ILLUMINA,136950.0,2015-02-10,SRR1796906,2013-10-09T21:19:41Z,SRS605560,SRP012000,TARGET-20-PASVVS-09A-03R,RNA,TARGET-20-PASVVS-09A-03R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASVVS,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1796906,"INFANT_Acute Myeloid Leukemia, KMT2A rearrangement,n=17",0.775342465753424,AML-KMT2A_INFANT,"INFANT_Acute Myeloid Leukemia, KMT2A rearrangement,n=17",Acute Myeloid Leukemia,"INFANT,KMT2A rearrangement,n=17/TARGET"
SRR1796907,RNA-Seq,,150,PRJNA89525,SAMN02047530,BCCAGSC,PCR,sra,SRX542460,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31974,2015-02-10,12005,8049,ILLUMINA,137279.0,2015-02-10,SRR1796907,2013-10-23T18:55:59Z,SRS605647,SRP012000,TARGET-20-PARXBT-09A-02R,RNA,TARGET-20-PARXBT-09A-02R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARXBT,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1796907,"Acute Myeloid Leukemia,n=476",9.26301369863013,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1796908,RNA-Seq,,150,PRJNA89525,SAMN02260492,BCCAGSC,PCR,sra,SRX543476,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32006,2015-02-10,12105,7814,ILLUMINA,137346.0,2015-02-10,SRR1796908,2013-10-25T18:29:47Z,SRS605581,SRP012000,TARGET-20-PARYFN-04A-01R,RNA,TARGET-20-PARYFN-04A-01R,Recurrent Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARYFN,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1796908,"Acute Myeloid Leukemia,n=476",4.37534246575342,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1796909,RNA-Seq,,150,PRJNA89525,SAMN02260664,BCCAGSC,PCR,sra,SRX542454,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31919,2015-02-10,16554,11157,ILLUMINA,137286.0,2015-02-10,SRR1796909,2013-10-23T18:58:01Z,SRS605625,SRP012000,TARGET-20-PASMHY-03A-03R,RNA,TARGET-20-PASMHY-03A-03R,Primary Blood Derived Cancer - Peripheral Blood,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASMHY,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute leukemia of Ambiguous Lineage (ALAL),SRR1796909,"Acute Myeloid Leukemia,n=476",19.1205479452054,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1796910,RNA-Seq,,150,PRJNA89525,SAMN02443062,BCCAGSC,PCR,sra,SRX548863,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A34414,2015-02-10,18064,11994,ILLUMINA,138621.0,2015-02-10,SRR1796910,2013-12-31T21:28:22Z,SRS616782,SRP012000,TARGET-20-PANGDN-09A-05R,RNA,TARGET-20-PANGDN-09A-05R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PANGDN,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute leukemia of Ambiguous Lineage (ALAL),SRR1796910,"Acute Myeloid Leukemia,n=476",18.0547945205479,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1796911,RNA-Seq,,150,PRJNA89525,SAMN02260661,BCCAGSC,PCR,sra,SRX542530,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31936,2015-02-10,18595,12615,ILLUMINA,137229.0,2015-02-10,SRR1796911,2013-10-22T18:40:51Z,SRS605617,SRP012000,TARGET-20-PASTUH-03A-01R,RNA,TARGET-20-PASTUH-03A-01R,Primary Blood Derived Cancer - Peripheral Blood,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASTUH,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute leukemia of Ambiguous Lineage (ALAL),SRR1796911,"Acute Myeloid Leukemia, KMT2A rearrangement,n=60",14.5342465753424,AML-KMT2A,"Acute Myeloid Leukemia, KMT2A rearrangement,n=60",Acute Myeloid Leukemia,"KMT2A rearrangement,n=60/TARGET"
SRR1796912,RNA-Seq,,150,PRJNA89525,SAMN02443026,BCCAGSC,PCR,sra,SRX548922,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A34422,2015-02-10,13266,8931,ILLUMINA,138619.0,2015-02-10,SRR1796912,2013-12-31T21:26:54Z,SRS616790,SRP012000,TARGET-20-PARENB-09A-03R,RNA,TARGET-20-PARENB-09A-03R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARENB,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute leukemia of Ambiguous Lineage (ALAL),SRR1796912,"Acute Myeloid Leukemia,n=476",7.55616438356164,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1796913,RNA-Seq,,150,PRJNA89525,SAMN02443233,BCCAGSC,PCR,sra,SRX543496,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A34428,2015-02-10,17589,11680,ILLUMINA,138635.0,2015-02-10,SRR1796913,2013-12-31T21:30:01Z,SRS607426,SRP012000,TARGET-20-PARCZL-04A-02R,RNA,TARGET-20-PARCZL-04A-02R,Recurrent Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARCZL,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute leukemia of Ambiguous Lineage (ALAL),SRR1796913,"Acute Myeloid Leukemia,n=476",10.4273972602739,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1796914,RNA-Seq,,150,PRJNA89525,SAMN02260479,BCCAGSC,PCR,sra,SRX542512,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31917,2015-02-10,23042,15668,ILLUMINA,137291.0,2015-02-10,SRR1796914,2013-10-23T18:58:12Z,SRS605634,SRP012000,TARGET-20-PADZCG-09A-02R,RNA,TARGET-20-PADZCG-09A-02R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PADZCG,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1796914,"Acute Myeloid Leukemia,n=476",14.5890410958904,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1796915,RNA-Seq,,150,PRJNA89525,SAMN02260654,BCCAGSC,PCR,sra,SRX542523,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31953,2015-02-10,15022,10055,ILLUMINA,137285.0,2015-02-10,SRR1796915,2013-10-23T18:57:58Z,SRS605586,SRP012000,TARGET-20-PARIZR-03A-02R,RNA,TARGET-20-PARIZR-03A-02R,Primary Blood Derived Cancer - Peripheral Blood,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARIZR,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1796915,"Acute Myeloid Leukemia,n=476",7.38356164383561,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1796916,RNA-Seq,,150,PRJNA89525,SAMN02260641,BCCAGSC,PCR,sra,SRX542476,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31951,2015-02-10,18863,12686,ILLUMINA,137288.0,2015-02-10,SRR1796916,2013-10-23T18:58:05Z,SRS605603,SRP012000,TARGET-20-PARXMP-09A-02R,RNA,TARGET-20-PARXMP-09A-02R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARXMP,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1796916,"Acute Myeloid Leukemia,n=476",1.46301369863013,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1796917,RNA-Seq,,150,PRJNA89525,SAMN02260503,BCCAGSC,PCR,sra,SRX542524,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31996,2015-02-10,16949,11204,ILLUMINA,136947.0,2015-02-10,SRR1796917,2013-10-09T21:19:32Z,SRS605661,SRP012000,TARGET-20-PASGZS-04A-01R,RNA,TARGET-20-PASGZS-04A-01R,Recurrent Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASGZS,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute leukemia of Ambiguous Lineage (ALAL),SRR1796917,"Acute Myeloid Leukemia, KMT2A rearrangement,n=60",1.22191780821917,AML-KMT2A,"Acute Myeloid Leukemia, KMT2A rearrangement,n=60",Acute Myeloid Leukemia,"KMT2A rearrangement,n=60/TARGET"
SRR1796918,RNA-Seq,,200,PRJNA89525,SAMN02260639,BCCAGSC,PCR,sra,SRX543490,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32026,2015-02-10,32301,20674,ILLUMINA,137768.0,2015-02-10,SRR1796918,2013-11-15T21:17:03Z,SRS605619,SRP012000,TARGET-20-PATDNN-04A-02R,RNA,TARGET-20-PATDNN-04A-02R,Recurrent Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PATDNN,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute leukemia of Ambiguous Lineage (ALAL),SRR1796918,"Acute Myeloid Leukemia, KMT2A rearrangement,n=60",3.45753424657534,AML-KMT2A,"Acute Myeloid Leukemia, KMT2A rearrangement,n=60",Acute Myeloid Leukemia,"KMT2A rearrangement,n=60/TARGET"
SRR1796919,RNA-Seq,,150,PRJNA89525,SAMN02260570,BCCAGSC,PCR,sra,SRX542459,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31987,2015-02-10,21402,14128,ILLUMINA,137351.0,2015-02-10,SRR1796919,2013-10-25T18:29:59Z,SRS605646,SRP012000,TARGET-20-PARCCH-03A-03R,RNA,TARGET-20-PARCCH-03A-03R,Primary Blood Derived Cancer - Peripheral Blood,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARCCH,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1796919,"INFANT_Acute Myeloid Leukemia,n=21",0.928767123287671,AML_INFANT,"INFANT_Acute Myeloid Leukemia,n=21",Acute Myeloid Leukemia,"INFANT,n=21/TARGET"
SRR1796920,RNA-Seq,,150,PRJNA89525,SAMN02260469,BCCAGSC,PCR,sra,SRX542503,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31922,2015-02-10,17251,11548,ILLUMINA,137285.0,2015-02-10,SRR1796920,2013-10-23T18:57:58Z,SRS605649,SRP012000,TARGET-20-PARTAL-09A-02R,RNA,TARGET-20-PARTAL-09A-02R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARTAL,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1796920,"Acute Myeloid Leukemia,n=476",16.4383561643835,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1796921,RNA-Seq,,150,PRJNA89525,SAMN02260579,BCCAGSC,PCR,sra,SRX542482,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31982,2015-02-10,19662,13271,ILLUMINA,137348.0,2015-02-10,SRR1796921,2013-10-25T18:29:52Z,SRS605659,SRP012000,TARGET-20-PAMYGX-09A-03R,RNA,TARGET-20-PAMYGX-09A-03R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PAMYGX,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute leukemia of Ambiguous Lineage (ALAL),SRR1796921,"Acute Myeloid Leukemia,n=476",3.44931506849315,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1796922,RNA-Seq,,150,PRJNA89525,SAMN02260663,BCCAGSC,PCR,sra,SRX542474,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31918,2015-02-10,10690,7299,ILLUMINA,137290.0,2015-02-10,SRR1796922,2013-10-23T18:58:09Z,SRS605614,SRP012000,TARGET-20-PAEFGT-03A-01R,RNA,TARGET-20-PAEFGT-03A-01R,Primary Blood Derived Cancer - Peripheral Blood,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PAEFGT,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute leukemia of Ambiguous Lineage (ALAL),SRR1796922,"Acute Myeloid Leukemia,n=476",14.9369863013698,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1796923,RNA-Seq,,150,PRJNA89525,SAMN02260520,BCCAGSC,PCR,sra,SRX542468,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31998,2015-02-10,16226,10770,ILLUMINA,136945.0,2015-02-10,SRR1796923,2013-10-09T21:14:51Z,SRS605588,SRP012000,TARGET-20-PASPLU-04A-01R,RNA,TARGET-20-PASPLU-04A-01R,Recurrent Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASPLU,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1796923,"Acute Myeloid Leukemia,n=476",9.31232876712328,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1796924,RNA-Seq,,150,PRJNA89525,SAMN02260634,BCCAGSC,PCR,sra,SRX542502,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31981,2015-02-10,15638,10086,ILLUMINA,137701.0,2015-02-10,SRR1796924,2013-11-13T22:42:33Z,SRS605616,SRP012000,TARGET-20-PARKCX-09A-03R,RNA,TARGET-20-PARKCX-09A-03R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARKCX,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute leukemia of Ambiguous Lineage (ALAL),SRR1796924,"INFANT_Acute Myeloid Leukemia, KMT2A rearrangement,n=17",0.8,AML-KMT2A_INFANT,"INFANT_Acute Myeloid Leukemia, KMT2A rearrangement,n=17",Acute Myeloid Leukemia,"INFANT,KMT2A rearrangement,n=17/TARGET"
SRR1796925,RNA-Seq,,150,PRJNA89525,SAMN02260590,BCCAGSC,PCR,sra,SRX542455,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31956,2015-02-10,19470,12929,ILLUMINA,136945.0,2015-02-10,SRR1796925,2013-10-09T21:14:51Z,SRS605585,SRP012000,TARGET-20-PARZUU-09A-04R,RNA,TARGET-20-PARZUU-09A-04R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARZUU,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1796925,"Acute Myeloid Leukemia,n=476",8.96712328767123,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1796926,RNA-Seq,,150,PRJNA89525,SAMN02260512,BCCAGSC,PCR,sra,SRX542525,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31947,2015-02-10,15989,10623,ILLUMINA,137352.0,2015-02-10,SRR1796926,2013-10-25T18:30:02Z,SRS605858,SRP012000,TARGET-20-PASPGA-09A-02R,RNA,TARGET-20-PASPGA-09A-02R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASPGA,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1796926,"Acute Myeloid Leukemia,n=476",3.25753424657534,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1796927,RNA-Seq,,150,PRJNA89525,SAMN02260624,BCCAGSC,PCR,sra,SRX542518,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31935,2015-02-10,16722,11276,ILLUMINA,137348.0,2015-02-10,SRR1796927,2013-10-25T18:29:52Z,SRS605651,SRP012000,TARGET-20-PARYVW-09A-01R,RNA,TARGET-20-PARYVW-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARYVW,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1796927,"Acute Myeloid Leukemia,n=476",1.81917808219178,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1796928,RNA-Seq,,150,PRJNA89525,SAMN02260481,BCCAGSC,PCR,sra,SRX542464,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31986,2015-02-10,19096,12951,ILLUMINA,137287.0,2015-02-10,SRR1796928,2013-10-23T18:58:03Z,SRS605852,SRP012000,TARGET-20-PASIBG-09A-01R,RNA,TARGET-20-PASIBG-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASIBG,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1796928,"Acute Myeloid Leukemia,n=476",2.04931506849315,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1796929,RNA-Seq,,150,PRJNA89525,SAMN02260640,BCCAGSC,PCR,sra,SRX543485,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32005,2015-02-10,13117,8831,ILLUMINA,136783.0,2015-02-10,SRR1796929,2013-10-02T18:29:44Z,SRS605855,SRP012000,TARGET-20-PARTAL-04A-01R,RNA,TARGET-20-PARTAL-04A-01R,Recurrent Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARTAL,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1796929,"Acute Myeloid Leukemia,n=476",16.4383561643835,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1796930,RNA-Seq,,150,PRJNA89525,SAMN02260504,BCCAGSC,PCR,sra,SRX542472,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31932,2015-02-10,17135,11186,ILLUMINA,137357.0,2015-02-10,SRR1796930,2013-10-25T18:34:49Z,SRS605589,SRP012000,TARGET-20-PARUNX-09A-04R,RNA,TARGET-20-PARUNX-09A-04R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARUNX,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1796930,"Acute Myeloid Leukemia,n=476",6.35890410958904,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1796931,RNA-Seq,,150,PRJNA89525,SAMN02260490,BCCAGSC,PCR,sra,SRX542521,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31957,2015-02-10,21112,14124,ILLUMINA,137292.0,2015-02-10,SRR1796931,2013-10-23T18:58:14Z,SRS605600,SRP012000,TARGET-20-PANDIX-09A-03R,RNA,TARGET-20-PANDIX-09A-03R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PANDIX,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1796931,"Acute Myeloid Leukemia,n=476",18.0082191780821,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1796932,RNA-Seq,,150,PRJNA89525,SAMN02260484,BCCAGSC,PCR,sra,SRX542497,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A31984,2015-02-10,20696,13881,ILLUMINA,137283.0,2015-02-10,SRR1796932,2013-10-23T18:56:07Z,SRS605572,SRP012000,TARGET-20-PANYSN-03A-04R,RNA,TARGET-20-PANYSN-03A-04R,Primary Blood Derived Cancer - Peripheral Blood,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PANYSN,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1796932,"Acute Myeloid Leukemia,n=476",17.7260273972602,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1796933,RNA-Seq,,200,PRJNA89525,SAMN02260660,BCCAGSC,PCR,sra,SRX590870,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32032,2015-02-10,11814,7538,ILLUMINA,139993.0,2015-02-10,SRR1796933,2014-02-27T20:45:34Z,SRS605618,SRP012000,TARGET-20-PARUBT-40A-01R,RNA,TARGET-20-PARUBT-40A-01R,Recurrent Blood Derived Cancer - Peripheral Blood,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARUBT,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute leukemia of Ambiguous Lineage (ALAL),SRR1796933,"Acute Myeloid Leukemia,n=476",7.37534246575342,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1797066,RNA-Seq,,150,PRJNA89529,SAMN02385948,BCCAGSC,PCR,sra,SRX547585,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A32743,2015-02-10,22265,14745,ILLUMINA,138010.0,2015-02-10,SRR1797066,2013-11-27T21:55:20Z,SRS602178,SRP011999,TARGET-10-PAPHZT-09A-01R,RNA,TARGET-10-PAPHZT-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PAPHZT,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1797066,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",1.50958904109589,BALL-NOS,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",B-cell Acute Lymphoblastic Leukemia,"NOS,n=71/TARGET"
SRR1810574,RNA-Seq,,150,PRJNA89525,SAMN01778094,BCCAGSC,PCR,sra,SRX548871,214,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12525,2015-02-18,11689,7117,ILLUMINA,136777.0,2015-02-18,SRR1810574,2013-10-02T18:27:57Z,SRS380395,SRP012000,TARGET-20-PANLJN-09A-03R,RNA,TARGET-20-PANLJN-09A-03R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PANLJN,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1810574,"Acute Myeloid Leukemia,n=476",17.8739726027397,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1810575,RNA-Seq,,150,PRJNA89525,SAMN01778086,BCCAGSC,PCR,sra,SRX548852,214,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12535,2015-02-18,10161,6280,ILLUMINA,136777.0,2015-02-18,SRR1810575,2013-10-02T18:27:57Z,SRS380340,SRP012000,TARGET-20-PANVGE-09A-02R,RNA,TARGET-20-PANVGE-09A-02R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PANVGE,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1810575,"Acute Myeloid Leukemia,n=476",14.6465753424657,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1810576,RNA-Seq,,150,PRJNA89525,SAMN01778014,BCCAGSC,PCR,sra,SRX548892,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12597,2015-02-18,15699,10777,ILLUMINA,136394.0,2015-02-18,SRR1810576,2013-09-17T19:38:42Z,SRS380283,SRP012000,TARGET-20-PASSSI-09A-02R,RNA,TARGET-20-PASSSI-09A-02R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASSSI,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1810576,"Acute Myeloid Leukemia, KMT2A rearrangement,n=60",1.45205479452054,AML-KMT2A,"Acute Myeloid Leukemia, KMT2A rearrangement,n=60",Acute Myeloid Leukemia,"KMT2A rearrangement,n=60/TARGET"
SRR1810577,RNA-Seq,,150,PRJNA89525,SAMN01778064,BCCAGSC,PCR,sra,SRX548918,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12532,2015-02-18,17364,12015,ILLUMINA,136476.0,2015-02-18,SRR1810577,2013-09-18T20:31:06Z,SRS380423,SRP012000,TARGET-20-PANTPW-09A-02R,RNA,TARGET-20-PANTPW-09A-02R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PANTPW,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1810577,"Acute Myeloid Leukemia,n=476",2.24931506849315,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1810578,RNA-Seq,,150,PRJNA89525,SAMN01778162,BCCAGSC,PCR,sra,SRX548881,215,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12583,2015-02-18,16542,11427,ILLUMINA,136393.0,2015-02-18,SRR1810578,2013-09-17T19:33:38Z,SRS380345,SRP012000,TARGET-20-PARZWH-09A-03R,RNA,TARGET-20-PARZWH-09A-03R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARZWH,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1810578,"Acute Myeloid Leukemia,n=476",11.6246575342465,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1810579,RNA-Seq,,150,PRJNA89525,SAMN01778247,BCCAGSC,PCR,sra,SRX548889,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12627,2015-02-18,19162,12988,ILLUMINA,136394.0,2015-02-18,SRR1810579,2013-09-17T19:38:42Z,SRS380397,SRP012000,TARGET-20-PASMGW-09A-01R,RNA,TARGET-20-PASMGW-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASMGW,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1810579,"Acute Myeloid Leukemia, KMT2A rearrangement,n=60",8.46301369863013,AML-KMT2A,"Acute Myeloid Leukemia, KMT2A rearrangement,n=60",Acute Myeloid Leukemia,"KMT2A rearrangement,n=60/TARGET"
SRR1810580,RNA-Seq,,150,PRJNA89525,SAMN01778184,BCCAGSC,PCR,sra,SRX548876,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12632,2015-02-18,19631,13594,ILLUMINA,136467.0,2015-02-18,SRR1810580,2013-09-18T20:30:18Z,SRS380299,SRP012000,TARGET-20-PASFLM-09A-01R,RNA,TARGET-20-PASFLM-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASFLM,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1810580,"Acute Myeloid Leukemia,n=476",14.0821917808219,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1810581,RNA-Seq,,150,PRJNA89525,SAMN01778108,BCCAGSC,PCR,sra,SRX548864,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12614,2015-02-18,19385,13248,ILLUMINA,136400.0,2015-02-18,SRR1810581,2013-09-17T19:38:56Z,SRS380358,SRP012000,TARGET-20-PASHBI-09A-01R,RNA,TARGET-20-PASHBI-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASHBI,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1810581,"Acute Myeloid Leukemia,n=476",15.6904109589041,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1810582,RNA-Seq,,150,PRJNA89525,SAMN01778211,BCCAGSC,PCR,sra,SRX548856,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12600,2015-02-18,16623,11216,ILLUMINA,136398.0,2015-02-18,SRR1810582,2013-09-17T19:38:52Z,SRS380448,SRP012000,TARGET-20-PATDNN-09A-03R,RNA,TARGET-20-PATDNN-09A-03R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PATDNN,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1810582,"Acute Myeloid Leukemia, KMT2A rearrangement,n=60",3.45753424657534,AML-KMT2A,"Acute Myeloid Leukemia, KMT2A rearrangement,n=60",Acute Myeloid Leukemia,"KMT2A rearrangement,n=60/TARGET"
SRR1810583,RNA-Seq,,150,PRJNA89525,SAMN01778282,BCCAGSC,PCR,sra,SRX548925,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12519,2015-02-18,17744,12396,ILLUMINA,136469.0,2015-02-18,SRR1810583,2013-09-18T20:30:22Z,SRS380296,SRP012000,TARGET-20-PANINI-09A-03R,RNA,TARGET-20-PANINI-09A-03R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PANINI,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1810583,"Acute Myeloid Leukemia,n=476",16.7616438356164,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1810584,RNA-Seq,,150,PRJNA89525,SAMN01778109,BCCAGSC,PCR,sra,SRX548920,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12514,2015-02-18,15610,10861,ILLUMINA,136476.0,2015-02-18,SRR1810584,2013-09-18T20:31:06Z,SRS380386,SRP012000,TARGET-20-PANDER-09A-02R,RNA,TARGET-20-PANDER-09A-02R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PANDER,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1810584,"Acute Myeloid Leukemia,n=476",11.8136986301369,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1810585,RNA-Seq,,150,PRJNA89525,SAMN01778183,BCCAGSC,PCR,sra,SRX548926,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12529,2015-02-18,12366,7881,ILLUMINA,136533.0,2015-02-18,SRR1810585,2013-09-19T20:28:01Z,SRS380382,SRP012000,TARGET-20-PANPTM-09A-02R,RNA,TARGET-20-PANPTM-09A-02R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PANPTM,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1810585,"Acute Myeloid Leukemia,n=476",16.0356164383561,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1810586,RNA-Seq,,150,PRJNA89525,SAMN01778310,BCCAGSC,PCR,sra,SRX548896,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12644,2015-02-18,16991,11650,ILLUMINA,136386.0,2015-02-18,SRR1810586,2013-09-17T19:33:19Z,SRS380284,SRP012000,TARGET-20-PASWPT-09A-01R,RNA,TARGET-20-PASWPT-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASWPT,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1810586,"Acute Myeloid Leukemia,n=476",9.41917808219178,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1810587,RNA-Seq,,150,PRJNA89525,SAMN01778294,BCCAGSC,PCR,sra,SRX548894,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12531,2015-02-18,13973,9448,ILLUMINA,136396.0,2015-02-18,SRR1810587,2013-09-17T19:38:47Z,SRS380333,SRP012000,TARGET-20-PANTNA-09A-02R,RNA,TARGET-20-PANTNA-09A-02R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PANTNA,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1810587,"Acute Myeloid Leukemia,n=476",17.5780821917808,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1810588,RNA-Seq,,150,PRJNA89525,SAMN01778229,BCCAGSC,PCR,sra,SRX548849,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12520,2015-02-18,18603,12818,ILLUMINA,136466.0,2015-02-18,SRR1810588,2013-09-18T20:30:15Z,SRS380396,SRP012000,TARGET-20-PANJGR-09A-03R,RNA,TARGET-20-PANJGR-09A-03R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PANJGR,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1810588,"Acute Myeloid Leukemia,n=476",12.1232876712328,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1810589,RNA-Seq,,150,PRJNA89525,SAMN01778112,BCCAGSC,PCR,sra,SRX548866,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12551,2015-02-18,13504,9393,ILLUMINA,136467.0,2015-02-18,SRR1810589,2013-09-18T20:30:18Z,SRS380311,SRP012000,TARGET-20-PARAJX-09A-02R,RNA,TARGET-20-PARAJX-09A-02R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARAJX,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1810589,"Acute Myeloid Leukemia,n=476",1.6931506849315,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1810590,RNA-Seq,,150,PRJNA89525,SAMN01778252,BCCAGSC,PCR,sra,SRX548902,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12649,2015-02-18,15908,11020,ILLUMINA,136391.0,2015-02-18,SRR1810590,2013-09-17T19:33:32Z,SRS380288,SRP012000,TARGET-20-PASVYA-09A-01R,RNA,TARGET-20-PASVYA-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASVYA,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1810590,"Acute Myeloid Leukemia,n=476",1.61643835616438,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1810591,RNA-Seq,,150,PRJNA89525,SAMN01778299,BCCAGSC,PCR,sra,SRX548905,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12507,2015-02-18,16604,11655,ILLUMINA,136392.0,2015-02-18,SRR1810591,2013-09-17T19:33:35Z,SRS380360,SRP012000,TARGET-20-PAMVKZ-09A-03R,RNA,TARGET-20-PAMVKZ-09A-03R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PAMVKZ,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1810591,"Acute Myeloid Leukemia,n=476",16.2575342465753,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1810592,RNA-Seq,,150,PRJNA89525,SAMN01778077,BCCAGSC,PCR,sra,SRX548913,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12626,2015-02-18,16029,10838,ILLUMINA,136388.0,2015-02-18,SRR1810592,2013-09-17T19:33:25Z,SRS380413,SRP012000,TARGET-20-PATAST-09A-01R,RNA,TARGET-20-PATAST-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PATAST,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1810592,"Acute Myeloid Leukemia,n=476",16.2356164383561,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1810593,RNA-Seq,,150,PRJNA89525,SAMN01778259,BCCAGSC,PCR,sra,SRX548877,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12548,2015-02-18,17950,12587,ILLUMINA,136477.0,2015-02-18,SRR1810593,2013-09-18T20:31:08Z,SRS380394,SRP012000,TARGET-20-PAPXWI-09A-03R,RNA,TARGET-20-PAPXWI-09A-03R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PAPXWI,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1810593,"Acute Myeloid Leukemia,n=476",3.91780821917808,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1810594,RNA-Seq,,150,PRJNA89525,SAMN01778321,BCCAGSC,PCR,sra,SRX548848,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12552,2015-02-18,15739,10942,ILLUMINA,136472.0,2015-02-18,SRR1810594,2013-09-18T20:30:29Z,SRS380376,SRP012000,TARGET-20-PARANT-09A-02R,RNA,TARGET-20-PARANT-09A-02R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARANT,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1810594,"Acute Myeloid Leukemia,n=476",17.5260273972602,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1810595,RNA-Seq,,150,PRJNA89525,SAMN01778283,BCCAGSC,PCR,sra,SRX548895,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12523,2015-02-18,17140,11795,ILLUMINA,136475.0,2015-02-18,SRR1810595,2013-09-18T20:31:04Z,SRS380279,SRP012000,TARGET-20-PANKKE-09A-03R,RNA,TARGET-20-PANKKE-09A-03R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PANKKE,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1810595,"INFANT_Acute Myeloid Leukemia,n=21",0.715068493150684,AML_INFANT,"INFANT_Acute Myeloid Leukemia,n=21",Acute Myeloid Leukemia,"INFANT,n=21/TARGET"
SRR1810596,RNA-Seq,,150,PRJNA89525,SAMN01778177,BCCAGSC,PCR,sra,SRX548915,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12513,2015-02-18,19778,13717,ILLUMINA,136399.0,2015-02-18,SRR1810596,2013-09-17T19:38:54Z,SRS380434,SRP012000,TARGET-20-PANBZH-09A-03R,RNA,TARGET-20-PANBZH-09A-03R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PANBZH,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1810596,"Acute Myeloid Leukemia,n=476",10.7424657534246,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1810597,RNA-Seq,,150,PRJNA89525,SAMN01778285,BCCAGSC,PCR,sra,SRX548900,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12536,2015-02-18,18129,12581,ILLUMINA,136480.0,2015-02-18,SRR1810597,2013-09-18T20:31:15Z,SRS380357,SRP012000,TARGET-20-PANWHP-09A-02R,RNA,TARGET-20-PANWHP-09A-02R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PANWHP,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1810597,"Acute Myeloid Leukemia,n=476",5.07397260273972,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1810598,RNA-Seq,,150,PRJNA89525,SAMN01778221,BCCAGSC,PCR,sra,SRX548891,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12530,2015-02-18,22332,15585,ILLUMINA,136478.0,2015-02-18,SRR1810598,2013-09-18T20:31:10Z,SRS380424,SRP012000,TARGET-20-PANSJB-09A-03R,RNA,TARGET-20-PANSJB-09A-03R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PANSJB,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1810598,"Acute Myeloid Leukemia,n=476",11.1616438356164,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1810599,RNA-Seq,,150,PRJNA89525,SAMN01778260,BCCAGSC,PCR,sra,SRX548867,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12643,2015-02-18,17451,12079,ILLUMINA,136473.0,2015-02-18,SRR1810599,2013-09-18T20:30:31Z,SRS380303,SRP012000,TARGET-20-PATDHA-09A-01R,RNA,TARGET-20-PATDHA-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PATDHA,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1810599,"Acute Myeloid Leukemia,n=476",15.1890410958904,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1810600,RNA-Seq,,150,PRJNA89525,SAMN01778036,BCCAGSC,PCR,sra,SRX548882,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12561,2015-02-18,11844,7542,ILLUMINA,136534.0,2015-02-18,SRR1810600,2013-09-19T20:28:03Z,SRS380378,SRP012000,TARGET-20-PARCUK-09A-03R,RNA,TARGET-20-PARCUK-09A-03R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARCUK,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1810600,"Acute Myeloid Leukemia,n=476",16.4027397260274,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1810601,RNA-Seq,,150,PRJNA89525,SAMN01778248,BCCAGSC,PCR,sra,SRX548847,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12640,2015-02-18,18216,12185,ILLUMINA,136396.0,2015-02-18,SRR1810601,2013-09-17T19:38:47Z,SRS380409,SRP012000,TARGET-20-PASZLJ-09A-01R,RNA,TARGET-20-PASZLJ-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASZLJ,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1810601,"Acute Myeloid Leukemia, KMT2A rearrangement,n=60",9.70684931506849,AML-KMT2A,"Acute Myeloid Leukemia, KMT2A rearrangement,n=60",Acute Myeloid Leukemia,"KMT2A rearrangement,n=60/TARGET"
SRR1810602,RNA-Seq,,150,PRJNA89525,SAMN01778303,BCCAGSC,PCR,sra,SRX548875,214,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12580,2015-02-18,19390,13204,ILLUMINA,136401.0,2015-02-18,SRR1810602,2013-09-17T19:38:59Z,SRS380446,SRP012000,TARGET-20-PARUTH-09A-04R,RNA,TARGET-20-PARUTH-09A-04R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARUTH,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1810602,"Acute Myeloid Leukemia,n=476",9.46301369863013,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1810603,RNA-Seq,,150,PRJNA89525,SAMN01778200,BCCAGSC,PCR,sra,SRX548888,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12612,2015-02-18,15909,10129,ILLUMINA,136534.0,2015-02-18,SRR1810603,2013-09-19T20:28:03Z,SRS380361,SRP012000,TARGET-20-PARGVC-03A-03R,RNA,TARGET-20-PARGVC-03A-03R,Primary Blood Derived Cancer - Peripheral Blood,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARGVC,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1810603,"Acute Myeloid Leukemia,n=476",4.93698630136986,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1810604,RNA-Seq,,150,PRJNA89525,SAMN01778242,BCCAGSC,PCR,sra,SRX548854,215,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12557,2015-02-18,17872,12402,ILLUMINA,136393.0,2015-02-18,SRR1810604,2013-09-17T19:33:38Z,SRS380404,SRP012000,TARGET-20-PARBRA-09A-03R,RNA,TARGET-20-PARBRA-09A-03R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARBRA,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1810604,"Acute Myeloid Leukemia,n=476",7.64931506849315,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1810605,RNA-Seq,,150,PRJNA89525,SAMN01778024,BCCAGSC,PCR,sra,SRX548862,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12526,2015-02-18,15897,10574,ILLUMINA,136535.0,2015-02-18,SRR1810605,2013-09-19T20:28:05Z,SRS380315,SRP012000,TARGET-20-PANLKB-09A-03R,RNA,TARGET-20-PANLKB-09A-03R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PANLKB,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1810605,"Acute Myeloid Leukemia,n=476",4.5972602739726,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1810606,RNA-Seq,,150,PRJNA89525,SAMN01778175,BCCAGSC,PCR,sra,SRX548912,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12541,2015-02-18,13860,9504,ILLUMINA,136474.0,2015-02-18,SRR1810606,2013-09-18T20:31:01Z,SRS380411,SRP012000,TARGET-20-PAPVCN-09A-03R,RNA,TARGET-20-PAPVCN-09A-03R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PAPVCN,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1810606,"Acute Myeloid Leukemia,n=476",11.5917808219178,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1810607,RNA-Seq,,150,PRJNA89525,SAMN01778037,BCCAGSC,PCR,sra,SRX548911,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12602,2015-02-18,18687,13095,ILLUMINA,136468.0,2015-02-18,SRR1810607,2013-09-18T20:30:20Z,SRS380443,SRP012000,TARGET-20-PASWAJ-09A-04R,RNA,TARGET-20-PASWAJ-09A-04R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASWAJ,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1810607,"Acute Myeloid Leukemia, KMT2A rearrangement,n=60",9.03561643835616,AML-KMT2A,"Acute Myeloid Leukemia, KMT2A rearrangement,n=60",Acute Myeloid Leukemia,"KMT2A rearrangement,n=60/TARGET"
SRR1810608,RNA-Seq,,150,PRJNA89525,SAMN01778152,BCCAGSC,PCR,sra,SRX548885,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12599,2015-02-18,16531,11148,ILLUMINA,136398.0,2015-02-18,SRR1810608,2013-09-17T19:38:52Z,SRS380433,SRP012000,TARGET-20-PARPWL-09A-03R,RNA,TARGET-20-PARPWL-09A-03R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARPWL,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1810608,"Acute Myeloid Leukemia,n=476",2.0986301369863,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1810609,RNA-Seq,,150,PRJNA89525,SAMN01778091,BCCAGSC,PCR,sra,SRX548899,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12655,2015-02-18,16570,11464,ILLUMINA,136399.0,2015-02-18,SRR1810609,2013-09-17T19:38:54Z,SRS380388,SRP012000,TARGET-20-PASWAT-09A-01R,RNA,TARGET-20-PASWAT-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASWAT,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1810609,"Acute Myeloid Leukemia,n=476",14.1287671232876,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1810610,RNA-Seq,,150,PRJNA89525,SAMN01778220,BCCAGSC,PCR,sra,SRX548886,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12539,2015-02-18,12091,8459,ILLUMINA,136478.0,2015-02-18,SRR1810610,2013-09-18T20:31:10Z,SRS380372,SRP012000,TARGET-20-PANZWB-09A-02R,RNA,TARGET-20-PANZWB-09A-02R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PANZWB,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1810610,"Acute Myeloid Leukemia,n=476",13.5123287671232,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1810611,RNA-Seq,,150,PRJNA89525,SAMN01778235,BCCAGSC,PCR,sra,SRX548861,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12554,2015-02-18,19476,13197,ILLUMINA,136387.0,2015-02-18,SRR1810611,2013-09-17T19:33:22Z,SRS380285,SRP012000,TARGET-20-PARBFJ-09A-02R,RNA,TARGET-20-PARBFJ-09A-02R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARBFJ,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1810611,"Acute Myeloid Leukemia,n=476",12.8794520547945,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1810612,RNA-Seq,,150,PRJNA89525,SAMN01778034,BCCAGSC,PCR,sra,SRX548901,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12576,2015-02-18,16292,11139,ILLUMINA,136389.0,2015-02-18,SRR1810612,2013-09-17T19:33:27Z,SRS380267,SRP012000,TARGET-20-PARMZF-09A-02R,RNA,TARGET-20-PARMZF-09A-02R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARMZF,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1810612,"Acute Myeloid Leukemia,n=476",8.66575342465753,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1810613,RNA-Seq,,150,PRJNA89525,SAMN01778206,BCCAGSC,PCR,sra,SRX548909,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12501,2015-02-18,16798,11431,ILLUMINA,136388.0,2015-02-18,SRR1810613,2013-09-17T19:33:25Z,SRS380277,SRP012000,TARGET-20-PAKLPD-09A-02R,RNA,TARGET-20-PAKLPD-09A-02R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PAKLPD,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1810613,"INFANT_Acute Myeloid Leukemia,n=21",0.402739726027397,AML_INFANT,"INFANT_Acute Myeloid Leukemia,n=21",Acute Myeloid Leukemia,"INFANT,n=21/TARGET"
SRR1810614,RNA-Seq,,150,PRJNA89525,SAMN01778057,BCCAGSC,PCR,sra,SRX548910,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12522,2015-02-18,15391,10710,ILLUMINA,136469.0,2015-02-18,SRR1810614,2013-09-18T20:30:22Z,SRS380369,SRP012000,TARGET-20-PANKFZ-09A-04R,RNA,TARGET-20-PANKFZ-09A-04R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PANKFZ,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1810614,"Acute Myeloid Leukemia,n=476",1.8904109589041,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1810615,RNA-Seq,,150,PRJNA89525,SAMN01778002,BCCAGSC,PCR,sra,SRX548908,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12516,2015-02-18,16083,11255,ILLUMINA,136480.0,2015-02-18,SRR1810615,2013-09-18T20:31:15Z,SRS380442,SRP012000,TARGET-20-PANGCM-03A-03R,RNA,TARGET-20-PANGCM-03A-03R,Primary Blood Derived Cancer - Peripheral Blood,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PANGCM,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR1810615,"Acute Myeloid Leukemia,n=476",8.86301369863013,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1810616,RNA-Seq,,150,PRJNA89525,SAMN01778173,BCCAGSC,PCR,sra,SRX548880,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12538,2015-02-18,17352,12183,ILLUMINA,136479.0,2015-02-18,SRR1810616,2013-09-18T20:31:12Z,SRS380302,SRP012000,TARGET-20-PANZKA-09A-02R,RNA,TARGET-20-PANZKA-09A-02R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PANZKA,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1810616,"Acute Myeloid Leukemia,n=476",1.74520547945205,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1810617,RNA-Seq,,150,PRJNA89525,SAMN01778155,BCCAGSC,PCR,sra,SRX548924,217,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12570,2015-02-18,15390,10619,ILLUMINA,136470.0,2015-02-18,SRR1810617,2013-09-18T20:30:25Z,SRS380336,SRP012000,TARGET-20-PARJCR-09A-01R,RNA,TARGET-20-PARJCR-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARJCR,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1810617,"Acute Myeloid Leukemia, KMT2A rearrangement,n=60",14.6520547945205,AML-KMT2A,"Acute Myeloid Leukemia, KMT2A rearrangement,n=60",Acute Myeloid Leukemia,"KMT2A rearrangement,n=60/TARGET"
SRR1810618,RNA-Seq,,150,PRJNA89525,SAMN01778233,BCCAGSC,PCR,sra,SRX548846,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12528,2015-02-18,17904,12555,ILLUMINA,136471.0,2015-02-18,SRR1810618,2013-09-18T20:30:27Z,SRS380289,SRP012000,TARGET-20-PANNJI-09A-03R,RNA,TARGET-20-PANNJI-09A-03R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PANNJI,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1810618,"Acute Myeloid Leukemia,n=476",14.1835616438356,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1810619,RNA-Seq,,150,PRJNA89525,SAMN01778115,BCCAGSC,PCR,sra,SRX548923,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12619,2015-02-18,17215,11666,ILLUMINA,136389.0,2015-02-18,SRR1810619,2013-09-17T19:33:27Z,SRS380344,SRP012000,TARGET-20-PASLSD-03A-01R,RNA,TARGET-20-PASLSD-03A-01R,Primary Blood Derived Cancer - Peripheral Blood,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASLSD,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1810619,"Acute Myeloid Leukemia, KMT2A rearrangement,n=60",2.65479452054794,AML-KMT2A,"Acute Myeloid Leukemia, KMT2A rearrangement,n=60",Acute Myeloid Leukemia,"KMT2A rearrangement,n=60/TARGET"
SRR1810620,RNA-Seq,,150,PRJNA89525,SAMN01778136,BCCAGSC,PCR,sra,SRX548869,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12537,2015-02-18,14632,9823,ILLUMINA,136395.0,2015-02-18,SRR1810620,2013-09-17T19:38:45Z,SRS380365,SRP012000,TARGET-20-PANYGP-09A-01R,RNA,TARGET-20-PANYGP-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PANYGP,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1810620,"Acute Myeloid Leukemia,n=476",5.64109589041095,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1810621,RNA-Seq,,150,PRJNA89525,SAMN01778012,BCCAGSC,PCR,sra,SRX548872,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12544,2015-02-18,16813,11810,ILLUMINA,136471.0,2015-02-18,SRR1810621,2013-09-18T20:30:27Z,SRS380268,SRP012000,TARGET-20-PAPWHS-09A-03R,RNA,TARGET-20-PAPWHS-09A-03R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PAPWHS,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1810621,"Acute Myeloid Leukemia,n=476",13.2931506849315,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1810622,RNA-Seq,,150,PRJNA89525,SAMN01778062,BCCAGSC,PCR,sra,SRX548903,217,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12625,2015-02-18,16065,11057,ILLUMINA,136470.0,2015-02-18,SRR1810622,2013-09-18T20:30:25Z,SRS380273,SRP012000,TARGET-20-PASCCS-09A-01R,RNA,TARGET-20-PASCCS-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASCCS,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1810622,"Acute Myeloid Leukemia,n=476",11.9369863013698,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1810623,RNA-Seq,,150,PRJNA89525,SAMN01778215,BCCAGSC,PCR,sra,SRX548859,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12604,2015-02-18,15358,9765,ILLUMINA,136533.0,2015-02-18,SRR1810623,2013-09-19T20:28:01Z,SRS380354,SRP012000,TARGET-20-PAPAWN-09A-02R,RNA,TARGET-20-PAPAWN-09A-02R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PAPAWN,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1810623,"Acute Myeloid Leukemia,n=476",5.90136986301369,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1810624,RNA-Seq,,150,PRJNA89525,SAMN01778224,BCCAGSC,PCR,sra,SRX548884,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12553,2015-02-18,19228,13422,ILLUMINA,136392.0,2015-02-18,SRR1810624,2013-09-17T19:33:35Z,SRS380308,SRP012000,TARGET-20-PARASV-03A-03R,RNA,TARGET-20-PARASV-03A-03R,Primary Blood Derived Cancer - Peripheral Blood,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARASV,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1810624,"Acute Myeloid Leukemia,n=476",12.0575342465753,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1810625,RNA-Seq,,150,PRJNA89525,SAMN01778250,BCCAGSC,PCR,sra,SRX548860,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12509,2015-02-18,14998,10432,ILLUMINA,136473.0,2015-02-18,SRR1810625,2013-09-18T20:30:31Z,SRS380291,SRP012000,TARGET-20-PAMYAS-09A-03R,RNA,TARGET-20-PAMYAS-09A-03R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PAMYAS,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1810625,"Acute Myeloid Leukemia,n=476",10.8821917808219,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1810626,RNA-Seq,,150,PRJNA89525,SAMN01778146,BCCAGSC,PCR,sra,SRX548917,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12569,2015-02-18,17165,11522,ILLUMINA,136395.0,2015-02-18,SRR1810626,2013-09-17T19:38:45Z,SRS380271,SRP012000,TARGET-20-PARHVK-09A-04R,RNA,TARGET-20-PARHVK-09A-04R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARHVK,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1810626,"Acute Myeloid Leukemia, KMT2A rearrangement,n=60",13.6520547945205,AML-KMT2A,"Acute Myeloid Leukemia, KMT2A rearrangement,n=60",Acute Myeloid Leukemia,"KMT2A rearrangement,n=60/TARGET"
SRR1810627,RNA-Seq,,150,PRJNA89525,SAMN01778249,BCCAGSC,PCR,sra,SRX548916,214,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12581,2015-02-18,15896,10519,ILLUMINA,136939.0,2015-02-18,SRR1810627,2013-10-09T21:14:37Z,SRS380390,SRP012000,TARGET-20-PARUWX-09A-02R,RNA,TARGET-20-PARUWX-09A-02R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARUWX,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1810627,"Acute Myeloid Leukemia,n=476",2.87397260273972,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1810628,RNA-Seq,,150,PRJNA89525,SAMN01778293,BCCAGSC,PCR,sra,SRX548919,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12587,2015-02-18,17344,11831,ILLUMINA,136474.0,2015-02-18,SRR1810628,2013-09-18T20:31:01Z,SRS380403,SRP012000,TARGET-20-PASHYZ-09A-03R,RNA,TARGET-20-PASHYZ-09A-03R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASHYZ,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1810628,"Acute Myeloid Leukemia,n=476",4.64383561643835,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1810629,RNA-Seq,,150,PRJNA89525,SAMN01778121,BCCAGSC,PCR,sra,SRX548851,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12622,2015-02-18,16041,10994,ILLUMINA,136386.0,2015-02-18,SRR1810629,2013-09-17T19:33:19Z,SRS380417,SRP012000,TARGET-20-PATIAK-09A-01R,RNA,TARGET-20-PATIAK-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PATIAK,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1810629,"INFANT_Acute Myeloid Leukemia,n=21",0.621917808219178,AML_INFANT,"INFANT_Acute Myeloid Leukemia,n=21",Acute Myeloid Leukemia,"INFANT,n=21/TARGET"
SRR1810630,RNA-Seq,,150,PRJNA89525,SAMN01778174,BCCAGSC,PCR,sra,SRX548855,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12639,2015-02-18,17836,11729,ILLUMINA,136535.0,2015-02-18,SRR1810630,2013-09-19T20:28:05Z,SRS380359,SRP012000,TARGET-20-PASIEJ-09A-01R,RNA,TARGET-20-PASIEJ-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASIEJ,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1810630,"Acute Myeloid Leukemia,n=476",7.35890410958904,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1810631,RNA-Seq,,150,PRJNA89525,SAMN01778308,BCCAGSC,PCR,sra,SRX548858,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12598,2015-02-18,16297,11466,ILLUMINA,136468.0,2015-02-18,SRR1810631,2013-09-18T20:30:20Z,SRS380356,SRP012000,TARGET-20-PASYJI-09A-03R,RNA,TARGET-20-PASYJI-09A-03R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASYJI,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1810631,"Acute Myeloid Leukemia,n=476",12.4520547945205,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1810632,RNA-Seq,,150,PRJNA89525,SAMN01778128,BCCAGSC,PCR,sra,SRX548868,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12615,2015-02-18,14446,9866,ILLUMINA,136397.0,2015-02-18,SRR1810632,2013-09-17T19:38:49Z,SRS380304,SRP012000,TARGET-20-PASGMZ-09A-01R,RNA,TARGET-20-PASGMZ-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASGMZ,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1810632,"Acute Myeloid Leukemia,n=476",14.0520547945205,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1810633,RNA-Seq,,150,PRJNA89525,SAMN01778230,BCCAGSC,PCR,sra,SRX548898,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12571,2015-02-18,17190,11877,ILLUMINA,136481.0,2015-02-18,SRR1810633,2013-09-18T20:31:17Z,SRS380418,SRP012000,TARGET-20-PARJYP-03A-01R,RNA,TARGET-20-PARJYP-03A-01R,Primary Blood Derived Cancer - Peripheral Blood,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARJYP,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1810633,"Acute Myeloid Leukemia,n=476",14.8849315068493,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1810634,RNA-Seq,,150,PRJNA89525,SAMN01778039,BCCAGSC,PCR,sra,SRX548921,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12658,2015-02-18,16128,11148,ILLUMINA,136481.0,2015-02-18,SRR1810634,2013-09-18T20:31:17Z,SRS380432,SRP012000,TARGET-20-PASWLN-09A-01R,RNA,TARGET-20-PASWLN-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASWLN,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1810634,"Acute Myeloid Leukemia, KMT2A rearrangement,n=60",18.1671232876712,AML-KMT2A,"Acute Myeloid Leukemia, KMT2A rearrangement,n=60",Acute Myeloid Leukemia,"KMT2A rearrangement,n=60/TARGET"
SRR1810635,RNA-Seq,,150,PRJNA89525,SAMN01778167,BCCAGSC,PCR,sra,SRX548914,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12518,2015-02-18,17475,12242,ILLUMINA,136472.0,2015-02-18,SRR1810635,2013-09-18T20:30:29Z,SRS380426,SRP012000,TARGET-20-PANGJY-09A-03R,RNA,TARGET-20-PANGJY-09A-03R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PANGJY,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1810635,"Acute Myeloid Leukemia,n=476",1.62739726027397,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1810636,RNA-Seq,,150,PRJNA89525,SAMN01778124,BCCAGSC,PCR,sra,SRX548857,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12524,2015-02-18,12944,8857,ILLUMINA,136387.0,2015-02-18,SRR1810636,2013-09-17T19:33:22Z,SRS380272,SRP012000,TARGET-20-PANKNB-09A-03R,RNA,TARGET-20-PANKNB-09A-03R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PANKNB,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1810636,"Acute Myeloid Leukemia,n=476",17.6986301369863,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1810637,RNA-Seq,,150,PRJNA89525,SAMN01778056,BCCAGSC,PCR,sra,SRX548879,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12545,2015-02-18,14414,9930,ILLUMINA,136475.0,2015-02-18,SRR1810637,2013-09-18T20:31:04Z,SRS380373,SRP012000,TARGET-20-PAPWIU-09A-03R,RNA,TARGET-20-PAPWIU-09A-03R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PAPWIU,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1810637,"Acute Myeloid Leukemia,n=476",12.1123287671232,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1810638,RNA-Seq,,150,PRJNA89525,SAMN01778081,BCCAGSC,PCR,sra,SRX548845,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12533,2015-02-18,18165,12800,ILLUMINA,136479.0,2015-02-18,SRR1810638,2013-09-18T20:31:12Z,SRS380334,SRP012000,TARGET-20-PANUUA-09A-02R,RNA,TARGET-20-PANUUA-09A-02R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PANUUA,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1810638,"Acute Myeloid Leukemia,n=476",14.8082191780821,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1810639,RNA-Seq,,150,PRJNA89525,SAMN01778269,BCCAGSC,PCR,sra,SRX548904,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12641,2015-02-18,20526,14137,ILLUMINA,136391.0,2015-02-18,SRR1810639,2013-09-17T19:33:32Z,SRS380318,SRP012000,TARGET-20-PATJHJ-09A-01R,RNA,TARGET-20-PATJHJ-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PATJHJ,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1810639,"INFANT_Acute Myeloid Leukemia, KMT2A rearrangement,n=17",0.375342465753424,AML-KMT2A_INFANT,"INFANT_Acute Myeloid Leukemia, KMT2A rearrangement,n=17",Acute Myeloid Leukemia,"INFANT,KMT2A rearrangement,n=17/TARGET"
SRR1810640,RNA-Seq,,150,PRJNA89525,SAMN01778316,BCCAGSC,PCR,sra,SRX548906,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12510,2015-02-18,13545,9348,ILLUMINA,136466.0,2015-02-18,SRR1810640,2013-09-18T20:30:15Z,SRS380383,SRP012000,TARGET-20-PANAEV-09A-03R,RNA,TARGET-20-PANAEV-09A-03R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PANAEV,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1810640,"Acute Myeloid Leukemia,n=476",9.6958904109589,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1810641,RNA-Seq,,150,PRJNA89525,SAMN01778272,BCCAGSC,PCR,sra,SRX548893,214,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12543,2015-02-18,15988,10929,ILLUMINA,136401.0,2015-02-18,SRR1810641,2013-09-17T19:38:59Z,SRS380368,SRP012000,TARGET-20-PAPVZK-09A-03R,RNA,TARGET-20-PAPVZK-09A-03R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PAPVZK,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1810641,"Acute Myeloid Leukemia,n=476",15.9506849315068,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1810642,RNA-Seq,,150,PRJNA89525,SAMN01778030,BCCAGSC,PCR,sra,SRX548883,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12610,2015-02-18,18069,12606,ILLUMINA,136477.0,2015-02-18,SRR1810642,2013-09-18T20:31:08Z,SRS380329,SRP012000,TARGET-20-PASPKE-09A-04R,RNA,TARGET-20-PASPKE-09A-04R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASPKE,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1810642,"Acute Myeloid Leukemia,n=476",8.76712328767123,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1810643,RNA-Seq,,150,PRJNA89525,SAMN01778237,BCCAGSC,PCR,sra,SRX548897,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12546,2015-02-18,16090,11104,ILLUMINA,136400.0,2015-02-18,SRR1810643,2013-09-17T19:38:56Z,SRS380309,SRP012000,TARGET-20-PAPWYK-09A-03R,RNA,TARGET-20-PAPWYK-09A-03R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PAPWYK,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1810643,"Acute Myeloid Leukemia,n=476",22.5506849315068,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1810644,RNA-Seq,,150,PRJNA89525,SAMN01778031,BCCAGSC,PCR,sra,SRX548870,214,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12636,2015-02-18,19184,12625,ILLUMINA,136939.0,2015-02-18,SRR1810644,2013-10-09T21:14:37Z,SRS380328,SRP012000,TARGET-20-PASVYL-09A-01R,RNA,TARGET-20-PASVYL-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASVYL,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1810644,"Acute Myeloid Leukemia, KMT2A rearrangement,n=60",16.6849315068493,AML-KMT2A,"Acute Myeloid Leukemia, KMT2A rearrangement,n=60",Acute Myeloid Leukemia,"KMT2A rearrangement,n=60/TARGET"
SRR1810645,RNA-Seq,,150,PRJNA89525,SAMN01778197,BCCAGSC,PCR,sra,SRX548850,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A12489,2015-02-18,21526,14786,ILLUMINA,136397.0,2015-02-18,SRR1810645,2013-09-17T19:38:49Z,SRS380429,SRP012000,TARGET-20-PAEAKL-09A-03R,RNA,TARGET-20-PAEAKL-09A-03R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PAEAKL,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR1810645,"Acute Myeloid Leukemia,n=476",14.2958904109589,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1821181,RNA-Seq,,150,PRJNA89525,SAMN02443372,BCCAGSC,PCR,sra,SRX542496,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A34415,2015-02-26,18010,12082,ILLUMINA,138617.0,2015-02-26,SRR1821181,2013-12-31T21:26:50Z,SRS606816,SRP012000,TARGET-20-PANKFG-09A-02R,RNA,TARGET-20-PANKFG-09A-02R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PANKFG,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute leukemia of Ambiguous Lineage (ALAL),SRR1821181,"Acute Myeloid Leukemia,n=476",1.11780821917808,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR1821182,RNA-Seq,,150,PRJNA89525,SAMN02442949,BCCAGSC,PCR,sra,SRX542494,0,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,A34412,2015-02-26,32899,21712,ILLUMINA,138620.0,2015-02-26,SRR1821182,2013-12-31T21:28:19Z,SRS606815,SRP012000,TARGET-20-PAMYJX-09A-04R,RNA,TARGET-20-PAMYJX-09A-04R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PAMYJX,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute leukemia of Ambiguous Lineage (ALAL),SRR1821182,"Acute Myeloid Leukemia,n=476",12.6219178082191,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2083106,RNA-Seq,,150,PRJNA89525,SAMN01778239,BCCAGSC,PCR,sra,SRX1077639,209,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A12573,2015-06-30,19250,9386,ILLUMINA,148321.0,2015-06-30,SRR2083106,2014-12-30T22:37:00Z,SRS380419,SRP012000,TARGET-20-PARLSW-09A-02R,RNA,TARGET-20-PARLSW-09A-02R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARLSW,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR2083106,"Acute Myeloid Leukemia,n=476",13.4410958904109,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2083107,RNA-Seq,,150,PRJNA89525,SAMN01778100,BCCAGSC,PCR,sra,SRX1077649,209,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A12484,2015-06-30,23117,11796,ILLUMINA,148332.0,2015-06-30,SRR2083107,2014-12-30T22:39:39Z,SRS380351,SRP012000,TARGET-20-PABHKY-03A-02R,RNA,TARGET-20-PABHKY-03A-02R,Primary Blood Derived Cancer - Peripheral Blood,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PABHKY,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR2083107,"Acute Myeloid Leukemia,n=476",12.8712328767123,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2083108,RNA-Seq,,150,PRJNA89525,SAMN01778313,BCCAGSC,PCR,sra,SRX1077687,209,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A12491,2015-06-30,26721,14011,ILLUMINA,148308.0,2015-06-30,SRR2083108,2014-12-30T20:29:19Z,SRS380295,SRP012000,TARGET-20-PAEENN-09A-01R,RNA,TARGET-20-PAEENN-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PAEENN,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR2083108,"Acute Myeloid Leukemia,n=476",3.91780821917808,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2083109,RNA-Seq,,150,PRJNA89525,SAMN01778218,BCCAGSC,PCR,sra,SRX1077644,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A12654,2015-06-30,25006,12660,ILLUMINA,147876.0,2015-06-30,SRR2083109,2014-12-08T21:30:04Z,SRS380420,SRP012000,TARGET-20-PATBFL-09A-01R,RNA,TARGET-20-PATBFL-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PATBFL,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR2083109,"Acute Myeloid Leukemia,n=476",11.0958904109589,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2083110,RNA-Seq,,150,PRJNA89525,SAMN01778292,BCCAGSC,PCR,sra,SRX1077667,209,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A12559,2015-06-30,21185,10807,ILLUMINA,148328.0,2015-06-30,SRR2083110,2014-12-30T22:39:26Z,SRS380305,SRP012000,TARGET-20-PARBVE-09A-02R,RNA,TARGET-20-PARBVE-09A-02R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARBVE,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR2083110,"Acute Myeloid Leukemia,n=476",12.7808219178082,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2083111,RNA-Seq,,150,PRJNA89525,SAMN01778035,BCCAGSC,PCR,sra,SRX1077706,206,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A12645,2015-06-30,20372,9494,ILLUMINA,147584.0,2015-06-30,SRR2083111,2014-12-01T22:43:42Z,SRS380377,SRP012000,TARGET-20-PAPWZR-09A-01R,RNA,TARGET-20-PAPWZR-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PAPWZR,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR2083111,"Acute Myeloid Leukemia, KMT2A rearrangement,n=60",13.5232876712328,AML-KMT2A,"Acute Myeloid Leukemia, KMT2A rearrangement,n=60",Acute Myeloid Leukemia,"KMT2A rearrangement,n=60/TARGET"
SRR2083112,RNA-Seq,,150,PRJNA89525,SAMN01778095,BCCAGSC,PCR,sra,SRX1077701,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A12656,2015-06-30,20907,10150,ILLUMINA,147862.0,2015-06-30,SRR2083112,2014-12-08T21:16:26Z,SRS380384,SRP012000,TARGET-20-PAPUNR-09A-02R,RNA,TARGET-20-PAPUNR-09A-02R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PAPUNR,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR2083112,"Acute Myeloid Leukemia,n=476",13.2767123287671,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2083113,RNA-Seq,,150,PRJNA89525,SAMN01778052,BCCAGSC,PCR,sra,SRX1077672,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A12620,2015-06-30,19562,9426,ILLUMINA,147586.0,2015-06-30,SRR2083113,2014-12-01T22:43:47Z,SRS380327,SRP012000,TARGET-20-PATFDF-09A-01R,RNA,TARGET-20-PATFDF-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PATFDF,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR2083113,"Acute Myeloid Leukemia, KMT2A rearrangement,n=60",2.37260273972602,AML-KMT2A,"Acute Myeloid Leukemia, KMT2A rearrangement,n=60",Acute Myeloid Leukemia,"KMT2A rearrangement,n=60/TARGET"
SRR2083114,RNA-Seq,,150,PRJNA89525,SAMN01778089,BCCAGSC,PCR,sra,SRX1077659,204,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A12606,2015-06-30,22066,10458,ILLUMINA,147596.0,2015-06-30,SRR2083114,2014-12-01T22:46:16Z,SRS380298,SRP012000,TARGET-20-PASNIY-09A-02R,RNA,TARGET-20-PASNIY-09A-02R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASNIY,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR2083114,"Acute Myeloid Leukemia, KMT2A rearrangement,n=60",2.55342465753424,AML-KMT2A,"Acute Myeloid Leukemia, KMT2A rearrangement,n=60",Acute Myeloid Leukemia,"KMT2A rearrangement,n=60/TARGET"
SRR2083115,RNA-Seq,,150,PRJNA89525,SAMN01778114,BCCAGSC,PCR,sra,SRX1077675,209,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A12512,2015-06-30,25640,12000,ILLUMINA,148334.0,2015-06-30,SRR2083115,2014-12-30T22:39:45Z,SRS380335,SRP012000,TARGET-20-PANBYS-09A-03R,RNA,TARGET-20-PANBYS-09A-03R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PANBYS,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR2083115,"Acute Myeloid Leukemia,n=476",12.2164383561643,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2083116,RNA-Seq,,150,PRJNA89525,SAMN01778063,BCCAGSC,PCR,sra,SRX1077661,209,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A12500,2015-06-30,21463,10936,ILLUMINA,148324.0,2015-06-30,SRR2083116,2014-12-30T22:37:09Z,SRS380450,SRP012000,TARGET-20-PAKKBK-09A-02R,RNA,TARGET-20-PAKKBK-09A-02R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PAKKBK,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR2083116,"Acute Myeloid Leukemia,n=476",1.93150684931506,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2083117,RNA-Seq,,150,PRJNA89525,SAMN01778317,BCCAGSC,PCR,sra,SRX1077693,209,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A12572,2015-06-30,22515,10711,ILLUMINA,148326.0,2015-06-30,SRR2083117,2014-12-30T22:37:15Z,SRS380310,SRP012000,TARGET-20-PARKFB-09A-02R,RNA,TARGET-20-PARKFB-09A-02R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARKFB,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR2083117,"Acute Myeloid Leukemia, KMT2A rearrangement,n=60",18.1671232876712,AML-KMT2A,"Acute Myeloid Leukemia, KMT2A rearrangement,n=60",Acute Myeloid Leukemia,"KMT2A rearrangement,n=60/TARGET"
SRR2083118,RNA-Seq,,150,PRJNA89525,SAMN01778232,BCCAGSC,PCR,sra,SRX1077655,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A12617,2015-06-30,27152,13661,ILLUMINA,147865.0,2015-06-30,SRR2083118,2014-12-08T21:16:35Z,SRS380294,SRP012000,TARGET-20-PASSWG-03A-01R,RNA,TARGET-20-PASSWG-03A-01R,Primary Blood Derived Cancer - Peripheral Blood,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASSWG,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR2083118,"INFANT_Acute Myeloid Leukemia, KMT2A rearrangement,n=17",0.30958904109589,AML-KMT2A_INFANT,"INFANT_Acute Myeloid Leukemia, KMT2A rearrangement,n=17",Acute Myeloid Leukemia,"INFANT,KMT2A rearrangement,n=17/TARGET"
SRR2083119,RNA-Seq,,150,PRJNA89525,SAMN01778268,BCCAGSC,PCR,sra,SRX1077684,209,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A12488,2015-06-30,24976,13211,ILLUMINA,148307.0,2015-06-30,SRR2083119,2014-12-30T20:29:16Z,SRS380412,SRP012000,TARGET-20-PAEAFC-09A-03R,RNA,TARGET-20-PAEAFC-09A-03R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PAEAFC,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR2083119,"Acute Myeloid Leukemia,n=476",13.9945205479452,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2083120,RNA-Seq,,150,PRJNA89525,SAMN01778193,BCCAGSC,PCR,sra,SRX1077674,209,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A12558,2015-06-30,21463,10395,ILLUMINA,148322.0,2015-06-30,SRR2083120,2014-12-30T22:37:03Z,SRS380371,SRP012000,TARGET-20-PARBTV-09A-02R,RNA,TARGET-20-PARBTV-09A-02R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARBTV,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR2083120,"Acute Myeloid Leukemia,n=476",17.186301369863,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2083121,RNA-Seq,,150,PRJNA89525,SAMN01778054,BCCAGSC,PCR,sra,SRX1077692,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A12659,2015-06-30,23599,11650,ILLUMINA,147866.0,2015-06-30,SRR2083121,2014-12-08T21:16:38Z,SRS380324,SRP012000,TARGET-20-PALBYP-09A-02R,RNA,TARGET-20-PALBYP-09A-02R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PALBYP,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR2083121,"Acute Myeloid Leukemia,n=476",5.87671232876712,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2083122,RNA-Seq,,150,PRJNA89525,SAMN01778319,BCCAGSC,PCR,sra,SRX1077688,209,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A12502,2015-06-30,11505,5427,ILLUMINA,148334.0,2015-06-30,SRR2083122,2014-12-30T22:39:45Z,SRS380317,SRP012000,TARGET-20-PAKRUP-09A-02R,RNA,TARGET-20-PAKRUP-09A-02R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PAKRUP,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR2083122,"Acute Myeloid Leukemia,n=476",8.20547945205479,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2083123,RNA-Seq,,150,PRJNA89525,SAMN01778178,BCCAGSC,PCR,sra,SRX1077680,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A12624,2015-06-30,21967,10471,ILLUMINA,147591.0,2015-06-30,SRR2083123,2014-12-01T22:45:59Z,SRS380375,SRP012000,TARGET-20-PASECW-09A-04R,RNA,TARGET-20-PASECW-09A-04R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASECW,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR2083123,"Acute Myeloid Leukemia,n=476",2.28493150684931,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2083124,RNA-Seq,,150,PRJNA89525,SAMN01778071,BCCAGSC,PCR,sra,SRX1077645,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A12577,2015-06-30,22545,11469,ILLUMINA,147872.0,2015-06-30,SRR2083124,2014-12-08T21:29:53Z,SRS380387,SRP012000,TARGET-20-PARPBF-09A-02R,RNA,TARGET-20-PARPBF-09A-02R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARPBF,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR2083124,"Acute Myeloid Leukemia,n=476",17.6,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2083125,RNA-Seq,,150,PRJNA89525,SAMN01778288,BCCAGSC,PCR,sra,SRX1077617,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A12657,2015-06-30,22113,10839,ILLUMINA,147864.0,2015-06-30,SRR2083125,2014-12-08T21:16:32Z,SRS380341,SRP012000,TARGET-20-PARLMY-09A-01R,RNA,TARGET-20-PARLMY-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARLMY,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR2083125,"Acute Myeloid Leukemia,n=476",7.95616438356164,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2083126,RNA-Seq,,150,PRJNA89525,SAMN01778203,BCCAGSC,PCR,sra,SRX1077707,209,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A12496,2015-06-30,27229,14467,ILLUMINA,148306.0,2015-06-30,SRR2083126,2014-12-30T20:29:13Z,SRS380339,SRP012000,TARGET-20-PAEJBT-09A-02R,RNA,TARGET-20-PAEJBT-09A-02R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PAEJBT,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR2083126,"Acute Myeloid Leukemia,n=476",10.0630136986301,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2083127,RNA-Seq,,150,PRJNA89525,SAMN01778291,BCCAGSC,PCR,sra,SRX1077625,209,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A12492,2015-06-30,21923,11044,ILLUMINA,148304.0,2015-06-30,SRR2083127,2014-12-30T20:29:05Z,SRS380428,SRP012000,TARGET-20-PAEEYP-09A-02R,RNA,TARGET-20-PAEEYP-09A-02R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PAEEYP,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR2083127,"Acute Myeloid Leukemia,n=476",1.55342465753424,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2083128,RNA-Seq,,150,PRJNA89525,SAMN01778011,BCCAGSC,PCR,sra,SRX1077682,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A12634,2015-06-30,19868,9764,ILLUMINA,147875.0,2015-06-30,SRR2083128,2014-12-08T21:30:02Z,SRS380438,SRP012000,TARGET-20-PARVUA-03A-02R,RNA,TARGET-20-PARVUA-03A-02R,Primary Blood Derived Cancer - Peripheral Blood,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARVUA,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR2083128,"Acute Myeloid Leukemia,n=476",15.8520547945205,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2083129,RNA-Seq,,150,PRJNA89525,SAMN01778214,BCCAGSC,PCR,sra,SRX1077622,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A12653,2015-06-30,15894,8004,ILLUMINA,147874.0,2015-06-30,SRR2083129,2014-12-08T21:29:59Z,SRS380441,SRP012000,TARGET-20-PARJWH-09A-01R,RNA,TARGET-20-PARJWH-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARJWH,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR2083129,"INFANT_Acute Myeloid Leukemia,n=21",0.956164383561643,AML_INFANT,"INFANT_Acute Myeloid Leukemia,n=21",Acute Myeloid Leukemia,"INFANT,n=21/TARGET"
SRR2083130,RNA-Seq,,150,PRJNA89525,SAMN01778219,BCCAGSC,PCR,sra,SRX1077665,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A12579,2015-06-30,21893,10569,ILLUMINA,147585.0,2015-06-30,SRR2083130,2014-12-01T22:43:44Z,SRS380312,SRP012000,TARGET-20-PARURW-09A-02R,RNA,TARGET-20-PARURW-09A-02R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARURW,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR2083130,"Acute Myeloid Leukemia,n=476",10.5561643835616,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2083131,RNA-Seq,,150,PRJNA89525,SAMN01778009,BCCAGSC,PCR,sra,SRX1077630,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A12635,2015-06-30,20995,10362,ILLUMINA,147861.0,2015-06-30,SRR2083131,2014-12-08T21:16:23Z,SRS380350,SRP012000,TARGET-20-PASKGH-09A-01R,RNA,TARGET-20-PASKGH-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASKGH,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR2083131,"Acute Myeloid Leukemia,n=476",10.386301369863,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2083132,RNA-Seq,,150,PRJNA89525,SAMN01778246,BCCAGSC,PCR,sra,SRX1077678,209,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A12499,2015-06-30,22985,11497,ILLUMINA,148305.0,2015-06-30,SRR2083132,2014-12-30T20:29:10Z,SRS380297,SRP012000,TARGET-20-PAKHBF-09A-01R,RNA,TARGET-20-PAKHBF-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PAKHBF,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR2083132,"Acute Myeloid Leukemia,n=476",2.23561643835616,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2083133,RNA-Seq,,150,PRJNA89525,SAMN01778318,BCCAGSC,PCR,sra,SRX1077697,209,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A12483,2015-06-30,21409,10222,ILLUMINA,148321.0,2015-06-30,SRR2083133,2014-12-30T22:37:00Z,SRS380431,SRP012000,TARGET-20-PABHET-03A-02R,RNA,TARGET-20-PABHET-03A-02R,Primary Blood Derived Cancer - Peripheral Blood,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PABHET,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR2083133,"Acute Myeloid Leukemia,n=476",14.7068493150684,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2083134,RNA-Seq,,150,PRJNA89525,SAMN01778053,BCCAGSC,PCR,sra,SRX1077704,209,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A12568,2015-06-30,27108,14015,ILLUMINA,148327.0,2015-06-30,SRR2083134,2014-12-30T22:37:18Z,SRS380398,SRP012000,TARGET-20-PARHVI-03A-03R,RNA,TARGET-20-PARHVI-03A-03R,Primary Blood Derived Cancer - Peripheral Blood,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARHVI,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR2083134,"Acute Myeloid Leukemia,n=476",16.4547945205479,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2083135,RNA-Seq,,150,PRJNA89525,SAMN01778267,BCCAGSC,PCR,sra,SRX1077696,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A12578,2015-06-30,20964,10114,ILLUMINA,147583.0,2015-06-30,SRR2083135,2014-12-01T22:43:40Z,SRS380410,SRP012000,TARGET-20-PARPVZ-09A-02R,RNA,TARGET-20-PARPVZ-09A-02R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARPVZ,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR2083135,"Acute Myeloid Leukemia,n=476",11.3835616438356,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2083136,RNA-Seq,,150,PRJNA89525,SAMN01778179,BCCAGSC,PCR,sra,SRX1077660,209,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A12566,2015-06-30,20171,9773,ILLUMINA,148322.0,2015-06-30,SRR2083136,2014-12-30T22:37:03Z,SRS380326,SRP012000,TARGET-20-PARHBA-03A-02R,RNA,TARGET-20-PARHBA-03A-02R,Primary Blood Derived Cancer - Peripheral Blood,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARHBA,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR2083136,"Acute Myeloid Leukemia,n=476",18.8465753424657,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2083137,RNA-Seq,,150,PRJNA89525,SAMN01778140,BCCAGSC,PCR,sra,SRX1077694,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A12663,2015-06-30,23359,11238,ILLUMINA,147590.0,2015-06-30,SRR2083137,2014-12-01T22:44:00Z,SRS380348,SRP012000,TARGET-20-PARTXH-09A-03R,RNA,TARGET-20-PARTXH-09A-03R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARTXH,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR2083137,"Acute Myeloid Leukemia,n=476",9.27671232876712,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2083138,RNA-Seq,,150,PRJNA89525,SAMN01778264,BCCAGSC,PCR,sra,SRX1077666,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A12608,2015-06-30,24097,11882,ILLUMINA,147873.0,2015-06-30,SRR2083138,2014-12-08T21:29:56Z,SRS380346,SRP012000,TARGET-20-PAPVGE-09A-03R,RNA,TARGET-20-PAPVGE-09A-03R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PAPVGE,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR2083138,"Acute Myeloid Leukemia,n=476",13.1698630136986,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2083139,RNA-Seq,,150,PRJNA89525,SAMN01778022,BCCAGSC,PCR,sra,SRX1077619,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A12616,2015-06-30,17996,8774,ILLUMINA,147863.0,2015-06-30,SRR2083139,2014-12-08T21:16:29Z,SRS380319,SRP012000,TARGET-20-PARTXH-09A-02R,RNA,TARGET-20-PARTXH-09A-02R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARTXH,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR2083139,"Acute Myeloid Leukemia,n=476",9.27671232876712,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2083140,RNA-Seq,,150,PRJNA89525,SAMN01778004,BCCAGSC,PCR,sra,SRX1077705,194,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A12646,2015-06-30,19004,8980,ILLUMINA,147587.0,2015-06-30,SRR2083140,2014-12-01T22:43:50Z,SRS380385,SRP012000,TARGET-20-PATGAN-03A-01R,RNA,TARGET-20-PATGAN-03A-01R,Primary Blood Derived Cancer - Peripheral Blood,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PATGAN,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR2083140,"INFANT_Acute Myeloid Leukemia,n=21",0.758904109589041,AML_INFANT,"INFANT_Acute Myeloid Leukemia,n=21",Acute Myeloid Leukemia,"INFANT,n=21/TARGET"
SRR2083141,RNA-Seq,,150,PRJNA89525,SAMN01778201,BCCAGSC,PCR,sra,SRX1077636,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A12594,2015-06-30,23166,11335,ILLUMINA,147583.0,2015-06-30,SRR2083141,2014-12-01T22:43:40Z,SRS380301,SRP012000,TARGET-20-PASREH-09A-02R,RNA,TARGET-20-PASREH-09A-02R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASREH,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR2083141,"Acute Myeloid Leukemia,n=476",7.14520547945205,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2083142,RNA-Seq,,150,PRJNA89525,SAMN01778289,BCCAGSC,PCR,sra,SRX1077708,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A12596,2015-06-30,23262,11013,ILLUMINA,147588.0,2015-06-30,SRR2083142,2014-12-01T22:43:53Z,SRS380337,SRP012000,TARGET-20-PASRTP-09A-01R,RNA,TARGET-20-PASRTP-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASRTP,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR2083142,"Acute Myeloid Leukemia,n=476",14.7643835616438,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2083143,RNA-Seq,,150,PRJNA89525,SAMN01778033,BCCAGSC,PCR,sra,SRX1077643,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A12613,2015-06-30,23899,11769,ILLUMINA,147861.0,2015-06-30,SRR2083143,2014-12-08T21:16:23Z,SRS380269,SRP012000,TARGET-20-PASPWZ-03A-01R,RNA,TARGET-20-PASPWZ-03A-01R,Primary Blood Derived Cancer - Peripheral Blood,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASPWZ,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR2083143,"INFANT_Acute Myeloid Leukemia,n=21",0.0273972602739726,AML_INFANT,"INFANT_Acute Myeloid Leukemia,n=21",Acute Myeloid Leukemia,"INFANT,n=21/TARGET"
SRR2083144,RNA-Seq,,150,PRJNA89525,SAMN01778245,BCCAGSC,PCR,sra,SRX1077685,209,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A12487,2015-06-30,25194,12720,ILLUMINA,148331.0,2015-06-30,SRR2083144,2014-12-30T22:39:36Z,SRS380307,SRP012000,TARGET-20-PADZKD-09A-02R,RNA,TARGET-20-PADZKD-09A-02R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PADZKD,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR2083144,"Acute Myeloid Leukemia, KMT2A rearrangement,n=60",13.3890410958904,AML-KMT2A,"Acute Myeloid Leukemia, KMT2A rearrangement,n=60",Acute Myeloid Leukemia,"KMT2A rearrangement,n=60/TARGET"
SRR2083145,RNA-Seq,,150,PRJNA89525,SAMN01778210,BCCAGSC,PCR,sra,SRX1077647,209,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A12549,2015-06-30,23712,12374,ILLUMINA,148325.0,2015-06-30,SRR2083145,2014-12-30T22:37:12Z,SRS380306,SRP012000,TARGET-20-PAPZIZ-09A-03R,RNA,TARGET-20-PAPZIZ-09A-03R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PAPZIZ,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR2083145,"Acute Myeloid Leukemia,n=476",15.372602739726,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2083146,RNA-Seq,,150,PRJNA89525,SAMN01778301,BCCAGSC,PCR,sra,SRX1077703,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A12603,2015-06-30,17851,8738,ILLUMINA,147593.0,2015-06-30,SRR2083146,2014-12-01T22:46:06Z,SRS380447,SRP012000,TARGET-20-PARTYV-09A-03R,RNA,TARGET-20-PARTYV-09A-03R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARTYV,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR2083146,"Acute Myeloid Leukemia,n=476",4.48219178082191,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2083147,RNA-Seq,,150,PRJNA89525,SAMN01778073,BCCAGSC,PCR,sra,SRX1077646,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A12611,2015-06-30,25472,12622,ILLUMINA,147875.0,2015-06-30,SRR2083147,2014-12-08T21:30:02Z,SRS380422,SRP012000,TARGET-20-PAREFM-09A-02R,RNA,TARGET-20-PAREFM-09A-02R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PAREFM,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR2083147,"Acute Myeloid Leukemia,n=476",11.9260273972602,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2083148,RNA-Seq,,150,PRJNA89525,SAMN01778137,BCCAGSC,PCR,sra,SRX1077700,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A12665,2015-06-30,24574,12121,ILLUMINA,147592.0,2015-06-30,SRR2083148,2014-12-01T22:46:03Z,SRS380399,SRP012000,TARGET-20-PASWAT-09A-02R,RNA,TARGET-20-PASWAT-09A-02R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASWAT,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR2083148,"Acute Myeloid Leukemia,n=476",14.1287671232876,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2083149,RNA-Seq,,150,PRJNA89525,SAMN01778017,BCCAGSC,PCR,sra,SRX1077638,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A12607,2015-06-30,22505,11196,ILLUMINA,147870.0,2015-06-30,SRR2083149,2014-12-08T21:29:47Z,SRS380380,SRP012000,TARGET-20-PASBPW-09A-02R,RNA,TARGET-20-PASBPW-09A-02R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASBPW,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR2083149,"Acute Myeloid Leukemia,n=476",14.2876712328767,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2083150,RNA-Seq,,150,PRJNA89525,SAMN01778257,BCCAGSC,PCR,sra,SRX1077681,209,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A12494,2015-06-30,22286,11832,ILLUMINA,148308.0,2015-06-30,SRR2083150,2014-12-30T20:29:19Z,SRS380320,SRP012000,TARGET-20-PAEGRE-03A-02R,RNA,TARGET-20-PAEGRE-03A-02R,Primary Blood Derived Cancer - Peripheral Blood,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PAEGRE,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR2083150,"Acute Myeloid Leukemia,n=476",15.0849315068493,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2083151,RNA-Seq,,150,PRJNA89525,SAMN01778046,BCCAGSC,PCR,sra,SRX1077654,209,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A12550,2015-06-30,22846,11933,ILLUMINA,148329.0,2015-06-30,SRR2083151,2014-12-30T22:39:30Z,SRS380437,SRP012000,TARGET-20-PAPZLT-09A-02R,RNA,TARGET-20-PAPZLT-09A-02R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PAPZLT,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR2083151,"Acute Myeloid Leukemia, KMT2A rearrangement,n=60",3.72054794520547,AML-KMT2A,"Acute Myeloid Leukemia, KMT2A rearrangement,n=60",Acute Myeloid Leukemia,"KMT2A rearrangement,n=60/TARGET"
SRR2083152,RNA-Seq,,150,PRJNA89525,SAMN01778119,BCCAGSC,PCR,sra,SRX1077679,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A12652,2015-06-30,21981,11005,ILLUMINA,147871.0,2015-06-30,SRR2083152,2014-12-08T21:29:50Z,SRS380349,SRP012000,TARGET-20-PASWTY-09A-01R,RNA,TARGET-20-PASWTY-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASWTY,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR2083152,"Acute Myeloid Leukemia, KMT2A rearrangement,n=60",13.9972602739726,AML-KMT2A,"Acute Myeloid Leukemia, KMT2A rearrangement,n=60",Acute Myeloid Leukemia,"KMT2A rearrangement,n=60/TARGET"
SRR2083153,RNA-Seq,,150,PRJNA89525,SAMN01778160,BCCAGSC,PCR,sra,SRX1077676,209,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A12555,2015-06-30,14985,6909,ILLUMINA,148320.0,2015-06-30,SRR2083153,2014-12-30T22:36:56Z,SRS380400,SRP012000,TARGET-20-PARBFZ-03A-02R,RNA,TARGET-20-PARBFZ-03A-02R,Primary Blood Derived Cancer - Peripheral Blood,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARBFZ,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR2083153,"Acute Myeloid Leukemia,n=476",14.5150684931506,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2083154,RNA-Seq,,150,PRJNA89525,SAMN01778192,BCCAGSC,PCR,sra,SRX1077633,209,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A12562,2015-06-30,20595,10690,ILLUMINA,148330.0,2015-06-30,SRR2083154,2014-12-30T22:39:33Z,SRS380313,SRP012000,TARGET-20-PARDZW-09A-01R,RNA,TARGET-20-PARDZW-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARDZW,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR2083154,"Acute Myeloid Leukemia,n=476",7.6931506849315,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2083155,RNA-Seq,,150,PRJNA89525,SAMN01778093,BCCAGSC,PCR,sra,SRX1077663,209,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A12547,2015-06-30,26657,14049,ILLUMINA,148330.0,2015-06-30,SRR2083155,2014-12-30T22:39:33Z,SRS380392,SRP012000,TARGET-20-PAPXUF-09A-01R,RNA,TARGET-20-PAPXUF-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PAPXUF,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR2083155,"Acute Myeloid Leukemia,n=476",17.6328767123287,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2083156,RNA-Seq,,150,PRJNA89525,SAMN01778188,BCCAGSC,PCR,sra,SRX1077613,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A12590,2015-06-30,28234,13687,ILLUMINA,147874.0,2015-06-30,SRR2083156,2014-12-08T21:29:59Z,SRS380393,SRP012000,TARGET-20-PASLDL-09A-02R,RNA,TARGET-20-PASLDL-09A-02R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASLDL,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR2083156,"Acute Myeloid Leukemia,n=476",8.12054794520548,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2083157,RNA-Seq,,150,PRJNA89525,SAMN01778103,BCCAGSC,PCR,sra,SRX1077651,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A12660,2015-06-30,22581,11099,ILLUMINA,147585.0,2015-06-30,SRR2083157,2014-12-01T22:43:44Z,SRS380332,SRP012000,TARGET-20-PALVKV-09A-02R,RNA,TARGET-20-PALVKV-09A-02R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PALVKV,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR2083157,"Acute Myeloid Leukemia,n=476",13.4301369863013,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2083158,RNA-Seq,,150,PRJNA89525,SAMN01778172,BCCAGSC,PCR,sra,SRX1077652,209,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A12482,2015-06-30,19352,9574,ILLUMINA,148335.0,2015-06-30,SRR2083158,2014-12-30T22:39:48Z,SRS380281,SRP012000,TARGET-20-PABGKN-09A-01R,RNA,TARGET-20-PABGKN-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PABGKN,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR2083158,"Acute Myeloid Leukemia,n=476",18.1945205479452,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2083159,RNA-Seq,,150,PRJNA89525,SAMN01778296,BCCAGSC,PCR,sra,SRX1077626,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A12650,2015-06-30,23369,11748,ILLUMINA,147594.0,2015-06-30,SRR2083159,2014-12-01T22:46:09Z,SRS380325,SRP012000,TARGET-20-PASHWN-09A-01R,RNA,TARGET-20-PASHWN-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASHWN,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR2083159,"Acute Myeloid Leukemia,n=476",7.13972602739726,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2083160,RNA-Seq,,150,PRJNA89525,SAMN01778295,BCCAGSC,PCR,sra,SRX1077673,194,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A12661,2015-06-30,22760,10765,ILLUMINA,147587.0,2015-06-30,SRR2083160,2014-12-01T22:43:50Z,SRS380342,SRP012000,TARGET-20-PANLRE-09A-05R,RNA,TARGET-20-PANLRE-09A-05R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PANLRE,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR2083160,"Acute Myeloid Leukemia,n=476",9.36164383561643,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2083161,RNA-Seq,,150,PRJNA89525,SAMN01778314,BCCAGSC,PCR,sra,SRX1077702,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A12629,2015-06-30,24805,12570,ILLUMINA,147594.0,2015-06-30,SRR2083161,2014-12-01T22:46:09Z,SRS380445,SRP012000,TARGET-20-PASPFE-09A-01R,RNA,TARGET-20-PASPFE-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASPFE,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR2083161,"Acute Myeloid Leukemia, KMT2A rearrangement,n=60",1.26575342465753,AML-KMT2A,"Acute Myeloid Leukemia, KMT2A rearrangement,n=60",Acute Myeloid Leukemia,"KMT2A rearrangement,n=60/TARGET"
SRR2083162,RNA-Seq,,150,PRJNA89525,SAMN01778254,BCCAGSC,PCR,sra,SRX1077620,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A12595,2015-06-30,24228,11670,ILLUMINA,147586.0,2015-06-30,SRR2083162,2014-12-01T22:43:47Z,SRS380270,SRP012000,TARGET-20-PASRRB-03A-01R,RNA,TARGET-20-PASRRB-03A-01R,Primary Blood Derived Cancer - Peripheral Blood,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASRRB,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR2083162,"Acute Myeloid Leukemia,n=476",12.2328767123287,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2083163,RNA-Seq,,150,PRJNA89525,SAMN01778099,BCCAGSC,PCR,sra,SRX1077656,209,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A12485,2015-06-30,11523,5705,ILLUMINA,148335.0,2015-06-30,SRR2083163,2014-12-30T22:39:48Z,SRS380427,SRP012000,TARGET-20-PACDZR-09A-02R,RNA,TARGET-20-PACDZR-09A-02R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PACDZR,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR2083163,"Acute Myeloid Leukemia,n=476",4.55068493150684,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2083164,RNA-Seq,,150,PRJNA89525,SAMN01778147,BCCAGSC,PCR,sra,SRX1077642,209,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A12495,2015-06-30,22997,11544,ILLUMINA,148304.0,2015-06-30,SRR2083164,2014-12-30T20:29:05Z,SRS380381,SRP012000,TARGET-20-PAEGRI-03A-01R,RNA,TARGET-20-PAEGRI-03A-01R,Primary Blood Derived Cancer - Peripheral Blood,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PAEGRI,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR2083164,"Acute Myeloid Leukemia, KMT2A rearrangement,n=60",16.4958904109589,AML-KMT2A,"Acute Myeloid Leukemia, KMT2A rearrangement,n=60",Acute Myeloid Leukemia,"KMT2A rearrangement,n=60/TARGET"
SRR2083165,RNA-Seq,,150,PRJNA89525,SAMN01778151,BCCAGSC,PCR,sra,SRX1077677,204,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A12630,2015-06-30,20737,10049,ILLUMINA,147596.0,2015-06-30,SRR2083165,2014-12-01T22:46:16Z,SRS380321,SRP012000,TARGET-20-PARDDA-09A-02R,RNA,TARGET-20-PARDDA-09A-02R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARDDA,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR2083165,"Acute Myeloid Leukemia,n=476",12.5835616438356,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2083166,RNA-Seq,,150,PRJNA89525,SAMN01778165,BCCAGSC,PCR,sra,SRX1077690,209,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A12503,2015-06-30,22926,11797,ILLUMINA,148332.0,2015-06-30,SRR2083166,2014-12-30T22:39:39Z,SRS380421,SRP012000,TARGET-20-PAKVYM-09A-02R,RNA,TARGET-20-PAKVYM-09A-02R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PAKVYM,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR2083166,"Acute Myeloid Leukemia,n=476",15.8821917808219,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2083167,RNA-Seq,,150,PRJNA89525,SAMN01778117,BCCAGSC,PCR,sra,SRX1077691,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A12586,2015-06-30,23343,11798,ILLUMINA,147595.0,2015-06-30,SRR2083167,2014-12-01T22:46:13Z,SRS380290,SRP012000,TARGET-20-PASEGC-09A-01R,RNA,TARGET-20-PASEGC-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASEGC,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR2083167,"Acute Myeloid Leukemia,n=476",11.8136986301369,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2083168,RNA-Seq,,150,PRJNA89525,SAMN01778020,BCCAGSC,PCR,sra,SRX1077634,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A12637,2015-06-30,25324,12510,ILLUMINA,147863.0,2015-06-30,SRR2083168,2014-12-08T21:16:29Z,SRS380280,SRP012000,TARGET-20-PASFNP-09A-02R,RNA,TARGET-20-PASFNP-09A-02R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASFNP,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR2083168,"Acute Myeloid Leukemia,n=476",5.30136986301369,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2083169,RNA-Seq,,150,PRJNA89525,SAMN01778021,BCCAGSC,PCR,sra,SRX1077698,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A12490,2015-06-30,19382,9595,ILLUMINA,147866.0,2015-06-30,SRR2083169,2014-12-08T21:16:38Z,SRS380374,SRP012000,TARGET-20-PAECBZ-09A-03R,RNA,TARGET-20-PAECBZ-09A-03R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PAECBZ,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR2083169,"Acute Myeloid Leukemia,n=476",3.81917808219178,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2083170,RNA-Seq,,150,PRJNA89525,SAMN01778154,BCCAGSC,PCR,sra,SRX1077689,209,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A12567,2015-06-30,21258,11224,ILLUMINA,148306.0,2015-06-30,SRR2083170,2014-12-30T20:29:13Z,SRS380449,SRP012000,TARGET-20-PARHJV-09A-01R,RNA,TARGET-20-PARHJV-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARHJV,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR2083170,"Acute Myeloid Leukemia,n=476",2.57260273972602,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2083171,RNA-Seq,,150,PRJNA89525,SAMN01778244,BCCAGSC,PCR,sra,SRX1077635,209,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A12498,2015-06-30,20168,10309,ILLUMINA,148331.0,2015-06-30,SRR2083171,2014-12-30T22:39:36Z,SRS380353,SRP012000,TARGET-20-PAESVN-09A-02R,RNA,TARGET-20-PAESVN-09A-02R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PAESVN,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR2083171,"Acute Myeloid Leukemia,n=476",10.6602739726027,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2083172,RNA-Seq,,150,PRJNA89525,SAMN01778074,BCCAGSC,PCR,sra,SRX1077670,209,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A12534,2015-06-30,21197,9772,ILLUMINA,148320.0,2015-06-30,SRR2083172,2014-12-30T22:36:56Z,SRS380435,SRP012000,TARGET-20-PANVBP-09A-02R,RNA,TARGET-20-PANVBP-09A-02R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PANVBP,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR2083172,"Acute Myeloid Leukemia,n=476",15.7506849315068,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2083173,RNA-Seq,,150,PRJNA89525,SAMN01778305,BCCAGSC,PCR,sra,SRX1077621,209,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A12560,2015-06-30,24023,12232,ILLUMINA,148328.0,2015-06-30,SRR2083173,2014-12-30T22:39:26Z,SRS380293,SRP012000,TARGET-20-PARCEV-09A-02R,RNA,TARGET-20-PARCEV-09A-02R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARCEV,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR2083173,"Acute Myeloid Leukemia,n=476",11.3753424657534,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2083174,RNA-Seq,,150,PRJNA89525,SAMN01778186,BCCAGSC,PCR,sra,SRX1077671,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A12592,2015-06-30,20918,10135,ILLUMINA,147862.0,2015-06-30,SRR2083174,2014-12-08T21:16:26Z,SRS380338,SRP012000,TARGET-20-PASLYX-09A-02R,RNA,TARGET-20-PASLYX-09A-02R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASLYX,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR2083174,"Acute Myeloid Leukemia,n=476",14.772602739726,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2083175,RNA-Seq,,150,PRJNA89525,SAMN01778307,BCCAGSC,PCR,sra,SRX1077637,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A12585,2015-06-30,19255,9390,ILLUMINA,147593.0,2015-06-30,SRR2083175,2014-12-01T22:46:06Z,SRS380347,SRP012000,TARGET-20-PASDGX-09A-02R,RNA,TARGET-20-PASDGX-09A-02R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASDGX,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR2083175,"Acute Myeloid Leukemia, KMT2A rearrangement,n=60",16.3643835616438,AML-KMT2A,"Acute Myeloid Leukemia, KMT2A rearrangement,n=60",Acute Myeloid Leukemia,"KMT2A rearrangement,n=60/TARGET"
SRR2083176,RNA-Seq,,150,PRJNA89525,SAMN01778212,BCCAGSC,PCR,sra,SRX1077662,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A12601,2015-06-30,23509,11623,ILLUMINA,147591.0,2015-06-30,SRR2083176,2014-12-01T22:45:59Z,SRS380322,SRP012000,TARGET-20-PASPTW-09A-02R,RNA,TARGET-20-PASPTW-09A-02R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASPTW,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR2083176,"Acute Myeloid Leukemia,n=476",6.8931506849315,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2083177,RNA-Seq,,150,PRJNA89525,SAMN01778106,BCCAGSC,PCR,sra,SRX1077699,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A12593,2015-06-30,19802,9496,ILLUMINA,147864.0,2015-06-30,SRR2083177,2014-12-08T21:16:32Z,SRS380364,SRP012000,TARGET-20-PASPSV-09A-02R,RNA,TARGET-20-PASPSV-09A-02R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASPSV,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR2083177,"Acute Myeloid Leukemia,n=476",13.0328767123287,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2083178,RNA-Seq,,150,PRJNA89525,SAMN01778198,BCCAGSC,PCR,sra,SRX1077640,209,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A12527,2015-06-30,20222,10166,ILLUMINA,148305.0,2015-06-30,SRR2083178,2014-12-30T20:29:10Z,SRS380430,SRP012000,TARGET-20-PANLXK-09A-03R,RNA,TARGET-20-PANLXK-09A-03R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PANLXK,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR2083178,"Acute Myeloid Leukemia,n=476",2.70136986301369,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2083179,RNA-Seq,,150,PRJNA89525,SAMN01778262,BCCAGSC,PCR,sra,SRX1077616,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A12589,2015-06-30,22928,11306,ILLUMINA,147872.0,2015-06-30,SRR2083179,2014-12-08T21:29:53Z,SRS380425,SRP012000,TARGET-20-PASJEJ-09A-02R,RNA,TARGET-20-PASJEJ-09A-02R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASJEJ,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR2083179,"Acute Myeloid Leukemia,n=476",17.3561643835616,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2083180,RNA-Seq,,150,PRJNA89525,SAMN01778135,BCCAGSC,PCR,sra,SRX1077650,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A12651,2015-06-30,19737,9633,ILLUMINA,147869.0,2015-06-30,SRR2083180,2014-12-08T21:29:43Z,SRS380282,SRP012000,TARGET-20-PARCHW-09A-01R,RNA,TARGET-20-PARCHW-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARCHW,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR2083180,"Acute Myeloid Leukemia,n=476",11.531506849315,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2083181,RNA-Seq,,150,PRJNA89525,SAMN01778180,BCCAGSC,PCR,sra,SRX1077632,209,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A12540,2015-06-30,23823,11901,ILLUMINA,148324.0,2015-06-30,SRR2083181,2014-12-30T22:37:09Z,SRS380331,SRP012000,TARGET-20-PAPAEG-09A-02R,RNA,TARGET-20-PAPAEG-09A-02R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PAPAEG,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR2083181,"Acute Myeloid Leukemia,n=476",8.07671232876712,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2083182,RNA-Seq,,150,PRJNA89525,SAMN01778144,BCCAGSC,PCR,sra,SRX1077648,209,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A12486,2015-06-30,21959,10855,ILLUMINA,148323.0,2015-06-30,SRR2083182,2014-12-30T22:37:06Z,SRS380362,SRP012000,TARGET-20-PADDXZ-03A-02R,RNA,TARGET-20-PADDXZ-03A-02R,Primary Blood Derived Cancer - Peripheral Blood,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PADDXZ,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR2083182,"Acute Myeloid Leukemia,n=476",13.317808219178,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2083183,RNA-Seq,,150,PRJNA89525,SAMN01778025,BCCAGSC,PCR,sra,SRX1077614,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A12582,2015-06-30,20425,9965,ILLUMINA,147588.0,2015-06-30,SRR2083183,2014-12-01T22:43:53Z,SRS380370,SRP012000,TARGET-20-PARWXU-09A-02R,RNA,TARGET-20-PARWXU-09A-02R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARWXU,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR2083183,"Acute Myeloid Leukemia,n=476",1.52602739726027,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2083184,RNA-Seq,,150,PRJNA89525,SAMN01778287,BCCAGSC,PCR,sra,SRX1077623,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A12642,2015-06-30,18993,9765,ILLUMINA,147865.0,2015-06-30,SRR2083184,2014-12-08T21:16:35Z,SRS380401,SRP012000,TARGET-20-PARXZP-09A-01R,RNA,TARGET-20-PARXZP-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARXZP,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR2083184,"Acute Myeloid Leukemia, KMT2A rearrangement,n=60",18.2383561643835,AML-KMT2A,"Acute Myeloid Leukemia, KMT2A rearrangement,n=60",Acute Myeloid Leukemia,"KMT2A rearrangement,n=60/TARGET"
SRR2083185,RNA-Seq,,150,PRJNA89525,SAMN01778118,BCCAGSC,PCR,sra,SRX1077710,209,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A12521,2015-06-30,20806,10629,ILLUMINA,148333.0,2015-06-30,SRR2083185,2014-12-30T22:39:42Z,SRS380414,SRP012000,TARGET-20-PANJVI-03A-02R,RNA,TARGET-20-PANJVI-03A-02R,Primary Blood Derived Cancer - Peripheral Blood,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PANJVI,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR2083185,"Acute Myeloid Leukemia,n=476",6.23835616438356,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2083186,RNA-Seq,,150,PRJNA89525,SAMN01778018,BCCAGSC,PCR,sra,SRX1077631,206,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A12618,2015-06-30,20342,9607,ILLUMINA,147584.0,2015-06-30,SRR2083186,2014-12-01T22:43:42Z,SRS380367,SRP012000,TARGET-20-PASEFD-09A-01R,RNA,TARGET-20-PASEFD-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASEFD,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR2083186,"Acute Myeloid Leukemia, KMT2A rearrangement,n=60",3.76164383561643,AML-KMT2A,"Acute Myeloid Leukemia, KMT2A rearrangement,n=60",Acute Myeloid Leukemia,"KMT2A rearrangement,n=60/TARGET"
SRR2083187,RNA-Seq,,150,PRJNA89525,SAMN01778096,BCCAGSC,PCR,sra,SRX1077683,209,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A12508,2015-06-30,24594,12507,ILLUMINA,148333.0,2015-06-30,SRR2083187,2014-12-30T22:39:42Z,SRS380314,SRP012000,TARGET-20-PAMVVP-09A-03R,RNA,TARGET-20-PAMVVP-09A-03R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PAMVVP,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR2083187,"Acute Myeloid Leukemia,n=476",9.18904109589041,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2083188,RNA-Seq,,150,PRJNA89525,SAMN01778164,BCCAGSC,PCR,sra,SRX1077653,209,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A12506,2015-06-30,17872,8484,ILLUMINA,148326.0,2015-06-30,SRR2083188,2014-12-30T22:37:15Z,SRS380286,SRP012000,TARGET-20-PALHVV-09A-02R,RNA,TARGET-20-PALHVV-09A-02R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PALHVV,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR2083188,"Acute Myeloid Leukemia,n=476",13.2520547945205,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2083189,RNA-Seq,,150,PRJNA89525,SAMN01778015,BCCAGSC,PCR,sra,SRX1077709,209,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A12504,2015-06-30,19810,10175,ILLUMINA,148327.0,2015-06-30,SRR2083189,2014-12-30T22:37:18Z,SRS380275,SRP012000,TARGET-20-PALFVW-09A-01R,RNA,TARGET-20-PALFVW-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PALFVW,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR2083189,"Acute Myeloid Leukemia,n=476",11.4602739726027,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2083190,RNA-Seq,,150,PRJNA89525,SAMN01778216,BCCAGSC,PCR,sra,SRX1077615,209,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A12493,2015-06-30,24323,12844,ILLUMINA,148307.0,2015-06-30,SRR2083190,2014-12-30T20:29:16Z,SRS380402,SRP012000,TARGET-20-PAEFHC-09A-02R,RNA,TARGET-20-PAEFHC-09A-02R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PAEFHC,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR2083190,"Acute Myeloid Leukemia,n=476",7.00821917808219,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2083191,RNA-Seq,,150,PRJNA89525,SAMN01778265,BCCAGSC,PCR,sra,SRX1077629,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A12591,2015-06-30,20427,10137,ILLUMINA,147876.0,2015-06-30,SRR2083191,2014-12-08T21:30:04Z,SRS380278,SRP012000,TARGET-20-PASLTF-09A-02R,RNA,TARGET-20-PASLTF-09A-02R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASLTF,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR2083191,"Acute Myeloid Leukemia,n=476",16.8684931506849,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2083192,RNA-Seq,,150,PRJNA89525,SAMN01778279,BCCAGSC,PCR,sra,SRX1077628,209,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A12565,2015-06-30,21430,10630,ILLUMINA,148323.0,2015-06-30,SRR2083192,2014-12-30T22:37:06Z,SRS380406,SRP012000,TARGET-20-PARGTL-09A-02R,RNA,TARGET-20-PARGTL-09A-02R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARGTL,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR2083192,"Acute Myeloid Leukemia,n=476",15.8547945205479,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2083193,RNA-Seq,,150,PRJNA89525,SAMN01778055,BCCAGSC,PCR,sra,SRX1077669,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A12574,2015-06-30,25532,12867,ILLUMINA,147595.0,2015-06-30,SRR2083193,2014-12-01T22:46:13Z,SRS380436,SRP012000,TARGET-20-PARMME-09A-02R,RNA,TARGET-20-PARMME-09A-02R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARMME,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR2083193,"Acute Myeloid Leukemia,n=476",10.4986301369863,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2083194,RNA-Seq,,150,PRJNA89525,SAMN01778088,BCCAGSC,PCR,sra,SRX1077627,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A12584,2015-06-30,21028,10194,ILLUMINA,147590.0,2015-06-30,SRR2083194,2014-12-01T22:44:00Z,SRS380274,SRP012000,TARGET-20-PASBSB-03A-01R,RNA,TARGET-20-PASBSB-03A-01R,Primary Blood Derived Cancer - Peripheral Blood,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASBSB,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR2083194,"Acute Myeloid Leukemia,n=476",17.0986301369863,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2083195,RNA-Seq,,150,PRJNA89525,SAMN01778078,BCCAGSC,PCR,sra,SRX1077641,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A12621,2015-06-30,20915,10355,ILLUMINA,147589.0,2015-06-30,SRR2083195,2014-12-01T22:43:56Z,SRS380415,SRP012000,TARGET-20-PARTST-09A-02R,RNA,TARGET-20-PARTST-09A-02R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARTST,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR2083195,"Acute Myeloid Leukemia,n=476",3.38082191780821,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2083196,RNA-Seq,,150,PRJNA89525,SAMN01778007,BCCAGSC,PCR,sra,SRX1077664,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A12647,2015-06-30,26328,13161,ILLUMINA,147589.0,2015-06-30,SRR2083196,2014-12-01T22:43:56Z,SRS380287,SRP012000,TARGET-20-PASXVC-09A-01R,RNA,TARGET-20-PASXVC-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASXVC,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR2083196,"Acute Myeloid Leukemia,n=476",20.3890410958904,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2083197,RNA-Seq,,150,PRJNA89525,SAMN01778157,BCCAGSC,PCR,sra,SRX1077658,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A12575,2015-06-30,24289,11909,ILLUMINA,147869.0,2015-06-30,SRR2083197,2014-12-08T21:29:43Z,SRS380316,SRP012000,TARGET-20-PARMZC-09A-02R,RNA,TARGET-20-PARMZC-09A-02R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARMZC,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR2083197,"Acute Myeloid Leukemia,n=476",16.4547945205479,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2083198,RNA-Seq,,150,PRJNA89525,SAMN01778208,BCCAGSC,PCR,sra,SRX1077624,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A12648,2015-06-30,21113,10468,ILLUMINA,147592.0,2015-06-30,SRR2083198,2014-12-01T22:46:03Z,SRS380379,SRP012000,TARGET-20-PARVSF-09A-02R,RNA,TARGET-20-PARVSF-09A-02R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARVSF,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR2083198,"Acute Myeloid Leukemia,n=476",6.38356164383561,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2083199,RNA-Seq,,150,PRJNA89525,SAMN01778320,BCCAGSC,PCR,sra,SRX1077618,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A12633,2015-06-30,20196,9929,ILLUMINA,147873.0,2015-06-30,SRR2083199,2014-12-08T21:29:56Z,SRS380366,SRP012000,TARGET-20-PASTPU-09A-01R,RNA,TARGET-20-PASTPU-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASTPU,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR2083199,"Acute Myeloid Leukemia,n=476",16.2109589041095,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2083200,RNA-Seq,,150,PRJNA89525,SAMN01778105,BCCAGSC,PCR,sra,SRX1077686,209,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A12511,2015-06-30,24344,12683,ILLUMINA,148329.0,2015-06-30,SRR2083200,2014-12-30T22:39:30Z,SRS380439,SRP012000,TARGET-20-PANBWF-09A-03R,RNA,TARGET-20-PANBWF-09A-03R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PANBWF,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR2083200,"Acute Myeloid Leukemia,n=476",17.0383561643835,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2083201,RNA-Seq,,150,PRJNA89525,SAMN01778067,BCCAGSC,PCR,sra,SRX1077657,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A12631,2015-06-30,24081,12192,ILLUMINA,147871.0,2015-06-30,SRR2083201,2014-12-08T21:29:50Z,SRS380416,SRP012000,TARGET-20-PASUHK-09A-01R,RNA,TARGET-20-PASUHK-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASUHK,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR2083201,"Acute Myeloid Leukemia,n=476",1.50410958904109,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2083202,RNA-Seq,,150,PRJNA89525,SAMN01778116,BCCAGSC,PCR,sra,SRX1077668,209,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A12497,2015-06-30,22610,11319,ILLUMINA,148325.0,2015-06-30,SRR2083202,2014-12-30T22:37:12Z,SRS380405,SRP012000,TARGET-20-PAERAH-09A-03R,RNA,TARGET-20-PAERAH-09A-03R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PAERAH,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR2083202,"Acute Myeloid Leukemia,n=476",17.4410958904109,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2083203,RNA-Seq,,150,PRJNA89525,SAMN01778225,BCCAGSC,PCR,sra,SRX1077695,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A12588,2015-06-30,21326,10209,ILLUMINA,147870.0,2015-06-30,SRR2083203,2014-12-08T21:29:47Z,SRS380343,SRP012000,TARGET-20-PASIZX-09A-01R,RNA,TARGET-20-PASIZX-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASIZX,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR2083203,"Acute Myeloid Leukemia,n=476",6.23287671232876,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2239653,RNA-Seq,,102,PRJNA89525,SAMN01778271,HAIB,PCR,sra,SRX1182020,160,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,1170-SL-0036,2015-09-04,2317,1632,ILLUMINA,,2015-09-30,SRR2239653,,SRS1054357,SRP012000,TARGET-20-PABHET-09A-01R,RNA,TARGET-20-PABHET-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PABHET,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR2239653,"Acute Myeloid Leukemia,n=476",14.7068493150684,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2239654,RNA-Seq,,102,PRJNA89525,SAMN01778126,HAIB,PCR,sra,SRX1182021,160,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,1170-SL-0037,2015-09-04,3758,2680,ILLUMINA,,2015-09-30,SRR2239654,,SRS1054356,SRP012000,TARGET-20-PABHKY-03A-01R,RNA,TARGET-20-PABHKY-03A-01R,Primary Blood Derived Cancer - Peripheral Blood,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PABHKY,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR2239654,"Acute Myeloid Leukemia,n=476",12.8712328767123,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2239655,RNA-Seq,,102,PRJNA89525,SAMN01778099,HAIB,PCR,sra,SRX1182022,160,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,1170-SL-0016,2015-09-04,2550,1831,ILLUMINA,,2015-09-04,SRR2239655,,SRS380427,SRP012000,TARGET-20-PACDZR-09A-02R,RNA,TARGET-20-PACDZR-09A-02R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PACDZR,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR2239655,"Acute Myeloid Leukemia,n=476",4.55068493150684,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2239656,RNA-Seq,,102,PRJNA89525,SAMN01778144,HAIB,PCR,sra,SRX1182023,160,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,1170-SL-0041,2015-09-04,2324,1662,ILLUMINA,,2015-09-04,SRR2239656,,SRS380362,SRP012000,TARGET-20-PADDXZ-03A-02R,RNA,TARGET-20-PADDXZ-03A-02R,Primary Blood Derived Cancer - Peripheral Blood,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PADDXZ,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR2239656,"Acute Myeloid Leukemia,n=476",13.317808219178,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2239657,RNA-Seq,,102,PRJNA89525,SAMN01778153,HAIB,PCR,sra,SRX1182024,160,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,1170-SL-0023,2015-09-04,1669,1181,ILLUMINA,,2015-09-30,SRR2239657,,SRS1054355,SRP012000,TARGET-20-PAEAFC-09A-01R,RNA,TARGET-20-PAEAFC-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PAEAFC,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR2239657,"Acute Myeloid Leukemia,n=476",13.9945205479452,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2239658,RNA-Seq,,102,PRJNA89525,SAMN01778133,HAIB,PCR,sra,SRX1182025,160,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,1170-SL-0028,2015-09-04,2339,1657,ILLUMINA,,2015-09-30,SRR2239658,,SRS1054354,SRP012000,TARGET-20-PAEFHC-09A-01R,RNA,TARGET-20-PAEFHC-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PAEFHC,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR2239658,"Acute Myeloid Leukemia,n=476",7.00821917808219,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2239659,RNA-Seq,,102,PRJNA89525,SAMN01778131,HAIB,PCR,sra,SRX1182026,160,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,1170-SL-0066,2015-09-04,2497,2080,ILLUMINA,,2015-09-30,SRR2239659,,SRS1054353,SRP012000,TARGET-20-PAERAH-09A-01R,RNA,TARGET-20-PAERAH-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PAERAH,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR2239659,"Acute Myeloid Leukemia,n=476",17.4410958904109,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2239660,RNA-Seq,,102,PRJNA89525,SAMN01778196,HAIB,PCR,sra,SRX1182027,160,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,1170-SL-0047,2015-09-04,2583,1841,ILLUMINA,,2015-09-30,SRR2239660,,SRS1054352,SRP012000,TARGET-20-PAKVYM-09A-01R,RNA,TARGET-20-PAKVYM-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PAKVYM,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR2239660,"Acute Myeloid Leukemia,n=476",15.8821917808219,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2239661,RNA-Seq,,102,PRJNA89525,SAMN01778189,HAIB,PCR,sra,SRX1182028,160,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,1170-SL-0018,2015-09-04,2054,1478,ILLUMINA,,2015-09-30,SRR2239661,,SRS1054351,SRP012000,TARGET-20-PALHVV-09A-01R,RNA,TARGET-20-PALHVV-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PALHVV,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR2239661,"Acute Myeloid Leukemia,n=476",13.2520547945205,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2239662,RNA-Seq,,102,PRJNA89525,SAMN01778038,HAIB,PCR,sra,SRX1182029,160,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,1170-SL-0004,2015-09-04,1906,1345,ILLUMINA,,2015-09-30,SRR2239662,,SRS1054350,SRP012000,TARGET-20-PALNAT-09A-01R,RNA,TARGET-20-PALNAT-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PALNAT,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR2239662,"INFANT_Acute Myeloid Leukemia,n=21",0.827397260273972,AML_INFANT,"INFANT_Acute Myeloid Leukemia,n=21",Acute Myeloid Leukemia,"INFANT,n=21/TARGET"
SRR2239663,RNA-Seq,,100,PRJNA89525,SAMN01778275,HAIB,PCR,sra,SRX1182030,160,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,1170-SL-0050,2015-09-04,2623,1743,ILLUMINA,,2015-09-30,SRR2239663,,SRS1054349,SRP012000,TARGET-20-PALVKV-09A-01R,RNA,TARGET-20-PALVKV-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PALVKV,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR2239663,"Acute Myeloid Leukemia,n=476",13.4301369863013,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2239664,RNA-Seq,,102,PRJNA89525,SAMN01778003,HAIB,PCR,sra,SRX1182031,160,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,1170-SL-0019,2015-09-04,2755,1941,ILLUMINA,,2015-09-30,SRR2239664,,SRS1054348,SRP012000,TARGET-20-PAMYWW-09A-01R,RNA,TARGET-20-PAMYWW-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PAMYWW,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR2239664,"Acute Myeloid Leukemia,n=476",20.8191780821917,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2239665,RNA-Seq,,102,PRJNA89525,SAMN01778087,HAIB,PCR,sra,SRX1182032,160,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,1170-SL-0024,2015-09-04,1998,1436,ILLUMINA,,2015-09-30,SRR2239665,,SRS1054347,SRP012000,TARGET-20-PANBWF-09A-01R,RNA,TARGET-20-PANBWF-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PANBWF,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR2239665,"Acute Myeloid Leukemia,n=476",17.0383561643835,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2239666,RNA-Seq,,102,PRJNA89525,SAMN01778098,HAIB,PCR,sra,SRX1182033,160,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,1170-SL-0038,2015-09-04,2679,1844,ILLUMINA,,2015-09-30,SRR2239666,,SRS1054346,SRP012000,TARGET-20-PANDER-09A-01R,RNA,TARGET-20-PANDER-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PANDER,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR2239666,"Acute Myeloid Leukemia,n=476",11.8136986301369,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2239667,RNA-Seq,,102,PRJNA89525,SAMN01778111,HAIB,PCR,sra,SRX1182034,160,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,1170-SL-0046,2015-09-04,2813,1952,ILLUMINA,,2015-09-30,SRR2239667,,SRS1054345,SRP012000,TARGET-20-PANGCM-03A-01R,RNA,TARGET-20-PANGCM-03A-01R,Primary Blood Derived Cancer - Peripheral Blood,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PANGCM,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR2239667,"Acute Myeloid Leukemia,n=476",8.86301369863013,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2239668,RNA-Seq,,102,PRJNA89525,SAMN01778290,HAIB,PCR,sra,SRX1182035,160,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,1170-SL-0039,2015-09-04,2078,1483,ILLUMINA,,2015-09-30,SRR2239668,,SRS1054343,SRP012000,TARGET-20-PANJGR-09A-01R,RNA,TARGET-20-PANJGR-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PANJGR,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute leukemia of Ambiguous Lineage (ALAL),SRR2239668,"Acute Myeloid Leukemia,n=476",12.1232876712328,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2239669,RNA-Seq,,102,PRJNA89525,SAMN01778166,HAIB,PCR,sra,SRX1182036,160,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,1170-SL-0040,2015-09-04,2337,1608,ILLUMINA,,2015-09-30,SRR2239669,,SRS1054344,SRP012000,TARGET-20-PANJTK-09A-01R,RNA,TARGET-20-PANJTK-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PANJTK,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute leukemia of Ambiguous Lineage (ALAL),SRR2239669,"Acute Myeloid Leukemia,n=476",14.8164383561643,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2239670,RNA-Seq,,102,PRJNA89525,SAMN01778161,HAIB,PCR,sra,SRX1182037,160,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,1170-SL-0059,2015-09-04,2222,1598,ILLUMINA,,2015-09-30,SRR2239670,,SRS1054342,SRP012000,TARGET-20-PANKNB-09A-01R,RNA,TARGET-20-PANKNB-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PANKNB,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute leukemia of Ambiguous Lineage (ALAL),SRR2239670,"Acute Myeloid Leukemia,n=476",17.6986301369863,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2239671,RNA-Seq,,102,PRJNA89525,SAMN01778304,HAIB,PCR,sra,SRX1182038,160,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,1170-SL-0065,2015-09-04,2766,1672,ILLUMINA,,2015-09-30,SRR2239671,,SRS1054341,SRP012000,TARGET-20-PANLIZ-09A-01R,RNA,TARGET-20-PANLIZ-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PANLIZ,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute leukemia of Ambiguous Lineage (ALAL),SRR2239671,"Acute Myeloid Leukemia,n=476",8.4986301369863,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2239672,RNA-Seq,,102,PRJNA89525,SAMN01778263,HAIB,PCR,sra,SRX1182039,160,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,1170-SL-0043,2015-09-04,2369,1630,ILLUMINA,,2015-09-30,SRR2239672,,SRS1054340,SRP012000,TARGET-20-PANLRE-09A-01R,RNA,TARGET-20-PANLRE-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PANLRE,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute leukemia of Ambiguous Lineage (ALAL),SRR2239672,"Acute Myeloid Leukemia,n=476",9.36164383561643,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2239673,RNA-Seq,,102,PRJNA89525,SAMN01778070,HAIB,PCR,sra,SRX1182040,160,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,1170-SL-0026,2015-09-04,2197,1521,ILLUMINA,,2015-09-30,SRR2239673,,SRS1054339,SRP012000,TARGET-20-PANLXM-09A-01R,RNA,TARGET-20-PANLXM-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PANLXM,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute leukemia of Ambiguous Lineage (ALAL),SRR2239673,"Acute Myeloid Leukemia,n=476",10.2684931506849,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2239674,RNA-Seq,,102,PRJNA89525,SAMN01778048,HAIB,PCR,sra,SRX1182041,160,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,1170-SL-0025,2015-09-04,2392,1696,ILLUMINA,,2015-09-30,SRR2239674,,SRS1054338,SRP012000,TARGET-20-PANRIK-09A-01R,RNA,TARGET-20-PANRIK-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PANRIK,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute leukemia of Ambiguous Lineage (ALAL),SRR2239674,"Acute Myeloid Leukemia,n=476",15.4794520547945,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2239675,RNA-Seq,,102,PRJNA89525,SAMN01778068,HAIB,PCR,sra,SRX1182042,160,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,1170-SL-0029,2015-09-04,1817,1264,ILLUMINA,,2015-09-30,SRR2239675,,SRS1054337,SRP012000,TARGET-20-PANSJB-09A-01R,RNA,TARGET-20-PANSJB-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PANSJB,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute leukemia of Ambiguous Lineage (ALAL),SRR2239675,"Acute Myeloid Leukemia,n=476",11.1616438356164,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2239676,RNA-Seq,,102,PRJNA89525,SAMN01778042,HAIB,PCR,sra,SRX1182043,160,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,1170-SL-0060,2015-09-04,2634,2190,ILLUMINA,,2015-09-30,SRR2239676,,SRS1054336,SRP012000,TARGET-20-PANTPW-09A-01R,RNA,TARGET-20-PANTPW-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PANTPW,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute leukemia of Ambiguous Lineage (ALAL),SRR2239676,"Acute Myeloid Leukemia,n=476",2.24931506849315,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2239677,RNA-Seq,,102,PRJNA89525,SAMN01778066,HAIB,PCR,sra,SRX1182044,160,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,1170-SL-0052,2015-09-04,2153,1457,ILLUMINA,,2015-09-30,SRR2239677,,SRS1054335,SRP012000,TARGET-20-PANUTB-09A-01R,RNA,TARGET-20-PANUTB-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PANUTB,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute leukemia of Ambiguous Lineage (ALAL),SRR2239677,"Acute Myeloid Leukemia,n=476",15.3068493150684,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2239678,RNA-Seq,,102,PRJNA89525,SAMN01778028,HAIB,PCR,sra,SRX1182045,160,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,1170-SL-0042,2015-09-04,3155,2179,ILLUMINA,,2015-09-30,SRR2239678,,SRS1054334,SRP012000,TARGET-20-PANVGP-09A-01R,RNA,TARGET-20-PANVGP-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PANVGP,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute leukemia of Ambiguous Lineage (ALAL),SRR2239678,"Acute Myeloid Leukemia,n=476",13.5616438356164,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2239679,RNA-Seq,,102,PRJNA89525,SAMN01778209,HAIB,PCR,sra,SRX1182046,160,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,1170-SL-0044,2015-09-04,2206,1524,ILLUMINA,,2015-09-30,SRR2239679,,SRS1054333,SRP012000,TARGET-20-PANWHP-09A-01R,RNA,TARGET-20-PANWHP-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PANWHP,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute leukemia of Ambiguous Lineage (ALAL),SRR2239679,"Acute Myeloid Leukemia,n=476",5.07397260273972,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2239680,RNA-Seq,,102,PRJNA89525,SAMN01778058,HAIB,PCR,sra,SRX1182047,160,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,1170-SL-0020,2015-09-04,2753,1917,ILLUMINA,,2015-09-30,SRR2239680,,SRS1054332,SRP012000,TARGET-20-PAPAEG-09A-01R,RNA,TARGET-20-PAPAEG-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PAPAEG,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute leukemia of Ambiguous Lineage (ALAL),SRR2239680,"Acute Myeloid Leukemia,n=476",8.07671232876712,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2239681,RNA-Seq,,102,PRJNA89525,SAMN01778047,HAIB,PCR,sra,SRX1182048,160,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,1170-SL-0053,2015-09-04,1833,1324,ILLUMINA,,2015-09-30,SRR2239681,,SRS1054331,SRP012000,TARGET-20-PAPVCN-09A-01R,RNA,TARGET-20-PAPVCN-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PAPVCN,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute leukemia of Ambiguous Lineage (ALAL),SRR2239681,"Acute Myeloid Leukemia,n=476",11.5917808219178,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2239682,RNA-Seq,,102,PRJNA89525,SAMN01778238,HAIB,PCR,sra,SRX1182049,160,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,1170-SL-0054,2015-09-04,3168,2159,ILLUMINA,,2015-09-30,SRR2239682,,SRS1054302,SRP012000,TARGET-20-PAPVZK-09A-01R,RNA,TARGET-20-PAPVZK-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PAPVZK,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute leukemia of Ambiguous Lineage (ALAL),SRR2239682,"Acute Myeloid Leukemia,n=476",15.9506849315068,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2239683,RNA-Seq,,102,PRJNA89525,SAMN01778138,HAIB,PCR,sra,SRX1182050,160,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,1170-SL-0005,2015-09-04,1522,1030,ILLUMINA,,2015-09-30,SRR2239683,,SRS1054330,SRP012000,TARGET-20-PAPWIU-09A-01R,RNA,TARGET-20-PAPWIU-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PAPWIU,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute leukemia of Ambiguous Lineage (ALAL),SRR2239683,"Acute Myeloid Leukemia,n=476",12.1123287671232,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2239684,RNA-Seq,,102,PRJNA89525,SAMN01778093,HAIB,PCR,sra,SRX1182051,160,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,1170-SL-0021,2015-09-04,2557,1793,ILLUMINA,,2015-09-04,SRR2239684,,SRS380392,SRP012000,TARGET-20-PAPXUF-09A-01R,RNA,TARGET-20-PAPXUF-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PAPXUF,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR2239684,"Acute Myeloid Leukemia,n=476",17.6328767123287,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2239685,RNA-Seq,,100,PRJNA89525,SAMN01778005,HAIB,PCR,sra,SRX1182052,160,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,1170-SL-0055,2015-09-04,1314,877,ILLUMINA,,2015-09-30,SRR2239685,,SRS1054329,SRP012000,TARGET-20-PARAHF-09A-01R,RNA,TARGET-20-PARAHF-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARAHF,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute leukemia of Ambiguous Lineage (ALAL),SRR2239685,"Acute Myeloid Leukemia,n=476",14.9917808219178,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2239686,RNA-Seq,,102,PRJNA89525,SAMN01778027,HAIB,PCR,sra,SRX1182053,160,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,1170-SL-0015,2015-09-04,2179,1519,ILLUMINA,,2015-09-30,SRR2239686,,SRS1054327,SRP012000,TARGET-20-PARBFJ-09A-01R,RNA,TARGET-20-PARBFJ-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARBFJ,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute leukemia of Ambiguous Lineage (ALAL),SRR2239686,"Acute Myeloid Leukemia,n=476",12.8794520547945,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2239687,RNA-Seq,,102,PRJNA89525,SAMN01778040,HAIB,PCR,sra,SRX1182054,160,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,1170-SL-0001,2015-09-04,2073,1473,ILLUMINA,,2015-09-30,SRR2239687,,SRS1054328,SRP012000,TARGET-20-PARBTV-09A-01R,RNA,TARGET-20-PARBTV-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARBTV,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute leukemia of Ambiguous Lineage (ALAL),SRR2239687,"Acute Myeloid Leukemia,n=476",17.186301369863,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2239688,RNA-Seq,,102,PRJNA89525,SAMN01778168,HAIB,PCR,sra,SRX1182055,160,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,1170-SL-0034,2015-09-04,1643,1135,ILLUMINA,,2015-09-30,SRR2239688,,SRS1054326,SRP012000,TARGET-20-PARDDA-09A-01R,RNA,TARGET-20-PARDDA-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARDDA,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute leukemia of Ambiguous Lineage (ALAL),SRR2239688,"Acute Myeloid Leukemia,n=476",12.5835616438356,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2239689,RNA-Seq,,102,PRJNA89525,SAMN01778084,HAIB,PCR,sra,SRX1182056,160,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,1170-SL-0032,2015-09-04,2263,1563,ILLUMINA,,2015-09-30,SRR2239689,,SRS1054303,SRP012000,TARGET-20-PARENB-09A-01R,RNA,TARGET-20-PARENB-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARENB,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute leukemia of Ambiguous Lineage (ALAL),SRR2239689,"Acute Myeloid Leukemia,n=476",7.55616438356164,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2239690,RNA-Seq,,102,PRJNA89525,SAMN01778085,HAIB,PCR,sra,SRX1182057,160,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,1170-SL-0009,2015-09-04,1850,1265,ILLUMINA,,2015-09-30,SRR2239690,,SRS1054325,SRP012000,TARGET-20-PARFGK-09A-01R,RNA,TARGET-20-PARFGK-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARFGK,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute leukemia of Ambiguous Lineage (ALAL),SRR2239690,"INFANT_Acute Myeloid Leukemia, KMT2A rearrangement,n=17",0.926027397260273,AML-KMT2A_INFANT,"INFANT_Acute Myeloid Leukemia, KMT2A rearrangement,n=17",Acute Myeloid Leukemia,"INFANT,KMT2A rearrangement,n=17/TARGET"
SRR2239691,RNA-Seq,,102,PRJNA89525,SAMN01778125,HAIB,PCR,sra,SRX1182058,160,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,1170-SL-0003,2015-09-04,1461,1015,ILLUMINA,,2015-09-30,SRR2239691,,SRS1054324,SRP012000,TARGET-20-PARHPP-03A-01R,RNA,TARGET-20-PARHPP-03A-01R,Primary Blood Derived Cancer - Peripheral Blood,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARHPP,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute leukemia of Ambiguous Lineage (ALAL),SRR2239691,"Acute Myeloid Leukemia,n=476",13.0958904109589,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2239692,RNA-Seq,,102,PRJNA89525,SAMN01778230,HAIB,PCR,sra,SRX1182059,160,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,1170-SL-0002,2015-09-04,1755,1227,ILLUMINA,,2015-09-04,SRR2239692,,SRS380418,SRP012000,TARGET-20-PARJYP-03A-01R,RNA,TARGET-20-PARJYP-03A-01R,Primary Blood Derived Cancer - Peripheral Blood,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARJYP,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR2239692,"Acute Myeloid Leukemia,n=476",14.8849315068493,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2239693,RNA-Seq,,102,PRJNA89525,SAMN01778079,HAIB,PCR,sra,SRX1182060,160,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,1170-SL-0017,2015-09-04,1620,1139,ILLUMINA,,2015-09-30,SRR2239693,,SRS1054323,SRP012000,TARGET-20-PARLVL-09A-01R,RNA,TARGET-20-PARLVL-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARLVL,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute leukemia of Ambiguous Lineage (ALAL),SRR2239693,"Acute Myeloid Leukemia,n=476",2.63835616438356,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2239694,RNA-Seq,,102,PRJNA89525,SAMN01778159,HAIB,PCR,sra,SRX1182061,160,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,1170-SL-0051,2015-09-04,1828,1316,ILLUMINA,,2015-09-30,SRR2239694,,SRS1054322,SRP012000,TARGET-20-PARMZF-09A-01R,RNA,TARGET-20-PARMZF-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARMZF,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute leukemia of Ambiguous Lineage (ALAL),SRR2239694,"Acute Myeloid Leukemia,n=476",8.66575342465753,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2239695,RNA-Seq,,102,PRJNA89525,SAMN01778132,HAIB,PCR,sra,SRX1182062,160,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,1170-SL-0014,2015-09-04,1811,1260,ILLUMINA,,2015-09-30,SRR2239695,,SRS1054321,SRP012000,TARGET-20-PARTYK-09A-01R,RNA,TARGET-20-PARTYK-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARTYK,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute leukemia of Ambiguous Lineage (ALAL),SRR2239695,"Acute Myeloid Leukemia,n=476",5.38904109589041,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2239696,RNA-Seq,,102,PRJNA89525,SAMN01778277,HAIB,PCR,sra,SRX1182063,160,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,1170-SL-0064,2015-09-04,2258,1934,ILLUMINA,,2015-09-30,SRR2239696,,SRS1054320,SRP012000,TARGET-20-PARUTH-09A-01R,RNA,TARGET-20-PARUTH-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARUTH,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute leukemia of Ambiguous Lineage (ALAL),SRR2239696,"Acute Myeloid Leukemia,n=476",9.46301369863013,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2239697,RNA-Seq,,102,PRJNA89525,SAMN01778231,HAIB,PCR,sra,SRX1182064,160,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,1170-SL-0033,2015-09-04,1483,1037,ILLUMINA,,2015-09-30,SRR2239697,,SRS1054319,SRP012000,TARGET-20-PARUUB-09A-01R,RNA,TARGET-20-PARUUB-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARUUB,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute leukemia of Ambiguous Lineage (ALAL),SRR2239697,"Acute Myeloid Leukemia,n=476",17.3013698630136,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2239698,RNA-Seq,,102,PRJNA89525,SAMN01778101,HAIB,PCR,sra,SRX1182065,160,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,1170-SL-0048,2015-09-04,4434,3191,ILLUMINA,,2015-09-30,SRR2239698,,SRS1054318,SRP012000,TARGET-20-PARXBT-09A-01R,RNA,TARGET-20-PARXBT-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARXBT,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute leukemia of Ambiguous Lineage (ALAL),SRR2239698,"Acute Myeloid Leukemia,n=476",9.26301369863013,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2239699,RNA-Seq,,102,PRJNA89525,SAMN01778083,HAIB,PCR,sra,SRX1182066,160,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,1170-SL-0013,2015-09-04,2987,2154,ILLUMINA,,2015-09-04,SRR2239699,,SRS605613,SRP012000,TARGET-20-PARXNG-09A-01R,RNA,TARGET-20-PARXNG-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARXNG,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute leukemia of Ambiguous Lineage (ALAL),SRR2239699,"Acute Myeloid Leukemia,n=476",10.1013698630136,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2239700,RNA-Seq,,102,PRJNA89525,SAMN01778190,HAIB,PCR,sra,SRX1182067,160,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,1170-SL-0010,2015-09-04,2725,1894,ILLUMINA,,2015-09-30,SRR2239700,,SRS1054304,SRP012000,TARGET-20-PARYEB-09A-01R,RNA,TARGET-20-PARYEB-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARYEB,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute leukemia of Ambiguous Lineage (ALAL),SRR2239700,"Acute Myeloid Leukemia,n=476",19.1397260273972,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2239701,RNA-Seq,,102,PRJNA89525,SAMN01778236,HAIB,PCR,sra,SRX1182068,160,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,1170-SL-0011,2015-09-04,1529,1051,ILLUMINA,,2015-09-30,SRR2239701,,SRS1054317,SRP012000,TARGET-20-PARYGA-09A-01R,RNA,TARGET-20-PARYGA-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARYGA,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute leukemia of Ambiguous Lineage (ALAL),SRR2239701,"Acute Myeloid Leukemia,n=476",16.2082191780821,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2239702,RNA-Seq,,102,PRJNA89525,SAMN01778312,HAIB,PCR,sra,SRX1182069,160,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,1170-SL-0067,2015-09-04,2245,1358,ILLUMINA,,2015-09-30,SRR2239702,,SRS1054315,SRP012000,TARGET-20-PARZUU-09A-01R,RNA,TARGET-20-PARZUU-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARZUU,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute leukemia of Ambiguous Lineage (ALAL),SRR2239702,"Acute Myeloid Leukemia,n=476",8.96712328767123,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2239703,RNA-Seq,,102,PRJNA89525,SAMN01778276,HAIB,PCR,sra,SRX1182070,160,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,1170-SL-0008,2015-09-04,2450,1705,ILLUMINA,,2015-09-30,SRR2239703,,SRS1054316,SRP012000,TARGET-20-PARZWH-09A-01R,RNA,TARGET-20-PARZWH-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PARZWH,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute leukemia of Ambiguous Lineage (ALAL),SRR2239703,"Acute Myeloid Leukemia,n=476",11.6246575342465,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2239704,RNA-Seq,,102,PRJNA89525,SAMN01778065,HAIB,PCR,sra,SRX1182071,160,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,1170-SL-0012,2015-09-04,2860,2016,ILLUMINA,,2015-09-04,SRR2239704,,SRS976498,SRP012000,TARGET-20-PASAFM-09A-01R,RNA,TARGET-20-PASAFM-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASAFM,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute leukemia of Ambiguous Lineage (ALAL),SRR2239704,"Acute Myeloid Leukemia,n=476",10.0547945205479,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2239705,RNA-Seq,,102,PRJNA89525,SAMN01778195,HAIB,PCR,sra,SRX1182072,160,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,1170-SL-0056,2015-09-04,2089,1420,ILLUMINA,,2015-09-30,SRR2239705,,SRS1054305,SRP012000,TARGET-20-PASFJB-09A-01R,RNA,TARGET-20-PASFJB-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASFJB,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute leukemia of Ambiguous Lineage (ALAL),SRR2239705,"Acute Myeloid Leukemia,n=476",11.372602739726,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2239706,RNA-Seq,,102,PRJNA89525,SAMN01778108,HAIB,PCR,sra,SRX1182073,160,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,1170-SL-0035,2015-09-04,1499,1049,ILLUMINA,,2015-09-04,SRR2239706,,SRS380358,SRP012000,TARGET-20-PASHBI-09A-01R,RNA,TARGET-20-PASHBI-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASHBI,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR2239706,"Acute Myeloid Leukemia,n=476",15.6904109589041,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2239707,RNA-Seq,,102,PRJNA89525,SAMN01778102,HAIB,PCR,sra,SRX1182074,160,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,1170-SL-0022,2015-09-04,2138,1483,ILLUMINA,,2015-09-04,SRR2239707,,SRS976197,SRP012000,TARGET-20-PASIEP-09A-01R,RNA,TARGET-20-PASIEP-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASIEP,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute leukemia of Ambiguous Lineage (ALAL),SRR2239707,"Acute Myeloid Leukemia,n=476",16.6630136986301,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2239708,RNA-Seq,,102,PRJNA89525,SAMN01778069,HAIB,PCR,sra,SRX1182075,160,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,1170-SL-0061,2015-09-04,2389,1980,ILLUMINA,,2015-09-30,SRR2239708,,SRS1054314,SRP012000,TARGET-20-PASILA-09A-01R,RNA,TARGET-20-PASILA-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASILA,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute leukemia of Ambiguous Lineage (ALAL),SRR2239708,"Acute Myeloid Leukemia,n=476",14.7561643835616,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2239709,RNA-Seq,,102,PRJNA89525,SAMN01778082,HAIB,PCR,sra,SRX1182076,160,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,1170-SL-0031,2015-09-04,2914,2032,ILLUMINA,,2015-09-30,SRR2239709,,SRS1054313,SRP012000,TARGET-20-PASKUA-09A-01R,RNA,TARGET-20-PASKUA-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASKUA,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute leukemia of Ambiguous Lineage (ALAL),SRR2239709,"Acute Myeloid Leukemia,n=476",10.0876712328767,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2239710,RNA-Seq,,102,PRJNA89525,SAMN01778205,HAIB,PCR,sra,SRX1182077,160,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,1170-SL-0006,2015-09-04,2191,1550,ILLUMINA,,2015-09-30,SRR2239710,,SRS1054312,SRP012000,TARGET-20-PASPGA-09A-01R,RNA,TARGET-20-PASPGA-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASPGA,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute leukemia of Ambiguous Lineage (ALAL),SRR2239710,"Acute Myeloid Leukemia,n=476",3.25753424657534,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2239711,RNA-Seq,,102,PRJNA89525,SAMN01778185,HAIB,PCR,sra,SRX1182078,160,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,1170-SL-0063,2015-09-04,1811,1097,ILLUMINA,,2015-09-30,SRR2239711,,SRS1054306,SRP012000,TARGET-20-PASPKE-09A-01R,RNA,TARGET-20-PASPKE-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASPKE,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute leukemia of Ambiguous Lineage (ALAL),SRR2239711,"Acute Myeloid Leukemia,n=476",8.76712328767123,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2239712,RNA-Seq,,102,PRJNA89525,SAMN01778129,HAIB,PCR,sra,SRX1182079,160,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,1170-SL-0030,2015-09-04,2581,1831,ILLUMINA,,2015-09-30,SRR2239712,,SRS1054311,SRP012000,TARGET-20-PASPLU-09A-01R,RNA,TARGET-20-PASPLU-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASPLU,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute leukemia of Ambiguous Lineage (ALAL),SRR2239712,"Acute Myeloid Leukemia,n=476",9.31232876712328,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2239713,RNA-Seq,,102,PRJNA89525,SAMN01778156,HAIB,PCR,sra,SRX1182080,160,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,1170-SL-0007,2015-09-04,1732,1180,ILLUMINA,,2015-09-30,SRR2239713,,SRS1054310,SRP012000,TARGET-20-PASPTM-09A-01R,RNA,TARGET-20-PASPTM-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASPTM,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute leukemia of Ambiguous Lineage (ALAL),SRR2239713,"Acute Myeloid Leukemia,n=476",14.0328767123287,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2239714,RNA-Seq,,102,PRJNA89525,SAMN01778289,HAIB,PCR,sra,SRX1182081,160,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,1170-SL-0027,2015-09-04,2447,1689,ILLUMINA,,2015-09-04,SRR2239714,,SRS380337,SRP012000,TARGET-20-PASRTP-09A-01R,RNA,TARGET-20-PASRTP-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASRTP,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR2239714,"Acute Myeloid Leukemia,n=476",14.7643835616438,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2239716,RNA-Seq,,102,PRJNA89525,SAMN01778270,HAIB,PCR,sra,SRX1182083,160,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,1170-SL-0062,2015-09-03,2189,1866,ILLUMINA,,2015-09-30,SRR2239716,,SRS1054308,SRP012000,TARGET-20-PASXYG-09A-01R,RNA,TARGET-20-PASXYG-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASXYG,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute leukemia of Ambiguous Lineage (ALAL),SRR2239716,"Acute Myeloid Leukemia,n=476",11.2410958904109,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2239717,RNA-Seq,,100,PRJNA89525,SAMN01778142,HAIB,PCR,sra,SRX1182084,160,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,1170-SL-0049,2015-09-03,1967,1299,ILLUMINA,,2015-09-30,SRR2239717,,SRS1054307,SRP012000,TARGET-20-PASYDC-09A-01R,RNA,TARGET-20-PASYDC-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,male,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASYDC,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute leukemia of Ambiguous Lineage (ALAL),SRR2239717,"Acute Myeloid Leukemia,n=476",10.6520547945205,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2239718,RNA-Seq,,102,PRJNA89525,SAMN01778169,HAIB,PCR,sra,SRX1182085,160,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,1170-SL-0045,2015-09-03,2527,1735,ILLUMINA,,2015-09-30,SRR2239718,,SRS1054361,SRP012000,TARGET-20-PASYJI-09A-01R,RNA,TARGET-20-PASYJI-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PASYJI,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR2239718,"Acute Myeloid Leukemia,n=476",12.4520547945205,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR2239720,RNA-Seq,,102,PRJNA89525,SAMN01778127,HAIB,PCR,sra,SRX1182087,160,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,1170-SL-0058,2015-09-03,2590,1768,ILLUMINA,,2015-09-30,SRR2239720,,SRS1054359,SRP012000,TARGET-20-PATELT-03A-01R,RNA,TARGET-20-PATELT-03A-01R,Primary Blood Derived Cancer - Peripheral Blood,phs000465,phs000218,AML,Yes,female,TARGET: Acute Myeloid Leukemia (AML),TARGET-20-PATELT,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR2239720,"Acute Myeloid Leukemia,n=476",12.0575342465753,AML,"Acute Myeloid Leukemia,n=476",Acute Myeloid Leukemia,"NOS,n=476/TARGET"
SRR3162129,RNA-Seq,,202,PRJNA89529,SAMN04486237,STJUDE,PCR,sra,SRX1571362,158,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015582_D1_RNASEQ_1,2016-02-11,10937,7248,ILLUMINA,,2016-04-14,SRR3162129,,SRS1284189,SRP011999,TARGET-10-PARASZ-09A-01R,RNA,TARGET-10-PARASZ-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PARASZ,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162129,"T-cell Acute Lymphoblastic Leukemia,n=265",4.41095890410958,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162130,RNA-Seq,,202,PRJNA89529,SAMN04486315,STJUDE,PCR,sra,SRX1571363,164,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015586_D1_RNASEQ_1,2016-02-11,10175,6604,ILLUMINA,,2016-04-14,SRR3162130,,SRS1284188,SRP011999,TARGET-10-PARAYM-09A-01R,RNA,TARGET-10-PARAYM-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PARAYM,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162130,"T-cell Acute Lymphoblastic Leukemia,n=265",15.2575342465753,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162131,RNA-Seq,,202,PRJNA89529,SAMN04486272,STJUDE,PCR,sra,SRX1571364,161,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015255_D1_RNASEQ_1,2016-02-11,10536,6811,ILLUMINA,,2016-04-14,SRR3162131,,SRS1284187,SRP011999,TARGET-10-PARCVM-03A-01R,RNA,TARGET-10-PARCVM-03A-01R,Primary Blood Derived Cancer - Peripheral Blood,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PARCVM,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162131,"T-cell Acute Lymphoblastic Leukemia,n=265",3.9972602739726,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162132,RNA-Seq,,202,PRJNA89529,SAMN04486332,STJUDE,PCR,sra,SRX1571365,170,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL016630_D1_RNASEQ_1,2016-02-12,11513,7635,ILLUMINA,,2016-04-14,SRR3162132,,SRS1284186,SRP011999,TARGET-10-PAREGZ-09A-01R,RNA,TARGET-10-PAREGZ-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PAREGZ,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162132,"T-cell Acute Lymphoblastic Leukemia,n=265",8.56986301369863,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162133,RNA-Seq,,202,PRJNA89529,SAMN04486122,STJUDE,PCR,sra,SRX1571366,162,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJTALL002007_D1_RNASEQ_1,2016-02-12,10016,6460,ILLUMINA,,2016-04-14,SRR3162133,,SRS1284185,SRP011999,TARGET-10-PARFDL-09A-01R,RNA,TARGET-10-PARFDL-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PARFDL,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162133,"T-cell Acute Lymphoblastic Leukemia,n=265",20.5232876712328,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162134,RNA-Seq,,202,PRJNA89529,SAMN04486135,STJUDE,PCR,sra,SRX1571367,178,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015241_D1_RNASEQ_1,2016-02-11,10406,6828,ILLUMINA,,2016-04-14,SRR3162134,,SRS1284184,SRP011999,TARGET-10-PARFIH-09A-01R,RNA,TARGET-10-PARFIH-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PARFIH,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162134,"T-cell Acute Lymphoblastic Leukemia,n=265",5.27397260273972,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162135,RNA-Seq,,202,PRJNA89529,SAMN04486212,STJUDE,PCR,sra,SRX1571368,165,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015242_D1-TARGET-10-PARFPJ-09A-01D,2016-02-11,11125,7760,ILLUMINA,,2016-04-14,SRR3162135,,SRS1284183,SRP011999,TARGET-10-PARFPJ-09A-01R,RNA,TARGET-10-PARFPJ-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PARFPJ,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162135,"T-cell Acute Lymphoblastic Leukemia,n=265",3.6931506849315,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162136,RNA-Seq,,202,PRJNA89529,SAMN04486164,STJUDE,PCR,sra,SRX1571369,167,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015243_D1_RNASEQ_1,2016-02-11,9980,6450,ILLUMINA,,2016-04-14,SRR3162136,,SRS1284182,SRP011999,TARGET-10-PARFXJ-09A-01R,RNA,TARGET-10-PARFXJ-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PARFXJ,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162136,"T-cell Acute Lymphoblastic Leukemia,n=265",11.6301369863013,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162137,RNA-Seq,,202,PRJNA89529,SAMN04486119,STJUDE,PCR,sra,SRX1571370,172,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015256_D1_RNASEQ_1,2016-02-11,9382,6152,ILLUMINA,,2016-04-14,SRR3162137,,SRS1284446,SRP011999,TARGET-10-PARGFL-09A-01R,RNA,TARGET-10-PARGFL-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PARGFL,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162137,"T-cell Acute Lymphoblastic Leukemia,n=265",4.10684931506849,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162138,RNA-Seq,,202,PRJNA89529,SAMN04486269,STJUDE,PCR,sra,SRX1571371,163,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJTALL022433_D2_RNASEQ_1,2016-02-13,10977,7093,ILLUMINA,,2016-04-14,SRR3162138,,SRS1284445,SRP011999,TARGET-10-PARHBI-09A-01R,RNA,TARGET-10-PARHBI-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PARHBI,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162138,"T-cell Acute Lymphoblastic Leukemia,n=265",7.8986301369863,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162139,RNA-Seq,,202,PRJNA89529,SAMN04486112,STJUDE,PCR,sra,SRX1571372,152,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJTALL021648_D2_RNASEQ_1,2016-02-13,10113,6543,ILLUMINA,,2016-04-14,SRR3162139,,SRS1284444,SRP011999,TARGET-10-PARHBT-09A-01R,RNA,TARGET-10-PARHBT-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PARHBT,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162139,"T-cell Acute Lymphoblastic Leukemia,n=265",17.0219178082191,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162140,RNA-Seq,,202,PRJNA89529,SAMN04486265,STJUDE,PCR,sra,SRX1571373,159,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015257_D1_RNASEQ_1,2016-02-11,9348,6110,ILLUMINA,,2016-04-14,SRR3162140,,SRS1284443,SRP011999,TARGET-10-PARHES-09A-01R,RNA,TARGET-10-PARHES-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PARHES,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162140,"T-cell Acute Lymphoblastic Leukemia,n=265",4.65205479452054,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162141,RNA-Seq,,202,PRJNA89529,SAMN04486294,STJUDE,PCR,sra,SRX1571374,172,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015258_D1_RNASEQ_1,2016-02-11,10457,6927,ILLUMINA,,2016-04-14,SRR3162141,,SRS1284442,SRP011999,TARGET-10-PARIYD-09A-01R,RNA,TARGET-10-PARIYD-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PARIYD,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162141,"T-cell Acute Lymphoblastic Leukemia,n=265",8.98082191780822,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162142,RNA-Seq,,202,PRJNA89529,SAMN04486335,STJUDE,PCR,sra,SRX1571375,165,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015259_D1_RNASEQ_1,2016-02-11,10430,6723,ILLUMINA,,2016-04-14,SRR3162142,,SRS1284441,SRP011999,TARGET-10-PARIZN-09A-01R,RNA,TARGET-10-PARIZN-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PARIZN,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162142,"T-cell Acute Lymphoblastic Leukemia,n=265",10.2027397260273,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162143,RNA-Seq,,202,PRJNA89529,SAMN04486155,STJUDE,PCR,sra,SRX1571376,162,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015270_D1_RNASEQ_1,2016-02-11,10545,6847,ILLUMINA,,2016-04-14,SRR3162143,,SRS1284440,SRP011999,TARGET-10-PARJAY-09A-01R,RNA,TARGET-10-PARJAY-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PARJAY,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162143,"T-cell Acute Lymphoblastic Leukemia,n=265",15.4849315068493,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162144,RNA-Seq,,202,PRJNA89529,SAMN04486224,STJUDE,PCR,sra,SRX1571377,167,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015271_D1_RNASEQ_1,2016-02-11,10723,6944,ILLUMINA,,2016-04-14,SRR3162144,,SRS1284439,SRP011999,TARGET-10-PARJNX-09A-01R,RNA,TARGET-10-PARJNX-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PARJNX,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162144,"T-cell Acute Lymphoblastic Leukemia,n=265",3.0986301369863,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162145,RNA-Seq,,202,PRJNA89529,SAMN04486289,STJUDE,PCR,sra,SRX1571378,174,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015278_D1_RNASEQ_1,2016-02-11,10310,6740,ILLUMINA,,2016-04-14,SRR3162145,,SRS1284438,SRP011999,TARGET-10-PARJPL-09A-01R,RNA,TARGET-10-PARJPL-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PARJPL,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162145,"T-cell Acute Lymphoblastic Leukemia,n=265",3.76438356164383,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162146,RNA-Seq,,202,PRJNA89529,SAMN04486202,STJUDE,PCR,sra,SRX1571379,168,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015279_D1_RNASEQ_1,2016-02-11,9319,6106,ILLUMINA,,2016-04-14,SRR3162146,,SRS1284437,SRP011999,TARGET-10-PARJXW-09A-01R,RNA,TARGET-10-PARJXW-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PARJXW,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162146,"T-cell Acute Lymphoblastic Leukemia,n=265",14.8301369863013,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162147,RNA-Seq,,202,PRJNA89529,SAMN04486163,STJUDE,PCR,sra,SRX1571380,175,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015244_D1_RNASEQ_1,2016-02-11,9351,6192,ILLUMINA,,2016-04-14,SRR3162147,,SRS1284436,SRP011999,TARGET-10-PARKLK-09A-01R,RNA,TARGET-10-PARKLK-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PARKLK,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162147,"T-cell Acute Lymphoblastic Leukemia,n=265",1.81369863013698,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162148,RNA-Seq,,202,PRJNA89529,SAMN04486160,STJUDE,PCR,sra,SRX1571381,164,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015245_D1_RNASEQ_1,2016-02-11,9407,6071,ILLUMINA,,2016-04-14,SRR3162148,,SRS1284435,SRP011999,TARGET-10-PARLJA-09A-01R,RNA,TARGET-10-PARLJA-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PARLJA,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162148,"T-cell Acute Lymphoblastic Leukemia,n=265",8.63287671232876,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162149,RNA-Seq,,202,PRJNA89529,SAMN04486116,STJUDE,PCR,sra,SRX1571382,167,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJTALL002019_D1_RNASEQ_1,2016-02-12,10344,6666,ILLUMINA,,2016-04-14,SRR3162149,,SRS1284434,SRP011999,TARGET-10-PARLST-09A-01R,RNA,TARGET-10-PARLST-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PARLST,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162149,"T-cell Acute Lymphoblastic Leukemia,n=265",9.44657534246575,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162150,RNA-Seq,,202,PRJNA89529,SAMN04486341,STJUDE,PCR,sra,SRX1571383,161,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015246_D1_RNASEQ_1,2016-02-11,11280,7343,ILLUMINA,,2016-04-14,SRR3162150,,SRS1284433,SRP011999,TARGET-10-PARMFF-09A-01R,RNA,TARGET-10-PARMFF-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PARMFF,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162150,"T-cell Acute Lymphoblastic Leukemia,n=265",8.32602739726027,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162151,RNA-Seq,,202,PRJNA89529,SAMN04486261,STJUDE,PCR,sra,SRX1571384,165,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015247_D1_RNASEQ_1,2016-02-11,9181,5835,ILLUMINA,,2016-04-14,SRR3162151,,SRS1284432,SRP011999,TARGET-10-PARMIH-09A-01R,RNA,TARGET-10-PARMIH-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PARMIH,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162151,"T-cell Acute Lymphoblastic Leukemia,n=265",12.4301369863013,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162152,RNA-Seq,,202,PRJNA89529,SAMN04486326,STJUDE,PCR,sra,SRX1571385,169,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015260_D1_RNASEQ_1,2016-02-11,8272,5232,ILLUMINA,,2016-04-14,SRR3162152,,SRS1284430,SRP011999,TARGET-10-PARMKK-09A-01R,RNA,TARGET-10-PARMKK-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PARMKK,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162152,"T-cell Acute Lymphoblastic Leukemia,n=265",3.34794520547945,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162153,RNA-Seq,,202,PRJNA89529,SAMN04486142,STJUDE,PCR,sra,SRX1571386,162,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015261_D1_RNASEQ_1,2016-02-11,7449,4672,ILLUMINA,,2016-04-14,SRR3162153,,SRS1284431,SRP011999,TARGET-10-PARMKM-03A-01R,RNA,TARGET-10-PARMKM-03A-01R,Primary Blood Derived Cancer - Peripheral Blood,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PARMKM,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162153,"T-cell Acute Lymphoblastic Leukemia,n=265",1.5917808219178,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162154,RNA-Seq,,202,PRJNA89529,SAMN04486320,STJUDE,PCR,sra,SRX1571387,166,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015262_D1_RNASEQ_1,2016-02-11,10010,6428,ILLUMINA,,2016-04-14,SRR3162154,,SRS1284429,SRP011999,TARGET-10-PARMMV-09A-01R,RNA,TARGET-10-PARMMV-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PARMMV,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162154,"T-cell Acute Lymphoblastic Leukemia,n=265",6.36164383561643,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162155,RNA-Seq,,202,PRJNA89529,SAMN04486301,STJUDE,PCR,sra,SRX1571388,148,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015263_D1_RNASEQ_1,2016-02-11,9403,6258,ILLUMINA,,2016-04-14,SRR3162155,,SRS1284428,SRP011999,TARGET-10-PARMRF-09A-01R,RNA,TARGET-10-PARMRF-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PARMRF,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162155,"T-cell Acute Lymphoblastic Leukemia,n=265",5.98904109589041,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162156,RNA-Seq,,202,PRJNA89529,SAMN04486243,STJUDE,PCR,sra,SRX1571389,164,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015272_D1_RNASEQ_1,2016-02-11,10427,6741,ILLUMINA,,2016-04-14,SRR3162156,,SRS1284427,SRP011999,TARGET-10-PARMUC-03A-01R,RNA,TARGET-10-PARMUC-03A-01R,Primary Blood Derived Cancer - Peripheral Blood,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PARMUC,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162156,"T-cell Acute Lymphoblastic Leukemia,n=265",2.65205479452054,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162157,RNA-Seq,,202,PRJNA89529,SAMN04486168,STJUDE,PCR,sra,SRX1571390,176,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJTALL021655_D2_RNASEQ_1,2016-02-13,11798,7864,ILLUMINA,,2016-04-14,SRR3162157,,SRS1284426,SRP011999,TARGET-10-PARMWH-09A-01R,RNA,TARGET-10-PARMWH-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PARMWH,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162157,"T-cell Acute Lymphoblastic Leukemia,n=265",20.5835616438356,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162158,RNA-Seq,,202,PRJNA89529,SAMN04486134,STJUDE,PCR,sra,SRX1571391,149,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJTALL002005_D1_RNASEQ_1,2016-02-12,11062,7268,ILLUMINA,,2016-04-14,SRR3162158,,SRS1284425,SRP011999,TARGET-10-PARNBN-09A-01R,RNA,TARGET-10-PARNBN-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PARNBN,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162158,"T-cell Acute Lymphoblastic Leukemia,n=265",10.0657534246575,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162159,RNA-Seq,,202,PRJNA89529,SAMN04486096,STJUDE,PCR,sra,SRX1571392,163,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJTALL002009_D1_RNASEQ_1,2016-02-12,10433,6700,ILLUMINA,,2016-04-14,SRR3162159,,SRS1284424,SRP011999,TARGET-10-PARNEH-09A-01R,RNA,TARGET-10-PARNEH-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PARNEH,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162159,"T-cell Acute Lymphoblastic Leukemia,n=265",4.00821917808219,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162160,RNA-Seq,,202,PRJNA89529,SAMN04486343,STJUDE,PCR,sra,SRX1571393,166,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJTALL170_E_RNASEQ_1,2016-02-13,8710,5522,ILLUMINA,,2016-04-14,SRR3162160,,SRS1284423,SRP011999,TARGET-10-PARNJB-09A-01R,RNA,TARGET-10-PARNJB-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PARNJB,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162160,"T-cell Acute Lymphoblastic Leukemia,n=265",22.5534246575342,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162161,RNA-Seq,,202,PRJNA89529,SAMN04486161,STJUDE,PCR,sra,SRX1571394,174,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015280_D1_RNASEQ_1,2016-02-11,10413,6859,ILLUMINA,,2016-04-14,SRR3162161,,SRS1284421,SRP011999,TARGET-10-PARNMV-09A-01R,RNA,TARGET-10-PARNMV-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PARNMV,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162161,"T-cell Acute Lymphoblastic Leukemia,n=265",9.53698630136986,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162162,RNA-Seq,,202,PRJNA89529,SAMN04486307,STJUDE,PCR,sra,SRX1571395,177,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015281_D1_RNASEQ_1,2016-02-11,10043,6560,ILLUMINA,,2016-04-14,SRR3162162,,SRS1284422,SRP011999,TARGET-10-PARNSP-09A-01R,RNA,TARGET-10-PARNSP-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PARNSP,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162162,"T-cell Acute Lymphoblastic Leukemia,n=265",6.04383561643835,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162163,RNA-Seq,,202,PRJNA89529,SAMN04486197,STJUDE,PCR,sra,SRX1571396,171,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015275_D1_RNASEQ_1,2016-02-11,10191,6626,ILLUMINA,,2016-04-14,SRR3162163,,SRS1284419,SRP011999,TARGET-10-PARNXJ-09A-01R,RNA,TARGET-10-PARNXJ-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PARNXJ,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162163,"T-cell Acute Lymphoblastic Leukemia,n=265",4.82191780821917,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162164,RNA-Seq,,202,PRJNA89529,SAMN04486205,STJUDE,PCR,sra,SRX1571397,172,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015248_D1_RNASEQ_1,2016-02-11,10672,7054,ILLUMINA,,2016-04-14,SRR3162164,,SRS1284420,SRP011999,TARGET-10-PARPET-09A-01R,RNA,TARGET-10-PARPET-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PARPET,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162164,"T-cell Acute Lymphoblastic Leukemia,n=265",4.96164383561643,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162165,RNA-Seq,,202,PRJNA89529,SAMN04486146,STJUDE,PCR,sra,SRX1571398,164,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015249_D1_RNASEQ_1,2016-02-11,9441,5994,ILLUMINA,,2016-04-14,SRR3162165,,SRS1284418,SRP011999,TARGET-10-PARPHB-09A-01R,RNA,TARGET-10-PARPHB-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PARPHB,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162165,"T-cell Acute Lymphoblastic Leukemia,n=265",1.0958904109589,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162166,RNA-Seq,,202,PRJNA89529,SAMN04486181,STJUDE,PCR,sra,SRX1571399,166,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL016653_D1_RNASEQ_1,2016-02-12,9180,5719,ILLUMINA,,2016-04-14,SRR3162166,,SRS1284417,SRP011999,TARGET-10-PARPUL-09A-01R,RNA,TARGET-10-PARPUL-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PARPUL,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162166,"T-cell Acute Lymphoblastic Leukemia,n=265",2.24657534246575,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162167,RNA-Seq,,202,PRJNA89529,SAMN04486110,STJUDE,PCR,sra,SRX1571400,170,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015250_D1_RNASEQ_1,2016-02-11,9400,5908,ILLUMINA,,2016-04-14,SRR3162167,,SRS1284416,SRP011999,TARGET-10-PARPYJ-09A-01R,RNA,TARGET-10-PARPYJ-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PARPYJ,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162167,"T-cell Acute Lymphoblastic Leukemia,n=265",7.44931506849315,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162168,RNA-Seq,,202,PRJNA89529,SAMN04486290,STJUDE,PCR,sra,SRX1571401,152,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJTALL002036_D1_RNASEQ_1,2016-02-12,9181,5952,ILLUMINA,,2016-04-14,SRR3162168,,SRS1284415,SRP011999,TARGET-10-PARRKK-09A-01R,RNA,TARGET-10-PARRKK-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PARRKK,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162168,"T-cell Acute Lymphoblastic Leukemia,n=265",8.88767123287671,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162169,RNA-Seq,,202,PRJNA89529,SAMN04486333,STJUDE,PCR,sra,SRX1571402,174,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015251_D1_RNASEQ_1,2016-02-11,11291,7579,ILLUMINA,,2016-04-14,SRR3162169,,SRS1284414,SRP011999,TARGET-10-PARSET-09A-01R,RNA,TARGET-10-PARSET-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PARSET,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162169,"T-cell Acute Lymphoblastic Leukemia,n=265",10.9205479452054,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162170,RNA-Seq,,202,PRJNA89529,SAMN04486117,STJUDE,PCR,sra,SRX1571403,153,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015264_D1_RNASEQ_1,2016-02-11,9765,6297,ILLUMINA,,2016-04-14,SRR3162170,,SRS1284413,SRP011999,TARGET-10-PARSJG-09A-01R,RNA,TARGET-10-PARSJG-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PARSJG,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162170,"T-cell Acute Lymphoblastic Leukemia,n=265",11.9753424657534,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162171,RNA-Seq,,202,PRJNA89529,SAMN04486114,STJUDE,PCR,sra,SRX1571404,172,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJTALL002048_D1_RNASEQ_1,2016-02-13,11694,7781,ILLUMINA,,2016-04-14,SRR3162171,,SRS1284412,SRP011999,TARGET-10-PARSNX-09A-01R,RNA,TARGET-10-PARSNX-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PARSNX,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162171,"T-cell Acute Lymphoblastic Leukemia,n=265",13.4657534246575,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162172,RNA-Seq,,202,PRJNA89529,SAMN04486336,STJUDE,PCR,sra,SRX1571405,164,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015265_D1_RNASEQ_1,2016-02-11,10293,6602,ILLUMINA,,2016-04-14,SRR3162172,,SRS1284411,SRP011999,TARGET-10-PARTBP-09A-01R,RNA,TARGET-10-PARTBP-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PARTBP,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162172,"T-cell Acute Lymphoblastic Leukemia,n=265",5.63561643835616,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162173,RNA-Seq,,202,PRJNA89529,SAMN04486199,STJUDE,PCR,sra,SRX1571425,162,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJTALL175_E_RNASEQ_1,2016-02-13,8815,5507,ILLUMINA,,2016-04-14,SRR3162173,,SRS1284391,SRP011999,TARGET-10-PASFLK-09A-01R,RNA,TARGET-10-PASFLK-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PASFLK,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162173,"T-cell Acute Lymphoblastic Leukemia,n=265",12.0273972602739,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162174,RNA-Seq,,202,PRJNA89529,SAMN04486120,STJUDE,PCR,sra,SRX1571426,159,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJTALL021661_D2_RNASEQ_1,2016-02-13,10877,7107,ILLUMINA,,2016-04-14,SRR3162174,,SRS1284390,SRP011999,TARGET-10-PASGFH-09A-01R,RNA,TARGET-10-PASGFH-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PASGFH,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162174,"T-cell Acute Lymphoblastic Leukemia,n=265",17.7753424657534,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162175,RNA-Seq,,202,PRJNA89529,SAMN04486252,STJUDE,PCR,sra,SRX1571427,162,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJTALL022654_D2_RNASEQ_1,2016-02-13,10651,6900,ILLUMINA,,2016-04-14,SRR3162175,,SRS1284389,SRP011999,TARGET-10-PASHDV-09A-01R,RNA,TARGET-10-PASHDV-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PASHDV,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162175,"T-cell Acute Lymphoblastic Leukemia,n=265",11.6630136986301,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162176,RNA-Seq,,202,PRJNA89529,SAMN04486101,STJUDE,PCR,sra,SRX1571428,170,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015621_D1_RNASEQ_1,2016-02-12,10917,7148,ILLUMINA,,2016-04-14,SRR3162176,,SRS1284388,SRP011999,TARGET-10-PASHNK-09A-01R,RNA,TARGET-10-PASHNK-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PASHNK,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162176,"T-cell Acute Lymphoblastic Leukemia,n=265",6.61917808219178,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162177,RNA-Seq,,202,PRJNA89529,SAMN04486118,STJUDE,PCR,sra,SRX1571490,161,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015646_D1_RNASEQ_1,2016-02-12,11002,7188,ILLUMINA,,2016-04-14,SRR3162177,,SRS1284326,SRP011999,TARGET-10-PASYIS-09A-01R,RNA,TARGET-10-PASYIS-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PASYIS,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162177,"T-cell Acute Lymphoblastic Leukemia,n=265",8.04657534246575,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162178,RNA-Seq,,202,PRJNA89529,SAMN04486152,STJUDE,PCR,sra,SRX1571491,168,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015647_D1-TARGET-10-PASYSJ-09A-01,2016-02-12,11060,7960,ILLUMINA,,2016-04-14,SRR3162178,,SRS1284325,SRP011999,TARGET-10-PASYSJ-09A-01R,RNA,TARGET-10-PASYSJ-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PASYSJ,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162178,"T-cell Acute Lymphoblastic Leukemia,n=265",14.7369863013698,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162179,RNA-Seq,,202,PRJNA89529,SAMN04486254,STJUDE,PCR,sra,SRX1571492,166,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015648_D1_RNASEQ_1,2016-02-12,8410,5234,ILLUMINA,,2016-04-14,SRR3162179,,SRS1284324,SRP011999,TARGET-10-PASYWF-03A-01R,RNA,TARGET-10-PASYWF-03A-01R,Primary Blood Derived Cancer - Peripheral Blood,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PASYWF,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162179,"T-cell Acute Lymphoblastic Leukemia,n=265",5.53972602739726,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162180,RNA-Seq,,202,PRJNA89529,SAMN04486325,STJUDE,PCR,sra,SRX1571493,172,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015649_D1-TARGET-10-PASZEW-09A-01,2016-02-12,11813,8494,ILLUMINA,,2016-04-14,SRR3162180,,SRS1284323,SRP011999,TARGET-10-PASZEW-09A-01R,RNA,TARGET-10-PASZEW-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PASZEW,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162180,"T-cell Acute Lymphoblastic Leukemia,n=265",7.34520547945205,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162181,RNA-Seq,,202,PRJNA89529,SAMN04486151,STJUDE,PCR,sra,SRX1571494,167,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015650_D1-TARGET-10-PASZIY-09A-01,2016-02-12,11673,8320,ILLUMINA,,2016-04-14,SRR3162181,,SRS1284322,SRP011999,TARGET-10-PASZIY-09A-01R,RNA,TARGET-10-PASZIY-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PASZIY,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162181,"T-cell Acute Lymphoblastic Leukemia,n=265",14.3397260273972,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162182,RNA-Seq,,202,PRJNA89529,SAMN04486156,STJUDE,PCR,sra,SRX1571406,169,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJTALL171_E-TARGET-10-PARTLY-09A-01D,2016-02-13,10171,7086,ILLUMINA,,2016-04-14,SRR3162182,,SRS1284410,SRP011999,TARGET-10-PARTLY-09A-01R,RNA,TARGET-10-PARTLY-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PARTLY,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162182,"T-cell Acute Lymphoblastic Leukemia,n=265",12.3068493150684,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162183,RNA-Seq,,202,PRJNA89529,SAMN04486129,STJUDE,PCR,sra,SRX1571407,171,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015266_D1_RNASEQ_1,2016-02-11,11396,7466,ILLUMINA,,2016-04-14,SRR3162183,,SRS1284409,SRP011999,TARGET-10-PARTPW-09A-01R,RNA,TARGET-10-PARTPW-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PARTPW,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162183,"T-cell Acute Lymphoblastic Leukemia,n=265",15.0219178082191,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162184,RNA-Seq,,202,PRJNA89529,SAMN04486255,STJUDE,PCR,sra,SRX1571408,172,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015267_D1_RNASEQ_1,2016-02-11,9626,6233,ILLUMINA,,2016-04-14,SRR3162184,,SRS1284407,SRP011999,TARGET-10-PARUEU-09A-01R,RNA,TARGET-10-PARUEU-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PARUEU,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162184,"T-cell Acute Lymphoblastic Leukemia,n=265",5.57808219178082,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162185,RNA-Seq,,202,PRJNA89529,SAMN04486345,STJUDE,PCR,sra,SRX1571409,172,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015273_D1_RNASEQ_1,2016-02-11,10449,6890,ILLUMINA,,2016-04-14,SRR3162185,,SRS1284408,SRP011999,TARGET-10-PARUKW-09A-01R,RNA,TARGET-10-PARUKW-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PARUKW,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162185,"T-cell Acute Lymphoblastic Leukemia,n=265",9.7972602739726,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162186,RNA-Seq,,202,PRJNA89529,SAMN04486233,STJUDE,PCR,sra,SRX1571410,164,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015282_D1_RNASEQ_1,2016-02-11,10569,6848,ILLUMINA,,2016-04-14,SRR3162186,,SRS1284406,SRP011999,TARGET-10-PARVEI-09A-01R,RNA,TARGET-10-PARVEI-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PARVEI,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162186,"T-cell Acute Lymphoblastic Leukemia,n=265",3.43287671232876,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162187,RNA-Seq,,202,PRJNA89529,SAMN04486133,STJUDE,PCR,sra,SRX1571411,169,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJTALL002030_D1-TARGET-10-PARVHY-09A-01,2016-02-12,10322,7067,ILLUMINA,,2016-04-14,SRR3162187,,SRS1284405,SRP011999,TARGET-10-PARVHY-09A-01R,RNA,TARGET-10-PARVHY-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PARVHY,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162187,"T-cell Acute Lymphoblastic Leukemia,n=265",15.6657534246575,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162188,RNA-Seq,,202,PRJNA89529,SAMN04486143,STJUDE,PCR,sra,SRX1571412,164,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL016429_D1-TARGET-10-PARVMR-09A-01,2016-02-12,9993,6896,ILLUMINA,,2016-04-14,SRR3162188,,SRS1284403,SRP011999,TARGET-10-PARVMR-09A-01R,RNA,TARGET-10-PARVMR-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PARVMR,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162188,"T-cell Acute Lymphoblastic Leukemia,n=265",4.96164383561643,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162189,RNA-Seq,,202,PRJNA89529,SAMN04486232,STJUDE,PCR,sra,SRX1571495,170,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJTALL021672_D2_RNASEQ_1,2016-02-13,10671,6982,ILLUMINA,,2016-04-14,SRR3162189,,SRS1284321,SRP011999,TARGET-10-PASZJW-03A-01R,RNA,TARGET-10-PASZJW-03A-01R,Primary Blood Derived Cancer - Peripheral Blood,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PASZJW,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162189,"T-cell Acute Lymphoblastic Leukemia,n=265",29.9890410958904,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162190,RNA-Seq,,202,PRJNA89529,SAMN04486158,STJUDE,PCR,sra,SRX1571496,167,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015651_D1_RNASEQ_1,2016-02-12,10520,6863,ILLUMINA,,2016-04-14,SRR3162190,,SRS1284320,SRP011999,TARGET-10-PATALJ-09A-01R,RNA,TARGET-10-PATALJ-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PATALJ,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162190,"T-cell Acute Lymphoblastic Leukemia,n=265",12.7917808219178,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162191,RNA-Seq,,202,PRJNA89529,SAMN04486277,STJUDE,PCR,sra,SRX1571497,168,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJTALL002075_D1_RNASEQ_1,2016-02-13,10500,6976,ILLUMINA,,2016-04-14,SRR3162191,,SRS1284319,SRP011999,TARGET-10-PATAXS-09A-01R,RNA,TARGET-10-PATAXS-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PATAXS,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162191,"T-cell Acute Lymphoblastic Leukemia,n=265",1.00547945205479,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162192,RNA-Seq,,202,PRJNA89529,SAMN04486271,STJUDE,PCR,sra,SRX1571498,159,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL016437_D1_RNASEQ_1,2016-02-12,10322,6732,ILLUMINA,,2016-04-14,SRR3162192,,SRS1284317,SRP011999,TARGET-10-PATAYT-09A-01R,RNA,TARGET-10-PATAYT-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PATAYT,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162192,"T-cell Acute Lymphoblastic Leukemia,n=265",5.91232876712328,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162193,RNA-Seq,,202,PRJNA89529,SAMN04486090,STJUDE,PCR,sra,SRX1571499,165,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015652_D1_RNASEQ_1,2016-02-12,10436,6829,ILLUMINA,,2016-04-14,SRR3162193,,SRS1284318,SRP011999,TARGET-10-PATBDJ-09A-01R,RNA,TARGET-10-PATBDJ-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PATBDJ,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162193,"T-cell Acute Lymphoblastic Leukemia,n=265",15.8986301369863,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162194,RNA-Seq,,202,PRJNA89529,SAMN04486131,STJUDE,PCR,sra,SRX1571500,163,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015653_D1_RNASEQ_1,2016-02-12,10267,6770,ILLUMINA,,2016-04-14,SRR3162194,,SRS1284316,SRP011999,TARGET-10-PATBDK-09A-01R,RNA,TARGET-10-PATBDK-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PATBDK,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162194,"T-cell Acute Lymphoblastic Leukemia,n=265",7.94794520547945,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162195,RNA-Seq,,202,PRJNA89529,SAMN04486123,STJUDE,PCR,sra,SRX1571413,161,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJTALL002258_D1-TARGET-10-PARWDM-09B-01,2016-02-13,10454,7188,ILLUMINA,,2016-04-14,SRR3162195,,SRS1284404,SRP011999,TARGET-10-PARWDM-09B-01R,RNA,TARGET-10-PARWDM-09B-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PARWDM,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162195,"T-cell Acute Lymphoblastic Leukemia,n=265",15.9287671232876,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162196,RNA-Seq,,202,PRJNA89529,SAMN04486100,STJUDE,PCR,sra,SRX1571414,162,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015283_D1-TARGET-10-PARWID-09A-01D,2016-02-11,10413,7094,ILLUMINA,,2016-04-14,SRR3162196,,SRS1284402,SRP011999,TARGET-10-PARWID-09A-01R,RNA,TARGET-10-PARWID-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PARWID,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162196,"T-cell Acute Lymphoblastic Leukemia,n=265",19.3232876712328,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162197,RNA-Seq,,202,PRJNA89529,SAMN04486305,STJUDE,PCR,sra,SRX1571415,159,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015276_D1-TARGET-10-PARWLP-09A-01D,2016-02-11,10574,7277,ILLUMINA,,2016-04-14,SRR3162197,,SRS1284401,SRP011999,TARGET-10-PARWLP-09A-01R,RNA,TARGET-10-PARWLP-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PARWLP,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162197,"T-cell Acute Lymphoblastic Leukemia,n=265",7.90136986301369,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162198,RNA-Seq,,202,PRJNA89529,SAMN04486190,STJUDE,PCR,sra,SRX1571416,161,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015252_D1-TARGET-10-PARWMF-09A-01D,2016-02-11,10229,7098,ILLUMINA,,2016-04-14,SRR3162198,,SRS1284400,SRP011999,TARGET-10-PARWMF-09A-01R,RNA,TARGET-10-PARWMF-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PARWMF,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162198,"T-cell Acute Lymphoblastic Leukemia,n=265",11.7123287671232,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162199,RNA-Seq,,202,PRJNA89529,SAMN04486309,STJUDE,PCR,sra,SRX1571417,160,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJTALL002045_D1-TARGET-10-PARWNW-09A-01,2016-02-12,10552,7262,ILLUMINA,,2016-04-14,SRR3162199,,SRS1284399,SRP011999,TARGET-10-PARWNW-09A-01R,RNA,TARGET-10-PARWNW-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PARWNW,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162199,"T-cell Acute Lymphoblastic Leukemia,n=265",11.9616438356164,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162200,RNA-Seq,,202,PRJNA89529,SAMN04486324,STJUDE,PCR,sra,SRX1571418,154,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJTALL002049_D1-TARGET-10-PARXHT-03A-01,2016-02-12,10665,7422,ILLUMINA,,2016-04-14,SRR3162200,,SRS1284398,SRP011999,TARGET-10-PARXHT-03A-01R,RNA,TARGET-10-PARXHT-03A-01R,Primary Blood Derived Cancer - Peripheral Blood,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PARXHT,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162200,"T-cell Acute Lymphoblastic Leukemia,n=265",13.9890410958904,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162201,RNA-Seq,,202,PRJNA89529,SAMN04486340,STJUDE,PCR,sra,SRX1571419,175,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015253_D1_RNASEQ_1,2016-02-11,10803,7105,ILLUMINA,,2016-04-14,SRR3162201,,SRS1284397,SRP011999,TARGET-10-PARXLS-09A-01R,RNA,TARGET-10-PARXLS-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PARXLS,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162201,"T-cell Acute Lymphoblastic Leukemia,n=265",4.38630136986301,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162202,RNA-Seq,,202,PRJNA89529,SAMN04486196,STJUDE,PCR,sra,SRX1571420,175,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJTALL022653_D2_RNASEQ_1,2016-02-13,10350,6777,ILLUMINA,,2016-04-14,SRR3162202,,SRS1284396,SRP011999,TARGET-10-PARXMV-03A-01R,RNA,TARGET-10-PARXMV-03A-01R,Primary Blood Derived Cancer - Peripheral Blood,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PARXMV,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162202,"T-cell Acute Lymphoblastic Leukemia,n=265",12.3917808219178,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162203,RNA-Seq,,202,PRJNA89529,SAMN04486201,STJUDE,PCR,sra,SRX1571421,166,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJTALL002060_D1_RNASEQ_1,2016-02-12,7428,4569,ILLUMINA,,2016-04-14,SRR3162203,,SRS1284394,SRP011999,TARGET-10-PARXVS-09A-01R,RNA,TARGET-10-PARXVS-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PARXVS,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162203,"T-cell Acute Lymphoblastic Leukemia,n=265",11.758904109589,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162204,RNA-Seq,,202,PRJNA89529,SAMN04486180,STJUDE,PCR,sra,SRX1571422,168,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015254_D1_RNASEQ_1,2016-02-11,10388,6748,ILLUMINA,,2016-04-14,SRR3162204,,SRS1284395,SRP011999,TARGET-10-PARYGI-03A-01R,RNA,TARGET-10-PARYGI-03A-01R,Primary Blood Derived Cancer - Peripheral Blood,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PARYGI,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162204,"T-cell Acute Lymphoblastic Leukemia,n=265",5.07945205479452,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162205,RNA-Seq,,202,PRJNA89529,SAMN04486140,STJUDE,PCR,sra,SRX1571423,171,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015268_D1_RNASEQ_1,2016-02-11,8209,5112,ILLUMINA,,2016-04-14,SRR3162205,,SRS1284392,SRP011999,TARGET-10-PASFHR-09A-01R,RNA,TARGET-10-PASFHR-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PASFHR,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162205,"T-cell Acute Lymphoblastic Leukemia,n=265",14.5835616438356,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162206,RNA-Seq,,202,PRJNA89529,SAMN04486165,STJUDE,PCR,sra,SRX1571424,165,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015269_D1-TARGET-10-PASFKA-09A-01D,2016-02-11,10879,7564,ILLUMINA,,2016-04-14,SRR3162206,,SRS1284393,SRP011999,TARGET-10-PASFKA-09A-01R,RNA,TARGET-10-PASFKA-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PASFKA,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162206,"T-cell Acute Lymphoblastic Leukemia,n=265",12.7835616438356,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162207,RNA-Seq,,202,PRJNA89529,SAMN04486312,STJUDE,PCR,sra,SRX1571429,170,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015274_D1-TARGET-10-PASHUP-09A-01D,2016-02-11,10448,7441,ILLUMINA,,2016-04-14,SRR3162207,,SRS1284387,SRP011999,TARGET-10-PASHUP-09A-01R,RNA,TARGET-10-PASHUP-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PASHUP,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162207,"T-cell Acute Lymphoblastic Leukemia,n=265",9.68219178082191,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162208,RNA-Seq,,202,PRJNA89529,SAMN04486178,STJUDE,PCR,sra,SRX1571430,170,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJTALL022091_D2-TARGET-10-PASHXL-09A-01,2016-02-13,10536,7611,ILLUMINA,,2016-04-14,SRR3162208,,SRS1284386,SRP011999,TARGET-10-PASHXL-09A-01R,RNA,TARGET-10-PASHXL-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PASHXL,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162208,"T-cell Acute Lymphoblastic Leukemia,n=265",13.5397260273972,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162209,RNA-Seq,,202,PRJNA89529,SAMN04486291,STJUDE,PCR,sra,SRX1571431,164,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJTALL022655_D2-TARGET-10-PASIIY-09A-01,2016-02-13,11049,7680,ILLUMINA,,2016-04-14,SRR3162209,,SRS1284385,SRP011999,TARGET-10-PASIIY-09A-01R,RNA,TARGET-10-PASIIY-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PASIIY,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162209,"T-cell Acute Lymphoblastic Leukemia,n=265",5.94794520547945,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162210,RNA-Seq,,202,PRJNA89529,SAMN04486267,STJUDE,PCR,sra,SRX1571432,170,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015622_D1-TARGET-10-PASILW-09A-01,2016-02-12,10931,7884,ILLUMINA,,2016-04-14,SRR3162210,,SRS1284383,SRP011999,TARGET-10-PASILW-09A-01R,RNA,TARGET-10-PASILW-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PASILW,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162210,"T-cell Acute Lymphoblastic Leukemia,n=265",12.4246575342465,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162211,RNA-Seq,,202,PRJNA89529,SAMN04486240,STJUDE,PCR,sra,SRX1571433,159,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015623_D1-TARGET-10-PASINX-09A-01,2016-02-12,10311,7127,ILLUMINA,,2016-04-14,SRR3162211,,SRS1284382,SRP011999,TARGET-10-PASINX-09A-01R,RNA,TARGET-10-PASINX-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PASINX,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162211,"T-cell Acute Lymphoblastic Leukemia,n=265",11.3643835616438,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162212,RNA-Seq,,202,PRJNA89529,SAMN04486306,STJUDE,PCR,sra,SRX1571434,161,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJTALL177_E_RNASEQ_1,2016-02-13,9862,6367,ILLUMINA,,2016-04-14,SRR3162212,,SRS1284384,SRP011999,TARGET-10-PASJJR-09A-01R,RNA,TARGET-10-PASJJR-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PASJJR,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162212,"T-cell Acute Lymphoblastic Leukemia,n=265",14.2904109589041,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162213,RNA-Seq,,202,PRJNA89529,SAMN04486209,STJUDE,PCR,sra,SRX1571435,166,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJTALL022656_D2_RNASEQ_1,2016-02-13,11496,7607,ILLUMINA,,2016-04-14,SRR3162213,,SRS1284381,SRP011999,TARGET-10-PASJLN-09A-01R,RNA,TARGET-10-PASJLN-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PASJLN,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162213,"T-cell Acute Lymphoblastic Leukemia,n=265",10.9342465753424,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162214,RNA-Seq,,202,PRJNA89529,SAMN04486091,STJUDE,PCR,sra,SRX1571436,139,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJTALL022093_D2-TARGET-10-PASJMK-09A-01,2016-02-13,11064,7790,ILLUMINA,,2016-04-14,SRR3162214,,SRS1284380,SRP011999,TARGET-10-PASJMK-09A-01R,RNA,TARGET-10-PASJMK-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PASJMK,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162214,"T-cell Acute Lymphoblastic Leukemia,n=265",6.30136986301369,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162215,RNA-Seq,,202,PRJNA89529,SAMN04486188,STJUDE,PCR,sra,SRX1571437,163,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL016430_D1-TARGET-10-PASJYI-09A-01,2016-02-12,11247,7883,ILLUMINA,,2016-04-14,SRR3162215,,SRS1284379,SRP011999,TARGET-10-PASJYI-09A-01R,RNA,TARGET-10-PASJYI-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PASJYI,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162215,"T-cell Acute Lymphoblastic Leukemia,n=265",14.3232876712328,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162216,RNA-Seq,,202,PRJNA89529,SAMN04486211,STJUDE,PCR,sra,SRX1571438,157,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL016431_D1_RNASEQ_1,2016-02-12,10309,6707,ILLUMINA,,2016-04-14,SRR3162216,,SRS1284378,SRP011999,TARGET-10-PASKAD-09A-01R,RNA,TARGET-10-PASKAD-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PASKAD,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162216,"T-cell Acute Lymphoblastic Leukemia,n=265",10.4356164383561,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162217,RNA-Seq,,202,PRJNA89529,SAMN04486124,STJUDE,PCR,sra,SRX1571439,163,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJBALL002373_D1-TARGET-10-PASKCL-09B-01,2016-02-12,10251,7040,ILLUMINA,,2016-04-14,SRR3162217,,SRS1284377,SRP011999,TARGET-10-PASKCL-09B-01R,RNA,TARGET-10-PASKCL-09B-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PASKCL,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162217,"T-cell Acute Lymphoblastic Leukemia,n=265",12.6876712328767,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162218,RNA-Seq,,202,PRJNA89529,SAMN04486121,STJUDE,PCR,sra,SRX1571440,158,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015284_D1-TARGET-10-PASKGG-09A-01D,2016-02-11,10381,7452,ILLUMINA,,2016-04-14,SRR3162218,,SRS1284376,SRP011999,TARGET-10-PASKGG-09A-01R,RNA,TARGET-10-PASKGG-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PASKGG,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162218,"T-cell Acute Lymphoblastic Leukemia,n=265",15.5671232876712,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162219,RNA-Seq,,202,PRJNA89529,SAMN04486329,STJUDE,PCR,sra,SRX1571441,164,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJTALL001777_D1_RNASEQ_1,2016-02-12,11250,7388,ILLUMINA,,2016-04-14,SRR3162219,,SRS1284375,SRP011999,TARGET-10-PASKIC-09A-01R,RNA,TARGET-10-PASKIC-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PASKIC,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162219,"T-cell Acute Lymphoblastic Leukemia,n=265",11.2109589041095,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162220,RNA-Seq,,202,PRJNA89529,SAMN04486230,STJUDE,PCR,sra,SRX1571442,168,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJTALL002042_D1-TARGET-10-PASKRN-03A-01,2016-02-12,10541,7330,ILLUMINA,,2016-04-14,SRR3162220,,SRS1284374,SRP011999,TARGET-10-PASKRN-03A-01R,RNA,TARGET-10-PASKRN-03A-01R,Primary Blood Derived Cancer - Peripheral Blood,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PASKRN,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162220,"T-cell Acute Lymphoblastic Leukemia,n=265",5.1917808219178,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162221,RNA-Seq,,202,PRJNA89529,SAMN04486184,STJUDE,PCR,sra,SRX1571443,160,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL016433_D1-TARGET-10-PASKSY-09A-01,2016-02-12,11402,8201,ILLUMINA,,2016-04-14,SRR3162221,,SRS1284372,SRP011999,TARGET-10-PASKSY-09A-01R,RNA,TARGET-10-PASKSY-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PASKSY,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162221,"T-cell Acute Lymphoblastic Leukemia,n=265",9.73150684931507,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162222,RNA-Seq,,202,PRJNA89529,SAMN04486214,STJUDE,PCR,sra,SRX1571444,164,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015285_D1-TARGET-10-PASKTG-09A-01D,2016-02-11,10301,7471,ILLUMINA,,2016-04-14,SRR3162222,,SRS1284373,SRP011999,TARGET-10-PASKTG-09A-01R,RNA,TARGET-10-PASKTG-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PASKTG,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162222,"T-cell Acute Lymphoblastic Leukemia,n=265",5.83561643835616,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162223,RNA-Seq,,202,PRJNA89529,SAMN04486126,STJUDE,PCR,sra,SRX1571445,147,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJTALL002050_D1-TARGET-10-PASKXN-09A-01,2016-02-13,11911,8229,ILLUMINA,,2016-04-14,SRR3162223,,SRS1284371,SRP011999,TARGET-10-PASKXN-09A-01R,RNA,TARGET-10-PASKXN-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PASKXN,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162223,"T-cell Acute Lymphoblastic Leukemia,n=265",9.42465753424657,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162224,RNA-Seq,,202,PRJNA89529,SAMN04486282,STJUDE,PCR,sra,SRX1571446,164,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJTALL022096_D2-TARGET-10-PASLAB-09A-01,2016-02-13,10716,7633,ILLUMINA,,2016-04-14,SRR3162224,,SRS1284370,SRP011999,TARGET-10-PASLAB-09A-01R,RNA,TARGET-10-PASLAB-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PASLAB,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162224,"T-cell Acute Lymphoblastic Leukemia,n=265",4.81369863013698,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162225,RNA-Seq,,202,PRJNA89529,SAMN04486331,STJUDE,PCR,sra,SRX1571447,156,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJTALL001786_D1-TARGET-10-PASLBB-09A-01,2016-02-12,9687,6786,ILLUMINA,,2016-04-14,SRR3162225,,SRS1284369,SRP011999,TARGET-10-PASLBB-09A-01R,RNA,TARGET-10-PASLBB-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PASLBB,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162225,"T-cell Acute Lymphoblastic Leukemia,n=265",7.87397260273972,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162226,RNA-Seq,,202,PRJNA89529,SAMN04486167,STJUDE,PCR,sra,SRX1571448,168,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015624_D1_RNASEQ_1,2016-02-12,10041,6532,ILLUMINA,,2016-04-14,SRR3162226,,SRS1284368,SRP011999,TARGET-10-PASMHF-09A-01R,RNA,TARGET-10-PASMHF-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PASMHF,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162226,"T-cell Acute Lymphoblastic Leukemia,n=265",12.0821917808219,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162227,RNA-Seq,,202,PRJNA89529,SAMN04486330,STJUDE,PCR,sra,SRX1571449,163,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015625_D1-TARGET-10-PASMIC-09A-01,2016-02-12,10569,7330,ILLUMINA,,2016-04-14,SRR3162227,,SRS1284367,SRP011999,TARGET-10-PASMIC-09A-01R,RNA,TARGET-10-PASMIC-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PASMIC,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162227,"T-cell Acute Lymphoblastic Leukemia,n=265",13.4684931506849,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162228,RNA-Seq,,202,PRJNA89529,SAMN04486220,STJUDE,PCR,sra,SRX1571450,170,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015626_D1-TARGET-10-PASMNV-09A-01,2016-02-12,10983,7761,ILLUMINA,,2016-04-14,SRR3162228,,SRS1284366,SRP011999,TARGET-10-PASMNV-09A-01R,RNA,TARGET-10-PASMNV-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PASMNV,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162228,"T-cell Acute Lymphoblastic Leukemia,n=265",12.772602739726,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162229,RNA-Seq,,202,PRJNA89529,SAMN04486103,STJUDE,PCR,sra,SRX1571451,168,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015627_D1-TARGET-10-PASNEH-09A-01,2016-02-12,11200,7882,ILLUMINA,,2016-04-14,SRR3162229,,SRS1284365,SRP011999,TARGET-10-PASNEH-09A-01R,RNA,TARGET-10-PASNEH-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PASNEH,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162229,"T-cell Acute Lymphoblastic Leukemia,n=265",5.93698630136986,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162230,RNA-Seq,,202,PRJNA89529,SAMN04486097,STJUDE,PCR,sra,SRX1571452,168,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL016434_D1-TARGET-10-PASNTZ-09A-01,2016-02-12,11274,8036,ILLUMINA,,2016-04-14,SRR3162230,,SRS1284364,SRP011999,TARGET-10-PASNTZ-09A-01R,RNA,TARGET-10-PASNTZ-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PASNTZ,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162230,"T-cell Acute Lymphoblastic Leukemia,n=265",7.1972602739726,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162231,RNA-Seq,,202,PRJNA89529,SAMN04486231,STJUDE,PCR,sra,SRX1571453,163,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015277_D1_RNASEQ_1,2016-02-11,10442,6807,ILLUMINA,,2016-04-14,SRR3162231,,SRS1284363,SRP011999,TARGET-10-PASPBU-09A-01R,RNA,TARGET-10-PASPBU-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PASPBU,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162231,"T-cell Acute Lymphoblastic Leukemia,n=265",15.5424657534246,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162232,RNA-Seq,,202,PRJNA89529,SAMN04486213,STJUDE,PCR,sra,SRX1571454,162,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJTALL022098_D2-TARGET-10-PASPDS-09A-01,2016-02-13,10819,7654,ILLUMINA,,2016-04-14,SRR3162232,,SRS1284362,SRP011999,TARGET-10-PASPDS-09A-01R,RNA,TARGET-10-PASPDS-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PASPDS,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162232,"T-cell Acute Lymphoblastic Leukemia,n=265",10.931506849315,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162233,RNA-Seq,,202,PRJNA89529,SAMN04486303,STJUDE,PCR,sra,SRX1571455,165,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJTALL022100_D2-TARGET-10-PASPPN-09A-01,2016-02-13,10361,7201,ILLUMINA,,2016-04-14,SRR3162233,,SRS1284361,SRP011999,TARGET-10-PASPPN-09A-01R,RNA,TARGET-10-PASPPN-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PASPPN,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162233,"T-cell Acute Lymphoblastic Leukemia,n=265",12.5835616438356,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162234,RNA-Seq,,202,PRJNA89529,SAMN04486092,STJUDE,PCR,sra,SRX1571456,160,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJTALL001785_D1_RNASEQ_1,2016-02-12,10509,6780,ILLUMINA,,2016-04-14,SRR3162234,,SRS1284360,SRP011999,TARGET-10-PASRCV-09A-01R,RNA,TARGET-10-PASRCV-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PASRCV,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162234,"T-cell Acute Lymphoblastic Leukemia,n=265",3.4,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162235,RNA-Seq,,202,PRJNA89529,SAMN04486229,STJUDE,PCR,sra,SRX1571457,163,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015628_D1-TARGET-10-PASRMM-09A-01,2016-02-12,10389,7143,ILLUMINA,,2016-04-14,SRR3162235,,SRS1284359,SRP011999,TARGET-10-PASRMM-09A-01R,RNA,TARGET-10-PASRMM-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PASRMM,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162235,"T-cell Acute Lymphoblastic Leukemia,n=265",4.36986301369863,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162236,RNA-Seq,,202,PRJNA89529,SAMN04486346,STJUDE,PCR,sra,SRX1571458,168,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015629_D1_RNASEQ_1,2016-02-12,10561,6803,ILLUMINA,,2016-04-14,SRR3162236,,SRS1284358,SRP011999,TARGET-10-PASSEF-09A-01R,RNA,TARGET-10-PASSEF-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PASSEF,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162236,"T-cell Acute Lymphoblastic Leukemia,n=265",4.94794520547945,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162237,RNA-Seq,,202,PRJNA89529,SAMN04486141,STJUDE,PCR,sra,SRX1571459,170,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015630_D1_RNASEQ_1,2016-02-12,10632,7076,ILLUMINA,,2016-04-14,SRR3162237,,SRS1284357,SRP011999,TARGET-10-PASSHC-09A-01R,RNA,TARGET-10-PASSHC-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PASSHC,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162237,"T-cell Acute Lymphoblastic Leukemia,n=265",15.2602739726027,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162238,RNA-Seq,,202,PRJNA89529,SAMN04486239,STJUDE,PCR,sra,SRX1571460,163,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015631_D1_RNASEQ_1,2016-02-12,10387,6659,ILLUMINA,,2016-04-14,SRR3162238,,SRS1284356,SRP011999,TARGET-10-PASSPP-09A-01R,RNA,TARGET-10-PASSPP-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PASSPP,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162238,"T-cell Acute Lymphoblastic Leukemia,n=265",9.97808219178082,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162239,RNA-Seq,,202,PRJNA89529,SAMN04486283,STJUDE,PCR,sra,SRX1571461,165,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015632_D1_RNASEQ_1,2016-02-12,9955,6702,ILLUMINA,,2016-04-14,SRR3162239,,SRS1284355,SRP011999,TARGET-10-PASSRP-09A-01R,RNA,TARGET-10-PASSRP-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PASSRP,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162239,"T-cell Acute Lymphoblastic Leukemia,n=265",4.50136986301369,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162240,RNA-Seq,,202,PRJNA89529,SAMN04486245,STJUDE,PCR,sra,SRX1571462,158,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015633_D1_RNASEQ_1,2016-02-12,10187,6506,ILLUMINA,,2016-04-14,SRR3162240,,SRS1284354,SRP011999,TARGET-10-PASSSR-09A-01R,RNA,TARGET-10-PASSSR-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PASSSR,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162240,"T-cell Acute Lymphoblastic Leukemia,n=265",7.88493150684931,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162241,RNA-Seq,,202,PRJNA89529,SAMN04486191,STJUDE,PCR,sra,SRX1571463,164,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015634_D1_RNASEQ_1,2016-02-12,9942,6426,ILLUMINA,,2016-04-14,SRR3162241,,SRS1284353,SRP011999,TARGET-10-PASSZA-09A-01R,RNA,TARGET-10-PASSZA-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PASSZA,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162241,"T-cell Acute Lymphoblastic Leukemia,n=265",14.8383561643835,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162242,RNA-Seq,,202,PRJNA89529,SAMN04486170,STJUDE,PCR,sra,SRX1571464,160,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL016435_D1-TARGET-10-PASTDU-09A-01,2016-02-12,10494,7216,ILLUMINA,,2016-04-14,SRR3162242,,SRS1284352,SRP011999,TARGET-10-PASTDU-09A-01R,RNA,TARGET-10-PASTDU-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PASTDU,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162242,"T-cell Acute Lymphoblastic Leukemia,n=265",8.86575342465753,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162243,RNA-Seq,,202,PRJNA89529,SAMN04486087,STJUDE,PCR,sra,SRX1571465,163,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015635_D1_RNASEQ_1,2016-02-12,10755,7011,ILLUMINA,,2016-04-14,SRR3162243,,SRS1284351,SRP011999,TARGET-10-PASTHE-09A-01R,RNA,TARGET-10-PASTHE-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PASTHE,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162243,"T-cell Acute Lymphoblastic Leukemia,n=265",6.37534246575342,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162244,RNA-Seq,,202,PRJNA89529,SAMN04486344,STJUDE,PCR,sra,SRX1571466,164,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJTALL002065_D1-TARGET-10-PASTLP-09A-01,2016-02-13,10495,7427,ILLUMINA,,2016-04-14,SRR3162244,,SRS1284350,SRP011999,TARGET-10-PASTLP-09A-01R,RNA,TARGET-10-PASTLP-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PASTLP,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162244,"T-cell Acute Lymphoblastic Leukemia,n=265",9.36986301369863,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162245,RNA-Seq,,202,PRJNA89529,SAMN04486260,STJUDE,PCR,sra,SRX1571467,164,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJBALL001782_D1-TARGET-10-PASTPT-09A-01,2016-02-12,10889,7611,ILLUMINA,,2016-04-14,SRR3162245,,SRS1284349,SRP011999,TARGET-10-PASTPT-09A-01R,RNA,TARGET-10-PASTPT-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PASTPT,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162245,"T-cell Acute Lymphoblastic Leukemia,n=265",4.86027397260274,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162246,RNA-Seq,,202,PRJNA89529,SAMN04486236,STJUDE,PCR,sra,SRX1571468,166,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJTALL002069_D1_RNASEQ_1,2016-02-13,10974,7162,ILLUMINA,,2016-04-14,SRR3162246,,SRS1284347,SRP011999,TARGET-10-PASTXU-09A-01R,RNA,TARGET-10-PASTXU-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PASTXU,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162246,"T-cell Acute Lymphoblastic Leukemia,n=265",12.9068493150684,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162247,RNA-Seq,,202,PRJNA89529,SAMN04486295,STJUDE,PCR,sra,SRX1571469,167,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJTALL001780_D1-TARGET-10-PASUGC-09A-01,2016-02-12,10226,7084,ILLUMINA,,2016-04-14,SRR3162247,,SRS1284348,SRP011999,TARGET-10-PASUGC-09A-01R,RNA,TARGET-10-PASUGC-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PASUGC,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162247,"T-cell Acute Lymphoblastic Leukemia,n=265",9.63013698630137,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162248,RNA-Seq,,202,PRJNA89529,SAMN04486276,STJUDE,PCR,sra,SRX1571470,165,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015636_D1-TARGET-10-PASUIN-09A-01,2016-02-12,9811,6848,ILLUMINA,,2016-04-14,SRR3162248,,SRS1284346,SRP011999,TARGET-10-PASUIN-09A-01R,RNA,TARGET-10-PASUIN-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PASUIN,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162248,"T-cell Acute Lymphoblastic Leukemia,n=265",13.7095890410958,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162249,RNA-Seq,,202,PRJNA89529,SAMN04486198,STJUDE,PCR,sra,SRX1571471,162,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015637_D1-TARGET-10-PASUSV-09A-01,2016-02-12,9687,6861,ILLUMINA,,2016-04-14,SRR3162249,,SRS1284345,SRP011999,TARGET-10-PASUSV-09A-01R,RNA,TARGET-10-PASUSV-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PASUSV,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162249,"T-cell Acute Lymphoblastic Leukemia,n=265",8.56712328767123,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162250,RNA-Seq,,202,PRJNA89529,SAMN04486338,STJUDE,PCR,sra,SRX1571472,166,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015638_D1-TARGET-10-PASVIN-09A-01,2016-02-12,10707,7260,ILLUMINA,,2016-04-14,SRR3162250,,SRS1284344,SRP011999,TARGET-10-PASVIN-09A-01R,RNA,TARGET-10-PASVIN-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PASVIN,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162250,"T-cell Acute Lymphoblastic Leukemia,n=265",7.17534246575342,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162251,RNA-Seq,,202,PRJNA89529,SAMN04486207,STJUDE,PCR,sra,SRX1571473,164,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJTALL002035_D1-TARGET-10-PASVPZ-09A-01,2016-02-12,10162,6935,ILLUMINA,,2016-04-14,SRR3162251,,SRS1284342,SRP011999,TARGET-10-PASVPZ-09A-01R,RNA,TARGET-10-PASVPZ-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PASVPZ,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162251,"T-cell Acute Lymphoblastic Leukemia,n=265",3.65205479452054,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162252,RNA-Seq,,202,PRJNA89529,SAMN04486259,STJUDE,PCR,sra,SRX1571474,170,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJTALL002039_D1-TARGET-10-PASWFN-09A-01,2016-02-12,10872,7436,ILLUMINA,,2016-04-14,SRR3162252,,SRS1284343,SRP011999,TARGET-10-PASWFN-09A-01R,RNA,TARGET-10-PASWFN-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PASWFN,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162252,"T-cell Acute Lymphoblastic Leukemia,n=265",11.331506849315,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162253,RNA-Seq,,202,PRJNA89529,SAMN04486241,STJUDE,PCR,sra,SRX1571475,165,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL016436_D1-TARGET-10-PASWNU-09A-01,2016-02-12,10448,7187,ILLUMINA,,2016-04-14,SRR3162253,,SRS1284341,SRP011999,TARGET-10-PASWNU-09A-01R,RNA,TARGET-10-PASWNU-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PASWNU,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162253,"T-cell Acute Lymphoblastic Leukemia,n=265",15.2876712328767,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162254,RNA-Seq,,202,PRJNA89529,SAMN04486302,STJUDE,PCR,sra,SRX1571476,164,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJTALL022107_D2_RNASEQ_1,2016-02-13,9189,5979,ILLUMINA,,2016-04-14,SRR3162254,,SRS1284340,SRP011999,TARGET-10-PASWSR-09A-01R,RNA,TARGET-10-PASWSR-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PASWSR,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162254,"T-cell Acute Lymphoblastic Leukemia,n=265",3.42191780821917,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162255,RNA-Seq,,202,PRJNA89529,SAMN04486284,STJUDE,PCR,sra,SRX1571477,165,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015639_D1-TARGET-10-PASWXB-09A-01,2016-02-12,10712,7447,ILLUMINA,,2016-04-14,SRR3162255,,SRS1284339,SRP011999,TARGET-10-PASWXB-09A-01R,RNA,TARGET-10-PASWXB-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PASWXB,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162255,"T-cell Acute Lymphoblastic Leukemia,n=265",9.66027397260274,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162256,RNA-Seq,,202,PRJNA89529,SAMN04486138,STJUDE,PCR,sra,SRX1571478,168,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJTALL001636_D1-TARGET-10-PASWXZ-09A-01,2016-02-12,10017,7078,ILLUMINA,,2016-04-14,SRR3162256,,SRS1284338,SRP011999,TARGET-10-PASWXZ-09A-01R,RNA,TARGET-10-PASWXZ-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PASWXZ,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162256,"T-cell Acute Lymphoblastic Leukemia,n=265",7.55890410958904,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162257,RNA-Seq,,202,PRJNA89529,SAMN04486169,STJUDE,PCR,sra,SRX1571479,165,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015640_D1-TARGET-10-PASWZJ-09A-01,2016-02-12,10487,7440,ILLUMINA,,2016-04-14,SRR3162257,,SRS1284337,SRP011999,TARGET-10-PASWZJ-09A-01R,RNA,TARGET-10-PASWZJ-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PASWZJ,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162257,"T-cell Acute Lymphoblastic Leukemia,n=265",5.22739726027397,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162258,RNA-Seq,,202,PRJNA89529,SAMN04486174,STJUDE,PCR,sra,SRX1571480,167,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJTALL002051_D1-TARGET-10-PASXIL-09A-01,2016-02-13,13320,9563,ILLUMINA,,2016-04-14,SRR3162258,,SRS1284336,SRP011999,TARGET-10-PASXIL-09A-01R,RNA,TARGET-10-PASXIL-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PASXIL,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162258,"T-cell Acute Lymphoblastic Leukemia,n=265",8.82739726027397,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162259,RNA-Seq,,202,PRJNA89529,SAMN04486286,STJUDE,PCR,sra,SRX1571481,166,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015641_D1-TARGET-10-PASXLT-09A-01,2016-02-12,10230,7147,ILLUMINA,,2016-04-14,SRR3162259,,SRS1284335,SRP011999,TARGET-10-PASXLT-09A-01R,RNA,TARGET-10-PASXLT-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PASXLT,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162259,"T-cell Acute Lymphoblastic Leukemia,n=265",4.08493150684931,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162260,RNA-Seq,,202,PRJNA89529,SAMN04486194,STJUDE,PCR,sra,SRX1571482,163,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJTALL001639_D1-TARGET-10-PASXLZ-09A-01,2016-02-12,10256,7117,ILLUMINA,,2016-04-14,SRR3162260,,SRS1284334,SRP011999,TARGET-10-PASXLZ-09A-01R,RNA,TARGET-10-PASXLZ-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PASXLZ,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162260,"T-cell Acute Lymphoblastic Leukemia,n=265",5.23287671232876,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162261,RNA-Seq,,202,PRJNA89529,SAMN04486297,STJUDE,PCR,sra,SRX1571483,166,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJTALL002055_D1-TARGET-10-PASXMF-09A-01D,2016-02-13,11169,7758,ILLUMINA,,2016-04-14,SRR3162261,,SRS1284333,SRP011999,TARGET-10-PASXMF-09A-01R,RNA,TARGET-10-PASXMF-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PASXMF,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162261,"T-cell Acute Lymphoblastic Leukemia,n=265",10.4520547945205,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162262,RNA-Seq,,202,PRJNA89529,SAMN04486319,STJUDE,PCR,sra,SRX1571484,167,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015642_D1_RNASEQ_1,2016-02-12,10985,7325,ILLUMINA,,2016-04-14,SRR3162262,,SRS1284332,SRP011999,TARGET-10-PASXSI-09A-01R,RNA,TARGET-10-PASXSI-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PASXSI,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162262,"T-cell Acute Lymphoblastic Leukemia,n=265",8.96438356164383,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162263,RNA-Seq,,202,PRJNA89529,SAMN04486128,STJUDE,PCR,sra,SRX1571485,163,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015643_D1_RNASEQ_1,2016-02-12,10297,6578,ILLUMINA,,2016-04-14,SRR3162263,,SRS1284331,SRP011999,TARGET-10-PASXUC-09A-01R,RNA,TARGET-10-PASXUC-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PASXUC,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162263,"T-cell Acute Lymphoblastic Leukemia,n=265",6.82191780821917,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162264,RNA-Seq,,202,PRJNA89529,SAMN04486247,STJUDE,PCR,sra,SRX1571486,158,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015644_D1_RNASEQ_1,2016-02-12,10038,6456,ILLUMINA,,2016-04-14,SRR3162264,,SRS1284330,SRP011999,TARGET-10-PASXUU-09A-01R,RNA,TARGET-10-PASXUU-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PASXUU,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162264,"T-cell Acute Lymphoblastic Leukemia,n=265",7.01917808219178,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162265,RNA-Seq,,202,PRJNA89529,SAMN04486253,STJUDE,PCR,sra,SRX1571487,164,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015645_D1_RNASEQ_1,2016-02-12,11093,7389,ILLUMINA,,2016-04-14,SRR3162265,,SRS1284329,SRP011999,TARGET-10-PASYAJ-09A-01R,RNA,TARGET-10-PASYAJ-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PASYAJ,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162265,"T-cell Acute Lymphoblastic Leukemia,n=265",3.04931506849315,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162266,RNA-Seq,,202,PRJNA89529,SAMN04486279,STJUDE,PCR,sra,SRX1571488,153,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJBALL001653_D1_RNASEQ_1,2016-02-12,16586,11313,ILLUMINA,,2016-04-14,SRR3162266,,SRS1284328,SRP011999,TARGET-10-PASYCN-09A-01R,RNA,TARGET-10-PASYCN-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PASYCN,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162266,"T-cell Acute Lymphoblastic Leukemia,n=265",10.9835616438356,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162267,RNA-Seq,,202,PRJNA89529,SAMN04486149,STJUDE,PCR,sra,SRX1571489,162,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJTALL021669_D2_RNASEQ_1,2016-02-13,10800,7003,ILLUMINA,,2016-04-14,SRR3162267,,SRS1284327,SRP011999,TARGET-10-PASYHN-09A-01R,RNA,TARGET-10-PASYHN-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PASYHN,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162267,"T-cell Acute Lymphoblastic Leukemia,n=265",17.4438356164383,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162268,RNA-Seq,,202,PRJNA89529,SAMN04486208,STJUDE,PCR,sra,SRX1571501,165,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL016438_D1-TARGET-10-PATBGC-09A-01,2016-02-12,10627,7366,ILLUMINA,,2016-04-14,SRR3162268,,SRS1284315,SRP011999,TARGET-10-PATBGC-09A-01R,RNA,TARGET-10-PATBGC-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PATBGC,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162268,"T-cell Acute Lymphoblastic Leukemia,n=265",10.8109589041095,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162269,RNA-Seq,,202,PRJNA89529,SAMN04486314,STJUDE,PCR,sra,SRX1571502,167,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL016439_D1-TARGET-10-PATBNT-09A-01,2016-02-12,10548,7281,ILLUMINA,,2016-04-14,SRR3162269,,SRS1284314,SRP011999,TARGET-10-PATBNT-09A-01R,RNA,TARGET-10-PATBNT-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PATBNT,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162269,"T-cell Acute Lymphoblastic Leukemia,n=265",13.5287671232876,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162270,RNA-Seq,,202,PRJNA89529,SAMN04486334,STJUDE,PCR,sra,SRX1571503,173,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL016440_D1_RNASEQ_1,2016-02-12,10539,6930,ILLUMINA,,2016-04-14,SRR3162270,,SRS1284312,SRP011999,TARGET-10-PATBRV-09A-01R,RNA,TARGET-10-PATBRV-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PATBRV,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162270,"T-cell Acute Lymphoblastic Leukemia,n=265",8.36712328767123,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162271,RNA-Seq,,202,PRJNA89529,SAMN04486147,STJUDE,PCR,sra,SRX1571504,171,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL016441_D1_RNASEQ_1,2016-02-12,10408,6843,ILLUMINA,,2016-04-14,SRR3162271,,SRS1284313,SRP011999,TARGET-10-PATBTX-09A-01R,RNA,TARGET-10-PATBTX-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PATBTX,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162271,"T-cell Acute Lymphoblastic Leukemia,n=265",3.15616438356164,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162272,RNA-Seq,,202,PRJNA89529,SAMN04486136,STJUDE,PCR,sra,SRX1571505,168,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJTALL021674_D2-TARGET-10-PATBYK-09A-01,2016-02-13,10446,7143,ILLUMINA,,2016-04-14,SRR3162272,,SRS1284310,SRP011999,TARGET-10-PATBYK-09A-01R,RNA,TARGET-10-PATBYK-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PATBYK,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162272,"T-cell Acute Lymphoblastic Leukemia,n=265",16.4383561643835,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162273,RNA-Seq,,202,PRJNA89529,SAMN04486238,STJUDE,PCR,sra,SRX1571506,163,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015989_D1-TARGET-10-PATCDM-09A-01,2016-02-12,10337,7241,ILLUMINA,,2016-04-14,SRR3162273,,SRS1284309,SRP011999,TARGET-10-PATCDM-09A-01R,RNA,TARGET-10-PATCDM-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PATCDM,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162273,"T-cell Acute Lymphoblastic Leukemia,n=265",3.26575342465753,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162274,RNA-Seq,,202,PRJNA89529,SAMN04486094,STJUDE,PCR,sra,SRX1571507,170,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015990_D1_RNASEQ_1,2016-02-12,9615,6272,ILLUMINA,,2016-04-14,SRR3162274,,SRS1284311,SRP011999,TARGET-10-PATCDZ-09A-01R,RNA,TARGET-10-PATCDZ-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PATCDZ,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162274,"T-cell Acute Lymphoblastic Leukemia,n=265",13.2520547945205,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162275,RNA-Seq,,202,PRJNA89529,SAMN04486273,STJUDE,PCR,sra,SRX1571508,168,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJTALL022647_D2_RNASEQ_1,2016-02-13,7391,4568,ILLUMINA,,2016-04-14,SRR3162275,,SRS1284308,SRP011999,TARGET-10-PATCKV-09A-01R,RNA,TARGET-10-PATCKV-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PATCKV,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162275,"T-cell Acute Lymphoblastic Leukemia,n=265",14.4273972602739,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162276,RNA-Seq,,202,PRJNA89529,SAMN04486189,STJUDE,PCR,sra,SRX1571509,167,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015991_D1_RNASEQ_1,2016-02-12,9354,5884,ILLUMINA,,2016-04-14,SRR3162276,,SRS1284307,SRP011999,TARGET-10-PATCNI-09A-01R,RNA,TARGET-10-PATCNI-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PATCNI,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162276,"T-cell Acute Lymphoblastic Leukemia,n=265",4.60821917808219,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162277,RNA-Seq,,202,PRJNA89529,SAMN04486235,STJUDE,PCR,sra,SRX1571510,167,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015654_D1-TARGET-10-PATCUK-09A-01,2016-02-12,10457,7362,ILLUMINA,,2016-04-14,SRR3162277,,SRS1284306,SRP011999,TARGET-10-PATCUK-09A-01R,RNA,TARGET-10-PATCUK-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PATCUK,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162277,"T-cell Acute Lymphoblastic Leukemia,n=265",12.0465753424657,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162278,RNA-Seq,,202,PRJNA89529,SAMN04486281,STJUDE,PCR,sra,SRX1571511,159,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJTALL022113_D2-TARGET-10-PATCZN-09A-01,2016-02-13,10174,7174,ILLUMINA,,2016-04-14,SRR3162278,,SRS1284305,SRP011999,TARGET-10-PATCZN-09A-01R,RNA,TARGET-10-PATCZN-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PATCZN,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162278,"T-cell Acute Lymphoblastic Leukemia,n=265",4.94794520547945,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162279,RNA-Seq,,202,PRJNA89529,SAMN04486109,STJUDE,PCR,sra,SRX1571512,166,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015992_D1-TARGET-10-PATDBU-09A-01,2016-02-12,12188,8500,ILLUMINA,,2016-04-14,SRR3162279,,SRS1284304,SRP011999,TARGET-10-PATDBU-09A-01R,RNA,TARGET-10-PATDBU-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PATDBU,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162279,"T-cell Acute Lymphoblastic Leukemia,n=265",9.72876712328767,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162280,RNA-Seq,,202,PRJNA89529,SAMN04486228,STJUDE,PCR,sra,SRX1571513,167,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015993_D1_RNASEQ_1,2016-02-12,9110,5829,ILLUMINA,,2016-04-14,SRR3162280,,SRS1284303,SRP011999,TARGET-10-PATDDZ-09A-01R,RNA,TARGET-10-PATDDZ-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PATDDZ,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162280,"T-cell Acute Lymphoblastic Leukemia,n=265",12.6027397260273,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162281,RNA-Seq,,202,PRJNA89529,SAMN04486171,STJUDE,PCR,sra,SRX1571514,145,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015994_D1_RNASEQ_1,2016-02-12,6771,4214,ILLUMINA,,2016-04-14,SRR3162281,,SRS1284302,SRP011999,TARGET-10-PATDFE-09A-01R,RNA,TARGET-10-PATDFE-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PATDFE,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162281,"T-cell Acute Lymphoblastic Leukemia,n=265",5.02739726027397,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162282,RNA-Seq,,202,PRJNA89529,SAMN04486246,STJUDE,PCR,sra,SRX1571515,170,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015655_D1_RNASEQ_1,2016-02-12,10572,7021,ILLUMINA,,2016-04-14,SRR3162282,,SRS1284300,SRP011999,TARGET-10-PATDGZ-09A-01R,RNA,TARGET-10-PATDGZ-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PATDGZ,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162282,"T-cell Acute Lymphoblastic Leukemia,n=265",2.56712328767123,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162283,RNA-Seq,,202,PRJNA89529,SAMN04486217,STJUDE,PCR,sra,SRX1571516,163,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJTALL021675_D2-TARGET-10-PATDKT-09A-01,2016-02-13,9526,6333,ILLUMINA,,2016-04-14,SRR3162283,,SRS1284301,SRP011999,TARGET-10-PATDKT-09A-01R,RNA,TARGET-10-PATDKT-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PATDKT,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162283,"T-cell Acute Lymphoblastic Leukemia,n=265",22.3808219178082,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162284,RNA-Seq,,202,PRJNA89529,SAMN04486328,STJUDE,PCR,sra,SRX1571517,164,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJBALL001675_D1-TARGET-10-PATDLG-09A-01,2016-02-12,10096,6662,ILLUMINA,,2016-04-14,SRR3162284,,SRS1284299,SRP011999,TARGET-10-PATDLG-09A-01R,RNA,TARGET-10-PATDLG-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PATDLG,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162284,"T-cell Acute Lymphoblastic Leukemia,n=265",11.7972602739726,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162285,RNA-Seq,,202,PRJNA89529,SAMN04486258,STJUDE,PCR,sra,SRX1571518,161,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015995_D1-TARGET-10-PATDMN-09A-01,2016-02-12,9522,6490,ILLUMINA,,2016-04-14,SRR3162285,,SRS1284298,SRP011999,TARGET-10-PATDMN-09A-01R,RNA,TARGET-10-PATDMN-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PATDMN,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162285,"T-cell Acute Lymphoblastic Leukemia,n=265",6.92054794520547,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162286,RNA-Seq,,202,PRJNA89529,SAMN04486227,STJUDE,PCR,sra,SRX1571519,165,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJTALL002091_D1-TARGET-10-PATDRC-03A-01D,2016-02-13,10654,7225,ILLUMINA,,2016-04-14,SRR3162286,,SRS1284297,SRP011999,TARGET-10-PATDRC-03A-01R,RNA,TARGET-10-PATDRC-03A-01R,Primary Blood Derived Cancer - Peripheral Blood,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PATDRC,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162286,"T-cell Acute Lymphoblastic Leukemia,n=265",6.74794520547945,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162287,RNA-Seq,,202,PRJNA89529,SAMN04486222,STJUDE,PCR,sra,SRX1571520,168,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJTALL001677_D1_RNASEQ_1,2016-02-12,10167,6731,ILLUMINA,,2016-04-14,SRR3162287,,SRS1284296,SRP011999,TARGET-10-PATEAK-09A-01R,RNA,TARGET-10-PATEAK-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PATEAK,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162287,"T-cell Acute Lymphoblastic Leukemia,n=265",17.9479452054794,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162288,RNA-Seq,,202,PRJNA89529,SAMN04486162,STJUDE,PCR,sra,SRX1571521,169,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015656_D1_RNASEQ_1,2016-02-12,9142,6067,ILLUMINA,,2016-04-14,SRR3162288,,SRS1284295,SRP011999,TARGET-10-PATEFF-09A-01R,RNA,TARGET-10-PATEFF-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PATEFF,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162288,"T-cell Acute Lymphoblastic Leukemia,n=265",6.48219178082191,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162289,RNA-Seq,,202,PRJNA89529,SAMN04486192,STJUDE,PCR,sra,SRX1571522,164,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015657_D1-TARGET-10-PATEHZ-03A-01,2016-02-12,9761,6503,ILLUMINA,,2016-04-14,SRR3162289,,SRS1284294,SRP011999,TARGET-10-PATEHZ-03A-01R,RNA,TARGET-10-PATEHZ-03A-01R,Primary Blood Derived Cancer - Peripheral Blood,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PATEHZ,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162289,"T-cell Acute Lymphoblastic Leukemia,n=265",8.76164383561643,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162290,RNA-Seq,,202,PRJNA89529,SAMN04486145,STJUDE,PCR,sra,SRX1571523,170,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015658_D1_RNASEQ_1,2016-02-12,9790,6519,ILLUMINA,,2016-04-14,SRR3162290,,SRS1284293,SRP011999,TARGET-10-PATEIT-09A-01R,RNA,TARGET-10-PATEIT-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PATEIT,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162290,"T-cell Acute Lymphoblastic Leukemia,n=265",9.54794520547945,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162291,RNA-Seq,,202,PRJNA89529,SAMN04486139,STJUDE,PCR,sra,SRX1571524,166,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJTALL021678_D2_RNASEQ_1,2016-02-13,9516,6295,ILLUMINA,,2016-04-14,SRR3162291,,SRS1284292,SRP011999,TARGET-10-PATEMI-09A-01R,RNA,TARGET-10-PATEMI-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PATEMI,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162291,"T-cell Acute Lymphoblastic Leukemia,n=265",17.7835616438356,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162292,RNA-Seq,,202,PRJNA89529,SAMN04486099,STJUDE,PCR,sra,SRX1571525,168,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015659_D1_RNASEQ_1,2016-02-12,7311,4596,ILLUMINA,,2016-04-14,SRR3162292,,SRS1284291,SRP011999,TARGET-10-PATENL-09A-01R,RNA,TARGET-10-PATENL-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PATENL,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162292,"T-cell Acute Lymphoblastic Leukemia,n=265",3.68493150684931,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162293,RNA-Seq,,202,PRJNA89529,SAMN04486106,STJUDE,PCR,sra,SRX1571526,157,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015996_D1-TARGET-10-PATEVL-09A-01,2016-02-12,8789,5890,ILLUMINA,,2016-04-14,SRR3162293,,SRS1284290,SRP011999,TARGET-10-PATEVL-09A-01R,RNA,TARGET-10-PATEVL-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PATEVL,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162293,"T-cell Acute Lymphoblastic Leukemia,n=265",3.36438356164383,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162294,RNA-Seq,,202,PRJNA89529,SAMN04486179,STJUDE,PCR,sra,SRX1571527,164,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015997_D1_RNASEQ_1,2016-02-12,8257,5212,ILLUMINA,,2016-04-14,SRR3162294,,SRS1284289,SRP011999,TARGET-10-PATEYS-09A-01R,RNA,TARGET-10-PATEYS-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PATEYS,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162294,"T-cell Acute Lymphoblastic Leukemia,n=265",5.23835616438356,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162295,RNA-Seq,,202,PRJNA89529,SAMN04486248,STJUDE,PCR,sra,SRX1571528,156,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL016442_D1-TARGET-10-PATFJD-09A-01,2016-02-12,9670,6430,ILLUMINA,,2016-04-14,SRR3162295,,SRS1284287,SRP011999,TARGET-10-PATFJD-09A-01R,RNA,TARGET-10-PATFJD-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PATFJD,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162295,"T-cell Acute Lymphoblastic Leukemia,n=265",2.52054794520547,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162296,RNA-Seq,,202,PRJNA89529,SAMN04486125,STJUDE,PCR,sra,SRX1571529,161,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015998_D1_RNASEQ_1,2016-02-12,8293,5288,ILLUMINA,,2016-04-14,SRR3162296,,SRS1284288,SRP011999,TARGET-10-PATFJP-09A-01R,RNA,TARGET-10-PATFJP-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PATFJP,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162296,"T-cell Acute Lymphoblastic Leukemia,n=265",8.90136986301369,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162297,RNA-Seq,,202,PRJNA89529,SAMN04486137,STJUDE,PCR,sra,SRX1571530,148,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJTALL022442_D2_RNASEQ_1,2016-02-13,7520,4683,ILLUMINA,,2016-04-14,SRR3162297,,SRS1284286,SRP011999,TARGET-10-PATFRM-09A-01R,RNA,TARGET-10-PATFRM-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PATFRM,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162297,"T-cell Acute Lymphoblastic Leukemia,n=265",18.345205479452,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162298,RNA-Seq,,202,PRJNA89529,SAMN04486218,STJUDE,PCR,sra,SRX1571531,166,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015660_D1-TARGET-10-PATFVG-09A-01,2016-02-12,9882,6372,ILLUMINA,,2016-04-14,SRR3162298,,SRS1284284,SRP011999,TARGET-10-PATFVG-09A-01R,RNA,TARGET-10-PATFVG-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PATFVG,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162298,"T-cell Acute Lymphoblastic Leukemia,n=265",5.83561643835616,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162299,RNA-Seq,,202,PRJNA89529,SAMN04486186,STJUDE,PCR,sra,SRX1571532,169,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJTALL021682_D2_RNASEQ_1,2016-02-13,10735,7161,ILLUMINA,,2016-04-14,SRR3162299,,SRS1284285,SRP011999,TARGET-10-PATFWF-09A-01R,RNA,TARGET-10-PATFWF-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PATFWF,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162299,"T-cell Acute Lymphoblastic Leukemia,n=265",17.4356164383561,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162300,RNA-Seq,,202,PRJNA89529,SAMN04486316,STJUDE,PCR,sra,SRX1571533,167,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJTALL022658_D2_RNASEQ_1,2016-02-13,8818,5869,ILLUMINA,,2016-04-14,SRR3162300,,SRS1284282,SRP011999,TARGET-10-PATFYZ-09A-01R,RNA,TARGET-10-PATFYZ-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PATFYZ,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162300,"T-cell Acute Lymphoblastic Leukemia,n=265",15.4082191780821,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162301,RNA-Seq,,202,PRJNA89529,SAMN04486300,STJUDE,PCR,sra,SRX1571534,164,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJTALL021684_D2_RNASEQ_1,2016-02-13,10890,7182,ILLUMINA,,2016-04-14,SRR3162301,,SRS1284283,SRP011999,TARGET-10-PATGBY-09A-01R,RNA,TARGET-10-PATGBY-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PATGBY,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162301,"T-cell Acute Lymphoblastic Leukemia,n=265",21.1369863013698,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162302,RNA-Seq,,202,PRJNA89529,SAMN04486225,STJUDE,PCR,sra,SRX1571535,176,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015661_D1_RNASEQ_1,2016-02-12,10223,6771,ILLUMINA,,2016-04-14,SRR3162302,,SRS1284281,SRP011999,TARGET-10-PATGKE-09A-01R,RNA,TARGET-10-PATGKE-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PATGKE,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162302,"T-cell Acute Lymphoblastic Leukemia,n=265",11.5123287671232,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162303,RNA-Seq,,202,PRJNA89529,SAMN04486317,STJUDE,PCR,sra,SRX1571536,164,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015999_D1-TARGET-10-PATGLV-09A-01,2016-02-12,9710,6540,ILLUMINA,,2016-04-14,SRR3162303,,SRS1284280,SRP011999,TARGET-10-PATGLV-09A-01R,RNA,TARGET-10-PATGLV-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PATGLV,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162303,"T-cell Acute Lymphoblastic Leukemia,n=265",6.18356164383561,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162304,RNA-Seq,,202,PRJNA89529,SAMN04486274,STJUDE,PCR,sra,SRX1571537,161,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL016000_D1-TARGET-10-PATGMP-09A-01,2016-02-12,9972,6633,ILLUMINA,,2016-04-14,SRR3162304,,SRS1284279,SRP011999,TARGET-10-PATGMP-09A-01R,RNA,TARGET-10-PATGMP-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PATGMP,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162304,"T-cell Acute Lymphoblastic Leukemia,n=265",10.7506849315068,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162305,RNA-Seq,,202,PRJNA89529,SAMN04486263,STJUDE,PCR,sra,SRX1571538,159,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL016001_D1-TARGET-10-PATGVX-09A-01,2016-02-12,10565,7112,ILLUMINA,,2016-04-14,SRR3162305,,SRS1284278,SRP011999,TARGET-10-PATGVX-09A-01R,RNA,TARGET-10-PATGVX-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PATGVX,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162305,"T-cell Acute Lymphoblastic Leukemia,n=265",7.30958904109589,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162306,RNA-Seq,,202,PRJNA89529,SAMN04486262,STJUDE,PCR,sra,SRX1571539,167,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL016002_D1_RNASEQ_1,2016-02-12,10246,6782,ILLUMINA,,2016-04-14,SRR3162306,,SRS1284277,SRP011999,TARGET-10-PATGWP-09A-01R,RNA,TARGET-10-PATGWP-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PATGWP,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162306,"T-cell Acute Lymphoblastic Leukemia,n=265",14.2246575342465,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162307,RNA-Seq,,202,PRJNA89529,SAMN04486089,STJUDE,PCR,sra,SRX1571540,158,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJTALL022117_D2-TARGET-10-PATGXS-09A-01,2016-02-13,9750,6504,ILLUMINA,,2016-04-14,SRR3162307,,SRS1284276,SRP011999,TARGET-10-PATGXS-09A-01R,RNA,TARGET-10-PATGXS-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PATGXS,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162307,"T-cell Acute Lymphoblastic Leukemia,n=265",13.904109589041,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162308,RNA-Seq,,202,PRJNA89529,SAMN04486102,STJUDE,PCR,sra,SRX1571541,163,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJTALL021685_D2-TARGET-10-PATGYH-09A-01,2016-02-13,10361,7012,ILLUMINA,,2016-04-14,SRR3162308,,SRS1284275,SRP011999,TARGET-10-PATGYH-09A-01R,RNA,TARGET-10-PATGYH-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PATGYH,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162308,"T-cell Acute Lymphoblastic Leukemia,n=265",16.3260273972602,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162309,RNA-Seq,,202,PRJNA89529,SAMN04486251,STJUDE,PCR,sra,SRX1571542,178,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL016443_D1_RNASEQ_1,2016-02-12,10287,6711,ILLUMINA,,2016-04-14,SRR3162309,,SRS1284274,SRP011999,TARGET-10-PATGZA-09A-01R,RNA,TARGET-10-PATGZA-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PATGZA,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162309,"T-cell Acute Lymphoblastic Leukemia,n=265",14.3917808219178,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162310,RNA-Seq,,202,PRJNA89529,SAMN04486321,STJUDE,PCR,sra,SRX1571543,160,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJTALL012398_D1-TARGET-10-PATHBG-09A-01,2016-02-13,9738,6391,ILLUMINA,,2016-04-14,SRR3162310,,SRS1284273,SRP011999,TARGET-10-PATHBG-09A-01R,RNA,TARGET-10-PATHBG-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PATHBG,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162310,"T-cell Acute Lymphoblastic Leukemia,n=265",2.96164383561643,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162311,RNA-Seq,,202,PRJNA89529,SAMN04486257,STJUDE,PCR,sra,SRX1571544,165,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL016003_D1_RNASEQ_1,2016-02-12,10700,7043,ILLUMINA,,2016-04-14,SRR3162311,,SRS1284271,SRP011999,TARGET-10-PATHFE-09A-01R,RNA,TARGET-10-PATHFE-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PATHFE,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162311,"T-cell Acute Lymphoblastic Leukemia,n=265",11.1808219178082,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162312,RNA-Seq,,202,PRJNA89529,SAMN04486093,STJUDE,PCR,sra,SRX1571545,166,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJTALL022118_D2_RNASEQ_1,2016-02-13,8606,5446,ILLUMINA,,2016-04-14,SRR3162312,,SRS1284272,SRP011999,TARGET-10-PATHGY-09A-01R,RNA,TARGET-10-PATHGY-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PATHGY,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162312,"T-cell Acute Lymphoblastic Leukemia,n=265",3.61369863013698,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162313,RNA-Seq,,202,PRJNA89529,SAMN04486349,STJUDE,PCR,sra,SRX1571586,174,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015688_D1_RNASEQ_1,2016-02-12,10988,7336,ILLUMINA,,2016-04-14,SRR3162313,,SRS1284230,SRP011999,TARGET-10-PATSIL-09A-01R,RNA,TARGET-10-PATSIL-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PATSIL,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162313,"T-cell Acute Lymphoblastic Leukemia,n=265",15.6164383561643,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162314,RNA-Seq,,202,PRJNA89529,SAMN04486223,STJUDE,PCR,sra,SRX1571603,166,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJTALL002151_D1_TRANSCRIPTOME_1,2016-02-13,12862,8754,ILLUMINA,,2016-04-14,SRR3162314,,SRS1284213,SRP011999,TARGET-10-PATYCH-09A-01R,RNA,TARGET-10-PATYCH-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PATYCH,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162314,"T-cell Acute Lymphoblastic Leukemia,n=265",3.92328767123287,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162315,RNA-Seq,,202,PRJNA89529,SAMN04486148,STJUDE,PCR,sra,SRX1571613,164,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJTALL002140_D1_TRANSCRIPTOME_1,2016-02-13,13555,9174,ILLUMINA,,2016-04-14,SRR3162315,,SRS1284203,SRP011999,TARGET-10-PAUACG-09A-01R,RNA,TARGET-10-PAUACG-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PAUACG,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162315,"T-cell Acute Lymphoblastic Leukemia,n=265",4.95068493150684,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162316,RNA-Seq,,202,PRJNA89529,SAMN04486308,STJUDE,PCR,sra,SRX1571614,163,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015706_D1_RNASEQ_1,2016-02-12,8462,5158,ILLUMINA,,2016-04-14,SRR3162316,,SRS1284202,SRP011999,TARGET-10-PAUAFN-09A-01R,RNA,TARGET-10-PAUAFN-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PAUAFN,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162316,"T-cell Acute Lymphoblastic Leukemia,n=265",3.93698630136986,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162317,RNA-Seq,,202,PRJNA89529,SAMN04486278,STJUDE,PCR,sra,SRX1571615,161,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015707_D1_TRANSCRIPTOME_1,2016-02-12,13350,9000,ILLUMINA,,2016-04-14,SRR3162317,,SRS1284201,SRP011999,TARGET-10-PAUAJA-09A-01R,RNA,TARGET-10-PAUAJA-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PAUAJA,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162317,"T-cell Acute Lymphoblastic Leukemia,n=265",11.8986301369863,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162318,RNA-Seq,,202,PRJNA89529,SAMN04486298,STJUDE,PCR,sra,SRX1571616,171,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL016446_D1_RNASEQ_1,2016-02-12,11127,7437,ILLUMINA,,2016-04-14,SRR3162318,,SRS1284200,SRP011999,TARGET-10-PAUAYB-09A-01R,RNA,TARGET-10-PAUAYB-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PAUAYB,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162318,"T-cell Acute Lymphoblastic Leukemia,n=265",18.3068493150684,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162319,RNA-Seq,,202,PRJNA89529,SAMN04486313,STJUDE,PCR,sra,SRX1571617,168,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015708_D1_RNASEQ_1,2016-02-12,9407,6222,ILLUMINA,,2016-04-14,SRR3162319,,SRS1284199,SRP011999,TARGET-10-PAUAZV-09A-01R,RNA,TARGET-10-PAUAZV-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PAUAZV,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162319,"T-cell Acute Lymphoblastic Leukemia,n=265",8.32602739726027,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162320,RNA-Seq,,202,PRJNA89529,SAMN04486154,STJUDE,PCR,sra,SRX1571618,163,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015709_D1_TRANSCRIPTOME_1,2016-02-12,14479,10096,ILLUMINA,,2016-04-14,SRR3162320,,SRS1284198,SRP011999,TARGET-10-PAUBCB-09A-01R,RNA,TARGET-10-PAUBCB-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PAUBCB,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162320,"T-cell Acute Lymphoblastic Leukemia,n=265",15.4054794520547,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162321,RNA-Seq,,202,PRJNA89529,SAMN04486318,STJUDE,PCR,sra,SRX1571619,163,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015710_D1_TRANSCRIPTOME_1,2016-02-12,15123,10230,ILLUMINA,,2016-04-14,SRR3162321,,SRS1284197,SRP011999,TARGET-10-PAUBCT-09A-01R,RNA,TARGET-10-PAUBCT-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PAUBCT,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162321,"T-cell Acute Lymphoblastic Leukemia,n=265",13.0328767123287,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162322,RNA-Seq,,202,PRJNA89529,SAMN04486242,STJUDE,PCR,sra,SRX1571620,162,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015711_D1_TRANSCRIPTOME_1,2016-02-12,13045,8848,ILLUMINA,,2016-04-14,SRR3162322,,SRS1284196,SRP011999,TARGET-10-PAUBLL-09A-01R,RNA,TARGET-10-PAUBLL-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PAUBLL,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162322,"T-cell Acute Lymphoblastic Leukemia,n=265",7.16986301369863,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162323,RNA-Seq,,202,PRJNA89529,SAMN04486098,STJUDE,PCR,sra,SRX1571621,176,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015712_D1_RNASEQ_1,2016-02-12,10162,6742,ILLUMINA,,2016-04-14,SRR3162323,,SRS1284195,SRP011999,TARGET-10-PAUBPY-09A-01R,RNA,TARGET-10-PAUBPY-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PAUBPY,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162323,"T-cell Acute Lymphoblastic Leukemia,n=265",11.558904109589,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162324,RNA-Seq,,202,PRJNA89529,SAMN04486234,STJUDE,PCR,sra,SRX1571622,165,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJTALL002126_D1_TRANSCRIPTOME_1,2016-02-13,13293,9363,ILLUMINA,,2016-04-14,SRR3162324,,SRS1284194,SRP011999,TARGET-10-PAUBRD-09A-01R,RNA,TARGET-10-PAUBRD-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PAUBRD,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162324,"T-cell Acute Lymphoblastic Leukemia,n=265",4.80821917808219,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162325,RNA-Seq,,202,PRJNA89529,SAMN04486172,STJUDE,PCR,sra,SRX1571623,168,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJTALL002130_D1_RNASEQ_1,2016-02-13,9655,6361,ILLUMINA,,2016-04-14,SRR3162325,,SRS1284193,SRP011999,TARGET-10-PAUBTC-09A-01R,RNA,TARGET-10-PAUBTC-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PAUBTC,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162325,"T-cell Acute Lymphoblastic Leukemia,n=265",1.82739726027397,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162326,RNA-Seq,,202,PRJNA89529,SAMN04486347,STJUDE,PCR,sra,SRX1571546,162,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJTALL002072_D1-TARGET-10-PATHJF-09A-01D,2016-02-13,10289,6736,ILLUMINA,,2016-04-14,SRR3162326,,SRS1284270,SRP011999,TARGET-10-PATHJF-09A-01R,RNA,TARGET-10-PATHJF-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PATHJF,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162326,"T-cell Acute Lymphoblastic Leukemia,n=265",10.2547945205479,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162327,RNA-Seq,,202,PRJNA89529,SAMN04486216,STJUDE,PCR,sra,SRX1571547,162,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015662_D1-TARGET-10-PATHRF-09A-01,2016-02-12,10187,6843,ILLUMINA,,2016-04-14,SRR3162327,,SRS1284269,SRP011999,TARGET-10-PATHRF-09A-01R,RNA,TARGET-10-PATHRF-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PATHRF,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162327,"T-cell Acute Lymphoblastic Leukemia,n=265",5.17534246575342,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162328,RNA-Seq,,202,PRJNA89529,SAMN04486159,STJUDE,PCR,sra,SRX1571548,165,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJTALL002080_D1_RNASEQ_1,2016-02-13,9168,5879,ILLUMINA,,2016-04-14,SRR3162328,,SRS1284268,SRP011999,TARGET-10-PATHWV-09A-01R,RNA,TARGET-10-PATHWV-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PATHWV,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162328,"T-cell Acute Lymphoblastic Leukemia,n=265",8.56712328767123,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162329,RNA-Seq,,202,PRJNA89529,SAMN04486200,STJUDE,PCR,sra,SRX1571549,163,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015663_D1-TARGET-10-PATIBE-09A-01,2016-02-12,10254,6842,ILLUMINA,,2016-04-14,SRR3162329,,SRS1284267,SRP011999,TARGET-10-PATIBE-09A-01R,RNA,TARGET-10-PATIBE-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PATIBE,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162329,"T-cell Acute Lymphoblastic Leukemia,n=265",11.2493150684931,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162330,RNA-Seq,,202,PRJNA89529,SAMN04486256,STJUDE,PCR,sra,SRX1571550,171,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015664_D1_RNASEQ_1,2016-02-12,9239,5991,ILLUMINA,,2016-04-14,SRR3162330,,SRS1284266,SRP011999,TARGET-10-PATIKN-03A-01R,RNA,TARGET-10-PATIKN-03A-01R,Primary Blood Derived Cancer - Peripheral Blood,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PATIKN,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162330,"T-cell Acute Lymphoblastic Leukemia,n=265",1.91506849315068,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162331,RNA-Seq,,202,PRJNA89529,SAMN04486249,STJUDE,PCR,sra,SRX1571551,161,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015665_D1-TARGET-10-PATITB-09A-01,2016-02-12,9978,6855,ILLUMINA,,2016-04-14,SRR3162331,,SRS1284265,SRP011999,TARGET-10-PATITB-09A-01R,RNA,TARGET-10-PATITB-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PATITB,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162331,"T-cell Acute Lymphoblastic Leukemia,n=265",15.1068493150684,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162332,RNA-Seq,,202,PRJNA89529,SAMN04486287,STJUDE,PCR,sra,SRX1571552,170,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJTALL002096_D1_RNASEQ_1,2016-02-13,8946,5840,ILLUMINA,,2016-04-14,SRR3162332,,SRS1284264,SRP011999,TARGET-10-PATITY-09A-01R,RNA,TARGET-10-PATITY-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PATITY,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162332,"T-cell Acute Lymphoblastic Leukemia,n=265",8.56164383561643,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162333,RNA-Seq,,202,PRJNA89529,SAMN04486299,STJUDE,PCR,sra,SRX1571553,167,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015667_D1_RNASEQ_1,2016-02-12,9548,5892,ILLUMINA,,2016-04-14,SRR3162333,,SRS1284263,SRP011999,TARGET-10-PATJBC-09A-01R,RNA,TARGET-10-PATJBC-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PATJBC,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162333,"T-cell Acute Lymphoblastic Leukemia,n=265",5.33698630136986,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162334,RNA-Seq,,202,PRJNA89529,SAMN04486285,STJUDE,PCR,sra,SRX1571554,162,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015668_D1-TARGET-10-PATJLT-09A-01,2016-02-12,11057,7337,ILLUMINA,,2016-04-14,SRR3162334,,SRS1284262,SRP011999,TARGET-10-PATJLT-09A-01R,RNA,TARGET-10-PATJLT-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PATJLT,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162334,"T-cell Acute Lymphoblastic Leukemia,n=265",12.0986301369863,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162335,RNA-Seq,,202,PRJNA89529,SAMN04486204,STJUDE,PCR,sra,SRX1571555,169,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJTALL021689_D2_RNASEQ_1,2016-02-13,11487,7655,ILLUMINA,,2016-04-14,SRR3162335,,SRS1284261,SRP011999,TARGET-10-PATJZK-09A-01R,RNA,TARGET-10-PATJZK-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PATJZK,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162335,"T-cell Acute Lymphoblastic Leukemia,n=265",18.7479452054794,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162336,RNA-Seq,,202,PRJNA89529,SAMN04486288,STJUDE,PCR,sra,SRX1571624,170,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015713_D1_RNASEQ_1,2016-02-12,9826,6477,ILLUMINA,,2016-04-14,SRR3162336,,SRS1284192,SRP011999,TARGET-10-PAUBXP-09A-01R,RNA,TARGET-10-PAUBXP-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PAUBXP,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162336,"T-cell Acute Lymphoblastic Leukemia,n=265",8.31506849315068,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162337,RNA-Seq,,202,PRJNA89529,SAMN04486130,STJUDE,PCR,sra,SRX1571625,163,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015714_D1_RNASEQ_1,2016-02-12,8038,5082,ILLUMINA,,2016-04-14,SRR3162337,,SRS1284191,SRP011999,TARGET-10-PAUCDC-09A-01R,RNA,TARGET-10-PAUCDC-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PAUCDC,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162337,"T-cell Acute Lymphoblastic Leukemia,n=265",16.8520547945205,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162338,RNA-Seq,,202,PRJNA89529,SAMN04486266,STJUDE,PCR,sra,SRX1571626,159,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJTALL002141_D1_TRANSCRIPTOME_1,2016-02-13,14577,10079,ILLUMINA,,2016-04-14,SRR3162338,,SRS1284190,SRP011999,TARGET-10-PAUCDY-09A-01R,RNA,TARGET-10-PAUCDY-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PAUCDY,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162338,"T-cell Acute Lymphoblastic Leukemia,n=265",9.95068493150685,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162339,RNA-Seq,,202,PRJNA89529,SAMN04486132,STJUDE,PCR,sra,SRX1571556,163,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015669_D1-TARGET-10-PATKGP-09A-01,2016-02-12,9565,6422,ILLUMINA,,2016-04-14,SRR3162339,,SRS1284260,SRP011999,TARGET-10-PATKGP-09A-01R,RNA,TARGET-10-PATKGP-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PATKGP,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162339,"T-cell Acute Lymphoblastic Leukemia,n=265",10.5780821917808,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162340,RNA-Seq,,202,PRJNA89529,SAMN04486339,STJUDE,PCR,sra,SRX1571557,167,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015670_D1_RNASEQ_1,2016-02-12,9356,6230,ILLUMINA,,2016-04-14,SRR3162340,,SRS1284259,SRP011999,TARGET-10-PATKVD-09A-01R,RNA,TARGET-10-PATKVD-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PATKVD,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162340,"T-cell Acute Lymphoblastic Leukemia,n=265",2.47671232876712,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162341,RNA-Seq,,202,PRJNA89529,SAMN04486226,STJUDE,PCR,sra,SRX1571558,172,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015671_D1_RNASEQ_1,2016-02-12,8873,5719,ILLUMINA,,2016-04-14,SRR3162341,,SRS1284258,SRP011999,TARGET-10-PATKWU-09A-01R,RNA,TARGET-10-PATKWU-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PATKWU,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162341,"T-cell Acute Lymphoblastic Leukemia,n=265",13.2438356164383,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162342,RNA-Seq,,202,PRJNA89529,SAMN04486327,STJUDE,PCR,sra,SRX1571559,164,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL016444_D1_RNASEQ_1,2016-02-12,10735,6936,ILLUMINA,,2016-04-14,SRR3162342,,SRS1284257,SRP011999,TARGET-10-PATKYI-09A-01R,RNA,TARGET-10-PATKYI-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PATKYI,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162342,"T-cell Acute Lymphoblastic Leukemia,n=265",20.8602739726027,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162343,RNA-Seq,,202,PRJNA89529,SAMN04486250,STJUDE,PCR,sra,SRX1571560,165,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJTALL002077_D1-TARGET-10-PATLGU-09A-01D,2016-02-13,10297,6878,ILLUMINA,,2016-04-14,SRR3162343,,SRS1284256,SRP011999,TARGET-10-PATLGU-09A-01R,RNA,TARGET-10-PATLGU-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PATLGU,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162343,"T-cell Acute Lymphoblastic Leukemia,n=265",7.06301369863013,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162344,RNA-Seq,,202,PRJNA89529,SAMN04486166,STJUDE,PCR,sra,SRX1571561,169,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015672_D1_RNASEQ_1,2016-02-12,9153,5916,ILLUMINA,,2016-04-14,SRR3162344,,SRS1284255,SRP011999,TARGET-10-PATLHH-09A-01R,RNA,TARGET-10-PATLHH-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PATLHH,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162344,"T-cell Acute Lymphoblastic Leukemia,n=265",7.75342465753424,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162345,RNA-Seq,,202,PRJNA89529,SAMN04486210,STJUDE,PCR,sra,SRX1571562,160,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJTALL022123_D2_RNASEQ_1,2016-02-13,8533,5322,ILLUMINA,,2016-04-14,SRR3162345,,SRS1284254,SRP011999,TARGET-10-PATLHS-09A-01R,RNA,TARGET-10-PATLHS-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PATLHS,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162345,"T-cell Acute Lymphoblastic Leukemia,n=265",10.9698630136986,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162346,RNA-Seq,,202,PRJNA89529,SAMN04486304,STJUDE,PCR,sra,SRX1571563,169,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJTALL002089_D1-TARGET-10-PATLMA-03A-01D,2016-02-13,10805,7606,ILLUMINA,,2016-04-14,SRR3162346,,SRS1284253,SRP011999,TARGET-10-PATLMA-03A-01R,RNA,TARGET-10-PATLMA-03A-01R,Primary Blood Derived Cancer - Peripheral Blood,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PATLMA,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162346,"T-cell Acute Lymphoblastic Leukemia,n=265",8.53424657534246,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162347,RNA-Seq,,202,PRJNA89529,SAMN04486107,STJUDE,PCR,sra,SRX1571564,162,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015673_D1-TARGET-10-PATLNS-09A-01,2016-02-12,9807,6744,ILLUMINA,,2016-04-14,SRR3162347,,SRS1284252,SRP011999,TARGET-10-PATLNS-09A-01R,RNA,TARGET-10-PATLNS-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PATLNS,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162347,"T-cell Acute Lymphoblastic Leukemia,n=265",2.25479452054794,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162348,RNA-Seq,,202,PRJNA89529,SAMN04486127,STJUDE,PCR,sra,SRX1571565,155,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015674_D1-TARGET-10-PATLNZ-09A-01,2016-02-12,10681,7189,ILLUMINA,,2016-04-14,SRR3162348,,SRS1284251,SRP011999,TARGET-10-PATLNZ-09A-01R,RNA,TARGET-10-PATLNZ-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PATLNZ,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162348,"T-cell Acute Lymphoblastic Leukemia,n=265",9.86575342465753,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162349,RNA-Seq,,202,PRJNA89529,SAMN04486176,STJUDE,PCR,sra,SRX1571566,170,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015675_D1_RNASEQ_1,2016-02-12,10438,6862,ILLUMINA,,2016-04-14,SRR3162349,,SRS1284250,SRP011999,TARGET-10-PATLPN-03A-01R,RNA,TARGET-10-PATLPN-03A-01R,Primary Blood Derived Cancer - Peripheral Blood,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PATLPN,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162349,"T-cell Acute Lymphoblastic Leukemia,n=265",2.58904109589041,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162350,RNA-Seq,,202,PRJNA89529,SAMN04486215,STJUDE,PCR,sra,SRX1571567,174,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJTALL002105_D1_RNASEQ_1,2016-02-13,10531,6943,ILLUMINA,,2016-04-14,SRR3162350,,SRS1284249,SRP011999,TARGET-10-PATLRZ-09A-01R,RNA,TARGET-10-PATLRZ-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PATLRZ,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162350,"T-cell Acute Lymphoblastic Leukemia,n=265",13.986301369863,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162351,RNA-Seq,,202,PRJNA89529,SAMN04486144,STJUDE,PCR,sra,SRX1571568,171,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJTALL002109_D1_RNASEQ_1,2016-02-13,11475,7590,ILLUMINA,,2016-04-14,SRR3162351,,SRS1284248,SRP011999,TARGET-10-PATMAF-09A-01R,RNA,TARGET-10-PATMAF-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PATMAF,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162351,"T-cell Acute Lymphoblastic Leukemia,n=265",16.4684931506849,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162352,RNA-Seq,,202,PRJNA89529,SAMN04486153,STJUDE,PCR,sra,SRX1571569,160,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJTALL002113_D1-TARGET-10-PATMRE-09A-01,2016-02-13,9879,6590,ILLUMINA,,2016-04-14,SRR3162352,,SRS1284247,SRP011999,TARGET-10-PATMRE-09A-01R,RNA,TARGET-10-PATMRE-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PATMRE,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162352,"T-cell Acute Lymphoblastic Leukemia,n=265",6.77260273972602,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162353,RNA-Seq,,202,PRJNA89529,SAMN04486104,STJUDE,PCR,sra,SRX1571570,169,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015678_D1_RNASEQ_1,2016-02-12,8872,5642,ILLUMINA,,2016-04-14,SRR3162353,,SRS1284246,SRP011999,TARGET-10-PATMTV-09A-01R,RNA,TARGET-10-PATMTV-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PATMTV,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162353,"T-cell Acute Lymphoblastic Leukemia,n=265",11.0821917808219,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162354,RNA-Seq,,202,PRJNA89529,SAMN04486342,STJUDE,PCR,sra,SRX1571571,167,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJTALL021697_D2_RNASEQ_1,2016-02-13,9774,6220,ILLUMINA,,2016-04-14,SRR3162354,,SRS1284245,SRP011999,TARGET-10-PATMVH-09A-01R,RNA,TARGET-10-PATMVH-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PATMVH,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162354,"T-cell Acute Lymphoblastic Leukemia,n=265",18.4219178082191,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162355,RNA-Seq,,202,PRJNA89529,SAMN04486337,STJUDE,PCR,sra,SRX1571572,168,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJTALL002078_D1_RNASEQ_1,2016-02-13,10850,7028,ILLUMINA,,2016-04-14,SRR3162355,,SRS1284244,SRP011999,TARGET-10-PATMXN-09A-01R,RNA,TARGET-10-PATMXN-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PATMXN,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162355,"T-cell Acute Lymphoblastic Leukemia,n=265",14.931506849315,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162356,RNA-Seq,,202,PRJNA89529,SAMN04486088,STJUDE,PCR,sra,SRX1571573,158,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015679_D1-TARGET-10-PATMYZ-09A-01,2016-02-12,10570,7064,ILLUMINA,,2016-04-14,SRR3162356,,SRS1284243,SRP011999,TARGET-10-PATMYZ-09A-01R,RNA,TARGET-10-PATMYZ-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PATMYZ,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162356,"T-cell Acute Lymphoblastic Leukemia,n=265",12.1123287671232,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162357,RNA-Seq,,202,PRJNA89529,SAMN04486183,STJUDE,PCR,sra,SRX1571574,168,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015680_D1_RNASEQ_1,2016-02-12,11469,7538,ILLUMINA,,2016-04-14,SRR3162357,,SRS1284242,SRP011999,TARGET-10-PATNAM-09A-01R,RNA,TARGET-10-PATNAM-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PATNAM,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162357,"T-cell Acute Lymphoblastic Leukemia,n=265",2.23013698630137,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162358,RNA-Seq,,202,PRJNA89529,SAMN04486310,STJUDE,PCR,sra,SRX1571575,169,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015681_D1_RNASEQ_1,2016-02-12,10575,7027,ILLUMINA,,2016-04-14,SRR3162358,,SRS1284241,SRP011999,TARGET-10-PATNIA-09A-01R,RNA,TARGET-10-PATNIA-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PATNIA,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162358,"T-cell Acute Lymphoblastic Leukemia,n=265",6.57808219178082,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162359,RNA-Seq,,202,PRJNA89529,SAMN04486219,STJUDE,PCR,sra,SRX1571576,165,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015682_D1_RNASEQ_1,2016-02-12,10450,6859,ILLUMINA,,2016-04-14,SRR3162359,,SRS1284240,SRP011999,TARGET-10-PATPDA-09A-01R,RNA,TARGET-10-PATPDA-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PATPDA,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162359,"T-cell Acute Lymphoblastic Leukemia,n=265",2.04657534246575,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162360,RNA-Seq,,202,PRJNA89529,SAMN04486182,STJUDE,PCR,sra,SRX1571577,163,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJTALL021698_D2-TARGET-10-PATPGE-09A-01,2016-02-13,9898,6594,ILLUMINA,,2016-04-14,SRR3162360,,SRS1284239,SRP011999,TARGET-10-PATPGE-09A-01R,RNA,TARGET-10-PATPGE-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PATPGE,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162360,"T-cell Acute Lymphoblastic Leukemia,n=265",19.7369863013698,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162361,RNA-Seq,,202,PRJNA89529,SAMN04486311,STJUDE,PCR,sra,SRX1571578,168,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015683_D1_RNASEQ_1,2016-02-12,10567,7045,ILLUMINA,,2016-04-14,SRR3162361,,SRS1284238,SRP011999,TARGET-10-PATPWF-03A-01R,RNA,TARGET-10-PATPWF-03A-01R,Primary Blood Derived Cancer - Peripheral Blood,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PATPWF,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162361,"T-cell Acute Lymphoblastic Leukemia,n=265",1.81095890410958,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162362,RNA-Seq,,202,PRJNA89529,SAMN04486264,STJUDE,PCR,sra,SRX1571579,168,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015684_D1_RNASEQ_1,2016-02-12,9944,6550,ILLUMINA,,2016-04-14,SRR3162362,,SRS1284237,SRP011999,TARGET-10-PATRAB-09A-01R,RNA,TARGET-10-PATRAB-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PATRAB,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162362,"T-cell Acute Lymphoblastic Leukemia,n=265",4.67671232876712,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162363,RNA-Seq,,202,PRJNA89529,SAMN04486115,STJUDE,PCR,sra,SRX1571580,163,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJTALL002110_D1-TARGET-10-PATRGV-09A-01D,2016-02-13,10023,6863,ILLUMINA,,2016-04-14,SRR3162363,,SRS1284236,SRP011999,TARGET-10-PATRGV-09A-01R,RNA,TARGET-10-PATRGV-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PATRGV,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162363,"T-cell Acute Lymphoblastic Leukemia,n=265",1.58082191780821,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162364,RNA-Seq,,202,PRJNA89529,SAMN04486113,STJUDE,PCR,sra,SRX1571581,171,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015685_D1_RNASEQ_1,2016-02-12,9854,6448,ILLUMINA,,2016-04-14,SRR3162364,,SRS1284235,SRP011999,TARGET-10-PATRHL-09A-01R,RNA,TARGET-10-PATRHL-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PATRHL,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162364,"T-cell Acute Lymphoblastic Leukemia,n=265",6.2986301369863,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162365,RNA-Seq,,202,PRJNA89529,SAMN04486322,STJUDE,PCR,sra,SRX1571582,166,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJTALL002118_D1_RNASEQ_1,2016-02-13,8799,5557,ILLUMINA,,2016-04-14,SRR3162365,,SRS1284234,SRP011999,TARGET-10-PATRNA-09A-01R,RNA,TARGET-10-PATRNA-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PATRNA,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162365,"T-cell Acute Lymphoblastic Leukemia,n=265",2.2,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162366,RNA-Seq,,202,PRJNA89529,SAMN04486203,STJUDE,PCR,sra,SRX1571583,166,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015686_D1_RNASEQ_1,2016-02-12,9104,5737,ILLUMINA,,2016-04-14,SRR3162366,,SRS1284233,SRP011999,TARGET-10-PATRUN-09A-01R,RNA,TARGET-10-PATRUN-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PATRUN,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162366,"T-cell Acute Lymphoblastic Leukemia,n=265",4.83013698630137,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162367,RNA-Seq,,202,PRJNA89529,SAMN04486351,STJUDE,PCR,sra,SRX1571584,171,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJTALL022659_D2_RNASEQ_1,2016-02-13,10628,7038,ILLUMINA,,2016-04-14,SRR3162367,,SRS1284232,SRP011999,TARGET-10-PATRXL-09A-01R,RNA,TARGET-10-PATRXL-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PATRXL,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162367,"T-cell Acute Lymphoblastic Leukemia,n=265",4.84109589041095,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162368,RNA-Seq,,202,PRJNA89529,SAMN04486280,STJUDE,PCR,sra,SRX1571585,165,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015687_D1_RNASEQ_1,2016-02-12,10746,7079,ILLUMINA,,2016-04-14,SRR3162368,,SRS1284231,SRP011999,TARGET-10-PATSDS-03A-01R,RNA,TARGET-10-PATSDS-03A-01R,Primary Blood Derived Cancer - Peripheral Blood,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PATSDS,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162368,"T-cell Acute Lymphoblastic Leukemia,n=265",14.8712328767123,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162369,RNA-Seq,,202,PRJNA89529,SAMN04486175,STJUDE,PCR,sra,SRX1571587,159,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015689_D1-TARGET-10-PATSIY-09A-01,2016-02-12,10472,7097,ILLUMINA,,2016-04-14,SRR3162369,,SRS1284229,SRP011999,TARGET-10-PATSIY-09A-01R,RNA,TARGET-10-PATSIY-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PATSIY,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162369,"T-cell Acute Lymphoblastic Leukemia,n=265",9.32602739726027,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162370,RNA-Seq,,202,PRJNA89529,SAMN04486275,STJUDE,PCR,sra,SRX1571588,165,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015690_D1_RNASEQ_1,2016-02-12,11230,7425,ILLUMINA,,2016-04-14,SRR3162370,,SRS1284228,SRP011999,TARGET-10-PATSLH-09A-01R,RNA,TARGET-10-PATSLH-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PATSLH,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162370,"T-cell Acute Lymphoblastic Leukemia,n=265",2.25753424657534,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162371,RNA-Seq,,202,PRJNA89529,SAMN04486173,STJUDE,PCR,sra,SRX1571589,167,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJTALL002142_D1_RNASEQ_1,2016-02-13,10812,7202,ILLUMINA,,2016-04-14,SRR3162371,,SRS1284227,SRP011999,TARGET-10-PATTHR-09A-01R,RNA,TARGET-10-PATTHR-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PATTHR,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162371,"T-cell Acute Lymphoblastic Leukemia,n=265",16.2109589041095,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162372,RNA-Seq,,202,PRJNA89529,SAMN04486292,STJUDE,PCR,sra,SRX1571590,163,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJTALL002146_D1_RNASEQ_1,2016-02-13,10254,6650,ILLUMINA,,2016-04-14,SRR3162372,,SRS1284226,SRP011999,TARGET-10-PATVDA-03A-01R,RNA,TARGET-10-PATVDA-03A-01R,Primary Blood Derived Cancer - Peripheral Blood,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PATVDA,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162372,"T-cell Acute Lymphoblastic Leukemia,n=265",2.13698630136986,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162373,RNA-Seq,,202,PRJNA89529,SAMN04486244,STJUDE,PCR,sra,SRX1571591,161,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015691_D1-TARGET-10-PATWHB-09A-01,2016-02-12,9660,6631,ILLUMINA,,2016-04-14,SRR3162373,,SRS1284225,SRP011999,TARGET-10-PATWHB-09A-01R,RNA,TARGET-10-PATWHB-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PATWHB,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162373,"T-cell Acute Lymphoblastic Leukemia,n=265",10.6958904109589,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162374,RNA-Seq,,202,PRJNA89529,SAMN04486221,STJUDE,PCR,sra,SRX1571592,162,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJTALL002154_D1-TARGET-10-PATWIJ-09A-01,2016-02-13,9411,6469,ILLUMINA,,2016-04-14,SRR3162374,,SRS1284224,SRP011999,TARGET-10-PATWIJ-09A-01R,RNA,TARGET-10-PATWIJ-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PATWIJ,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162374,"T-cell Acute Lymphoblastic Leukemia,n=265",14.2109589041095,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162375,RNA-Seq,,202,PRJNA89529,SAMN04486157,STJUDE,PCR,sra,SRX1571593,164,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJTALL022660_D2_RNASEQ_1,2016-02-13,7857,4989,ILLUMINA,,2016-04-14,SRR3162375,,SRS1284223,SRP011999,TARGET-10-PATWJU-09A-01R,RNA,TARGET-10-PATWJU-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PATWJU,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162375,"T-cell Acute Lymphoblastic Leukemia,n=265",5.82739726027397,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162376,RNA-Seq,,202,PRJNA89529,SAMN04486296,STJUDE,PCR,sra,SRX1571594,168,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015693_D1_RNASEQ_1,2016-02-12,10453,6949,ILLUMINA,,2016-04-14,SRR3162376,,SRS1284222,SRP011999,TARGET-10-PATWNL-09A-01R,RNA,TARGET-10-PATWNL-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PATWNL,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162376,"T-cell Acute Lymphoblastic Leukemia,n=265",1.73424657534246,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162377,RNA-Seq,,202,PRJNA89529,SAMN04486268,STJUDE,PCR,sra,SRX1571595,165,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015694_D1-TARGET-10-PATWXC-09A-01,2016-02-12,10580,7360,ILLUMINA,,2016-04-14,SRR3162377,,SRS1284221,SRP011999,TARGET-10-PATWXC-09A-01R,RNA,TARGET-10-PATWXC-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PATWXC,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162377,"T-cell Acute Lymphoblastic Leukemia,n=265",15.0356164383561,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162378,RNA-Seq,,202,PRJNA89529,SAMN04486185,STJUDE,PCR,sra,SRX1571596,166,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJTALL002124_D1-TARGET-10-PATWYL-09A-01,2016-02-13,10153,6827,ILLUMINA,,2016-04-14,SRR3162378,,SRS1284220,SRP011999,TARGET-10-PATWYL-09A-01R,RNA,TARGET-10-PATWYL-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PATWYL,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162378,"T-cell Acute Lymphoblastic Leukemia,n=265",15.304109589041,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162379,RNA-Seq,,202,PRJNA89529,SAMN04486150,STJUDE,PCR,sra,SRX1571597,164,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015695_D1_RNASEQ_1,2016-02-12,11307,7585,ILLUMINA,,2016-04-14,SRR3162379,,SRS1284219,SRP011999,TARGET-10-PATWYZ-09A-01R,RNA,TARGET-10-PATWYZ-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PATWYZ,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162379,"T-cell Acute Lymphoblastic Leukemia,n=265",3.7945205479452,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162380,RNA-Seq,,202,PRJNA89529,SAMN04486111,STJUDE,PCR,sra,SRX1571598,163,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJTALL022447_D2_TRANSCRIPTOME_1,2016-02-13,13602,9252,ILLUMINA,,2016-04-14,SRR3162380,,SRS1284218,SRP011999,TARGET-10-PATXAL-09A-01R,RNA,TARGET-10-PATXAL-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PATXAL,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162380,"T-cell Acute Lymphoblastic Leukemia,n=265",15.4136986301369,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162381,RNA-Seq,,202,PRJNA89529,SAMN04486206,STJUDE,PCR,sra,SRX1571599,167,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJTALL022649_D2_RNASEQ_1,2016-02-13,10325,6755,ILLUMINA,,2016-04-14,SRR3162381,,SRS1284217,SRP011999,TARGET-10-PATXKW-03A-01R,RNA,TARGET-10-PATXKW-03A-01R,Primary Blood Derived Cancer - Peripheral Blood,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PATXKW,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162381,"T-cell Acute Lymphoblastic Leukemia,n=265",18.1917808219178,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162382,RNA-Seq,,202,PRJNA89529,SAMN04486270,STJUDE,PCR,sra,SRX1571600,168,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015696_D1_RNASEQ_1,2016-02-12,10914,7210,ILLUMINA,,2016-04-14,SRR3162382,,SRS1284216,SRP011999,TARGET-10-PATXNK-09A-01R,RNA,TARGET-10-PATXNK-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PATXNK,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162382,"T-cell Acute Lymphoblastic Leukemia,n=265",9.3917808219178,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162383,RNA-Seq,,202,PRJNA89529,SAMN04486105,STJUDE,PCR,sra,SRX1571601,170,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015697_D1_RNASEQ_1,2016-02-12,10352,6798,ILLUMINA,,2016-04-14,SRR3162383,,SRS1284215,SRP011999,TARGET-10-PATXNR-09A-01R,RNA,TARGET-10-PATXNR-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PATXNR,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162383,"T-cell Acute Lymphoblastic Leukemia,n=265",17.145205479452,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162384,RNA-Seq,,202,PRJNA89529,SAMN04486177,STJUDE,PCR,sra,SRX1571602,171,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015698_D1_RNASEQ_1,2016-02-12,9729,6357,ILLUMINA,,2016-04-14,SRR3162384,,SRS1284214,SRP011999,TARGET-10-PATXSK-09A-01R,RNA,TARGET-10-PATXSK-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PATXSK,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162384,"T-cell Acute Lymphoblastic Leukemia,n=265",6.24383561643835,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162385,RNA-Seq,,202,PRJNA89529,SAMN04486108,STJUDE,PCR,sra,SRX1571604,168,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL016445_D1-TARGET-10-PATYJK-09A-01,2016-02-12,10748,7430,ILLUMINA,,2016-04-14,SRR3162385,,SRS1284212,SRP011999,TARGET-10-PATYJK-09A-01R,RNA,TARGET-10-PATYJK-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PATYJK,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162385,"T-cell Acute Lymphoblastic Leukemia,n=265",12.1945205479452,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162386,RNA-Seq,,202,PRJNA89529,SAMN04486095,STJUDE,PCR,sra,SRX1571605,164,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015699_D1_TRANSCRIPTOME_1,2016-02-12,13958,9534,ILLUMINA,,2016-04-14,SRR3162386,,SRS1284211,SRP011999,TARGET-10-PATYMP-09A-01R,RNA,TARGET-10-PATYMP-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PATYMP,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162386,"T-cell Acute Lymphoblastic Leukemia,n=265",18.4712328767123,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162387,RNA-Seq,,202,PRJNA89529,SAMN04486187,STJUDE,PCR,sra,SRX1571606,165,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015700_D1_RNASEQ_1,2016-02-12,8845,5763,ILLUMINA,,2016-04-14,SRR3162387,,SRS1284210,SRP011999,TARGET-10-PATYWV-09A-01R,RNA,TARGET-10-PATYWV-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PATYWV,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162387,"T-cell Acute Lymphoblastic Leukemia,n=265",7.66849315068493,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162388,RNA-Seq,,202,PRJNA89529,SAMN04486193,STJUDE,PCR,sra,SRX1571607,164,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015701_D1_RNASEQ_1,2016-02-12,9036,5672,ILLUMINA,,2016-04-14,SRR3162388,,SRS1284209,SRP011999,TARGET-10-PATZFF-09A-01R,RNA,TARGET-10-PATZFF-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PATZFF,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162388,"T-cell Acute Lymphoblastic Leukemia,n=265",10.7013698630137,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162389,RNA-Seq,,202,PRJNA89529,SAMN04486195,STJUDE,PCR,sra,SRX1571608,163,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015702_D1_RNASEQ_1,2016-02-12,8409,5278,ILLUMINA,,2016-04-14,SRR3162389,,SRS1284208,SRP011999,TARGET-10-PATZSL-09A-01R,RNA,TARGET-10-PATZSL-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PATZSL,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162389,"T-cell Acute Lymphoblastic Leukemia,n=265",10.0356164383561,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162390,RNA-Seq,,202,PRJNA89529,SAMN04486323,STJUDE,PCR,sra,SRX1571609,161,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJTALL002125_D1_TRANSCRIPTOME_1,2016-02-13,14006,9431,ILLUMINA,,2016-04-14,SRR3162390,,SRS1284207,SRP011999,TARGET-10-PATZVD-09A-01R,RNA,TARGET-10-PATZVD-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PATZVD,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162390,"T-cell Acute Lymphoblastic Leukemia,n=265",4.15890410958904,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162391,RNA-Seq,,202,PRJNA89529,SAMN04486350,STJUDE,PCR,sra,SRX1571610,168,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015703_D1-TARGET-10-PATZWA-03A-01,2016-02-12,10867,7636,ILLUMINA,,2016-04-14,SRR3162391,,SRS1284206,SRP011999,TARGET-10-PATZWA-03A-01R,RNA,TARGET-10-PATZWA-03A-01R,Primary Blood Derived Cancer - Peripheral Blood,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PATZWA,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162391,"T-cell Acute Lymphoblastic Leukemia,n=265",10.0986301369863,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162392,RNA-Seq,,202,PRJNA89529,SAMN04486293,STJUDE,PCR,sra,SRX1571611,161,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015704_D1_RNASEQ_1,2016-02-12,9912,6304,ILLUMINA,,2016-04-14,SRR3162392,,SRS1284205,SRP011999,TARGET-10-PATZYC-09A-01R,RNA,TARGET-10-PATZYC-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PATZYC,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR3162392,"T-cell Acute Lymphoblastic Leukemia,n=265",3.6986301369863,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR3162393,RNA-Seq,,202,PRJNA89529,SAMN04486348,STJUDE,PCR,sra,SRX1571612,171,Illumina HiSeq 2000,PAIRED,cDNA,TRANSCRIPTOMIC,SJALL015705_D1-TARGET-10-PATZYR-03A-01,2016-02-12,10903,7664,ILLUMINA,,2016-04-14,SRR3162393,,SRS1284204,SRP011999,TARGET-10-PATZYR-03A-01R,RNA,TARGET-10-PATZYR-03A-01R,Primary Blood Derived Cancer - Peripheral Blood,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PATZYR,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR3162393,"T-cell Acute Lymphoblastic Leukemia,n=265",8.92054794520548,TALL,"T-cell Acute Lymphoblastic Leukemia,n=265",T-cell Acute Lymphoblastic Leukemia,"NOS,n=265/TARGET"
SRR4376025,RNA-Seq,,150,PRJNA89529,SAMN05784712,BCCAGSC,PCR,sra,SRX2227107,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A59408,2016-10-08,14915,7250,ILLUMINA,178523.0,2016-10-26,SRR4376025,2016-04-28T15:40:34Z,SRS1761073,SRP011999,TARGET-15-SJMPAL011914-09B-01R,RNA,TARGET-15-SJMPAL011914-09B-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-15-SJMPAL011914,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR4376025,"Acute Leukemias of Ambiguous Lineage,n=106",7.15890410958904,ALAL,"Acute Leukemias of Ambiguous Lineage,n=106",Acute Leukemias of Ambiguous Lineage,"NOS,n=106/TARGET"
SRR4376026,RNA-Seq,,150,PRJNA89529,SAMN05784664,BCCAGSC,PCR,sra,SRX2227101,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A59394,2016-10-07,15353,7529,ILLUMINA,178526.0,2016-10-26,SRR4376026,2016-04-28T15:44:15Z,SRS1761067,SRP011999,TARGET-15-SJMPAL043775-09B-01R,RNA,TARGET-15-SJMPAL043775-09B-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-15-SJMPAL043775,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR4376026,"Acute Leukemias of Ambiguous Lineage, BCR-ABL1,n=2",1.91506849315068,ALAL-BCRABL1,"Acute Leukemias of Ambiguous Lineage, BCR-ABL1,n=2",Acute Leukemias of Ambiguous Lineage,"BCR-ABL1,n=2/TARGET"
SRR4376027,RNA-Seq,,150,PRJNA89529,SAMN05784883,BCCAGSC,PCR,sra,SRX2227110,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A59397,2016-10-07,15108,7104,ILLUMINA,179033.0,2016-10-26,SRR4376027,2016-05-03T19:11:59Z,SRS1761076,SRP011999,TARGET-15-PAUFIB-09B-01R,RNA,TARGET-15-PAUFIB-09B-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-15-PAUFIB,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR4376027,"Acute Leukemias of Ambiguous Lineage,n=106",100.0,ALAL,"Acute Leukemias of Ambiguous Lineage,n=106",Acute Leukemias of Ambiguous Lineage,"NOS,n=106/TARGET"
SRR4376028,RNA-Seq,,150,PRJNA89529,SAMN05784699,BCCAGSC,PCR,sra,SRX2227111,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A59411,2016-10-06,12813,6027,ILLUMINA,178529.0,2016-10-26,SRR4376028,2016-04-28T15:44:26Z,SRS1761077,SRP011999,TARGET-15-SJMPAL040037-09B-01R,RNA,TARGET-15-SJMPAL040037-09B-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-15-SJMPAL040037,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR4376028,"Acute Leukemias of Ambiguous Lineage,n=106",15.3260273972602,ALAL,"Acute Leukemias of Ambiguous Lineage,n=106",Acute Leukemias of Ambiguous Lineage,"NOS,n=106/TARGET"
SRR4376029,RNA-Seq,,150,PRJNA89529,SAMN05784791,BCCAGSC,PCR,sra,SRX2227092,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A59400,2016-10-07,12128,6038,ILLUMINA,178523.0,2016-10-26,SRR4376029,2016-04-28T15:40:34Z,SRS1761058,SRP011999,TARGET-15-SJMPAL040025-09B-01R,RNA,TARGET-15-SJMPAL040025-09B-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-15-SJMPAL040025,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR4376029,"Acute Leukemias of Ambiguous Lineage,n=106",9.0931506849315,ALAL,"Acute Leukemias of Ambiguous Lineage,n=106",Acute Leukemias of Ambiguous Lineage,"NOS,n=106/TARGET"
SRR4376030,RNA-Seq,,150,PRJNA89529,SAMN05784889,BCCAGSC,PCR,sra,SRX2227103,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A59416,2016-10-07,16522,7988,ILLUMINA,178523.0,2016-10-26,SRR4376030,2016-04-28T15:40:34Z,SRS1761069,SRP011999,TARGET-15-SJMPAL042801-09B-01R,RNA,TARGET-15-SJMPAL042801-09B-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-15-SJMPAL042801,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR4376030,"Acute Leukemias of Ambiguous Lineage,n=106",5.37808219178082,ALAL,"Acute Leukemias of Ambiguous Lineage,n=106",Acute Leukemias of Ambiguous Lineage,"NOS,n=106/TARGET"
SRR4376031,RNA-Seq,,150,PRJNA89529,SAMN05784669,BCCAGSC,PCR,sra,SRX2227102,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A59413,2016-10-08,14193,6565,ILLUMINA,179034.0,2016-10-26,SRR4376031,2016-05-03T19:12:03Z,SRS1761068,SRP011999,TARGET-15-SJMPAL042791-09B-01R,RNA,TARGET-15-SJMPAL042791-09B-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-15-SJMPAL042791,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR4376031,"Acute Leukemias of Ambiguous Lineage,n=106",13.2164383561643,ALAL,"Acute Leukemias of Ambiguous Lineage,n=106",Acute Leukemias of Ambiguous Lineage,"NOS,n=106/TARGET"
SRR4376032,RNA-Seq,,150,PRJNA89529,SAMN05784812,BCCAGSC,PCR,contigs sra,SRX2227096,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A59414,2016-10-06,10758,5044,ILLUMINA,179035.0,2016-10-26,SRR4376032,2016-05-03T19:12:07Z,SRS1761062,SRP011999,TARGET-15-SJMPAL042793-09B-01R,RNA,TARGET-15-SJMPAL042793-09B-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-15-SJMPAL042793,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR4376032,"Acute Leukemias of Ambiguous Lineage,n=106",4.81369863013698,ALAL,"Acute Leukemias of Ambiguous Lineage,n=106",Acute Leukemias of Ambiguous Lineage,"NOS,n=106/TARGET"
SRR4376033,RNA-Seq,,150,PRJNA89529,SAMN05784821,BCCAGSC,PCR,sra,SRX2227112,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A59420,2016-10-06,14877,7459,ILLUMINA,178531.0,2016-10-26,SRR4376033,2016-04-28T15:44:32Z,SRS1761078,SRP011999,TARGET-15-SJMPAL040036-03B-01R,RNA,TARGET-15-SJMPAL040036-03B-01R,Primary Blood Derived Cancer - Peripheral Blood,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-15-SJMPAL040036,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR4376033,"Acute Leukemias of Ambiguous Lineage,n=106",5.43287671232876,ALAL,"Acute Leukemias of Ambiguous Lineage,n=106",Acute Leukemias of Ambiguous Lineage,"NOS,n=106/TARGET"
SRR4376034,RNA-Seq,,150,PRJNA89529,SAMN05784638,BCCAGSC,PCR,sra,SRX2227095,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A59409,2016-10-08,14499,6982,ILLUMINA,178525.0,2016-10-26,SRR4376034,2016-04-28T15:40:40Z,SRS1761061,SRP011999,TARGET-15-PARWPU-09B-01R,RNA,TARGET-15-PARWPU-09B-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-15-PARWPU,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR4376034,"Acute Leukemias of Ambiguous Lineage,n=106",5.83287671232876,ALAL,"Acute Leukemias of Ambiguous Lineage,n=106",Acute Leukemias of Ambiguous Lineage,"NOS,n=106/TARGET"
SRR4376035,RNA-Seq,,150,PRJNA89529,SAMN05784887,BCCAGSC,PCR,sra,SRX2227105,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A59410,2016-10-07,15500,7577,ILLUMINA,178527.0,2016-10-26,SRR4376035,2016-04-28T15:44:19Z,SRS1761071,SRP011999,TARGET-15-SJMPAL016342-09B-01R,RNA,TARGET-15-SJMPAL016342-09B-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-15-SJMPAL016342,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR4376035,"INFANT_Acute Leukemias of Ambiguous Lineage,n=4",0.917808219178082,ALAL_INFANT,"INFANT_Acute Leukemias of Ambiguous Lineage,n=4",Acute Leukemias of Ambiguous Lineage,"INFANT,n=4/TARGET"
SRR4376036,RNA-Seq,,150,PRJNA89529,SAMN05784758,BCCAGSC,PCR,contigs sra,SRX2227106,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A59406,2016-10-06,10676,5007,ILLUMINA,179035.0,2016-10-26,SRR4376036,2016-05-03T19:12:07Z,SRS1761072,SRP011999,TARGET-15-SJMPAL042798-09B-01R,RNA,TARGET-15-SJMPAL042798-09B-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-15-SJMPAL042798,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR4376036,"Acute Leukemias of Ambiguous Lineage,n=106",4.7972602739726,ALAL,"Acute Leukemias of Ambiguous Lineage,n=106",Acute Leukemias of Ambiguous Lineage,"NOS,n=106/TARGET"
SRR4376037,RNA-Seq,,150,PRJNA89529,SAMN05784769,BCCAGSC,PCR,sra,SRX2227099,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A59407,2016-10-08,15320,7744,ILLUMINA,178521.0,2016-10-26,SRR4376037,2016-04-28T15:40:28Z,SRS1761065,SRP011999,TARGET-15-SJMPAL042799-09B-01R,RNA,TARGET-15-SJMPAL042799-09B-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-15-SJMPAL042799,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR4376037,"Acute Leukemias of Ambiguous Lineage,n=106",11.2054794520547,ALAL,"Acute Leukemias of Ambiguous Lineage,n=106",Acute Leukemias of Ambiguous Lineage,"NOS,n=106/TARGET"
SRR4376038,RNA-Seq,,150,PRJNA89529,SAMN05784899,BCCAGSC,PCR,sra,SRX2227113,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A59417,2016-10-08,15246,7392,ILLUMINA,178525.0,2016-10-26,SRR4376038,2016-04-28T15:40:40Z,SRS1761079,SRP011999,TARGET-15-SJMPAL043505-09B-01R,RNA,TARGET-15-SJMPAL043505-09B-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-15-SJMPAL043505,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR4376038,"Acute Leukemias of Ambiguous Lineage,n=106",3.47945205479452,ALAL,"Acute Leukemias of Ambiguous Lineage,n=106",Acute Leukemias of Ambiguous Lineage,"NOS,n=106/TARGET"
SRR4376039,RNA-Seq,,150,PRJNA89529,SAMN05784843,BCCAGSC,PCR,sra,SRX2227094,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A59404,2016-10-06,14086,6914,ILLUMINA,178531.0,2016-10-26,SRR4376039,2016-04-28T15:44:32Z,SRS1761060,SRP011999,TARGET-15-SJMPAL041120-09B-01R,RNA,TARGET-15-SJMPAL041120-09B-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-15-SJMPAL041120,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR4376039,"Acute Leukemias of Ambiguous Lineage,n=106",14.8136986301369,ALAL,"Acute Leukemias of Ambiguous Lineage,n=106",Acute Leukemias of Ambiguous Lineage,"NOS,n=106/TARGET"
SRR4376040,RNA-Seq,,150,PRJNA89529,SAMN05784733,BCCAGSC,PCR,sra,SRX2227091,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A59396,2016-10-06,15130,7388,ILLUMINA,178530.0,2016-10-26,SRR4376040,2016-04-28T15:44:29Z,SRS1761057,SRP011999,TARGET-15-PASZVW-09B-01R,RNA,TARGET-15-PASZVW-09B-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-15-PASZVW,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR4376040,"Acute Leukemias of Ambiguous Lineage,n=106",100.0,ALAL,"Acute Leukemias of Ambiguous Lineage,n=106",Acute Leukemias of Ambiguous Lineage,"NOS,n=106/TARGET"
SRR4376041,RNA-Seq,,150,PRJNA89529,SAMN05784725,BCCAGSC,PCR,sra,SRX2227093,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A59418,2016-10-08,14408,7070,ILLUMINA,178527.0,2016-10-26,SRR4376041,2016-04-28T15:44:19Z,SRS1761059,SRP011999,TARGET-15-SJMPAL040028-04B-01R,RNA,TARGET-15-SJMPAL040028-04B-01R,Recurrent Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-15-SJMPAL040028,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR4376041,"Acute Leukemias of Ambiguous Lineage,n=106",17.1643835616438,ALAL,"Acute Leukemias of Ambiguous Lineage,n=106",Acute Leukemias of Ambiguous Lineage,"NOS,n=106/TARGET"
SRR4376042,RNA-Seq,,150,PRJNA89529,SAMN05784810,BCCAGSC,PCR,sra,SRX2227097,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A59415,2016-10-08,17841,8934,ILLUMINA,178521.0,2016-10-26,SRR4376042,2016-04-28T15:40:28Z,SRS1761063,SRP011999,TARGET-15-SJMPAL042794-09B-01R,RNA,TARGET-15-SJMPAL042794-09B-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-15-SJMPAL042794,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR4376042,"Acute Leukemias of Ambiguous Lineage,n=106",15.1808219178082,ALAL,"Acute Leukemias of Ambiguous Lineage,n=106",Acute Leukemias of Ambiguous Lineage,"NOS,n=106/TARGET"
SRR4376043,RNA-Seq,,150,PRJNA89529,SAMN05784658,BCCAGSC,PCR,sra,SRX2227115,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A59399,2016-10-07,13382,6765,ILLUMINA,178521.0,2016-10-26,SRR4376043,2016-04-28T15:40:28Z,SRS1761081,SRP011999,TARGET-15-SJMPAL017975-03B-01R,RNA,TARGET-15-SJMPAL017975-03B-01R,Primary Blood Derived Cancer - Peripheral Blood,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-15-SJMPAL017975,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR4376043,"Acute Leukemias of Ambiguous Lineage,n=106",17.8821917808219,ALAL,"Acute Leukemias of Ambiguous Lineage,n=106",Acute Leukemias of Ambiguous Lineage,"NOS,n=106/TARGET"
SRR4376044,RNA-Seq,,150,PRJNA89529,SAMN05784837,BCCAGSC,PCR,contigs sra,SRX2227109,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A59398,2016-10-06,10430,4898,ILLUMINA,179035.0,2016-10-26,SRR4376044,2016-05-03T19:12:07Z,SRS1761075,SRP011999,TARGET-15-PAVFTF-09B-01R,RNA,TARGET-15-PAVFTF-09B-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-15-PAVFTF,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR4376044,"Acute Leukemias of Ambiguous Lineage,n=106",100.0,ALAL,"Acute Leukemias of Ambiguous Lineage,n=106",Acute Leukemias of Ambiguous Lineage,"NOS,n=106/TARGET"
SRR4376045,RNA-Seq,,150,PRJNA89529,SAMN05784877,BCCAGSC,PCR,sra,SRX2227116,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A59412,2016-10-06,15986,7792,ILLUMINA,178531.0,2016-10-26,SRR4376045,2016-04-28T15:44:32Z,SRS1761082,SRP011999,TARGET-15-SJMPAL040459-09B-01R,RNA,TARGET-15-SJMPAL040459-09B-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-15-SJMPAL040459,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR4376045,"Acute Leukemias of Ambiguous Lineage,n=106",7.03835616438356,ALAL,"Acute Leukemias of Ambiguous Lineage,n=106",Acute Leukemias of Ambiguous Lineage,"NOS,n=106/TARGET"
SRR4376046,RNA-Seq,,150,PRJNA89529,SAMN05784874,BCCAGSC,PCR,sra,SRX2227098,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A59403,2016-10-06,13203,6163,ILLUMINA,178529.0,2016-10-26,SRR4376046,2016-04-28T15:44:26Z,SRS1761064,SRP011999,TARGET-15-SJMPAL041119-09B-01R,RNA,TARGET-15-SJMPAL041119-09B-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-15-SJMPAL041119,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR4376046,"Acute Leukemias of Ambiguous Lineage,n=106",3.02739726027397,ALAL,"Acute Leukemias of Ambiguous Lineage,n=106",Acute Leukemias of Ambiguous Lineage,"NOS,n=106/TARGET"
SRR4376047,RNA-Seq,,150,PRJNA89529,SAMN05784930,BCCAGSC,PCR,sra,SRX2227090,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A59419,2016-10-06,13482,6380,ILLUMINA,178529.0,2016-10-26,SRR4376047,2016-04-28T15:44:26Z,SRS1761056,SRP011999,TARGET-15-SJMPAL040039-09B-01R,RNA,TARGET-15-SJMPAL040039-09B-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-15-SJMPAL040039,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR4376047,"Acute Leukemias of Ambiguous Lineage,n=106",8.46301369863013,ALAL,"Acute Leukemias of Ambiguous Lineage,n=106",Acute Leukemias of Ambiguous Lineage,"NOS,n=106/TARGET"
SRR4376048,RNA-Seq,,150,PRJNA89529,SAMN05784716,BCCAGSC,PCR,sra,SRX2227100,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A59401,2016-10-07,13730,6649,ILLUMINA,178525.0,2016-10-26,SRR4376048,2016-04-28T15:40:40Z,SRS1761066,SRP011999,TARGET-15-SJMPAL040038-09B-01R,RNA,TARGET-15-SJMPAL040038-09B-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-15-SJMPAL040038,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR4376048,"Acute Leukemias of Ambiguous Lineage,n=106",2.5972602739726,ALAL,"Acute Leukemias of Ambiguous Lineage,n=106",Acute Leukemias of Ambiguous Lineage,"NOS,n=106/TARGET"
SRR4376049,RNA-Seq,,150,PRJNA89529,SAMN05784835,BCCAGSC,PCR,sra,SRX2227104,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A59402,2016-10-07,13909,6733,ILLUMINA,178527.0,2016-10-26,SRR4376049,2016-04-28T15:44:19Z,SRS1761070,SRP011999,TARGET-15-SJMPAL041117-09B-01R,RNA,TARGET-15-SJMPAL041117-09B-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-15-SJMPAL041117,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR4376049,"Acute Leukemias of Ambiguous Lineage,n=106",15.131506849315,ALAL,"Acute Leukemias of Ambiguous Lineage,n=106",Acute Leukemias of Ambiguous Lineage,"NOS,n=106/TARGET"
SRR4376050,RNA-Seq,,150,PRJNA89529,SAMN05784673,BCCAGSC,PCR,sra,SRX2227108,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A59405,2016-10-07,14124,6531,ILLUMINA,179034.0,2016-10-26,SRR4376050,2016-05-03T19:12:03Z,SRS1761074,SRP011999,TARGET-15-SJMPAL042787-09B-01R,RNA,TARGET-15-SJMPAL042787-09B-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-15-SJMPAL042787,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR4376050,"Acute Leukemias of Ambiguous Lineage,n=106",13.5369863013698,ALAL,"Acute Leukemias of Ambiguous Lineage,n=106",Acute Leukemias of Ambiguous Lineage,"NOS,n=106/TARGET"
SRR4376051,RNA-Seq,,150,PRJNA89529,SAMN05784928,BCCAGSC,PCR,sra,SRX2227114,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A59395,2016-10-06,12716,6097,ILLUMINA,178528.0,2016-10-26,SRR4376051,2016-04-28T15:44:23Z,SRS1761080,SRP011999,TARGET-15-SJMPAL012419-09B-01R,RNA,TARGET-15-SJMPAL012419-09B-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-15-SJMPAL012419,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR4376051,"Acute Leukemias of Ambiguous Lineage,n=106",16.3643835616438,ALAL,"Acute Leukemias of Ambiguous Lineage,n=106",Acute Leukemias of Ambiguous Lineage,"NOS,n=106/TARGET"
SRR4416261,RNA-Seq,,150,PRJNA89529,SAMN05784696,BCCAGSC,PCR,sra,SRX2239286,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A59339,2016-10-12,16394,8448,ILLUMINA,179510.0,2016-10-26,SRR4416261,2016-05-10T18:55:52Z,SRS1761244,SRP011999,TARGET-10-PANWEZ-09B-01R,RNA,TARGET-10-PANWEZ-09B-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PANWEZ,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR4416261,"B-cell Acute Lymphoblastic Leukemia, ETV6-RUNX1,n=5",14.345205479452,BALL-ETV6RUNX1,"B-cell Acute Lymphoblastic Leukemia, ETV6-RUNX1,n=5",B-cell Acute Lymphoblastic Leukemia,"ETV6-RUNX1,n=5/TARGET"
SRR4416272,RNA-Seq,,150,PRJNA89529,SAMN05784702,BCCAGSC,PCR,sra,SRX2239292,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A59341,2016-10-11,16575,8254,ILLUMINA,179039.0,2016-10-26,SRR4416272,2016-05-03T19:12:20Z,SRS1761250,SRP011999,TARGET-10-PARUYU-03B-01R,RNA,TARGET-10-PARUYU-03B-01R,Primary Blood Derived Cancer - Peripheral Blood,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PARUYU,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR4416272,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",11.0246575342465,BALL-NOS,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",B-cell Acute Lymphoblastic Leukemia,"NOS,n=71/TARGET"
SRR4416273,RNA-Seq,,150,PRJNA89529,SAMN05784728,BCCAGSC,PCR,sra,SRX2239250,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A59366,2016-10-11,15226,8034,ILLUMINA,179042.0,2016-10-26,SRR4416273,2016-05-03T19:19:27Z,SRS1761208,SRP011999,TARGET-10-PANDBX-09B-01R,RNA,TARGET-10-PANDBX-09B-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PANDBX,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR4416273,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",3.83013698630137,BALL-NOS,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",B-cell Acute Lymphoblastic Leukemia,"NOS,n=71/TARGET"
SRR4416275,RNA-Seq,,150,PRJNA89529,SAMN05784748,BCCAGSC,PCR,sra,SRX2239263,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A59367,2016-10-11,15940,8098,ILLUMINA,179044.0,2016-10-26,SRR4416275,2016-05-03T19:19:34Z,SRS1761221,SRP011999,TARGET-10-PANSBK-03B-01R,RNA,TARGET-10-PANSBK-03B-01R,Primary Blood Derived Cancer - Peripheral Blood,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PANSBK,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR4416275,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",5.16164383561643,BALL-NOS,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",B-cell Acute Lymphoblastic Leukemia,"NOS,n=71/TARGET"
SRR4416300,RNA-Seq,,150,PRJNA89529,SAMN05784761,BCCAGSC,PCR,sra,SRX2239291,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A59369,2016-10-12,15658,8183,ILLUMINA,179507.0,2016-10-26,SRR4416300,2016-05-10T18:55:43Z,SRS1761249,SRP011999,TARGET-10-PAPHPX-03B-01R,RNA,TARGET-10-PAPHPX-03B-01R,Primary Blood Derived Cancer - Peripheral Blood,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PAPHPX,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR4416300,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",5.16986301369863,BALL-NOS,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",B-cell Acute Lymphoblastic Leukemia,"NOS,n=71/TARGET"
SRR4416304,RNA-Seq,,150,PRJNA89529,SAMN05784834,BCCAGSC,PCR,sra,SRX2239284,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A59365,2016-10-11,15911,7681,ILLUMINA,179040.0,2016-10-26,SRR4416304,2016-05-03T19:12:24Z,SRS1761242,SRP011999,TARGET-10-PANATY-09B-01R,RNA,TARGET-10-PANATY-09B-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PANATY,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR4416304,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",4.22465753424657,BALL-NOS,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",B-cell Acute Lymphoblastic Leukemia,"NOS,n=71/TARGET"
SRR4419553,RNA-Seq,,150,PRJNA89529,SAMN05784898,BCCAGSC,PCR,sra,SRX2241939,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A59379,2016-10-12,14699,7024,ILLUMINA,178528.0,2016-10-26,SRR4419553,2016-04-28T15:44:23Z,SRS1761086,SRP011999,TARGET-15-SJMPAL042946-04B-01R,RNA,TARGET-15-SJMPAL042946-04B-01R,Recurrent Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-15-SJMPAL042946,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR4419553,"Acute Leukemias of Ambiguous Lineage,n=106",15.3095890410958,ALAL,"Acute Leukemias of Ambiguous Lineage,n=106",Acute Leukemias of Ambiguous Lineage,"NOS,n=106/TARGET"
SRR4419554,RNA-Seq,,150,PRJNA89529,SAMN05784704,BCCAGSC,PCR,sra,SRX2241946,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A59380,2016-10-12,14879,7270,ILLUMINA,178530.0,2016-10-26,SRR4419554,2016-04-28T15:44:29Z,SRS1761093,SRP011999,TARGET-15-SJMPAL043507-04B-01R,RNA,TARGET-15-SJMPAL043507-04B-01R,Recurrent Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-15-SJMPAL043507,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR4419554,"Acute Leukemias of Ambiguous Lineage,n=106",7.41643835616438,ALAL,"Acute Leukemias of Ambiguous Lineage,n=106",Acute Leukemias of Ambiguous Lineage,"NOS,n=106/TARGET"
SRR4419555,RNA-Seq,,150,PRJNA89529,SAMN05784922,BCCAGSC,PCR,sra,SRX2241951,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A59392,2016-10-12,16276,8028,ILLUMINA,178522.0,2016-10-26,SRR4419555,2016-04-28T15:40:30Z,SRS1761098,SRP011999,TARGET-15-SJMPAL043773-03B-01R,RNA,TARGET-15-SJMPAL043773-03B-01R,Primary Blood Derived Cancer - Peripheral Blood,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-15-SJMPAL043773,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR4419555,"Acute Leukemias of Ambiguous Lineage,n=106",7.51506849315068,ALAL,"Acute Leukemias of Ambiguous Lineage,n=106",Acute Leukemias of Ambiguous Lineage,"NOS,n=106/TARGET"
SRR4419556,RNA-Seq,,150,PRJNA89529,SAMN05784937,BCCAGSC,PCR,sra,SRX2241947,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A59378,2016-10-12,13805,6679,ILLUMINA,178526.0,2016-10-26,SRR4419556,2016-04-28T15:44:15Z,SRS1761094,SRP011999,TARGET-15-SJMPAL042946-09B-01R,RNA,TARGET-15-SJMPAL042946-09B-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-15-SJMPAL042946,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR4419556,"Acute Leukemias of Ambiguous Lineage,n=106",15.3095890410958,ALAL,"Acute Leukemias of Ambiguous Lineage,n=106",Acute Leukemias of Ambiguous Lineage,"NOS,n=106/TARGET"
SRR4419557,RNA-Seq,,150,PRJNA89529,SAMN05784866,BCCAGSC,PCR,contigs sra,SRX2241943,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A59390,2016-10-12,10562,5027,ILLUMINA,179035.0,2016-10-26,SRR4419557,2016-05-03T19:12:07Z,SRS1761090,SRP011999,TARGET-15-SJMPAL043771-09B-01R,RNA,TARGET-15-SJMPAL043771-09B-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-15-SJMPAL043771,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR4419557,"Acute Leukemias of Ambiguous Lineage,n=106",9.70410958904109,ALAL,"Acute Leukemias of Ambiguous Lineage,n=106",Acute Leukemias of Ambiguous Lineage,"NOS,n=106/TARGET"
SRR4419558,RNA-Seq,,150,PRJNA89529,SAMN05784788,BCCAGSC,PCR,sra,SRX2241941,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A59385,2016-10-12,14396,6999,ILLUMINA,178524.0,2016-10-26,SRR4419558,2016-04-28T15:40:36Z,SRS1761088,SRP011999,TARGET-15-SJMPAL043769-03B-01R,RNA,TARGET-15-SJMPAL043769-03B-01R,Primary Blood Derived Cancer - Peripheral Blood,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-15-SJMPAL043769,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR4419558,"Acute Leukemias of Ambiguous Lineage,n=106",15.758904109589,ALAL,"Acute Leukemias of Ambiguous Lineage,n=106",Acute Leukemias of Ambiguous Lineage,"NOS,n=106/TARGET"
SRR4419559,RNA-Seq,,150,PRJNA89529,SAMN05784648,BCCAGSC,PCR,sra,SRX2241953,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A59388,2016-10-12,14906,7309,ILLUMINA,178530.0,2016-10-26,SRR4419559,2016-04-28T15:44:29Z,SRS1761100,SRP011999,TARGET-15-SJMPAL043512-09B-01R,RNA,TARGET-15-SJMPAL043512-09B-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-15-SJMPAL043512,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR4419559,"Acute Leukemias of Ambiguous Lineage,n=106",15.517808219178,ALAL,"Acute Leukemias of Ambiguous Lineage,n=106",Acute Leukemias of Ambiguous Lineage,"NOS,n=106/TARGET"
SRR4419560,RNA-Seq,,150,PRJNA89529,SAMN05784918,BCCAGSC,PCR,sra,SRX2241948,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A59383,2016-10-12,14809,7267,ILLUMINA,178520.0,2016-10-26,SRR4419560,2016-04-28T15:40:24Z,SRS1761095,SRP011999,TARGET-15-SJMPAL043767-09B-01R,RNA,TARGET-15-SJMPAL043767-09B-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-15-SJMPAL043767,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR4419560,"INFANT_Acute Leukemias of Ambiguous Lineage,n=4",0.378082191780821,ALAL_INFANT,"INFANT_Acute Leukemias of Ambiguous Lineage,n=4",Acute Leukemias of Ambiguous Lineage,"INFANT,n=4/TARGET"
SRR4419561,RNA-Seq,,150,PRJNA89529,SAMN05784678,BCCAGSC,PCR,sra,SRX2241937,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A59375,2016-10-12,14127,6994,ILLUMINA,178520.0,2016-10-26,SRR4419561,2016-04-28T15:40:24Z,SRS1761084,SRP011999,TARGET-15-SJMPAL012421-09B-01R,RNA,TARGET-15-SJMPAL012421-09B-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-15-SJMPAL012421,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR4419561,"Acute Leukemias of Ambiguous Lineage,n=106",12.2849315068493,ALAL,"Acute Leukemias of Ambiguous Lineage,n=106",Acute Leukemias of Ambiguous Lineage,"NOS,n=106/TARGET"
SRR4419562,RNA-Seq,,150,PRJNA89529,SAMN05784827,BCCAGSC,PCR,sra,SRX2241949,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A59377,2016-10-12,13551,6614,ILLUMINA,178524.0,2016-10-26,SRR4419562,2016-04-28T15:40:36Z,SRS1761096,SRP011999,TARGET-15-PAREAT-09B-01R,RNA,TARGET-15-PAREAT-09B-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-15-PAREAT,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR4419562,"Acute Leukemias of Ambiguous Lineage,n=106",6.57260273972602,ALAL,"Acute Leukemias of Ambiguous Lineage,n=106",Acute Leukemias of Ambiguous Lineage,"NOS,n=106/TARGET"
SRR4419563,RNA-Seq,,150,PRJNA89529,SAMN05784754,BCCAGSC,PCR,sra,SRX2241950,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A59393,2016-10-12,15342,7262,ILLUMINA,178524.0,2016-10-26,SRR4419563,2016-04-28T15:40:36Z,SRS1761097,SRP011999,TARGET-15-SJMPAL043774-09B-01R,RNA,TARGET-15-SJMPAL043774-09B-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-15-SJMPAL043774,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR4419563,"INFANT_Acute Leukemias of Ambiguous Lineage, KMT2A rearrangement,n=7",0.0328767123287671,ALAL-KMT2A_INFANT,"INFANT_Acute Leukemias of Ambiguous Lineage, KMT2A rearrangement,n=7",Acute Leukemias of Ambiguous Lineage,"INFANT,KMT2A rearrangement,n=7/TARGET"
SRR4419564,RNA-Seq,,150,PRJNA89529,SAMN05784868,BCCAGSC,PCR,sra,SRX2241952,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A59387,2016-10-12,14345,6870,ILLUMINA,178528.0,2016-10-26,SRR4419564,2016-04-28T15:44:23Z,SRS1761099,SRP011999,TARGET-15-SJMPAL043511-09B-01R,RNA,TARGET-15-SJMPAL043511-09B-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-15-SJMPAL043511,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR4419564,"Acute Leukemias of Ambiguous Lineage,n=106",9.78904109589041,ALAL,"Acute Leukemias of Ambiguous Lineage,n=106",Acute Leukemias of Ambiguous Lineage,"NOS,n=106/TARGET"
SRR4419565,RNA-Seq,,150,PRJNA89529,SAMN05784746,BCCAGSC,PCR,sra,SRX2241938,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A59381,2016-10-12,12740,5989,ILLUMINA,179033.0,2016-10-26,SRR4419565,2016-05-03T19:11:59Z,SRS1761085,SRP011999,TARGET-15-SJMPAL043508-09B-01R,RNA,TARGET-15-SJMPAL043508-09B-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-15-SJMPAL043508,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR4419565,"Acute Leukemias of Ambiguous Lineage,n=106",9.60273972602739,ALAL,"Acute Leukemias of Ambiguous Lineage,n=106",Acute Leukemias of Ambiguous Lineage,"NOS,n=106/TARGET"
SRR4419566,RNA-Seq,,150,PRJNA89529,SAMN05784657,BCCAGSC,PCR,sra,SRX2241940,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A59384,2016-10-12,13149,6430,ILLUMINA,178522.0,2016-10-26,SRR4419566,2016-04-28T15:40:30Z,SRS1761087,SRP011999,TARGET-15-SJMPAL043768-09B-01R,RNA,TARGET-15-SJMPAL043768-09B-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-15-SJMPAL043768,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR4419566,"INFANT_Acute Leukemias of Ambiguous Lineage,n=4",0.501369863013698,ALAL_INFANT,"INFANT_Acute Leukemias of Ambiguous Lineage,n=4",Acute Leukemias of Ambiguous Lineage,"INFANT,n=4/TARGET"
SRR4419567,RNA-Seq,,150,PRJNA89529,SAMN05784878,BCCAGSC,PCR,sra,SRX2241944,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A59382,2016-10-12,13347,6259,ILLUMINA,179034.0,2016-10-26,SRR4419567,2016-05-03T19:12:03Z,SRS1761091,SRP011999,TARGET-15-SJMPAL019076-04B-01R,RNA,TARGET-15-SJMPAL019076-04B-01R,Recurrent Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-15-SJMPAL019076,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR4419567,"Acute Leukemias of Ambiguous Lineage,n=106",5.52602739726027,ALAL,"Acute Leukemias of Ambiguous Lineage,n=106",Acute Leukemias of Ambiguous Lineage,"NOS,n=106/TARGET"
SRR4419568,RNA-Seq,,150,PRJNA89529,SAMN05784741,BCCAGSC,PCR,sra,SRX2241945,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A59389,2016-10-12,14541,6771,ILLUMINA,179033.0,2016-10-26,SRR4419568,2016-05-03T19:11:59Z,SRS1761092,SRP011999,TARGET-15-SJMPAL043513-04B-01R,RNA,TARGET-15-SJMPAL043513-04B-01R,Recurrent Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-15-SJMPAL043513,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR4419568,"Acute Leukemias of Ambiguous Lineage,n=106",10.6109589041095,ALAL,"Acute Leukemias of Ambiguous Lineage,n=106",Acute Leukemias of Ambiguous Lineage,"NOS,n=106/TARGET"
SRR4419569,RNA-Seq,,150,PRJNA89529,SAMN05784884,BCCAGSC,PCR,sra,SRX2241936,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A59391,2016-10-12,14368,7083,ILLUMINA,178520.0,2016-10-26,SRR4419569,2016-04-28T15:40:24Z,SRS1761083,SRP011999,TARGET-15-SJMPAL043772-04B-01R,RNA,TARGET-15-SJMPAL043772-04B-01R,Recurrent Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-15-SJMPAL043772,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR4419569,"Acute Leukemias of Ambiguous Lineage,n=106",4.92054794520547,ALAL,"Acute Leukemias of Ambiguous Lineage,n=106",Acute Leukemias of Ambiguous Lineage,"NOS,n=106/TARGET"
SRR4419570,RNA-Seq,,150,PRJNA89529,SAMN05784833,BCCAGSC,PCR,sra,SRX2241954,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A59386,2016-10-12,14423,6917,ILLUMINA,178526.0,2016-10-26,SRR4419570,2016-04-28T15:44:15Z,SRS1761101,SRP011999,TARGET-15-SJMPAL043770-09B-01R,RNA,TARGET-15-SJMPAL043770-09B-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-15-SJMPAL043770,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR4419570,"Acute Leukemias of Ambiguous Lineage,n=106",7.44109589041095,ALAL,"Acute Leukemias of Ambiguous Lineage,n=106",Acute Leukemias of Ambiguous Lineage,"NOS,n=106/TARGET"
SRR4419571,RNA-Seq,,150,PRJNA89529,SAMN05784814,BCCAGSC,PCR,sra,SRX2241942,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A59376,2016-10-12,15553,7719,ILLUMINA,178522.0,2016-10-26,SRR4419571,2016-04-28T15:40:30Z,SRS1761089,SRP011999,TARGET-15-SJMPAL043506-04B-01R,RNA,TARGET-15-SJMPAL043506-04B-01R,Recurrent Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-15-SJMPAL043506,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute myeloid leukemia (AML),SRR4419571,"Acute Leukemias of Ambiguous Lineage,n=106",6.07671232876712,ALAL,"Acute Leukemias of Ambiguous Lineage,n=106",Acute Leukemias of Ambiguous Lineage,"NOS,n=106/TARGET"
SRR457636,RNA-Seq,GCA_000001405.13,97,PRJNA89519,SAMN00260952,BCCAGSC,PCR,sra,SRX060106,0,Illumina Genome Analyzer II,PAIRED,cDNA,TRANSCRIPTOMIC,HS0825,2012-05-29,5174,3087,ILLUMINA,,2012-05-29,SRR457636,,SRS189984,SRP011998,TARGET-10-PAKHZT-03A-01R,RNA,TARGET-10-PAKHZT-03A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000463,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Pilot Phase 1,TARGET-10-PAKHZT,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Induction Failure AML (AML-IF),SRR457636,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",13.9205479452054,BALL-NOS,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",B-cell Acute Lymphoblastic Leukemia,"NOS,n=71/TARGET"
SRR457637,RNA-Seq,GCA_000001405.13,96,PRJNA89519,SAMN00260959,BCCAGSC,PCR,sra,SRX060107,0,Illumina Genome Analyzer II,PAIRED,cDNA,TRANSCRIPTOMIC,HS0894,2012-05-29,4793,2076,ILLUMINA,,2012-05-29,SRR457637,,SRS189991,SRP011998,TARGET-10-PAKVKK-03A-01R,RNA,TARGET-10-PAKVKK-03A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000463,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Pilot Phase 1,TARGET-10-PAKVKK,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Induction Failure AML (AML-IF),SRR457637,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",14.3835616438356,BALL-NOS,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",B-cell Acute Lymphoblastic Leukemia,"NOS,n=71/TARGET"
SRR457638,RNA-Seq,GCA_000001405.13,96,PRJNA89519,SAMN00260957,BCCAGSC,PCR,sra,SRX060108,0,Illumina Genome Analyzer II,PAIRED,cDNA,TRANSCRIPTOMIC,HS0897,2012-05-29,4680,2108,ILLUMINA,,2012-05-29,SRR457638,,SRS189989,SRP011998,TARGET-10-PAKTAL-03A-01R,RNA,TARGET-10-PAKTAL-03A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000463,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Pilot Phase 1,TARGET-10-PAKTAL,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Induction Failure AML (AML-IF),SRR457638,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",12.2438356164383,BALL-NOS,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",B-cell Acute Lymphoblastic Leukemia,"NOS,n=71/TARGET"
SRR457642,RNA-Seq,GCA_000001405.13,139,PRJNA89519,SAMN00260955,BCCAGSC,PCR,sra,SRX060112,0,Illumina Genome Analyzer IIx,PAIRED,cDNA,TRANSCRIPTOMIC,HS1533,2012-05-29,12061,6837,ILLUMINA,,2012-05-29,SRR457642,,SRS189987,SRP011998,TARGET-10-PAKKXB-03A-01R,RNA,TARGET-10-PAKKXB-03A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000463,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Pilot Phase 1,TARGET-10-PAKKXB,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Induction Failure AML (AML-IF),SRR457642,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",14.5479452054794,BALL-NOS,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",B-cell Acute Lymphoblastic Leukemia,"NOS,n=71/TARGET"
SRR457643,RNA-Seq,GCA_000001405.13,150,PRJNA89519,SAMN00260961,BCCAGSC,PCR,sra,SRX060113,0,Illumina Genome Analyzer IIx,PAIRED,cDNA,TRANSCRIPTOMIC,HS1534,2012-05-29,12113,6215,ILLUMINA,,2012-05-29,SRR457643,,SRS189993,SRP011998,TARGET-10-PAKYEP-03A-01R,RNA,TARGET-10-PAKYEP-03A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000463,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Pilot Phase 1,TARGET-10-PAKYEP,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Induction Failure AML (AML-IF),SRR457643,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",2.70684931506849,BALL-NOS,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",B-cell Acute Lymphoblastic Leukemia,"NOS,n=71/TARGET"
SRR457644,RNA-Seq,GCA_000001405.13,150,PRJNA89519,SAMN00752715,BCCAGSC,PCR,sra,SRX060114,0,Illumina Genome Analyzer IIx,PAIRED,cDNA,TRANSCRIPTOMIC,HS1535,2012-05-29,7582,4142,ILLUMINA,,2012-05-29,SRR457644,,SRS270494,SRP011998,TARGET-10-PALIBN-09A-01R,RNA,TARGET-10-PALIBN-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000463,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Pilot Phase 1,TARGET-10-PALIBN,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Induction Failure AML (AML-IF),SRR457644,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",14.3095890410958,BALL-NOS,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",B-cell Acute Lymphoblastic Leukemia,"NOS,n=71/TARGET"
SRR457645,RNA-Seq,GCA_000001405.13,150,PRJNA89519,SAMN00752718,BCCAGSC,PCR,sra,SRX060115,0,Illumina Genome Analyzer IIx,PAIRED,cDNA,TRANSCRIPTOMIC,HS1536,2012-05-29,7602,4132,ILLUMINA,,2012-05-29,SRR457645,,SRS270497,SRP011998,TARGET-10-PALJDL-09A-01R,RNA,TARGET-10-PALJDL-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000463,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Pilot Phase 1,TARGET-10-PALJDL,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Induction Failure AML (AML-IF),SRR457645,"Indeterminate : T vs B-Precursor,n=1",3.1972602739726,Indeterminate : T vs B-Precursor,"Indeterminate : T vs B-Precursor,n=1",T-cell Acute Lymphoblastic Leukemia,"NOS,n=1/TARGET"
SRR457646,RNA-Seq,GCA_000001405.13,150,PRJNA89519,SAMN00260964,BCCAGSC,PCR,sra,SRX060116,0,Illumina Genome Analyzer IIx,PAIRED,cDNA,TRANSCRIPTOMIC,HS1537,2012-05-29,10969,5940,ILLUMINA,,2012-05-29,SRR457646,,SRS189996,SRP011998,TARGET-10-PALETF-03A-01R,RNA,TARGET-10-PALETF-03A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000463,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Pilot Phase 1,TARGET-10-PALETF,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Induction Failure AML (AML-IF),SRR457646,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",7.63287671232876,BALL-NOS,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",B-cell Acute Lymphoblastic Leukemia,"NOS,n=71/TARGET"
SRR457653,RNA-Seq,GCA_000001405.13,150,PRJNA89519,SAMN00752722,BCCAGSC,PCR,sra,SRX060123,0,Illumina Genome Analyzer IIx,PAIRED,cDNA,TRANSCRIPTOMIC,HS1576,2012-05-29,9808,5194,ILLUMINA,,2012-05-29,SRR457653,,SRS270501,SRP011998,TARGET-10-PAMDRM-09A-01R,RNA,TARGET-10-PAMDRM-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000463,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Pilot Phase 1,TARGET-10-PAMDRM,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Induction Failure AML (AML-IF),SRR457653,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",7.87671232876712,BALL-NOS,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",B-cell Acute Lymphoblastic Leukemia,"NOS,n=71/TARGET"
SRR457655,RNA-Seq,GCA_000001405.13,145,PRJNA89519,SAMN00260954,BCCAGSC,PCR,sra,SRX060125,0,Illumina Genome Analyzer IIx,PAIRED,cDNA,TRANSCRIPTOMIC,HS1584,2012-05-29,9580,5191,ILLUMINA,,2012-05-29,SRR457655,,SRS189986,SRP011998,TARGET-10-PAKKCA-03A-01R,RNA,TARGET-10-PAKKCA-03A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000463,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Pilot Phase 1,TARGET-10-PAKKCA,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Induction Failure AML (AML-IF),SRR457655,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",11.6520547945205,BALL-NOS,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",B-cell Acute Lymphoblastic Leukemia,"NOS,n=71/TARGET"
SRR5115241,RNA-Seq,,150,PRJNA89529,SAMN05784792,BCCAGSC,PCR,sra,SRX2430610,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,A59343,2017-08-09,15757,7700,ILLUMINA,179043.0,2016-12-16,SRR5115241,2016-05-03T19:19:31Z,SRS1868081,SRP011999,TARGET-10-PAPHYN-09B-01R,RNA,TARGET-10-PAPHYN-09B-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-10-PAPHYN,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Acute lymphoblastic leukemia (ALL),SRR5115241,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",5.6958904109589,BALL-NOS,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",B-cell Acute Lymphoblastic Leukemia,"NOS,n=71/TARGET"
SRR527438,RNA-Seq,,202,PRJNA89519,SAMN01093638,STJUDE,PCR,sra,SRX171000,0,Illumina Genome Analyzer IIx,PAIRED,RANDOM PCR,TRANSCRIPTOMIC,SJBALL265,2012-07-26,8863,6255,ILLUMINA,,2012-07-26,SRR527438,,SRS352131,SRP011998,TARGET-10-PANNGL-09A-01R,RNA,TARGET-10-PANNGL-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000463,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Pilot Phase 1,TARGET-10-PANNGL,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Induction Failure AML (AML-IF),SRR527438,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",12.8602739726027,BALL-NOS,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",B-cell Acute Lymphoblastic Leukemia,"NOS,n=71/TARGET"
SRR527439,RNA-Seq,,202,PRJNA89519,SAMN01093636,STJUDE,PCR,sra,SRX171001,0,Illumina Genome Analyzer IIx,PAIRED,RANDOM PCR,TRANSCRIPTOMIC,SJBALL266,2012-07-26,8229,5806,ILLUMINA,,2012-07-26,SRR527439,,SRS352132,SRP011998,TARGET-10-PANSFD-09A-01R,RNA,TARGET-10-PANSFD-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000463,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Pilot Phase 1,TARGET-10-PANSFD,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Induction Failure AML (AML-IF),SRR527439,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",5.44383561643835,BALL-NOS,"B-cell Acute Lymphoblastic Leukemia, NOS,n=71",B-cell Acute Lymphoblastic Leukemia,"NOS,n=71/TARGET"
SRR527440,RNA-Seq,,202,PRJNA89519,SAMN01093637,STJUDE,PCR,sra,SRX171002,0,Illumina Genome Analyzer IIx,PAIRED,RANDOM PCR,TRANSCRIPTOMIC,SJBALL269,2012-07-26,15380,10789,ILLUMINA,,2012-07-26,SRR527440,,SRS352133,SRP011998,TARGET-10-PANEHF-09A-01R,RNA,TARGET-10-PANEHF-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000463,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Pilot Phase 1,TARGET-10-PANEHF,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Induction Failure AML (AML-IF),SRR527440,"B-cell Acute Lymphoblastic Leukemia, BCR-ABL1 like,n=1",15.6575342465753,BALL-BCRABL1L,"B-cell Acute Lymphoblastic Leukemia, BCR-ABL1 like,n=1",B-cell Acute Lymphoblastic Leukemia,"BCR-ABL1 like,n=1/TARGET"
SRR6010932,RNA-Seq,GCA_000001405.13,198,PRJNA89529,SAMN07444928,STJUDE-PHS000464,PCR,sra,SRX3164818,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,SJMPAL003414_D2,2017-09-18,10937,5102,ILLUMINA,,2017-09-18,SRR6010932,,SRS2623305,SRP011999,TARGET-15-SJMPAL003414-04A-01R,RNA,TARGET-15-SJMPAL003414-04A-01R,Recurrent Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-15-SJMPAL003414,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Induction Failure AML (AML-IF),SRR6010932,"Acute Leukemias of Ambiguous Lineage,n=106",5.32328767123287,ALAL,"Acute Leukemias of Ambiguous Lineage,n=106",Acute Leukemias of Ambiguous Lineage,"NOS,n=106/TARGET"
SRR6010933,RNA-Seq,GCA_000001405.13,202,PRJNA89529,SAMN07444855,STJUDE-PHS000464,PCR,sra,SRX3164819,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,SJMPAL004013_D1,2017-09-18,9506,4303,ILLUMINA,,2017-09-18,SRR6010933,,SRS2495542,SRP011999,TARGET-15-SJMPAL004013-04A-01R,RNA,TARGET-15-SJMPAL004013-04A-01R,Recurrent Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-15-SJMPAL004013,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Induction Failure AML (AML-IF),SRR6010933,"Acute Leukemias of Ambiguous Lineage,n=106",1.76712328767123,ALAL,"Acute Leukemias of Ambiguous Lineage,n=106",Acute Leukemias of Ambiguous Lineage,"NOS,n=106/TARGET"
SRR6010934,RNA-Seq,GCA_000001405.13,197,PRJNA89529,SAMN07445031,STJUDE-PHS000464,PCR,sra,SRX3164820,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,SJMPAL005001_R4,2017-09-18,9902,4357,ILLUMINA,,2017-09-18,SRR6010934,,SRS2623306,SRP011999,TARGET-15-SJMPAL005001-04A-01R,RNA,TARGET-15-SJMPAL005001-04A-01R,Recurrent Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-15-SJMPAL005001,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Induction Failure AML (AML-IF),SRR6010934,"Acute Leukemias of Ambiguous Lineage,n=106",10.0465753424657,ALAL,"Acute Leukemias of Ambiguous Lineage,n=106",Acute Leukemias of Ambiguous Lineage,"NOS,n=106/TARGET"
SRR6010935,RNA-Seq,GCA_000001405.13,202,PRJNA89529,SAMN07444968,STJUDE-PHS000464,PCR,sra,SRX3164821,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,SJMPAL011911_D1,2017-09-18,14399,6553,ILLUMINA,,2017-09-18,SRR6010935,,SRS2623307,SRP011999,TARGET-15-SJMPAL011911-03A-01R,RNA,TARGET-15-SJMPAL011911-03A-01R,Primary Blood Derived Cancer - Peripheral Blood,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-15-SJMPAL011911,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Induction Failure AML (AML-IF),SRR6010935,"Acute Leukemias of Ambiguous Lineage,n=106",15.7013698630137,ALAL,"Acute Leukemias of Ambiguous Lineage,n=106",Acute Leukemias of Ambiguous Lineage,"NOS,n=106/TARGET"
SRR6010936,RNA-Seq,GCA_000001405.13,202,PRJNA89529,SAMN07445073,STJUDE-PHS000464,PCR,sra,SRX3164822,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,SJMPAL011911_D2,2017-09-18,10267,4701,ILLUMINA,,2017-09-18,SRR6010936,,SRS2495544,SRP011999,TARGET-15-SJMPAL011911-03A.1-01D,DNA,TARGET-15-SJMPAL011911-03A.1-01D,Primary Blood Derived Cancer - Peripheral Blood,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-15-SJMPAL011911,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Induction Failure AML (AML-IF),SRR6010936,"Acute Leukemias of Ambiguous Lineage,n=106",15.7013698630137,ALAL,"Acute Leukemias of Ambiguous Lineage,n=106",Acute Leukemias of Ambiguous Lineage,"NOS,n=106/TARGET"
SRR6010937,RNA-Seq,GCA_000001405.13,201,PRJNA89529,SAMN07444879,STJUDE-PHS000464,PCR,sra,SRX3164823,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,SJMPAL011912_D1,2017-09-18,14597,6992,ILLUMINA,,2017-09-18,SRR6010937,,SRS2495545,SRP011999,TARGET-15-SJMPAL011912-09A-01R,RNA,TARGET-15-SJMPAL011912-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-15-SJMPAL011912,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Induction Failure AML (AML-IF),SRR6010937,"Acute Leukemias of Ambiguous Lineage,n=106",12.0164383561643,ALAL,"Acute Leukemias of Ambiguous Lineage,n=106",Acute Leukemias of Ambiguous Lineage,"NOS,n=106/TARGET"
SRR6010938,RNA-Seq,GCA_000001405.13,201,PRJNA89529,SAMN07444978,STJUDE-PHS000464,PCR,sra,SRX3164824,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,SJMPAL011913_D1,2018-03-22,20079,9855,ILLUMINA,,2017-09-18,SRR6010938,,SRS2623309,SRP011999,TARGET-15-SJMPAL011913-09A-01R,RNA,TARGET-15-SJMPAL011913-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-15-SJMPAL011913,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Induction Failure AML (AML-IF),SRR6010938,"Acute Leukemias of Ambiguous Lineage,n=106",13.0136986301369,ALAL,"Acute Leukemias of Ambiguous Lineage,n=106",Acute Leukemias of Ambiguous Lineage,"NOS,n=106/TARGET"
SRR6010939,RNA-Seq,GCA_000001405.13,202,PRJNA89529,SAMN07444938,STJUDE-PHS000464,PCR,sra,SRX3164825,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,SJMPAL011914_D1,2017-09-18,23113,10919,ILLUMINA,,2017-09-18,SRR6010939,,SRS2495547,SRP011999,TARGET-15-SJMPAL011914-09A-01R,RNA,TARGET-15-SJMPAL011914-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-15-SJMPAL011914,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Induction Failure AML (AML-IF),SRR6010939,"Acute Leukemias of Ambiguous Lineage,n=106",7.15890410958904,ALAL,"Acute Leukemias of Ambiguous Lineage,n=106",Acute Leukemias of Ambiguous Lineage,"NOS,n=106/TARGET"
SRR6010940,RNA-Seq,GCA_000001405.13,202,PRJNA89529,SAMN07445091,STJUDE-PHS000464,PCR,sra,SRX3164826,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,SJMPAL011915_D1,2017-09-18,4910,2470,ILLUMINA,,2017-09-18,SRR6010940,,SRS2623308,SRP011999,TARGET-15-SJMPAL011915-09A-01R,RNA,TARGET-15-SJMPAL011915-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-15-SJMPAL011915,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Induction Failure AML (AML-IF),SRR6010940,"Acute Leukemias of Ambiguous Lineage,n=106",2.71232876712328,ALAL,"Acute Leukemias of Ambiguous Lineage,n=106",Acute Leukemias of Ambiguous Lineage,"NOS,n=106/TARGET"
SRR6010941,RNA-Seq,GCA_000001405.13,202,PRJNA89529,SAMN07445106,STJUDE-PHS000464,PCR,sra,SRX3164827,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,SJMPAL012417_D1,2017-09-18,12592,5890,ILLUMINA,,2017-09-18,SRR6010941,,SRS2623310,SRP011999,TARGET-15-SJMPAL012417-09A-01R,RNA,TARGET-15-SJMPAL012417-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-15-SJMPAL012417,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Induction Failure AML (AML-IF),SRR6010941,"Acute Leukemias of Ambiguous Lineage,n=106",11.2547945205479,ALAL,"Acute Leukemias of Ambiguous Lineage,n=106",Acute Leukemias of Ambiguous Lineage,"NOS,n=106/TARGET"
SRR6010942,RNA-Seq,GCA_000001405.13,202,PRJNA89529,SAMN07444887,STJUDE-PHS000464,PCR,sra,SRX3164828,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,SJMPAL012418_D1,2017-09-18,12685,5764,ILLUMINA,,2017-09-18,SRR6010942,,SRS2495550,SRP011999,TARGET-15-SJMPAL012418-09A-01R,RNA,TARGET-15-SJMPAL012418-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-15-SJMPAL012418,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Induction Failure AML (AML-IF),SRR6010942,"Acute Leukemias of Ambiguous Lineage, KMT2A rearrangement,n=2",16.2739726027397,ALAL-KMT2A,"Acute Leukemias of Ambiguous Lineage, KMT2A rearrangement,n=2",Acute Leukemias of Ambiguous Lineage,"KMT2A rearrangement,n=2/TARGET"
SRR6010943,RNA-Seq,GCA_000001405.13,202,PRJNA89529,SAMN07444907,STJUDE-PHS000464,PCR,sra,SRX3164829,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,SJMPAL012419_D1,2017-09-18,13406,6050,ILLUMINA,,2017-09-18,SRR6010943,,SRS2495551,SRP011999,TARGET-15-SJMPAL012419-09A-01R,RNA,TARGET-15-SJMPAL012419-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-15-SJMPAL012419,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Induction Failure AML (AML-IF),SRR6010943,"Acute Leukemias of Ambiguous Lineage,n=106",16.3643835616438,ALAL,"Acute Leukemias of Ambiguous Lineage,n=106",Acute Leukemias of Ambiguous Lineage,"NOS,n=106/TARGET"
SRR6010944,RNA-Seq,GCA_000001405.13,202,PRJNA89529,SAMN07444911,STJUDE-PHS000464,PCR,sra,SRX3164830,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,SJMPAL012420_D1,2017-09-18,6482,2951,ILLUMINA,,2017-09-18,SRR6010944,,SRS2495552,SRP011999,TARGET-15-SJMPAL012420-09A-01R,RNA,TARGET-15-SJMPAL012420-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-15-SJMPAL012420,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Induction Failure AML (AML-IF),SRR6010944,"Acute Leukemias of Ambiguous Lineage,n=106",2.74246575342465,ALAL,"Acute Leukemias of Ambiguous Lineage,n=106",Acute Leukemias of Ambiguous Lineage,"NOS,n=106/TARGET"
SRR6010945,RNA-Seq,GCA_000001405.13,202,PRJNA89529,SAMN07445063,STJUDE-PHS000464,PCR,sra,SRX3164831,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,SJMPAL012422_D1,2017-09-18,9380,4382,ILLUMINA,,2017-09-18,SRR6010945,,SRS2495553,SRP011999,TARGET-15-SJMPAL012422-09A-01R,RNA,TARGET-15-SJMPAL012422-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-15-SJMPAL012422,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Induction Failure AML (AML-IF),SRR6010945,"Acute Leukemias of Ambiguous Lineage,n=106",6.9917808219178,ALAL,"Acute Leukemias of Ambiguous Lineage,n=106",Acute Leukemias of Ambiguous Lineage,"NOS,n=106/TARGET"
SRR6010946,RNA-Seq,GCA_000001405.13,202,PRJNA89529,SAMN07444898,STJUDE-PHS000464,PCR,sra,SRX3164832,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,SJMPAL012425_D1,2017-09-18,7963,3622,ILLUMINA,,2017-09-18,SRR6010946,,SRS2495554,SRP011999,TARGET-15-SJMPAL012425-09A-01R,RNA,TARGET-15-SJMPAL012425-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-15-SJMPAL012425,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Induction Failure AML (AML-IF),SRR6010946,"Acute Leukemias of Ambiguous Lineage,n=106",13.9808219178082,ALAL,"Acute Leukemias of Ambiguous Lineage,n=106",Acute Leukemias of Ambiguous Lineage,"NOS,n=106/TARGET"
SRR6010947,RNA-Seq,GCA_000001405.13,202,PRJNA89529,SAMN07444974,STJUDE-PHS000464,PCR,sra,SRX3164833,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,SJMPAL016340_D1,2017-09-18,9238,4281,ILLUMINA,,2017-09-18,SRR6010947,,SRS2623312,SRP011999,TARGET-15-SJMPAL016340-09A-01R,RNA,TARGET-15-SJMPAL016340-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-15-SJMPAL016340,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Induction Failure AML (AML-IF),SRR6010947,"Acute Leukemias of Ambiguous Lineage,n=106",9.66575342465753,ALAL,"Acute Leukemias of Ambiguous Lineage,n=106",Acute Leukemias of Ambiguous Lineage,"NOS,n=106/TARGET"
SRR6010948,RNA-Seq,GCA_000001405.13,202,PRJNA89529,SAMN07445016,STJUDE-PHS000464,PCR,sra,SRX3164834,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,SJMPAL016341_D1,2017-09-18,8653,3866,ILLUMINA,,2017-09-18,SRR6010948,,SRS2623311,SRP011999,TARGET-15-PARWPU-09A-01R,RNA,TARGET-15-PARWPU-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-15-PARWPU,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Induction Failure AML (AML-IF),SRR6010948,"Acute Leukemias of Ambiguous Lineage,n=106",5.83287671232876,ALAL,"Acute Leukemias of Ambiguous Lineage,n=106",Acute Leukemias of Ambiguous Lineage,"NOS,n=106/TARGET"
SRR6010949,RNA-Seq,GCA_000001405.13,202,PRJNA89529,SAMN07445030,STJUDE-PHS000464,PCR,sra,SRX3164835,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,SJMPAL016342_D1,2017-09-18,4166,1885,ILLUMINA,,2017-09-18,SRR6010949,,SRS2495557,SRP011999,TARGET-15-SJMPAL016342-09A-01R,RNA,TARGET-15-SJMPAL016342-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-15-SJMPAL016342,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Induction Failure AML (AML-IF),SRR6010949,"INFANT_Acute Leukemias of Ambiguous Lineage,n=4",0.917808219178082,ALAL_INFANT,"INFANT_Acute Leukemias of Ambiguous Lineage,n=4",Acute Leukemias of Ambiguous Lineage,"INFANT,n=4/TARGET"
SRR6010950,RNA-Seq,GCA_000001405.13,202,PRJNA89529,SAMN07445019,STJUDE-PHS000464,PCR,sra,SRX3164836,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,SJMPAL016343_D1,2017-09-18,9018,4202,ILLUMINA,,2017-09-18,SRR6010950,,SRS2495558,SRP011999,TARGET-15-SJMPAL016343-09A-01R,RNA,TARGET-15-SJMPAL016343-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-15-SJMPAL016343,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Induction Failure AML (AML-IF),SRR6010950,"Acute Leukemias of Ambiguous Lineage,n=106",3.28219178082191,ALAL,"Acute Leukemias of Ambiguous Lineage,n=106",Acute Leukemias of Ambiguous Lineage,"NOS,n=106/TARGET"
SRR6010951,RNA-Seq,GCA_000001405.13,197,PRJNA89529,SAMN07444832,STJUDE-PHS000464,PCR,sra,SRX3164837,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,SJMPAL016344_D1,2017-09-18,10641,4695,ILLUMINA,,2017-09-18,SRR6010951,,SRS2623313,SRP011999,TARGET-15-SJMPAL016344-09A-01R,RNA,TARGET-15-SJMPAL016344-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-15-SJMPAL016344,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Induction Failure AML (AML-IF),SRR6010951,"Acute Leukemias of Ambiguous Lineage,n=106",5.58082191780821,ALAL,"Acute Leukemias of Ambiguous Lineage,n=106",Acute Leukemias of Ambiguous Lineage,"NOS,n=106/TARGET"
SRR6010952,RNA-Seq,GCA_000001405.13,200,PRJNA89529,SAMN07445025,STJUDE-PHS000464,PCR,sra,SRX3164838,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,SJMPAL016447_D1,2017-09-18,7247,1732,ILLUMINA,,2017-09-18,SRR6010952,,SRS2623315,SRP011999,TARGET-15-SJMPAL016447-09A-01R,RNA,TARGET-15-SJMPAL016447-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-15-SJMPAL016447,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Induction Failure AML (AML-IF),SRR6010952,"Acute Leukemias of Ambiguous Lineage,n=106",9.0,ALAL,"Acute Leukemias of Ambiguous Lineage,n=106",Acute Leukemias of Ambiguous Lineage,"NOS,n=106/TARGET"
SRR6010953,RNA-Seq,GCA_000001405.13,198,PRJNA89529,SAMN07445104,STJUDE-PHS000464,PCR,sra,SRX3164839,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,SJMPAL016448_D1,2017-09-18,11348,5098,ILLUMINA,,2017-09-18,SRR6010953,,SRS2623314,SRP011999,TARGET-15-SJMPAL016448-09A-01R,RNA,TARGET-15-SJMPAL016448-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-15-SJMPAL016448,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Induction Failure AML (AML-IF),SRR6010953,"Acute Leukemias of Ambiguous Lineage,n=106",14.4986301369863,ALAL,"Acute Leukemias of Ambiguous Lineage,n=106",Acute Leukemias of Ambiguous Lineage,"NOS,n=106/TARGET"
SRR6010954,RNA-Seq,GCA_000001405.13,199,PRJNA89529,SAMN07445022,STJUDE-PHS000464,PCR,sra,SRX3164840,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,SJMPAL017973_D1,2017-09-18,8451,4224,ILLUMINA,,2017-09-18,SRR6010954,,SRS2495562,SRP011999,TARGET-15-SJMPAL017973-09A-01R,RNA,TARGET-15-SJMPAL017973-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-15-SJMPAL017973,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Induction Failure AML (AML-IF),SRR6010954,"Acute Leukemias of Ambiguous Lineage, BCR-ABL1,n=2",15.4986301369863,ALAL-BCRABL1,"Acute Leukemias of Ambiguous Lineage, BCR-ABL1,n=2",Acute Leukemias of Ambiguous Lineage,"BCR-ABL1,n=2/TARGET"
SRR6010955,RNA-Seq,GCA_000001405.13,202,PRJNA89529,SAMN07444988,STJUDE-PHS000464,PCR,sra,SRX3164841,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,SJMPAL017975_D1,2017-09-18,12176,6060,ILLUMINA,,2017-09-18,SRR6010955,,SRS2495563,SRP011999,TARGET-15-SJMPAL017975-03A-01R,RNA,TARGET-15-SJMPAL017975-03A-01R,Primary Blood Derived Cancer - Peripheral Blood,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-15-SJMPAL017975,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Induction Failure AML (AML-IF),SRR6010955,"Acute Leukemias of Ambiguous Lineage,n=106",17.8821917808219,ALAL,"Acute Leukemias of Ambiguous Lineage,n=106",Acute Leukemias of Ambiguous Lineage,"NOS,n=106/TARGET"
SRR6010956,RNA-Seq,GCA_000001405.13,198,PRJNA89529,SAMN07444894,STJUDE-PHS000464,PCR,sra,SRX3164842,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,SJMPAL017977_D1,2017-09-18,13739,5403,ILLUMINA,,2017-09-18,SRR6010956,,SRS2495564,SRP011999,TARGET-15-SJMPAL017977-09A-01R,RNA,TARGET-15-SJMPAL017977-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-15-SJMPAL017977,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Induction Failure AML (AML-IF),SRR6010956,"INFANT_Acute Leukemias of Ambiguous Lineage, KMT2A rearrangement,n=7",0.147945205479452,ALAL-KMT2A_INFANT,"INFANT_Acute Leukemias of Ambiguous Lineage, KMT2A rearrangement,n=7",Acute Leukemias of Ambiguous Lineage,"INFANT,KMT2A rearrangement,n=7/TARGET"
SRR6010957,RNA-Seq,GCA_000001405.13,198,PRJNA89529,SAMN07444964,STJUDE-PHS000464,PCR,sra,SRX3164843,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,SJMPAL017978_D1,2017-09-18,11784,5981,ILLUMINA,,2017-09-18,SRR6010957,,SRS2495565,SRP011999,TARGET-15-SJMPAL017978-09A-01R,RNA,TARGET-15-SJMPAL017978-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-15-SJMPAL017978,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Induction Failure AML (AML-IF),SRR6010957,"Acute Leukemias of Ambiguous Lineage,n=106",2.0,ALAL,"Acute Leukemias of Ambiguous Lineage,n=106",Acute Leukemias of Ambiguous Lineage,"NOS,n=106/TARGET"
SRR6010958,RNA-Seq,GCA_000001405.13,197,PRJNA89529,SAMN07444839,STJUDE-PHS000464,PCR,sra,SRX3164844,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,SJMPAL017981_D1,2017-09-18,9995,5062,ILLUMINA,,2017-09-18,SRR6010958,,SRS2495566,SRP011999,TARGET-15-SJMPAL017981-03A-01R,RNA,TARGET-15-SJMPAL017981-03A-01R,Primary Blood Derived Cancer - Peripheral Blood,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-15-SJMPAL017981,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Induction Failure AML (AML-IF),SRR6010958,"INFANT_Acute Leukemias of Ambiguous Lineage, KMT2A rearrangement,n=7",0.504109589041095,ALAL-KMT2A_INFANT,"INFANT_Acute Leukemias of Ambiguous Lineage, KMT2A rearrangement,n=7",Acute Leukemias of Ambiguous Lineage,"INFANT,KMT2A rearrangement,n=7/TARGET"
SRR6010959,RNA-Seq,GCA_000001405.13,202,PRJNA89529,SAMN07444983,STJUDE-PHS000464,PCR,sra,SRX3164845,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,SJMPAL022667_D1,2017-09-18,17628,8100,ILLUMINA,,2017-09-18,SRR6010959,,SRS2495568,SRP011999,TARGET-15-SJMPAL022667-09A-01R,RNA,TARGET-15-SJMPAL022667-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-15-SJMPAL022667,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Induction Failure AML (AML-IF),SRR6010959,"Acute Leukemias of Ambiguous Lineage,n=106",16.2821917808219,ALAL,"Acute Leukemias of Ambiguous Lineage,n=106",Acute Leukemias of Ambiguous Lineage,"NOS,n=106/TARGET"
SRR6010960,RNA-Seq,GCA_000001405.13,198,PRJNA89529,SAMN07444829,STJUDE-PHS000464,PCR,sra,SRX3164846,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,SJMPAL040024_D1,2017-09-18,11042,5528,ILLUMINA,,2017-09-18,SRR6010960,,SRS2495569,SRP011999,TARGET-15-SJMPAL040024-09A-01R,RNA,TARGET-15-SJMPAL040024-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-15-SJMPAL040024,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Induction Failure AML (AML-IF),SRR6010960,"Acute Leukemias of Ambiguous Lineage,n=106",1.00273972602739,ALAL,"Acute Leukemias of Ambiguous Lineage,n=106",Acute Leukemias of Ambiguous Lineage,"NOS,n=106/TARGET"
SRR6010961,RNA-Seq,GCA_000001405.13,199,PRJNA89529,SAMN07444835,STJUDE-PHS000464,PCR,sra,SRX3164847,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,SJMPAL040025_D1,2017-09-18,9049,4472,ILLUMINA,,2017-09-18,SRR6010961,,SRS2495567,SRP011999,TARGET-15-SJMPAL040025-09A-01R,RNA,TARGET-15-SJMPAL040025-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-15-SJMPAL040025,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Induction Failure AML (AML-IF),SRR6010961,"Acute Leukemias of Ambiguous Lineage,n=106",9.0931506849315,ALAL,"Acute Leukemias of Ambiguous Lineage,n=106",Acute Leukemias of Ambiguous Lineage,"NOS,n=106/TARGET"
SRR6010962,RNA-Seq,GCA_000001405.13,199,PRJNA89529,SAMN07445064,STJUDE-PHS000464,PCR,sra,SRX3164848,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,SJMPAL040026_D1,2017-09-18,9070,4446,ILLUMINA,,2017-09-18,SRR6010962,,SRS2495572,SRP011999,TARGET-15-SJMPAL040026-09A-01R,RNA,TARGET-15-SJMPAL040026-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-15-SJMPAL040026,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Induction Failure AML (AML-IF),SRR6010962,"INFANT_Acute Leukemias of Ambiguous Lineage, KMT2A rearrangement,n=7",0.498630136986301,ALAL-KMT2A_INFANT,"INFANT_Acute Leukemias of Ambiguous Lineage, KMT2A rearrangement,n=7",Acute Leukemias of Ambiguous Lineage,"INFANT,KMT2A rearrangement,n=7/TARGET"
SRR6010963,RNA-Seq,GCA_000001405.13,198,PRJNA89529,SAMN07445086,STJUDE-PHS000464,PCR,sra,SRX3164849,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,SJMPAL040027_D1,2017-09-18,7217,3570,ILLUMINA,,2017-09-18,SRR6010963,,SRS2495570,SRP011999,TARGET-15-SJMPAL040027-09A-01R,RNA,TARGET-15-SJMPAL040027-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-15-SJMPAL040027,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Induction Failure AML (AML-IF),SRR6010963,"Acute Leukemias of Ambiguous Lineage,n=106",15.4986301369863,ALAL,"Acute Leukemias of Ambiguous Lineage,n=106",Acute Leukemias of Ambiguous Lineage,"NOS,n=106/TARGET"
SRR6010964,RNA-Seq,GCA_000001405.13,202,PRJNA89529,SAMN07445088,STJUDE-PHS000464,PCR,sra,SRX3164850,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,SJMPAL040028_D1,2017-09-18,7776,3808,ILLUMINA,,2017-09-18,SRR6010964,,SRS2495571,SRP011999,TARGET-15-SJMPAL040028-04A-01R,RNA,TARGET-15-SJMPAL040028-04A-01R,Recurrent Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-15-SJMPAL040028,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Induction Failure AML (AML-IF),SRR6010964,"Acute Leukemias of Ambiguous Lineage,n=106",17.1643835616438,ALAL,"Acute Leukemias of Ambiguous Lineage,n=106",Acute Leukemias of Ambiguous Lineage,"NOS,n=106/TARGET"
SRR6010965,RNA-Seq,GCA_000001405.13,202,PRJNA89529,SAMN07444991,STJUDE-PHS000464,PCR,sra,SRX3164851,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,SJMPAL040030_D1,2017-09-18,10422,5041,ILLUMINA,,2017-09-18,SRR6010965,,SRS2495573,SRP011999,TARGET-15-SJMPAL040030-09A-01R,RNA,TARGET-15-SJMPAL040030-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-15-SJMPAL040030,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Induction Failure AML (AML-IF),SRR6010965,"Acute Leukemias of Ambiguous Lineage,n=106",13.5095890410958,ALAL,"Acute Leukemias of Ambiguous Lineage,n=106",Acute Leukemias of Ambiguous Lineage,"NOS,n=106/TARGET"
SRR6010966,RNA-Seq,GCA_000001405.13,202,PRJNA89529,SAMN07444868,STJUDE-PHS000464,PCR,sra,SRX3164852,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,SJMPAL040031_D1,2017-09-18,9744,4819,ILLUMINA,,2017-09-18,SRR6010966,,SRS2495574,SRP011999,TARGET-15-SJMPAL040031-09A-01R,RNA,TARGET-15-SJMPAL040031-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-15-SJMPAL040031,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Induction Failure AML (AML-IF),SRR6010966,"Acute Leukemias of Ambiguous Lineage,n=106",2.88767123287671,ALAL,"Acute Leukemias of Ambiguous Lineage,n=106",Acute Leukemias of Ambiguous Lineage,"NOS,n=106/TARGET"
SRR6010967,RNA-Seq,GCA_000001405.13,202,PRJNA89529,SAMN07444990,STJUDE-PHS000464,PCR,sra,SRX3164853,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,SJMPAL040033_D1,2017-09-18,16687,5969,ILLUMINA,,2017-09-18,SRR6010967,,SRS2495575,SRP011999,TARGET-15-SJMPAL040033-09A-01R,RNA,TARGET-15-SJMPAL040033-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-15-SJMPAL040033,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Induction Failure AML (AML-IF),SRR6010967,"Acute Leukemias of Ambiguous Lineage,n=106",14.3616438356164,ALAL,"Acute Leukemias of Ambiguous Lineage,n=106",Acute Leukemias of Ambiguous Lineage,"NOS,n=106/TARGET"
SRR6010968,RNA-Seq,GCA_000001405.13,198,PRJNA89529,SAMN07444908,STJUDE-PHS000464,PCR,sra,SRX3164854,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,SJMPAL040034_D1,2017-09-18,10067,4987,ILLUMINA,,2017-09-18,SRR6010968,,SRS2495576,SRP011999,TARGET-15-SJMPAL040034-09A-01R,RNA,TARGET-15-SJMPAL040034-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-15-SJMPAL040034,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Induction Failure AML (AML-IF),SRR6010968,"Acute Leukemias of Ambiguous Lineage,n=106",7.08219178082191,ALAL,"Acute Leukemias of Ambiguous Lineage,n=106",Acute Leukemias of Ambiguous Lineage,"NOS,n=106/TARGET"
SRR6010969,RNA-Seq,GCA_000001405.13,202,PRJNA89529,SAMN07444878,STJUDE-PHS000464,PCR,sra,SRX3164855,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,SJMPAL040035_D1,2017-09-18,7417,3428,ILLUMINA,,2017-09-18,SRR6010969,,SRS2495577,SRP011999,TARGET-15-SJMPAL040035-03A-01R,RNA,TARGET-15-SJMPAL040035-03A-01R,Primary Blood Derived Cancer - Peripheral Blood,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-15-SJMPAL040035,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Induction Failure AML (AML-IF),SRR6010969,"INFANT_Acute Leukemias of Ambiguous Lineage, KMT2A rearrangement,n=7",0.915068493150685,ALAL-KMT2A_INFANT,"INFANT_Acute Leukemias of Ambiguous Lineage, KMT2A rearrangement,n=7",Acute Leukemias of Ambiguous Lineage,"INFANT,KMT2A rearrangement,n=7/TARGET"
SRR6010970,RNA-Seq,GCA_000001405.13,197,PRJNA89529,SAMN07445103,STJUDE-PHS000464,PCR,sra,SRX3164856,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,SJMPAL040036_D1,2017-09-18,26306,8821,ILLUMINA,,2017-09-19,SRR6010970,,SRS2495578,SRP011999,TARGET-15-SJMPAL040036-03A-01R,RNA,TARGET-15-SJMPAL040036-03A-01R,Primary Blood Derived Cancer - Peripheral Blood,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-15-SJMPAL040036,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Induction Failure AML (AML-IF),SRR6010970,"Acute Leukemias of Ambiguous Lineage,n=106",5.43287671232876,ALAL,"Acute Leukemias of Ambiguous Lineage,n=106",Acute Leukemias of Ambiguous Lineage,"NOS,n=106/TARGET"
SRR6010971,RNA-Seq,GCA_000001405.13,202,PRJNA89529,SAMN07445034,STJUDE-PHS000464,PCR,sra,SRX3164857,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,SJMPAL040037_D1,2017-09-18,41135,10398,ILLUMINA,,2017-09-19,SRR6010971,,SRS2495579,SRP011999,TARGET-15-SJMPAL040037-09A-01R,RNA,TARGET-15-SJMPAL040037-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-15-SJMPAL040037,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Induction Failure AML (AML-IF),SRR6010971,"Acute Leukemias of Ambiguous Lineage,n=106",15.3260273972602,ALAL,"Acute Leukemias of Ambiguous Lineage,n=106",Acute Leukemias of Ambiguous Lineage,"NOS,n=106/TARGET"
SRR6010972,RNA-Seq,GCA_000001405.13,202,PRJNA89529,SAMN07445046,STJUDE-PHS000464,PCR,sra,SRX3164858,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,SJMPAL040038_D1,2017-09-18,6111,2790,ILLUMINA,,2017-09-18,SRR6010972,,SRS2495580,SRP011999,TARGET-15-SJMPAL040038-09A-01R,RNA,TARGET-15-SJMPAL040038-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-15-SJMPAL040038,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Induction Failure AML (AML-IF),SRR6010972,"Acute Leukemias of Ambiguous Lineage,n=106",2.5972602739726,ALAL,"Acute Leukemias of Ambiguous Lineage,n=106",Acute Leukemias of Ambiguous Lineage,"NOS,n=106/TARGET"
SRR6010973,RNA-Seq,GCA_000001405.13,202,PRJNA89529,SAMN07444945,STJUDE-PHS000464,PCR,sra,SRX3164859,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,SJMPAL040039_D1,2017-09-18,12266,5724,ILLUMINA,,2017-09-18,SRR6010973,,SRS2495581,SRP011999,TARGET-15-SJMPAL040039-09A-01R,RNA,TARGET-15-SJMPAL040039-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-15-SJMPAL040039,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Induction Failure AML (AML-IF),SRR6010973,"Acute Leukemias of Ambiguous Lineage,n=106",8.46301369863013,ALAL,"Acute Leukemias of Ambiguous Lineage,n=106",Acute Leukemias of Ambiguous Lineage,"NOS,n=106/TARGET"
SRR6010974,RNA-Seq,GCA_000001405.13,202,PRJNA89529,SAMN07445051,STJUDE-PHS000464,PCR,sra,SRX3164860,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,SJMPAL040459_D1,2017-09-18,6979,3356,ILLUMINA,,2017-09-18,SRR6010974,,SRS2495582,SRP011999,TARGET-15-SJMPAL040459-09A-01R,RNA,TARGET-15-SJMPAL040459-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-15-SJMPAL040459,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Induction Failure AML (AML-IF),SRR6010974,"Acute Leukemias of Ambiguous Lineage,n=106",7.03835616438356,ALAL,"Acute Leukemias of Ambiguous Lineage,n=106",Acute Leukemias of Ambiguous Lineage,"NOS,n=106/TARGET"
SRR6010975,RNA-Seq,GCA_000001405.13,197,PRJNA89529,SAMN07444980,STJUDE-PHS000464,PCR,sra,SRX3164861,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,SJMPAL041117_D1,2017-09-18,26277,6665,ILLUMINA,,2017-09-19,SRR6010975,,SRS2495583,SRP011999,TARGET-15-SJMPAL041117-09A-01R,RNA,TARGET-15-SJMPAL041117-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-15-SJMPAL041117,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Induction Failure AML (AML-IF),SRR6010975,"Acute Leukemias of Ambiguous Lineage,n=106",15.131506849315,ALAL,"Acute Leukemias of Ambiguous Lineage,n=106",Acute Leukemias of Ambiguous Lineage,"NOS,n=106/TARGET"
SRR6010976,RNA-Seq,GCA_000001405.13,202,PRJNA89529,SAMN07444834,STJUDE-PHS000464,PCR,sra,SRX3164862,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,SJMPAL041118_D1,2017-09-18,21887,10382,ILLUMINA,,2017-09-18,SRR6010976,,SRS2495584,SRP011999,TARGET-15-SJMPAL041118-09A-01R,RNA,TARGET-15-SJMPAL041118-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-15-SJMPAL041118,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Induction Failure AML (AML-IF),SRR6010976,"Acute Leukemias of Ambiguous Lineage,n=106",9.02739726027397,ALAL,"Acute Leukemias of Ambiguous Lineage,n=106",Acute Leukemias of Ambiguous Lineage,"NOS,n=106/TARGET"
SRR6010977,RNA-Seq,GCA_000001405.13,199,PRJNA89529,SAMN07444999,STJUDE-PHS000464,PCR,sra,SRX3164863,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,SJMPAL041119_D1,2017-09-18,12156,5821,ILLUMINA,,2017-09-19,SRR6010977,,SRS2495585,SRP011999,TARGET-15-SJMPAL041119-09A-01R,RNA,TARGET-15-SJMPAL041119-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-15-SJMPAL041119,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Induction Failure AML (AML-IF),SRR6010977,"Acute Leukemias of Ambiguous Lineage,n=106",3.02739726027397,ALAL,"Acute Leukemias of Ambiguous Lineage,n=106",Acute Leukemias of Ambiguous Lineage,"NOS,n=106/TARGET"
SRR6010978,RNA-Seq,GCA_000001405.13,201,PRJNA89529,SAMN07444849,STJUDE-PHS000464,PCR,sra,SRX3164864,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,SJMPAL041120_D1,2017-09-18,19230,6308,ILLUMINA,,2017-09-19,SRR6010978,,SRS2495586,SRP011999,TARGET-15-SJMPAL041120-09A-01R,RNA,TARGET-15-SJMPAL041120-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-15-SJMPAL041120,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Induction Failure AML (AML-IF),SRR6010978,"Acute Leukemias of Ambiguous Lineage,n=106",14.8136986301369,ALAL,"Acute Leukemias of Ambiguous Lineage,n=106",Acute Leukemias of Ambiguous Lineage,"NOS,n=106/TARGET"
SRR6010979,RNA-Seq,GCA_000001405.13,199,PRJNA89529,SAMN07444926,STJUDE-PHS000464,PCR,sra,SRX3164865,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,SJMPAL041122_D1,2017-09-18,12357,5938,ILLUMINA,,2017-09-18,SRR6010979,,SRS2495587,SRP011999,TARGET-15-SJMPAL041122-09A-01R,RNA,TARGET-15-SJMPAL041122-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-15-SJMPAL041122,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Induction Failure AML (AML-IF),SRR6010979,"Acute Leukemias of Ambiguous Lineage, KMT2A rearrangement,n=2",1.33150684931506,ALAL-KMT2A,"Acute Leukemias of Ambiguous Lineage, KMT2A rearrangement,n=2",Acute Leukemias of Ambiguous Lineage,"KMT2A rearrangement,n=2/TARGET"
SRR6010980,RNA-Seq,GCA_000001405.13,194,PRJNA89529,SAMN07444948,STJUDE-PHS000464,PCR,sra,SRX3164866,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,SJMPAL042787_D1,2017-09-18,9454,4722,ILLUMINA,,2017-09-19,SRR6010980,,SRS2495588,SRP011999,TARGET-15-SJMPAL042787-09A-01R,RNA,TARGET-15-SJMPAL042787-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-15-SJMPAL042787,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Induction Failure AML (AML-IF),SRR6010980,"Acute Leukemias of Ambiguous Lineage,n=106",13.5369863013698,ALAL,"Acute Leukemias of Ambiguous Lineage,n=106",Acute Leukemias of Ambiguous Lineage,"NOS,n=106/TARGET"
SRR6010981,RNA-Seq,GCA_000001405.13,194,PRJNA89529,SAMN07444844,STJUDE-PHS000464,PCR,sra,SRX3164867,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,SJMPAL042791_D1,2017-09-18,8100,3988,ILLUMINA,,2017-09-18,SRR6010981,,SRS2495589,SRP011999,TARGET-15-SJMPAL042791-09A-01R,RNA,TARGET-15-SJMPAL042791-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-15-SJMPAL042791,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Induction Failure AML (AML-IF),SRR6010981,"Acute Leukemias of Ambiguous Lineage,n=106",13.2164383561643,ALAL,"Acute Leukemias of Ambiguous Lineage,n=106",Acute Leukemias of Ambiguous Lineage,"NOS,n=106/TARGET"
SRR6010982,RNA-Seq,GCA_000001405.13,196,PRJNA89529,SAMN07444848,STJUDE-PHS000464,PCR,sra,SRX3164868,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,SJMPAL042792_D1,2017-09-18,8409,4032,ILLUMINA,,2017-09-19,SRR6010982,,SRS2495590,SRP011999,TARGET-15-SJMPAL042792-09A-01R,RNA,TARGET-15-SJMPAL042792-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-15-SJMPAL042792,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Induction Failure AML (AML-IF),SRR6010982,"Acute Leukemias of Ambiguous Lineage,n=106",4.18356164383561,ALAL,"Acute Leukemias of Ambiguous Lineage,n=106",Acute Leukemias of Ambiguous Lineage,"NOS,n=106/TARGET"
SRR6010983,RNA-Seq,GCA_000001405.13,194,PRJNA89529,SAMN07445075,STJUDE-PHS000464,PCR,sra,SRX3164869,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,SJMPAL042793_D1,2017-09-18,8007,3926,ILLUMINA,,2017-09-19,SRR6010983,,SRS2495592,SRP011999,TARGET-15-SJMPAL042793-09A-01R,RNA,TARGET-15-SJMPAL042793-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-15-SJMPAL042793,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Induction Failure AML (AML-IF),SRR6010983,"Acute Leukemias of Ambiguous Lineage,n=106",4.81369863013698,ALAL,"Acute Leukemias of Ambiguous Lineage,n=106",Acute Leukemias of Ambiguous Lineage,"NOS,n=106/TARGET"
SRR6010984,RNA-Seq,GCA_000001405.13,193,PRJNA89529,SAMN07444883,STJUDE-PHS000464,PCR,sra,SRX3164870,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,SJMPAL042794_D1,2017-09-18,10223,4756,ILLUMINA,,2017-09-18,SRR6010984,,SRS2495591,SRP011999,TARGET-15-SJMPAL042794-09A-01R,RNA,TARGET-15-SJMPAL042794-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-15-SJMPAL042794,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Induction Failure AML (AML-IF),SRR6010984,"Acute Leukemias of Ambiguous Lineage,n=106",15.1808219178082,ALAL,"Acute Leukemias of Ambiguous Lineage,n=106",Acute Leukemias of Ambiguous Lineage,"NOS,n=106/TARGET"
SRR6010985,RNA-Seq,GCA_000001405.13,198,PRJNA89529,SAMN07445033,STJUDE-PHS000464,PCR,sra,SRX3164871,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,SJMPAL042796_D1,2017-09-18,12742,6132,ILLUMINA,,2017-09-18,SRR6010985,,SRS2623318,SRP011999,TARGET-15-SJMPAL042796-09A-01R,RNA,TARGET-15-SJMPAL042796-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-15-SJMPAL042796,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Induction Failure AML (AML-IF),SRR6010985,"Acute Leukemias of Ambiguous Lineage,n=106",3.9917808219178,ALAL,"Acute Leukemias of Ambiguous Lineage,n=106",Acute Leukemias of Ambiguous Lineage,"NOS,n=106/TARGET"
SRR6010986,RNA-Seq,GCA_000001405.13,198,PRJNA89529,SAMN07444920,STJUDE-PHS000464,PCR,sra,SRX3164872,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,SJMPAL042797_D1,2017-09-18,10285,4988,ILLUMINA,,2017-09-18,SRR6010986,,SRS2623316,SRP011999,TARGET-15-SJMPAL042797-09A-01R,RNA,TARGET-15-SJMPAL042797-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-15-SJMPAL042797,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Induction Failure AML (AML-IF),SRR6010986,"Acute Leukemias of Ambiguous Lineage,n=106",6.13150684931506,ALAL,"Acute Leukemias of Ambiguous Lineage,n=106",Acute Leukemias of Ambiguous Lineage,"NOS,n=106/TARGET"
SRR6010987,RNA-Seq,GCA_000001405.13,196,PRJNA89529,SAMN07444944,STJUDE-PHS000464,PCR,sra,SRX3164873,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,SJMPAL042798_D1,2017-09-18,6734,3311,ILLUMINA,,2017-09-18,SRR6010987,,SRS2623317,SRP011999,TARGET-15-SJMPAL042798-09A-01R,RNA,TARGET-15-SJMPAL042798-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-15-SJMPAL042798,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Induction Failure AML (AML-IF),SRR6010987,"Acute Leukemias of Ambiguous Lineage,n=106",4.7972602739726,ALAL,"Acute Leukemias of Ambiguous Lineage,n=106",Acute Leukemias of Ambiguous Lineage,"NOS,n=106/TARGET"
SRR6010988,RNA-Seq,GCA_000001405.13,198,PRJNA89529,SAMN07444860,STJUDE-PHS000464,PCR,sra,SRX3164874,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,SJMPAL042799_D1,2017-09-18,8144,3918,ILLUMINA,,2017-09-18,SRR6010988,,SRS2623319,SRP011999,TARGET-15-SJMPAL042799-09A-01R,RNA,TARGET-15-SJMPAL042799-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-15-SJMPAL042799,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Induction Failure AML (AML-IF),SRR6010988,"Acute Leukemias of Ambiguous Lineage,n=106",11.2054794520547,ALAL,"Acute Leukemias of Ambiguous Lineage,n=106",Acute Leukemias of Ambiguous Lineage,"NOS,n=106/TARGET"
SRR6010989,RNA-Seq,GCA_000001405.13,198,PRJNA89529,SAMN07444941,STJUDE-PHS000464,PCR,sra,SRX3164875,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,SJMPAL042801_D1,2017-09-18,15625,7539,ILLUMINA,,2017-09-19,SRR6010989,,SRS2623320,SRP011999,TARGET-15-SJMPAL042801-09A-01R,RNA,TARGET-15-SJMPAL042801-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-15-SJMPAL042801,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Induction Failure AML (AML-IF),SRR6010989,"Acute Leukemias of Ambiguous Lineage,n=106",5.37808219178082,ALAL,"Acute Leukemias of Ambiguous Lineage,n=106",Acute Leukemias of Ambiguous Lineage,"NOS,n=106/TARGET"
SRR6010990,RNA-Seq,GCA_000001405.13,192,PRJNA89529,SAMN07444959,STJUDE-PHS000464,PCR,sra,SRX3164876,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,SJMPAL042943_D1,2017-09-18,7773,3794,ILLUMINA,,2017-09-19,SRR6010990,,SRS2495598,SRP011999,TARGET-15-SJMPAL042943-09A-01R,RNA,TARGET-15-SJMPAL042943-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-15-SJMPAL042943,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Induction Failure AML (AML-IF),SRR6010990,"INFANT_Acute Leukemias of Ambiguous Lineage, KMT2A rearrangement,n=7",0.331506849315068,ALAL-KMT2A_INFANT,"INFANT_Acute Leukemias of Ambiguous Lineage, KMT2A rearrangement,n=7",Acute Leukemias of Ambiguous Lineage,"INFANT,KMT2A rearrangement,n=7/TARGET"
SRR6010991,RNA-Seq,GCA_000001405.13,195,PRJNA89529,SAMN07445058,STJUDE-PHS000464,PCR,sra,SRX3164877,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,SJMPAL042946_D1,2017-09-18,9553,4738,ILLUMINA,,2017-09-19,SRR6010991,,SRS2495600,SRP011999,TARGET-15-SJMPAL042946-09A-01R,RNA,TARGET-15-SJMPAL042946-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-15-SJMPAL042946,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Induction Failure AML (AML-IF),SRR6010991,"Acute Leukemias of Ambiguous Lineage,n=106",15.3095890410958,ALAL,"Acute Leukemias of Ambiguous Lineage,n=106",Acute Leukemias of Ambiguous Lineage,"NOS,n=106/TARGET"
SRR6010992,RNA-Seq,GCA_000001405.13,198,PRJNA89529,SAMN07444915,STJUDE-PHS000464,PCR,sra,SRX3164878,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,SJMPAL043509_D1,2017-09-18,9025,3935,ILLUMINA,,2017-09-19,SRR6010992,,SRS2623321,SRP011999,TARGET-15-SJMPAL043509-04A-01R,RNA,TARGET-15-SJMPAL043509-04A-01R,Recurrent Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-15-SJMPAL043509,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Induction Failure AML (AML-IF),SRR6010992,"Acute Leukemias of Ambiguous Lineage,n=106",8.21643835616438,ALAL,"Acute Leukemias of Ambiguous Lineage,n=106",Acute Leukemias of Ambiguous Lineage,"NOS,n=106/TARGET"
SRR6010993,RNA-Seq,GCA_000001405.13,198,PRJNA89529,SAMN07444823,STJUDE-PHS000464,PCR,sra,SRX3164879,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,SJMPAL043510_D1,2017-09-18,9645,4357,ILLUMINA,,2017-09-19,SRR6010993,,SRS2623322,SRP011999,TARGET-15-SJMPAL043510-09A-01R,RNA,TARGET-15-SJMPAL043510-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-15-SJMPAL043510,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Induction Failure AML (AML-IF),SRR6010993,"Acute Leukemias of Ambiguous Lineage,n=106",10.4876712328767,ALAL,"Acute Leukemias of Ambiguous Lineage,n=106",Acute Leukemias of Ambiguous Lineage,"NOS,n=106/TARGET"
SRR6010994,RNA-Seq,GCA_000001405.13,197,PRJNA89529,SAMN07444965,STJUDE-PHS000464,PCR,sra,SRX3164880,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,SJMPAL043514_D1,2017-09-18,8515,3776,ILLUMINA,,2017-09-18,SRR6010994,,SRS2623324,SRP011999,TARGET-15-SJMPAL043514-09A-01R,RNA,TARGET-15-SJMPAL043514-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-15-SJMPAL043514,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Induction Failure AML (AML-IF),SRR6010994,"Acute Leukemias of Ambiguous Lineage,n=106",4.8,ALAL,"Acute Leukemias of Ambiguous Lineage,n=106",Acute Leukemias of Ambiguous Lineage,"NOS,n=106/TARGET"
SRR6010995,RNA-Seq,GCA_000001405.13,200,PRJNA89529,SAMN07444947,STJUDE-PHS000464,PCR,sra,SRX3164881,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,SJMPAL043773_R1,2017-09-18,6652,1439,ILLUMINA,,2017-09-19,SRR6010995,,SRS2623323,SRP011999,TARGET-15-SJMPAL043773-40A-01R,RNA,TARGET-15-SJMPAL043773-40A-01R,Recurrent Blood Derived Cancer - Peripheral Blood,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-15-SJMPAL043773,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Induction Failure AML (AML-IF),SRR6010995,"Acute Leukemias of Ambiguous Lineage,n=106",7.51506849315068,ALAL,"Acute Leukemias of Ambiguous Lineage,n=106",Acute Leukemias of Ambiguous Lineage,"NOS,n=106/TARGET"
SRR6010996,RNA-Seq,GCA_000001405.13,198,PRJNA89529,SAMN07444998,STJUDE-PHS000464,PCR,sra,SRX3164882,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,SJMPAL044948_D1,2017-09-18,18647,3333,ILLUMINA,,2017-09-19,SRR6010996,,SRS2623325,SRP011999,TARGET-15-SJMPAL044948-09A-01R,RNA,TARGET-15-SJMPAL044948-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-15-SJMPAL044948,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Induction Failure AML (AML-IF),SRR6010996,"Acute Leukemias of Ambiguous Lineage,n=106",1.4986301369863,ALAL,"Acute Leukemias of Ambiguous Lineage,n=106",Acute Leukemias of Ambiguous Lineage,"NOS,n=106/TARGET"
SRR6010997,RNA-Seq,GCA_000001405.13,199,PRJNA89529,SAMN07444892,STJUDE-PHS000464,PCR,sra,SRX3164883,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,SJMPAL044949_D1,2017-09-19,24057,4096,ILLUMINA,,2017-09-19,SRR6010997,,SRS2623327,SRP011999,TARGET-15-SJMPAL044949-09A-01R,RNA,TARGET-15-SJMPAL044949-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-15-SJMPAL044949,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Induction Failure AML (AML-IF),SRR6010997,"Acute Leukemias of Ambiguous Lineage,n=106",12.2493150684931,ALAL,"Acute Leukemias of Ambiguous Lineage,n=106",Acute Leukemias of Ambiguous Lineage,"NOS,n=106/TARGET"
SRR6010998,RNA-Seq,GCA_000001405.13,197,PRJNA89529,SAMN07444924,STJUDE-PHS000464,PCR,sra,SRX3164884,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,SJMPAL044950_D1,2017-09-19,23563,4164,ILLUMINA,,2017-09-19,SRR6010998,,SRS2623326,SRP011999,TARGET-15-SJMPAL044950-09A-01R,RNA,TARGET-15-SJMPAL044950-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-15-SJMPAL044950,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Induction Failure AML (AML-IF),SRR6010998,"INFANT_Acute Leukemias of Ambiguous Lineage, KMT2A rearrangement,n=7",0.112328767123287,ALAL-KMT2A_INFANT,"INFANT_Acute Leukemias of Ambiguous Lineage, KMT2A rearrangement,n=7",Acute Leukemias of Ambiguous Lineage,"INFANT,KMT2A rearrangement,n=7/TARGET"
SRR6010999,RNA-Seq,GCA_000001405.13,200,PRJNA89529,SAMN07445012,STJUDE-PHS000464,PCR,sra,SRX3164885,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,SJMPAL044953_D1,2017-09-19,8883,2114,ILLUMINA,,2017-09-19,SRR6010999,,SRS2495607,SRP011999,TARGET-15-SJMPAL044953-09A-01R,RNA,TARGET-15-SJMPAL044953-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-15-SJMPAL044953,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Induction Failure AML (AML-IF),SRR6010999,"Acute Leukemias of Ambiguous Lineage,n=106",14.4438356164383,ALAL,"Acute Leukemias of Ambiguous Lineage,n=106",Acute Leukemias of Ambiguous Lineage,"NOS,n=106/TARGET"
SRR6011000,RNA-Seq,GCA_000001405.13,202,PRJNA89529,SAMN07445080,STJUDE-PHS000464,PCR,sra,SRX3164886,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,SJMPAL046466_D1,2017-09-19,5823,2673,ILLUMINA,,2017-09-19,SRR6011000,,SRS2623328,SRP011999,TARGET-15-SJMPAL046466-09A-01R,RNA,TARGET-15-SJMPAL046466-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-15-SJMPAL046466,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Induction Failure AML (AML-IF),SRR6011000,"Acute Leukemias of Ambiguous Lineage,n=106",2.33150684931506,ALAL,"Acute Leukemias of Ambiguous Lineage,n=106",Acute Leukemias of Ambiguous Lineage,"NOS,n=106/TARGET"
SRR6011001,RNA-Seq,GCA_000001405.13,199,PRJNA89529,SAMN07445090,STJUDE-PHS000464,PCR,sra,SRX3164887,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,SJMPAL046467_D1,2017-09-19,10174,5185,ILLUMINA,,2017-09-19,SRR6011001,,SRS2495609,SRP011999,TARGET-15-SJMPAL046467-09A-01R,RNA,TARGET-15-SJMPAL046467-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-15-SJMPAL046467,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Induction Failure AML (AML-IF),SRR6011001,"Acute Leukemias of Ambiguous Lineage,n=106",6.16438356164383,ALAL,"Acute Leukemias of Ambiguous Lineage,n=106",Acute Leukemias of Ambiguous Lineage,"NOS,n=106/TARGET"
SRR6011002,RNA-Seq,GCA_000001405.13,202,PRJNA89529,SAMN07445027,STJUDE-PHS000464,PCR,sra,SRX3164888,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,SJMPAL046468_D1,2017-09-19,8407,3810,ILLUMINA,,2017-09-19,SRR6011002,,SRS2623329,SRP011999,TARGET-15-SJMPAL046468-09A-01R,RNA,TARGET-15-SJMPAL046468-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-15-SJMPAL046468,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Induction Failure AML (AML-IF),SRR6011002,"Acute Leukemias of Ambiguous Lineage,n=106",15.9150684931506,ALAL,"Acute Leukemias of Ambiguous Lineage,n=106",Acute Leukemias of Ambiguous Lineage,"NOS,n=106/TARGET"
SRR6011003,RNA-Seq,GCA_000001405.13,199,PRJNA89529,SAMN07444899,STJUDE-PHS000464,PCR,sra,SRX3164889,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,SJMPAL046469_D1,2017-09-19,10662,4919,ILLUMINA,,2017-09-19,SRR6011003,,SRS2623330,SRP011999,TARGET-15-SJMPAL046469-09A-01R,RNA,TARGET-15-SJMPAL046469-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-15-SJMPAL046469,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Induction Failure AML (AML-IF),SRR6011003,"Acute Leukemias of Ambiguous Lineage,n=106",4.24931506849315,ALAL,"Acute Leukemias of Ambiguous Lineage,n=106",Acute Leukemias of Ambiguous Lineage,"NOS,n=106/TARGET"
SRR6011004,RNA-Seq,GCA_000001405.13,198,PRJNA89529,SAMN07444869,STJUDE-PHS000464,PCR,sra,SRX3164890,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,SJMPAL046470_D1,2017-09-19,10957,4674,ILLUMINA,,2017-09-19,SRR6011004,,SRS2623331,SRP011999,TARGET-15-SJMPAL046470-09A-01R,RNA,TARGET-15-SJMPAL046470-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,female,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-15-SJMPAL046470,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Induction Failure AML (AML-IF),SRR6011004,"Acute Leukemias of Ambiguous Lineage,n=106",12.6657534246575,ALAL,"Acute Leukemias of Ambiguous Lineage,n=106",Acute Leukemias of Ambiguous Lineage,"NOS,n=106/TARGET"
SRR6011005,RNA-Seq,GCA_000001405.13,202,PRJNA89529,SAMN07445006,STJUDE-PHS000464,PCR,sra,SRX3164891,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,SJMPAL046471_D1,2017-09-18,9205,4233,ILLUMINA,,2017-09-19,SRR6011005,,SRS2623332,SRP011999,TARGET-15-SJMPAL046471-09A-01R,RNA,TARGET-15-SJMPAL046471-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-15-SJMPAL046471,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Induction Failure AML (AML-IF),SRR6011005,"Acute Leukemias of Ambiguous Lineage,n=106",2.0,ALAL,"Acute Leukemias of Ambiguous Lineage,n=106",Acute Leukemias of Ambiguous Lineage,"NOS,n=106/TARGET"
SRR6011006,RNA-Seq,GCA_000001405.13,202,PRJNA89529,SAMN07444891,STJUDE-PHS000464,PCR,sra,SRX3164892,0,Illumina HiSeq 2500,PAIRED,cDNA,TRANSCRIPTOMIC,SJMPAL046472_D1,2017-09-19,9673,4416,ILLUMINA,,2017-09-19,SRR6011006,,SRS2623333,SRP011999,TARGET-15-SJMPAL046472-09A-01R,RNA,TARGET-15-SJMPAL046472-09A-01R,Primary Blood Derived Cancer - Bone Marrow,phs000464,phs000218,ALL,Yes,male,TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2,TARGET-15-SJMPAL046472,ncbi,Homo sapiens,NCI_TARGET,Tumor vs. Matched-Normal,Induction Failure AML (AML-IF),SRR6011006,"Acute Leukemias of Ambiguous Lineage,n=106",16.6657534246575,ALAL,"Acute Leukemias of Ambiguous Lineage,n=106",Acute Leukemias of Ambiguous Lineage,"NOS,n=106/TARGET"
